<!DOCTYPE html><html dir=ltr lang=en><head><meta charset=utf-8><meta content="width=device-width, initial-scale=1, shrink-to-fit=no" name=viewport><meta content="New, high-quality SMLE questions for you" name=description><meta content="Internal Medicine" property=og:title><meta content=article property=og:type><meta content=https://cdn.jsdelivr.net/emojione/assets/3.1/png/128/1f469-1f3fc-2695.png property=og:image><title>Internal Medicine</title><link crossorigin=anonymous href=https://maxcdn.bootstrapcdn.com/bootstrap/4.0.0-beta.2/css/bootstrap.min.css integrity=sha384-PsH8R72JQ3SOdhVi3uxftmaW6Vc51MKb0q5P2rRUpPvrszuE4W1povHYgTpBfshb rel=stylesheet><link crossorigin=anonymous href=https://maxcdn.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css integrity=sha384-wvfXpqpZZVQGK6TAh5PVlGOfQNHSoD2xbE+QkPxCAFlNEevoEH3Sl0sibVcOQVnN rel=stylesheet><link href="https://fonts.googleapis.com/css?family=Roboto:400,700|Spectral+SC:700" rel=stylesheet><link href=https://cdn.jsdelivr.net/emojione/assets/3.1/png/128/1f469-1f3fc-2695.png rel=icon><style>body{font-family:'Roboto',sans-serif}h1{font-family:'Spectral SC',serif;font-weight:700;font-size:3.5rem}h1,.subtitle{text-align:center}h1{overflow-y:hidden;overflow-x:auto}.question-container+.question-container{border-top:1px solid #ededed}.explanation-text{background-color:#ededed}.question-number{-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none}#question-count,.question-number{color:#d21414}.subtitle{font-size:.8rem}.subtitle a{font-style:italic}.question-text{font-weight:bold;text-align:justify}ol li:hover{background-color:#ededed}@keyframes red-heart{0%{color:#d21414}75%{color:#d21414}100%{color:black}}.fa.fa-heart{color:#d21414;animation:red-heart 2s ease-in infinite alternate}#header-separator{text-align:center;color:#ededed}#header-separator:after{content:'\002665';display:inline-block;position:relative;top:-15px;padding:0 10px;background:white;color:#ededed;font-size:18px}</style></head> <body> <div class=container> <div class="row justify-content-center"> <div class="col col-md-8 col-lg-6"> <h1 class=mt-5>Internal Medicine</h1> <p class=subtitle><span id=question-count>170</span> new, high-quality questions for the <abbr title="Saudi Medical Licensing Exam">SMLE</abbr> <a href=index.html>(see all)</a></p> <hr id=header-separator> <div id=questions><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>1. </span> What is the diagnostic test of choice for a patient with hereditary spherocytosis? </p><ol class=mt-3 type=A><li>Schilling test</li><li>Acidified hemolysis test</li><li>Osmotic fragility test</li><li>Sugar water test</li></ol><button aria-controls=explanation-ZOQ aria-expanded=false class="btn btn-secondary" data-target=#explanation-ZOQ data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-ZOQ><p class=correct-answer><strong>Answer:</strong> C</p>Hereditary spherocytosis (HS)<br><br>1. Hereditary spherocytosis : Genetic defect of RBC membranes resulting in spherical RBCs.<br>2. HS is an autosomal dominant trait <br>3. It is the most common hereditary hemolytic anemia. <br>4. It is characterized by positive family history, splenomegaly, anemia, spherocytosis, jaundice and can cause cholecystitis due to pigmented gallstones. <br>5. Peripheral blood smear : Spherocytes<br>6. Diagnose with a peripheral smear and an osmotic fragility test.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>2. </span> A 24-year-old male patient presents to your clinic with an ulcer on his penis. Painless bilateral inguinal lymphadenopathy is present. Which of the following tests will most likely reveal a diagnosis? </p><ol class=mt-3 type=A><li>RPR</li><li>VDRL</li><li>FTA-Abs</li><li>Blood culture</li><li>Dark field microscopy</li></ol><button aria-controls=explanation-42K aria-expanded=false class="btn btn-secondary" data-target=#explanation-42K data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-42K><p class=correct-answer><strong>Answer:</strong> E</p>Syphilis is caused by the spirochete Treponema pallidum and is characterized by 3 sequential clinical, symptomatic stages separated by periods of asymptomatic latent infection. <br>Common manifestations include genital ulcers, skin lesions, meningitis, aortic disease, and neurologic syndromes. <br><br>Primary syphilis is the first stage after infection. Papules become painless ulcers with rolled edges (chancres) which appear 2–3 weeks after contact at the site of infection, most commonly the vulva, vagina, or cervix. Darkfield microscopy of lesion exudate is positive for the spirochete, but the nonspecific serologic tests VDRL or rapid plasma reagin [RPR] test) are not yet positive. Without treatment the chancre spontaneously disappears. <br><br>Diagnosis<br>1. The diagnosis of primary syphilis is best made via spirochete identification on dark field microscopy.<br>2. VDRL, RPR and FTA-Abs are tests looking for antibodies against syphilis. <br>3. Blood culture is never helpful for syphilis.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>3. </span> Which of the following is associated with recurrent oral and genital ulcers? </p><ol class=mt-3 type=A><li>Behcet’s disease</li><li>Fibromyalgia</li><li>Reactive arthritis</li><li>Sjogren syndrome</li></ol><button aria-controls=explanation-8CQ aria-expanded=false class="btn btn-secondary" data-target=#explanation-8CQ data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-8CQ><p class=correct-answer><strong>Answer:</strong> A</p>Behcet's disease<br><br>It is a multi-systemic inflammatory disease with an autoimmune etiology.<br><br>It is characterized by recurrent oral aphthae and any of several systemic manifestations including genital aphthae, ocular disease, skin lesions, gastrointestinal involvement, neurologic disease, vascular disease, or arthritis.<br><br>Most clinical manifestations of Behçet’s syndrome are believed to be due to <span style="text-decoration: underline;"><strong>vasculitis</strong></span>.<br><br>The international criteria for diagnosis includes: Recurrent oral ulcers plus <span style="text-decoration: underline;">two of the following</span> features: <br>1. Recurrent genital ulcers.<br>2. Eye lesions, including anterior uveitis and posterior uveitis.<br>3. Retinal vascularization.<br>4. Skin lesions including erythema nodosum (painful and nodular with areas of hyperpigmentation).<br>5. Positive pathergy test.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>4. </span> Which of the following is associated with crohn's disease? </p><ol class=mt-3 type=A><li>Fistula formation</li><li>Inflammation limited to the superficial layer of the bowel wall</li><li>Continuous mucosal areas of ulceration that affect the anus</li><li>Decreased risk of colon cancer</li></ol><button aria-controls=explanation-LZL aria-expanded=false class="btn btn-secondary" data-target=#explanation-LZL data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-LZL><p class=correct-answer><strong>Answer:</strong> A</p><img alt class=img-fluid height=581 src="data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wgARCAJFAtYDASIAAhEBAxEB/8QAGwABAAMAAwEAAAAAAAAAAAAAAAQFBgECAwf/xAAVAQEBAAAAAAAAAAAAAAAAAAAAAf/aAAwDAQACEAMQAAAB+i1D5+fQHz8fQHz8fQHz8fQHz8fQHz8fQHz8fQHz8fQHz8fQHz8fQHz8fQHz8fQHz8fQHz8fQHz8fQHz8fQHz8fQHz8fQHz8fQHz8fQHz8fQHz8fQHz8fQHz8fQHz8fQHz8fQHz8fQHz8fQHz8fQHz8fQHz8fQHz8fQHz8fQHz8fQHz8fQHz8fQHz8fQHz8fQHz8fQHz8fQHz8fQHz8fQHz8fQHz8fQHz8fYHgKb5/8AQPn4Ad70z659igaHxKRdTTML6vILVQiiXPiVjQRSpaGGVSynmeXcMgLLsVbTwilaPwKNayigXNMGlglQ0HQol5BILSQCqXHvFAlzap1vNM2u/czq8hletZBRNHnThaiqWvJUrG2Mwu+5QryOVbTeJn1lYGdXdIF15FU0ccpHpdlA1FcVDQ1JEAAB9ZBTfP8A6B8/ALH1qrkm8VPqW1pjfRNB4VVcuw8c96psqOp7L3savzS17V0VdpQ1vWLmJV2Nlvmu0KXT5iTMrWQM5yNZn4JpYNNybP5/Y1xoptdWJdy6Tus+t6STV42DYlpxU8kC+p+pbzstaEidReZKkwo5ae0GMX+WtaQ0KB5ln6w4xXbHPzT2kUfBooVPyWnao5NjnoUdLKkuqWXTxoXFnOqoa88byFGlte1RyWfn1rajAAA+sgpvn/0D5+AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAfWQU3z/wCgfPwAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAD6yCm+f/Q8OREsREsREsREsREsREsREsREsREsREsREsREsREsREsREsREsREsREsREsREsREsREsREsREsREsREsREsREsREsREsREsREsREsREsREsREsREsREsREsREsREsREsREsREsfTnI9okuIAAAAAAAAAAAAPH28T2PI9VF4mjV8Qu0COW6rmEhnZRcKjzLtWeRcKyOXaptgAAAAADx9vH2CDwT0GOWyj7lyzdoWCnhmkUssnszpTlnpRbquSS1HHNIqOxagAAng84kuIAAAAAAAAAAAAPH28T2yuq8D2+bayUZudZ9Kz8TbRzJ67vKSiymtmxCo9P5LI+fbmcV1BouT3tae4QFAAAAA8fbx9jM8XMZa/z9pSQ5XPMYu+uZFUnS+4Mja3nkmW0MPSrCpJEpKS2lVy9eLjmsvZTOZLcKABPBCqNH0M+0Az7QDPtAM+0Az7QDPtAM+0Az7QDPtAM+0Az7QDPtAM/56SMVDQDPtAM+0Az7QDPtAM+0Az7QDPtAM+0Az7QDPtAM+0Az7QDPtAM+0Az7QDN+lvJM+0Az7QDPtAM+0Az7QDPtAM+0Az7QDPtAM+0Az7QDPtAM+0Az7QDl3HZDoI1bEX9XCDELljNHJYKEt8zXtZfc5i0LMKAAAAAjyI5IK2LJiNBVuzHqaJmpCXqohy6Piszlm3UcoslF5y6FX2FAAAAAAAR5EeQGX8jWqjzLtl5xdKOOaQAAAAAAAAAAHjldgjAStqspa7VjBaa3S46do1mAk6jyM3a6IAoAAAACPIjkjr2RgrDWqwdzoxhbTTJMJ5fQC1eU36sBP1/J870ehJn7/kAoAAAAAEeRHkGXqd9wZLnWjK0X0cZ6h3469hAUAAAAAAAADy85IjcyBGSRHSBHSBGSRHSBGSRGSRGSRGSRGSRGSRGj2Mc4SRGSRGSRGSRGSRG5kCPxJEbmQIySIySIySIySIySIySIySIySK6RzII3MgRkkRkkR+JIjJIjJIjJIjJIjJIjJIjJIjJIjJIjJI6O48auRko3/GJ9DZc/PZ1bRihtOaqpkurHHTLdKxMo1jJw03DLVC/QGP7Gn98XKNUxekSwCo8iOSPD3gHn0rK82vGagJsPKi0CpXzuxNd6Yucahh7NNLCz/lLru+N7JsWEs7dR442Wab2x8VN2iylAAAjyI8grfSgrjfMr1NV55eCm8Y/0XQsNYG0Zaal2zSXTcYGXWt98VINZzlOE1jD3a3rJa2AoACL1mIyNrcjP+11wUnF6SFWaBbV0mvGanW5KDJfTBWQNEWg40CKDjQKppU/hOQqPIjkgFfU6YUdDuRT3HKMzYWyszJvRnLCzJm51sWl9LYUFTtUYuw0is10045AAABHkR5BV82aKmFo+Ch89Gsq6nVFy0+6GWtLUlFzeFzvvdjM02+RmPfQrM710haC/AAADy85IjJIjJIjJIj8SRGSRGSRGSRGSRGSRGSRGSRGSRGj2Mc4SRGSRGSRGSRGSRGSRGSRGSRGSRGSRGSRGSRGSRGSRGSRGSRXSOZBGSRGSRGSRGSRGSRGSRGSRGSRGSRGSRGSRGSRGSRGSR0dxFzmszkd7HCSa1fpVU6bH0wE1dl1yHCbuJV1C2NnVU6bXHyqZd93yHkmv9MT6rru+CspL32xPe3d+edrD6JG6eiSK2y6y5e8w95Wg4+cacv+mZqD6Fzmq02nXJRE1tzktaAoAAAAAAAEeRHkFHL8cjG+pYlRW588h5m6Y6Am65pKldlxlqo+kxPHHJuPTL+0t165mkr6J453saHnD+qbKVkJ5ogoADw7dDr34Hh7cjrx3Hh29RIh9+U56di8+fcdO3I4cjjp6Dz78o6duVevkjFijjrzyOnr1Hl35Hbx9Q8vTkSI4kI4kI4kI4kI4kI4kI4kI4kI4kI4SK6Sde/A8uvuO3Tng69+CefPoXz6+w9ovoOzqO3n2HTr6Do7jj06iQjiQjiQ6DuAAAAAAAAAAAABHkRyQAAAAAAAAAAAAAAACPIjyAAAAAAAAAAAAAAACFl9dnY9etdbWeHrB8zta1UteVfcnjaVHdNIFAAAAAAR5EckUN9Tx5ePtBsnVsb0W1iyaMvpWX1yV1bWXKyavv7krrGHf17wk5uabyXm9zdkkhHoFvfSNINMEBQI8iPIMZXaCBE/tGj2WddJhSzbTM6yyqprGOWnGZ1S1XWVwkv3z8lb6xz2hQFAAAAAcefSOkuOqRE7iQjiQjiQjiQjiQjiQjiQjiQjiQjiQjiRHRixRxIRxIRxIi9uDpMjCSjiQjiQjiQjiQjiRE7iQjiQjiQjiQjiQjhIrpJIRhJRxIRx5zIwko4kI4kI4kI4kI4kI4kI4kI4kI4kI4kOg7umdjSuvagHCjL0BERLFAAAAAAI8iOSCqi1UtvXdElwVlmBQrIsxQAAQVlnRElgBERLFAR5EeQFWLQAABWWYAARJYIhLAAAAABT+9jRRW0m19bMvW7+hl8aba8VQ1us6FFG13qmZiaiVLjthEtLPUKAAAAjyI5IzGniRnYuuhVnfXReBmom3h2U2vgekuJsbr0Mzzq+EoOb3hc3OtPBPGLpYy4mVoZJnedL7Jh7WwlGdia32MzE1EqWNbR5FkeRHkLko+qGBtrqcfPb2+6pibPS+65SNtIZjLDRUCQttG9DPwdjGXH3Oi8kothT3ACgAAAAAAAAAAAAAAAAI8iOSAAAAAAAAAAAAAAAAR5EeQDPmgYuMm94x1cv0LnHeabXrl+st9N+fSbNyxG3AUAAAAAAAAAAAAAAAAAAABHkRyQAAAAAAAAAAAAAAACPIjyBAniv8LcVOP8AoyKHm85qm5uBQ97slXZ8oC0AAAAAADy6SBHSBHSBHSBHSBHSBHSBHSBHSBHSBHSBHSBHSBHjWMcJAjpAjpAjpAjpAjpAjpAjpAjpAjpAjpAjpAjpAjpAjpAjpArpKQR0gR0gR0gR0gR0gR0gR0gR0gR0gR0gR0gR0gR0gR0gdHcQcvpMcaz2xNmdtBhL8vfDIWaXUnKcreR85altMxdwmkx20wS6uVUZw0Emrrk20KkirrrTD7hAVHkRz3pLuviJ41UCzUcx6Y1nfLzC34z3mt73y92mhrYVZLpvTIXFnW1z0aXVVdN4Vu4tNQybCxo+a62VFPJ/Wqzy/QecjrklhY8iPIKKyzsKNRxm4tW2j+d7wh98fYF9JxclNvX8UheRauCup9cjONR4VsVLvtidGes6l8Jb3zyNvVz743g1MvOTk0oUAACLX3SAKyzKAAAA86LQgABHkRyQAACtWSHTuM9oSgAAAAAAAKq1ACPIjyAV0WLN39nr4x+ZePTv7WRJgAoAAAAAAAAAAAAAAAAAAAAACPIjkgAAAAAAAAAAAAAAAEeRHkCHM8DE3N72jGwt1Gqg2MCwQFAAAAAAAAAA8ukgR0gR0gR0gR0gR0gR0gR0gR0gR0gR0gR0gR0gR41jHCQI6QI6QI6QI6QI6QI6QI6QI6QI6QI6QI6QI6QI6QI6QI6QK6SkEdIEZJEZJEZJEdIEdIEdIEdIEdIEdIEdIEdIEdIEdIHR3HCuwsfTGT8a2Sp4S3Y60W9UHmaNkfdNOzs0tVJ3lt+c372XqijrpWf0CAoCPIjkgz8aBjuLNkyPiu0YvUkpj7RL1QR40yhVfqHlb1DmQFAAAAAAR5EeQcMX4xuuc/4Wadi7YvlBRRvFH526DjO+iX7OyFulF0TQM9oQFAAAAAr6HW8xmKffc1nO2hJjdTJ4jL9NWrJeWz4M1KvBmYmxLiZ+nGaqtzzJRXjmgUBHkRyRCmjIc64fPNF73RjNRK5TE22gRmPLVjI1H0ZWQ8NsWJLEBQAAAAAI8iPIKOp2Qw3TeEy0LbDHcbEUnW+LiZ+nGWj7FGK6bdZjdmAKAAAAB5dJAjcyBHSBHSBHSBHSBHSBHSBHSBGSRHSBHSBHSBHjWMcJAjpAjcyBHSBHSBGSRHSBHSBHSBHSBHSBHSBHSBHSBHSBHSBXSUgjpAjcyBHSBHSBG5kCOkCOkCMkiOkCOkCOkCOkCOkCOkDo7jyq7DPRqWO8LNwx9ZL9EYCwrXc57QHIAAAAAAAEeRHJFdY5iLaxy/hWvZGTJpWViLtePn9lZrqzJyl1/ti56X/l8+0S6tivM3PGJuUvmNsF0MDITDZsrqkBQAI8iPIIEeBYxasgs18fESV1knCdU3zK6oBQAAAAAAAAPGrukZ2daKxVhpSUnN0lr7AsBQAAAAAAEeRHJECeiNWXgr/O0FNxc81ULD3jG3lrzVJ1vUUXrcKz86yRUetkKVdKoPS7ECeAAAEeRHkFfGuUZqzshnJttxVN62qKyzKAAAAAAAAAAAAAAAAAAAAAAAR5EckA8shqaUjz+LGTH2EibbR2fMqMxoonvZSSrT1W4AAAAAAAABHkR5AAAAAAAAAAAAAAAAQKg0zMjTMyNMzI0zMjTMyNMzI0zMjTMyNMzI0zMjTMyNMzI00eh6moZkaZmRpmZGmZkaZmRpmZGmZkaZmRpmZGmZkaZmRpmZGmZkaZmRpmZGmZkX0jL9jTMyNMzI0zMjTMyNMzI0zMjTMyNMzI0zMjTMyNMzI0zMjTMyNMzI0zxHsAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAD//EADIQAAICAgIBAwEHAwUBAQEAAAMEAAIBEwUUERIVMiQGECAwNEBQITE1FiIjM2AlNkH/2gAIAQEAAQUCcZoqP3lee8rz3lee8rz3lee8rz3lee8rz3lee8rz3lee8rz3lee8rz3lee8rz3lee8rz3lee8rz3lee8rz3lee8rz3lee8rz3lee8rz3lee8rz3lee8rz3lee8rz3lee8rz3lee8rz3lee8rz3lee8rz3lee8rz3lee8rz3lee8rz3lee8rz3lee8rz3lee8rz3lee8rz3lee8rz3lee8rz3lee8rz3lee8rz3lee8rz3lee8rz3lee8rz3lee8rz3lee8rz3lee8rz3lee8rz3lee8rz3lee8rz3lee8rz3lee8rz3lee8rz3leCvsH9oP0f/mUv0f2g/R/+ZS/R/aD9H99a5va6yi+VlaFmFQHFxiVGqccnhg41aW5Kiapycelg97g9Dlk0+yoli7aitLgZqr6MqgXG4rgOOTQwtXkF6rFSW7N6KqsRJYRKM9aJLdixsKa7qpihEL4ewsnYyqXqd49erLPGp0ai6mLYhVkwxhTS1ZDzyJBIxNcN1WevL8fWqCCvZuWiesK6/SY0+sy1MI9amOOssoICa4WXMKrHGuoPqs1XxjkF6rFMljBiLojJn+5V61QuvXHHtr1CFNXBaHwt6GFkl7pLhNCKgurxilWc6giZZWSBUaguuytkTl0xe5MUSp9wVR4W0CMfrJ7gJ//AECY9N2Vl12CrJCF1qe34UAFdmoq3/El+j+0H6P7+OzjDvKYzh8H+7hOD/oZImnjz4wpMY8faDtLLGGPOOO5Kn11tOW+IvYjqbtlqsjXInzv6lj/AG8Oa2CN83+o4v8A3KcNjOX1b1jFxkvx/wDu46ZquQiRbX5cNLd6mcZ5zjDAu1x+c1V/2kWnLx7+mXzXX5YOV+SiFq046uKNOYxizoDERY9K7qorjHw5rVuTjf8AnU5bPojJRDV4bOMv3sMfHqPZAJ8Icq81/wB/JXsIwDg5ApqazMf4cv8AheT/AEtf93BzlDBobiM1wN7NRICF6ON5sf8Azcr8D/4alanuhfJeWeMG1pyH+7juFzjD9qW71s4zzxv+7m/+5/8Ax+P8GHkPAuUXGC/4kv0f2g/R/gxyJfSJsojFeJcXYt1TtkNXuky5e3qu0zdjPbvp7hO2N242F3SBGy2RjAniUGwwRi52iFYbZu0QBrgJfkC5qFiwhQBrgIZ25KGaIWx2rmP7kaLs3AZViyxRMWEMDZAgmOTLjFzkufvF7JOQLairl16Y5G+LjJahcPlwY7xSjA9cIWT78rHsuYxLGLXkb4HRy9GVmrgwF4ghsskYyPkTUpls2Wc8kXxF3SAo00RmV5G+BjcIMx27GpnkyWlGr0g2r0XaZuxm7N7rMMWPi7FrLDbJRVctgGJyFr1i7ZAVM1ctvcjQLNxMGdsWjTFmbFYsUPYv1a8iXFTmucn4kv0f2g/R/wDmUv0f2g/R/wDmUv0f2g/R/wDmUv0f2g/R/wDmUv0f2g/R/wDmUv0fOUtdTrnnXPOuedc86551zzrnnXPOuedc86551zzrnnXPOuedc86551zzrnnXPOuedc86551zzrnnXPOuadc86551zzrnnXPOuedc86551zzrnnXPOuedc86551zzrnnXPOuedc86551zzrnnXPOuedc86551zzrnnXPOuedc86551zzrnnXPOuedc86551zzrnnXPOuedc86551zzrnnXPOuedc86551zzrnnXPOuedc86551zzrnnXPOuedc8654njwoX4/ui/H+AL8f3tfiX4/ui/GFvUQwclQxc8uLGTOAEuvyQTGC1QrFnxYyB4R0ly4ODHKjzCciCqLb417n5EYF02+1PcA+4OOjVyTkRjTTd7N/wA0vxhmaBOZqgmVmaMWbfCte/I0Gms9ulOXDbDzdEwkfrVZblqMSvIitg7VAmry9L2//nuwc2bfEvdZ4LA1T1ZXzyNPSty1GCU5AGVVHcM3/FX4l+P7ovxn2i/TY/sM5xK5pQTvP/Afc93pt9OfKYuK/wAZwH6Q3j21tRjsvNXbUVy3WvY+ndVKUr7d2uKT73q/NL8Zyf8ATkn/AOvM8N/28X49y+0Xn28fe1UuUnEcmbHuX2fJ9Nwv+EyPNvs0tbt8xxPf9HNer2pD0dLivHuJP85wf+J4b/t4L4oq4c4tRlmjf4q/Evx/dF+MMKhhL8bQBRJCELPHhsmvxwglCrQTFkBZyZMRklxYACvEixCoAIkyhU5DcYAi1OOxUWVR5SvxtLUvxgLJqI9Yn5pfjG1RtiUQEsS3E0yVjjQnsTjaETX4/TbPHizx4laDZGrQbaylF1QK0CogkNEOOHpXPjzXHEhpZrjxMEXSEAa/E1XystReyi1FcV48dVlEBrk/FX4t3zQfYvOxedi87F52LzsXnYvOxedi87F52LzsXnYvOxedi87F52LzsXnYvOxedi87F52LzsXnYvOxeXPbOOxedi87F52LzsXnYvOxedi87F52LzsXnYvOxedi87F52LzsXnYvOxedi87F52LzsXnYvOxedi87F52LzsXnYvOxedi8ue2cdi87F52LzsXnYvOxedi87F52LzsXnYvOxedi87F52LzsXnYvOxedi87F52LzsXnYvOxedi87F52LzsXnYvBZ8jtXFpqHNQ5qHNQ5qHNQ5qHNQ5qHNQ5qHNQ5qHNQ5qHNQ5qHNQ5qHNQ5qHNQ5qHNQ5qHNQ4YdPRqHNQ5qHNQ5qHNQ5qHNQ5qHNQ5qHNQ5qHNQ5qHNQ5qHNQ5qHNQ5qHNQ5qHNQ5qHNQ5qHNQ5qHNQ5qHNQ4YdPRqHNQ5qHNQ5qHNQ5qHNQ5qHNQ5qHNQ5qHNQ5qHNQ5qHNQ5qHNQ5qHNQ5qHNQ5qHNQ5qHNQ5qHMf0/eH+H8Af4fvm7XqtxGo1SckUK13cUwqxVmh3qjLyb/AK1hZqBQfJDtfHIUuyu/WnHU5CprC5GlAKNUa/OP8I2thjHE+kfHCdrctOYBdX3QeCHewTjr8hQZhO0KqR3BlOPtm/H9kl1y8gMeaNju0TkgjF7oPYmzRof55/hOT9V31D9Y4XakNV+pCq8iQrmXxY48/IUGxjlgWr+1Jb0D8dnksgN7c4PN3ONGKo6Wuk51TVDygLM8excj9ER2qZYRgLDvk/KpBLUqg745b80/wlv7UUNf7PKDBc+QF/0q1S+eVZCXIgDvjl8YZCAYb7eOrmvHrALhKq+AXzTpchcR7ompbPM8bS1WPzz/AAnJrYZfMiTA1BgKxxhLqBBWw+Svu9kBS+OYyAv+m8f2/fMB3VVUovn88/w/gD/D99bOcTZaeu02Wmy09dpstNlpstNlpstNlpstNlpstNlpstNlpstNlpstNlpstNlpstNlpstDXt6NlpstNlpstPXabLTZabLT12nrtNlpstNlpstPXabLT12my02Wmy02Wmy02Wmy02Wmy02Wmy02Wmy02Wmy0Ne3o2WnrtNlpstNlp67T12my02Wmy02Wmy02Wmy02Wmy02Wmy02Wmy02Wmy02Wmy02Wmy02Wmy02WmP7fuz/D+AP8P3xL1HQHJKnv8AkdsPZ/JqSlr/AIj/AAhSVFQjgBj76/XznGMDvUlDloAQWBmyuYbAoS9RUxnz+AjAhXrnGcfgJeoxivUo/wAk/wAI04FXKzImafdn+kGSpafcwai4qnHY34qEpfP5nI/oBZs4my9YDARF99SuRMAHDbwHcIHB3Brckz1Uy3aSvwoyYZcIxnkjtsrisVumLNGROwV8KFiNE5b3IxAnaL7gVkvuZm7LMku0lcZHT4RN2E/vP8IyvViHQuMXJt9jhVWbuDGwxkNdmXAhqHCbmQcZVxrSVj18NtOy0V5qqtCMA5LjWSlYNb1rbmiOUZZ3ifPmVuy4dN1glHDXyapdfHZ5Bm/Ggregvxn+E5UmnkmCHEK5G6X9bdWEHDP3XYY6Isu3aG5Y3FMtXY4Yu3vidu0bkDkoRm7CgsEYVeGy9niTjITnO3cFSZcWcE0a3E1YOxdh1kC7hyDeVZLfkPxMj3AWFoW9pJoypfD9eP8AFll2RWEj6FCI+tJsFGV6olsRRbr3dpe/N243N12lNwxo+bl/5gDW9Lw0jgy4mVqNJFZyTjqFJVEtiLp6aJg6yn3n+H3MjPeX4z1qZS8NMK2EdVSwzynGehSomtVuNzcJEr7s8ZjrlW9btkT3LdPGeNElraApgdllGF41YSraXHkzxeOPv68cdelqcX6QfkH+EOttb5BbtpuK750C5guPqA4eO1iEt6HacXYYbcXmy+RVWY4RXVh1Xs4umQ4Ap37FeO8cSZO1jnSHUAs5a5G/GE9FkLYntlbLVQNZiyRSsfwJ/h/AH+H762M5mu012mu012mu012mu012mu012mu012mu012mu012mu012mu012mu012mu012mu012hqW9Gu012mu012mu012mu012mu012mu012mu012mu012mu012mu012mu012mu012mu012mu012mu012mu012hqW9Gu012mu012mu012mu012mu012mu012mu012mu012mu012mu012mu012mu012mu012mu012mu0x/b92f4fwB/h++Y261T8iZjjuQqdahs2bO6KolWcEXw2vmxjiDCnEGpGQDxKMgvdF/LrfZ8MVYDa5uXJal2QjsQwhTLS+MEOIUy0DEKwEMb5BdYoGNpxMBNntL+Yf4RrszjW2jL2aBWm4esZxFt2A5N2geoZxEvgw80swGuMsgqXs391/Zn+EdZIM473GLN64ulyFCBIYQplpfGMkri9SVtYbIC3qwC5bMBqXLIMFmGA5Lk4q3vetJ219e4fp9ddmWQVNZgNSmOEMKyAMx/X8fG/rRgF/pdzJNl+p7VwmcjMMI/wDS1NtuRyplcJ749HJ2vfhnOtkPB1xjHKf9rYhhsWuMcNyJsFilcGbEuLqp1wbkqAF7RdjblXxlR7/ua09wQBZ4BTObLH+Et/bP/wCPZyNa+f8AdxDI6B5dX6JzIR/6dKOgeTGUY+GGGhnuVPgyoc+eb/Zn+EfCsxgxb24xko782h0va1R5u4JcXVCTw0wT14Y0+2Ndb2030TnKsbk29nQP1vY1Q0vznPVxceAC/wBQ18DVuXF+d4Xr9APV9iPUgBsM4Mb7P2zbh/xVpWudItWB0xeqi9baR5xpFqMuA2LqL3l1gEvBrhFelK0lgitmw6WmgXouuG5KhHXOofioR1zpF6bLhvmy4bCqIdciXCHOkeB1xjGD/D7tAtJgiNXQHxmlbWGsAV9AteR0zaywLEwIeLXWBe+B0xf9mf4Qy4TzA6YGNYAp1F/Vmlck1D8XXCQVBUpBLAFeiwKEwsDBrKgteVXDUuKVxe463nors0i9A1wimVgZNlYOSkWAQhACJelKjr+G1q1xvFN4pvFN4pvFN4pvFN4pvFN4pvFN4pvFN4pvFN4pvFN4pvFN4pvFN4pvFN4pvFN4oYw813im8U3im8U3im8U3im8U3im8U3im8U3im8U3im8U3im8U3im8U3im8U3im8U3im8U3im8U3im8U3im8UMYea7xTeKbxTeKbxTeKbxTeKbxTeKbxTeKbxTeKbxTeKbxTeKbxTeKbxTeKbxTeKbxTeKbxTeKbxTGfOP3Z/h/AH+H8yf4fwB/h++bwTK3E9Pz7l5QvyBd1eUznHfNZlzkTWSu4Wtr8p6Fbciap/c8VVVIYlfzz/CcsW9BB4tQN1XyM3E4Tte7X0CevlqnJHLUHIVMwkz2qtuGWhCEpz1eTrhZgx78hZ8ts35LzfHJGtXs1K9jlS5XOY3paYq1TkWukrV0lWDOlATLWlinI39X4j/Cc5o7tfR0KtWGPHJVwGjpanceIZPjWvTVJntVI6S9uPv6UzOlAQj1/cLvXaWReIFQjpPXZklwpMYaX/MJm2B+hhtxZf1c2uAlGeof2dchx8ndA+ONJRirbKTJ1WAEvyVQlGbiVyAt+ef4TklrMhAw5a4VmaceqlfHIZTP7GwAl3uOI1QT61lOLTBhZV1BkwyDaFydkDmASrbLYqNp1XQuucC5a3UUPQg1DY4UypslXRYGp9ovPtlxsuMXQZuNhQ1rtLFut+I/wnIjN3LKMFFoYXPdA7FLUZdPUDgEuQGQPFJgwsqIbStl0z0BdBm4whJjlV1TV48yprcXbj9LLSpMm4Vciyf5y4Brj+4YRjJ+1P8PxgAMGMgFY/wCYwEbA/wAo/wAPx5AKx/21vV48Fngs8Fngs8Fngs8Fngs8Fngs8Fngs8Fngs8Fngs8Fngs8Fngs8Fngs8Fngs8FngsNgvp8Fngs8Fngs8Fngs8Fngs8Fngs8Fngs8Fngs8Fngs8Fngs8Fngs8Fngs8Fngs8Fngs8Fngs8Fngs8FngsNgvp8Fngs8Fngs8Fngs8Fngs8Fngs8Fngs8Fngs8Fngs8Fngs8Fngs8Fngs8Fngs8Fngs8Fngs8FmP7fuz/D+AP8P31rYrWjzB8Y/t+BV/ev91zDocRfWT88/wAJyLWVAdhmg8Z843U7EIz6HfwLs7mfyOPZ7akyamD/AH3MOpxF9ZPwH+EOzqbOzqb/ABDZ9b34ampY/wB1i+lj8vlqWvxiJBlToAbz/wDUy4kQe62834nIBp8qr/j0FwvTlc0KNpcLHKsEuGNLCRIuoJilxFZSSuMiv5Z/hOf89Tk6MU4nkQ5xbrrG51LPhFPPgpLV9ZxdbkMEpmEzX1gVA1yggma43YI1OSDVQIUma2VD/wAXF2EDPMXzqyEaXKJKL34JmhLDIusxzKi1COEzj/SeBUd5RtJa3LsEuGNLCRIuoJinFksXjof4TlqktyRRsU5dcLDqt16M8116ezYpR7kj+cpPJhw5VIBeXXvTo7SrKuJrrM1EZ6L2zgYVQe+iAI/EPGIGuugeR4lcLS/5d+KTuQ6Cx7dUOa4CPB3+PxYC6QF71SXqMvHrFMXjVC2OmA+KrixZdBZcg1xDxfjlrUpXFK/ln+EOEZ6nFQ4jILmsVQJSE45UhaKBpnHFp4z0F96S2Fg44tPGS8cqUhEgXD0l8rVRXwEaC46U49alCcaHK5hUMNZIC+ccUliHRXOQ6gT2EGgrZ4pPMZRXZuVIBa4WFiy6Cy5BriHgIqhFD/CXAO5bgHct+OVuXQPDHTB12EgHnTBpuAdy1DSp78etceEwgEBDNmTcesYoVcCZuqG7FuOUsXC4sEEmAWfb1t/8Kf4fwB/h+Vn+mFGKtLfxp/h/AH+H3c6S4+LMIo+Qs0ZRcOWBMlwa/CO3xfNWTNCbxZbH+9TkOOtcizBCrS21ev8AFn+H8Af4fc4vVtYi1bs5RDbK6mQ2aWwQN+OHYueND1LI1uBdKgr+2iwtjjxaSp0IP+LP8P4A/wAP31q+rGms01mms01mms01mms01mms01mms01mms01mms01mms01mms01mms01mms01mms01hhV9Gms01mms01mms01mms01mms01mms01mms01mms01mms01mms01mms01mms01mms01mms01mms01mms01hhV9Gms01mms01mms01mms01mms01mms01mms01mms01mms01mms01mms01mms01mms01mms01mmsxjxj92f4fwB/h++dvkalTNhXK+sIrLYVpTkL2XYbCvO2DKwOQWMUfJKEizgGc+6pRh7r8qd6uUWHALWyamhTkDGAXkVRXI0Aa4n9/KB5AWFFmgs1xyqfkjq4z/gP8JyzN1lsZuoBblQFTo7UzPuicZbCtFmgtYYdAAgz5y9jlU85LyKorjvUlDcgqAh3VwZWZE1Vh7r8sNwBALuAYhuUDZWp6ZPl5eo8cmpmLnGwJhyyLvHb7LMPLLEu+tQ1DjuVcw2B/cf4RsxB8icwwUE4AglnQM35PlQjVrbwGnKJ3zln0OU5JS92HAL2pepKZfWwdjkFlyMM2w8TkVKFO8uAi5xsiZdAtazq1ALOAZtyTWVjrOAZyB9c5bcgvm6rdbju2GmccmnmyrQWcTkf0AwYWX5Vqxg1LRbkTWxfjcmonytq21dgLPNolsr9nUibObRbXrwaY7D5Zn+i28aXK1tggh/8A57j8Y9yVzrREYbHOIY/o2O5G3G1zJtlqs9+A/wAI4UAgoVrt2DLwTX+bFjH+nBGqq7wl63LyZaLNs0IZlxtcyXH4x7l9nv8AErMhTEoG4mUv8w0Ya/P77Uit/XzHjGPsfc1FOZ+fH3xj/UPCzkB55NlYhXla1/8Av8q3Y6vL7FzKhquv9x/hOWMMHI8gyNgtSVEEJN3KkYDX7O3/AEVGAk+zzOM4dycLHBkz1uS44VAo8Q0FddZkSVlhEFcLAg8QoOw+W4r9Rg40uUtTPXJ/n+ZtWjO/B+RqxlhrjsY1CvgATFqazFceFv8AOfjPW9xgUvhn7uPW6an5Nv7dIxSfhP8AD8TI2L5SWwsOW/t0jFJ+xsr63fvP8PxEr6xpA6yjA9wFRaFv48/w/gD/AA+56xhrY5DeW2cVr2QenDIMjzemL/yJ/h/AH+H3NHosvxVLots4awoLIlOKADsm4kmX2v5E/wAP4A/w+4g6ExcdCS2MWrYIrCID0CSXqqD9ta1a43im8U3im8U3im8U3im8U3im8U3im8U3im8U3im8U3im8U3im8U3im8U3im8U3im8UMYea7xTeKbxTeKbxTeKbxTeKbxTeKbxTeKbxTeKbxTeKbxTeKbxTeKbxTeKbxTeKbxTeKbxTeKbxTeKbxTeKGMPNd4pvFN4pvFN4pvFN4pvFN4pvFN4pvFN4pvFN4pvFN4pvFN4pvFN4pvFN4pvFN4pvFN4pvFN4pjPnH7s/w/gD/D+ZP8P4A/w/fcj+gXqrgXcqvfliGJwq7W87TWRFcfLlDiQ4CoF0rFrPltnJqH5TPJE1k5C3ZRa7VDOX7JjNVrfk8agPeSLNmPPcbeij1yP/iP8JzNS2TH0c8aoT02LypKqmKSvOO8kf2texLDE910guX7S7hmch5TN5R0mCMOlXtZwmXCOE2qmqwD88/wn2kpYs5Y/d41cpvb78piqJz5ryPethfHIa5yDByzmb6uNK6SrteTr1CNnAph8msTd75E9bcq9coKv3xn8x2liKZTJRSoSjNZBjPHpLESZbCajxlGDhFXwBCrSdBUbTqBC4DjE6BJdO4ORQDcR8jYVeaXOZpRI4wHTuZ9Xs6VEMBwkC43fxH+EZuQdOsc16Jl9bmGl+DoAnup0jEWXte4ukx02l7l5Lj+0qMSJL8ckripWePZKLk1ysGKhrbWpgYPzz/CMhuTkUeOIK/UY0CQYqjyfH910ybJ1uhU6jFXWpzASMcdQJMcv0WPQ32XOO5JLJ8WVv01FCC5CiFy3STxS38Of4fgxxquz92f4fvrerx5LPJZ5LPJZ5LPJZ5LPJZ5LPJZ5LPJZ5LPJZ5LPJZ5LPJZ5LPJZ5LPJZ5LPJZ5LPJYbJfT5LPJZ5LPJZ5LPJZ5LPJZ5LPJZ5LPJZ5LPJZ5LPJZ5LPJZ5LPJZ5LPJZ5LPJZ5LPJZ5LPJZ5LPJZ5LPJYbJfT5LPJZ5LPJZ5LPJZ5LPJZ5LPJZ5LPJZ5LPJZ5LPJZ5LPJZ5LPJZ5LPJZ5LPJZ5LPJZ5LPJZ5LMf2/dn+H8Af4fviWqOizu+/7k/wjrVVArsWNn8jLg6mFfBRwl6ipc46G/G0xVan5B/hGmRqjWbyYn34LTyuajAf2xxVOFe7CJglJnhv+VhkFbuQLRrqMkbDxzdCpBQvY7X7I/wAJz/nqOsuLonpdAnGVIVpu1zcizi1DFsRU1sHouPN13K1NThL3z2xEIzluowjZtc/CExld4NSuJ0KV1nGWtPFEHcb1rifSJe3JLMGItyy+lGmLq8r+M/wjX+b5K2ace0UmOOXwQvK9jNGUF8V5JQxaLFaPqR7FXP2habKBQrQxOKFeDTHQrg6VYX47Ht10MEV5P15VRXqop+yP8I0vVmhxUOIPH0GVZeq8bToza6NSBogOtLIjyIy2NnHcZXKF0x2JfjxWFfj8WleNBheqVfXfjBWz1R4ZylX1KK0WjCNWLlQoRjHFgwplDFhXWrdr8Z/hG1RtDClrzjiRekao6EpxQqzCdcN+3i9uykHKay2Q5/jz/D8ihKXz+3P8P5k/w+6+fFV3rYfRZKR3ljFCHkPUZYtm/cu3cFSAZwstc63EFMTHKidaoiu2Xtfsj/D+ZP8AD7mQ4YXHx5d2Ei3ZZoa+PbPpBq2w7bjq3oADGMY423QEkXui4+uEVgNDt+yP8P5k/wAP4A/w/fN+vX9RPqJ9RPqJ9RPqJ9RPqJ9RPqJ9RPqJ9RPqJ9RPqJ9RPqJ9RPqJ9RPqJ9RPqJ9RPqJnB8z6ifUT6ifUT6ifUT6ifUT6ifUT6ifUT6ifUT6ifUT6ifUT6ifUT6ifUT6ifUT6ifUT6ifUT6ifUT6ifUTOD5n1E+on1E+on1E+on1E+on1E+on1E+on1E+on1E+on1E+on1E+on1E+on1E+on1E+on1E+on1EF51/+b//EABoRAAEFAQAAAAAAAAAAAAAAAAERMEFQgJD/2gAIAQMBAT8BzCrJ6OzRDfv/xAAdEQACAQQDAAAAAAAAAAAAAAABcBEQQEFgIDCA/9oACAECAQE/Ad/y4hyw2SgTYD1aLYdhqNYltQ0f/8QAShAAAgECAgYGBwYFAwMCBQUAAQIDABEEEhMhMTIzkiJBUZGh0QUUYXFyseEQI0BCQ4EgMFBSwSRic2B0slPwNGNkgsIVRIOi0v/aAAgBAQAGPwIPIGIvbVW5L3CtyXuFbkvcK3Je4VuS9wrcl7hW5L3CtyXuFbkvcK3Je4VuS9wrcl7hW5L3CtyXuFbkvcK3Je4VuS9wrcl7hW5L3CtyXuFbkvcK3Je4VuS9wrcl7hW5L3CtyXuFbkvcK3Je4VuS9wrcl7hW5L3CtyXuFbkvcK3Je4VuS9wrcl7hW5L3CtyXuFbkvcK3Je4VuS9wrcl7hW5L3CtyXuFbkvcK3Je4VuS9wrcl7hW5L3CtyXuFbkvcK3Je4VuS9wrcl7hW5L3CtyXuFbkvcK3Je4VuS9wrcl7hW5L3CtyXuFbkvcK3Je4VuS9wrcl7hW5L3CtyXuFbkvcK3Je4VuS9wrcl7hW5L3CtyXuFbkvcK3Je4VuS9wrcl7hW5L3CtyXuFbkvcK3Je4VuS9wrcl7hW5L3CtyXuFbkvcK3Je4VuS9wpXGxhek+P/B/6ag+BflSfH/g/wDTUHwL8qT4/wDB/gCrtOqhHiJJDJ15NgqWRnK4dPzW1mnbCPJmTWVfrqQuWFtlqdJbgJttRw5LZbn308UMkolH9+ypNMSqpq1dtaFv7ster6SYSe21qlhlJ6AO7TzzuViXVq20Gw8jk/2sKQ4t5M768qdVI8bZ4n2GleMsVOo3pFQnWubXRucqKLs1MmGkk0g2Z9hqdsRnGi/tpfVjKe3PRu2WNBdmo6F5c4/uG2ohK8wLrfVa1DDqb3139laASy6TZm/LengmuMo6q0bk2t1VNmZgV2WrE6XMGiXq+yIStMC63uLWqOMnMj2sw7KOHjY5RruacLNKHHaNRqWacyWQ/lpfVtKe3PWlu2ltmI9lNmbLGguxpjDLJnHUw20J5zLrbL0aHq+crb89RYiMsbmzXr1hy2ctZRULzNNeRb9G1MgMmitcdtSHCvJnQXs9HEYl2Ed7ALtNKcPIzX2hhspFQmxXNrrDxxE3lW+ujE00ocbTbVWrZUM4JzOSKSe5zlrVh3Um8i3N6eWVskKbTQOHaXNfY9BZGxF7X1WqdnLiOMXFttPNhXc5N4PTmUlUXs7akjxOkyrqGWkLNP01zDZWGkcv94+U2owLr16qTDKz2/MadVM+kGrXa1/s0+KdlQ7oXaajjwhc5tufqrQaWXSbM1ujevV5r+8Uw7DUayGXRlM2rbeo5GbEWk2bKOIBbNny1HJi3e8msBK+4cuntH8cHwL8qT4/8H+CEtszVLftvU4XaGualY7oTXTSf/OFOw2zSr3V/wC/7aleGOQzax0tlJeWOOSRtIS5tWHmWxD21ipmjjvik1i526qmd94oSaZCgkibapoYqJNHZta0jflKaqwytvFripMLJuyICvvqO/8A6YrGIN8rSW6r3r0i5XMl727dtXii0QtsvesWq732YdJkvJowVudVPpxlexUCkX82kqS3UlWjw2jax15r1jWXaLGpsSn6kWv3/Zhv+IV6PQ74tfwp5I9ur5U6tDo5bXzLWJLpnUEar1GsUWjU7Re9SXmiKsuTIG104Av+VgamkSLRSRi+rZSmWLSDSbL2omNMi/23vWIw3XbMtQ4Zdka6/fWE0sGlumrpWtTECwynVTy4KO2bovr1rWieNZIj1Go8TAuTObZai/4xWFZdTLGK0c+HAkP5lp0vfKbVhviP+ah/5KwXwU2X8r6/sCyYfSNk3s1YvOLrk1il9UQCCXaeuo10scTu2fpm1JMtiHG0VhP+OsN8fnWHxh2KhzftSudrEmpVXD5Xzb+b7MGy7oFjS36wbUV/NpP80lupdfdT++of+MVgvcaP/JSxYmESoNlRtFqVxex6v44PgX5Unx/4P8Kh0ikK7GdbmmkUi7bRbUaMYVI0O0ILXrQWGTNm9tRB7fd7LUMRZM/hRY7Sb0ucKMosAKijstozcGvWNQfwp5lVLuLEdVZAsbJ2MtBWsFGxVGqgjLHIo2Zxe1ZpDs2DspZjYOOyg8gUG1tVZ4zY0wVYo820otialjUC0gsb/ZnjNjTLo4VzbSq7ajY2BjFhahN0Vcda1fJFpP78uujKtmY/3VpEAv7alRQtpNtSRLYq/b9i/dQkqLAlddaVzd73ppxkzMLEW1UUVY4wduRbUyKkbK23MKDrDApHYtCQbwN6kfLH094W1Vo7JGnWEFq0Wjidb36QvQJSNLf2C1CRLX9tNI+81IhihYKLDMtGZUjDEWsBqpwoVlfaGoR5InQbAy0NJaw2AbBSqVjfLsLLsrTlvvKORIkJ/Mq6/syAK6f2uKGewUbAuykQxQsFFhmWmkTKM21baqyZIkW9+gtq6UMDe9amyqn3u0W2U8NlZG7eqlzhRlFgBSQMFyrsPXUYYDoDKLUkBC5VNxTQC2RqWRLZl7aYGDD9Lrya/sKDKyH8rC4pDZEybMgtar5ItJ/fl11ph0n/AN1MphhF+sLrpS4UWGXVUUbAZY9ler2XJfN7aUMkL22FlrPIbn+OD4F+VJ8f+D/01B8C/Kk+P/B/6ag+BflSfH/g/wDTUHwL8qT4/wDB/wCmoPgX5Unx/wCD/wBNQfAvypAiljn6h7DXBk5a4MnLXBk5a4MnLXBk5a4MnLXBk5a4MnLXBk5a4MnLXBk5a4MnLXBk5a4MnLXBk5a4MnLXBk5a4MnLXBk5a4MnLXBk5a4MnLXBk5a4MnLXBk5a4MnLXCk5a4MnLXBk5a4MnLXBk5a4MnLXBk5a4MnLXBk5a4MnLXBk5a4MnLXBk5a4MnLXBk5a4MnLXBk5a4MnLXBk5a4MnLXBk5a4MnLXBk5a4MnLXBk5a4MnLXBk5a4MnLXBk5a4MnLXBk5a4MnLXBk5a4MnLXBk5a4MnLXBk5a4MnLXBk5a4MnLXBk5a4MnLXBk5a4MnLXBk5a4MnLXBk5a4MnLXBk5a4MnLXBk5a4MnLXBk5a4MnLXBk5a4MnLXBk5a4MnLXBk5a4MnLXBk5a4MnLXBk5ahB25B8vxg+IfP+gj4h8/xw/GD4h8/sLyMFUbSaVY4cTlbZJo+jUn3OIKRtlaQJqFLOz/AHbbtuuhEUlhkbdWVMuap4VDZobXv7axYs/+mF2+lHFJmyAEkddRyrfK4zC9MVw+JZFNi4S4r1tSXi/20I8ssspF8kS5jaopWimOkbKEC9K/upv9PiIcv/qplvXqln0nb1e6lVg7yNsSNbk16y8UwW+XIVs1/dRX1bExWF7ypl/nD4h8/sgiYNmlJAtUELBs017ftUwQN90+Q3oRnO8pF9HGtzXrDwzqM2XKUs1PfDYmIKM15UtSO0U6RNqEjJ0a0sgYi9gF2mop0hnlWTYI1uRXQw2Kya+mU6PfWFOWQDEbpI2e+oImDF5TYWoiPCYxwGy5ljuPs+5ixEy3tnjjutaPLJJLa+jjXMakaPNePeQixFJMgOV9YvUpSGeTRyaMhFuayJhcXvZSxj1KfbUmIN0jRipzUVEOIj67yJa/8Y/GD4h8/sgzcLTLpPdWrZXpHRwBojM+aTNu/tXohM2aEIcp7TasLl4unXJXpD1L1faubS37PZXpv1jJpcgvk2btX/QxcFj7Hy1hf+MfKpf+Z/nXpMx8L1gZe8V63gnUS5crI+xqwMkaqs3rIWzbM1SHHer2GzRX/wA0MVoZ9J6xps+To22bfdUWLwcirMq26WxhTZkCTxzhGHVe9N656tl6tFf/AD/OHxD5/Z6NPVnb5V6Nt/vPhXpD/uDXpHPxs45equja+kW1/fU3rnq2XIbaK/8AmsJh5otHhZCF02a/X2VhYskkixgyMsa5j2CpYLMuhcgBhY26qb/76w8qb8NpB+xppxw4Ywq+866k9X9V0OmbfzZttYnJty1BotzILV6Sz8XOOXqrEaPZ6t0/fWG+GvSH/cGsZ/3L1PEWynTsQew3r1TGhCxXMkidf8Y/GD4h8/saOVQyNtBpWSfE5V2RmTo1PGMxWZizX9tR4aTMyJuknWKEpeWaQbrSvmtU8yls01r39lYs3f8A1Is30r1WS+jsB7ajiW+VBlF6YafE6NiWKZ7Dwr1UAxw/7Kz6bER9ojksDUUCmSJY2zKUOu9TRtisVIJFynPJe3ur1XXosmSolGIxKZFy3SS1xXqwzombNcHpX99Z/WsVLqtaWS4/nD4h8/syTDruCNoNaTNLLLa2eVsxtUkiYrFx6RsxEclhSuWlSVRl0iNZq9XeadhfNmL3amJxWKlDLltJJcUMGS+jGw9dSz5mZ3ABv7KlxCls0gAYdVGBC2TXt266GGFzGFy660cRYgm92202jxeMQE5rLJYVY6x7a+5lxESbciSWWtJmkiltbPG2U06Jmu+8xNyaTJi8ZlTYmk6PdUxQt96+c3qTRljpHLm/aaaFXlAZ89w1jejJmklltbPK2Y2/jFAjtrYK2CtgrYK2CtgrYK2CtgrYK2CtgrYK2CtgrYK2CtgrYK2CtgrYK2CtgrYK2Ctg2itgrYK2CtgrYK2CtgrYK2CtgrYK2CtgrYK2CtgrYK2CtgrYK2CtgrYK2CtgrYK2CtgrYK2CtgrYK2DaK2CtgrYK2CtgrYK2CtgrYK2CtgrYK2CtgrYK2CtgrYK2CtgrYK2CtgrYK2CtgrYK2CtgpT7K1gGtxe6txe6txe6txe6txe6txe6txe6txe6txe6txe6txe6txe6txe6txe6txe6txe6txe6txe6txe6txe6txe6txe6txe6txe6txe6txe6h0F3l6vbW4vdW4vdW4vdW4vdW4vdW4vdW4vdW4vdW4vdW4vdW4vdW4vdW4vdW4vdW4vdW4vdW4vdW4vdW4vdW4vdW4vdW4vdW4vdW4vdW4vdW4vdW4vdW4vdW4vdW4vdW4vdW4vdQ6C7y9XtrcXurcXurcXurcXurcXurcXurcXurcXurcXurcXurcXurcXurcXurcXurcXurcXurcXurcXurcXurcXurcXurcXurcXurcXurcXurcXurcXurcXurcXurV+MHxL8/6CPiX5/j5WhF5Qpyj20ky4uaWUDpq0nX8PVWZBJOfWDHcqBbXs21H91LpX1iIAZvKiyXGU5WVtqmjEkUszrrYRi+WsN6rpSk8gUsmo+730GcuqKLnSG5HvqMNFNGsmpHdbBqkw6JLnQ5WIXUurbWGkkaSZ5NS9HpOfdU0QSaKVEzHMuysGH0sskyZlsmtqeyujobMjjWP5w+Jfn9gvJMmX/03K1FjcTiMQxsb5pCRt7K0bxyxSZcwEg2imxAjm0KgEtl8KCGHEB2F4wU3/dWJljMkLxamuoLKfdQgyTSy5A9kXbRmjSVrGxQDpX7KxYUSRTRobq2ojVtrDsxJYxqST7q9GuJpGzz2Jtlvt6hT/dyuke+6DUtaBbltHpL9VqnkYPlhk0bav8A321ozDiBKdaIV1v7qLIGWxysrDWD+AHxL8/swEOklRHL5sjlb6qxqSTtJhobEO5zEHrF6ETRSxOwuukG9WWGGaRc2UyKvRvWJifDyBIzqNhq1deulxln0ZsbdeungEU0kqgNZB1UjhZTCxtpMvRU+38MzZWa3Uu01h5sPh5Yit9LI6ZLi2z21L9091xeky21kZqixeTFGFo8hEeZXXX2DXTtCky52udNfMe+sUXhlkSYh1aNc3VsrClo2zNjNMyjXkBvU0Me+w1VBAuHmjIdWcutgtvnXpAsjDNLq1bdQr0ZOYZG0KsroF6Qv12rFkRuv+mAAYWJ29Veic0bjJAwa67p1Vj2KsFbJY226v5w+Jfn9hqCPI4lQhsm6TZqziPG6RFNjPn1d9CLRPpco6GXXvdlYBgrZVD3NtmqvTNo3Oe2XVvdHqpnKtk9XUXt13rF6NJRmxZJyr0snaKx5SLE5Hw9lMtyW29tYdWBDCNbg+6vRgMT3TEXYZdg6VTx4mPHMGcsphZ8rA+6opUhlaDQaIZFzFbHrrHXgkVnxSsFtrt0awz5TkEbgtbV1VjiykBpri426h+AHxL8/swAki0kQL5tWrZWNwmHRhFdZYhsHtW/7UjaPHCRL2Mxey99Jg5oJs6HLmVLqde29Y1GjktPYq+Xo7vbQwfqs+mSwbo6tR2g9dYpypyGNADbV11LHon0mY9HLr3/AOgACWWKxvdDTsGd5H3nc3J/AD4l+f8AQR8S/P8AH6lLe6uE/h51wn8POuE/h51wn8POuE/h51wn8POuE/h51wn8POuE/h51wn8POuE/h51wn8POuE/h51wn8POuE/h51wn8POuE/h51wn8POuE/h51wn8POuE/h51wn8POuE/h51wn8POuE/h51wn8POh90+8OztrhP4edcJ/DzrhP4edcJ/DzrhP4edcJ/DzrhP4edcJ/DzrhP4edcJ/DzrhP4edcJ/DzrhP4edcJ/DzrhP4edcJ/DzrhP4edcJ/DzrhP4edcJ/DzrhP4edcJ/DzrhP4edcJ/DzrhP4edcJ/DzrhP4edcJ/DzrhP4edcJ/DzrhP4edcJ/DzofdPvDs7a4T+HnXCfw864T+HnXCfw864T+HnXCfw864T+HnXCfw864T+HnXCfw864T+HnXCfw864T+HnXCfw864T+HnXCfw864T+HnXCfw864T+HnXCfw864T+HnXCfw864T+HnXCfw864T+HnXCfw864T+HnXCfw864T+HnWz8YPiX5/0EfEvz/Hs76lUXNKiSdJ93MpW/uv8AyfV895ewAm3v/lMisC67RfZ/GPiX5/ZmkNlrSNIMubJ7z2U8+ciJDZiVIt+1XOygyMGU6wRTSSGyKLk04jJOTU2qhJC2ZD1/YXkYKo2k/wAOWRwpyltfZQI1g9f8LO+pVFzSyIbqwuP5Q+Jfn9iCZiC+6ApN+6i0D5gNR6rfwB42DKdhH2mWY5UG000Qb7xQCR/GwRgxU2Njs/m4n/jb5V6PhihlGTIzSMmUC3ZQKYszDShWj0XRGv8Au7f3rFWxLjoKd0bNeqvSWIaZpBHK/RIHSPbUH3ks2kNnU4cqF9oNqxk7TgJEZFRQg6qweKknDiQoGjyC2unlUXbYo9pqBpsRpkkcRsuQC1+yscWnZgJiCCBr1DXUOHgl0aNGzMct6x8TyZ5YY9IkmUbDWHiMymfEtvZNUYtrt208eIk06aIyq2Wx1bRqpMV6yLuVumQWUE9VSwxzCOGNVc9G591HERSS5r9GAQEqRf8AutWSSdsLEQuj6Fw/vNGKXEHDpcaMZBaT969JsFUldGF1dZ7TUDTYjTRyOI2XIBa/ZWNZMTk0MjKgyDXbtqGYixdQ38A+Jfn9keZmGRw+rrrCnBnM+HJIEn577axYdDFLHYSIerWKxE4e0ABRY7eJr0THC6ppkOboDs7KbA4uTTRsmkVrWOo7DamyfmYsffWCiVihlZ+kEzEAE9VYsQiScooaN3iKk9urVWLkXFes2X88Y6J9opoIZdCsSKWYKCSTUi5l9YixCxZramBqOCabTJKhI6IGUiiMRiCs2u+GKAW9x669JYvUeiUjuL6l+tQYeCYRI2HDk5Ae6sbI83+nwzHoBRdujsqCUSSyFyM0WgIUA9htWI0M+hjhfRgZQcx9tejTI+uZ3D6ttr1j4S33a4bMB7ddYIetmC8Q1Kmdjq7Kw8kTATNPoiSuo6+ygJZNI/W1rX/kD4l+f2ejnKu2t9SLc7K9IY+NGhzBAgcazbrtUGG04M85LF8m4B2CpcH6xmcx6SKXKL+40zcOKJcrrqOZ/KvRYhdUMxyt0BbYeqsRhfW7aIBhJoxmN/CoJpMR6uzaiVW5J9grHrIxcxMFzlctxq6q9IerNlm0CZfGsEIGsrJpZfd2d9QQQELJMxGY68oG00iafTSzSBEZ1HR7qghmm08c17EqAVI91evHEDoXOTILMAeuoCmIdM0JIso1bNVY8oEz6cInRtrNttYNHxWljlchroB1Vi5i/wB4hkym2y17VBBHLozoRLJJlBP7VjI2kvNAUtJl2hj2VgURrLIzBh26qePEYgxOGOWAoLMvsP8AHJHe2dSt6jivfIoW9CD1r7hXzquTXtvrNesxy5QwCupW97ViVMl8PPctHl13PtpQ+K0kS9Rj1n96xMOk4zOb22Zqw+H0nCKHNbblp4ZN1qibFYnTLEbquTLr7TWIbNm0smfZsrD6KXRuIWN7X6xWKWWbNNiBZpMuz9qiyuUliN0cDZUkmLk07smj3coC+6osJh8b6xZ1yoE1gA/mNS4jNxFC5bbLUVw2KyQE3yNHmt7jTI+IAw7bU0evvrJJiB6tcHJk16vbWMMjXXEBRYfltUTYrE6ZYjdVyZdfaaxS576Z2fZsvUUObNkXLft/gHxL8/tXQTiIjbdM16xEbzXmnILyZez2VJLFJkEqZZEttPbXojDpKQyBgHt2L2U088ulmYZb5coA7LfZBGsxEsLFklC9vspw2KUyHdYRah+16xYlmvNiBlZwlgP2rTYafRSZcjXXMGrR6U5zKJXcjeN6hxGe2jDC1tt6WSbEh3jB0do8ties0cIrZQY8l6jmz3yw6K1vGsVmOdZ2zEW2arUiLi7wJsUx67dl6nyY3QGTW8WS5J/21gxnMOIiOdSRe1+o1iXlxGd54tGejsqB4MRkeOLQklL3H+Kii0xOSfTZiu3Xs/kj4l+f2YafNbQ5tVttxUkGbJm67XqJ0kMc0Ruj2vUztib4mRcmkybo9gpXw7aNcmR0tvdhrAppb+rG+7vVPiM19KFGW2y1YYRT2lgLWYpcG/srFxtiCTiGDZsuysRjJH6JQAi2y1Tz5Cmme6q35VpCrmOWM5kcdVZMTPmkDBkdEy5SKWfFTaZ0FksmULTYLS7QRny9p7Kgmil0bxrl1re4rGaeQ5JX0lwNysGVxXrWiJZiiWVdXzrERR4oph5iTkyaxf21A8E2jmjTR5stww9orEJNIXkn1vJa3urDTYjFaRoSdQSwOqo3xGIDpG+dVEdtfv8A6EPiX5/0EfEvz/H6mK+6uK/h5VxX8PKuK/h5VxX8PKuK/h5VxX8PKuK/h5VxX8PKuK/h5VxX8PKuK/h5VxX8PKuK/h5VxX8PKuK/h5VxX8PKuK/h5VxX8PKuK/h5VxX8PKuK/h5VxX8PKuK/h5VxX8PKuK/h5VxX8PKh96+8Oztriv4eVcV/Dyriv4eVcV/Dyriv4eVcV/Dyriv4eVcV/Dyriv4eVcV/Dyriv4eVcV/Dyriv4eVcV/Dyriv4eVcV/Dyriv4eVcV/Dyriv4eVcV/Dyriv4eVcV/Dyriv4eVcV/Dyriv4eVcV/Dyriv4eVcV/Dyriv4eVcV/Dyriv4eVcV/DyofevvDs7a4r+HlXFfw8q4r+HlXFfw8q4r+HlXFfw8q4r+HlXFfw8q4r+HlXFfw8q4r+HlXFfw8q4r+HlXFfw8q4r+HlXFfw8q4r+HlXFfw8q4r+HlXFfw8q4r+HlXFfw8q4r+HlXFfw8q4r+HlXFfw8q4r+HlXFfw8q4r+HlW38YPiX5/0EfEvz/Hn1coJP8AeLip0LYS0LhT0G1+NRNPJEk0l7Je19dSxFVsoBvm191TaGWJ5o1LZM16w7SsiySoDlvt1dVKonizNujONdDTSxx32ZmtWaaVI1PWzWpTJNGobZmYC/2FUmjZl2gMNVSCKSDQoSMt7u3t91TJJkSONQ2cuPl1UyLLGXXaobWKxMuGfDFITYKdbNr27dlBZZo0c7AWtX3kiJqv0mtqpCZ4gH3emOl7qOklRLC/Sa2qkvNF093pDpe6hppo477MzWqKOWRQZP8AcNXtNTJ0MiWIYODe/s6qIiljcjbla9qUaeK7bBnGv7B8S/P7B6q0I7dIpNR4nFPhUgbbYEHvvRZp4goNiSw20JNImQ7GvqplilR2XaFa9q0Wlj0v9mbX3Uq6ePM2wZhrpkjlRmXaA17UziRMi7WvqFXaaMC2bW3V20IzNGJDsXML16tYZNFpPbe/4QfEvz+yDD4cJpZb632C1Xxjwg3tddQ8aVSwDtsF9tA4iSGOQuygXtextX3siJqv0mtqpCZ4rPu9IdL3UELLnOsC+umUMpZdovsopHNG7jaFa5oxpNG0g2qG10I2ljEh2KW11ojNHpf7Mwv9miE0Zk/sza6ytKga9rZuuhnYLfULmi/rEWQGxbOLCkOkSzmym+2tHmXPa+W+uhEZoxL/AGZhehE00YkP5MwvQ00scd9mZrXoaWaNL7MzWv8AyPSX/KP/ABFSSZF0nSbN13zV6SMV8/q0ez96k9V0VtCcuX3VEMXbSyQroW6stt331I+QZ+k2brvmrFBpMOrFVtpkvdbdWuoJExEEskKMMsm6y0vpGLQ8EZsPL/b7KmeAMGMd7ddYH1LR6XSLo8m23X4Vi7Af/EPXpb/t1/zXosxIqnShdQ6rGvSdgP8A4hv/ACFY2MDDII1s7Si5bV1V6MMozn1W+vt1V6Y+7XfcDVs1Vg2lAc+pA6+29elfu11SSW1bLbK0VsOrLArPJOL3Br0K0lt8i59xr0nbh3hz2/t669H+p6PSZ/0/7La6xrlFzXkN7dYJqInaVFD4l+f2Gv2//KsNhYIoFL3IaQdEW/zWOTMjL60B0NS7V2V6O0ShLh1Nh1WqOIGGeKZ2KsN9Tt11i3yDPpHObr3q9GaJQl1ddXZavSKO4Vw0osfbXo0SqGAw17H9qx2QYaJYzl6Q6bEfKoidvqn+fwg+Jfn9ix4lgG2oc1mHtFTh5DLHBiFAl7VuKwAR1YhXOo+ysXptFfO+e+3bXo31lbuMMT0u3VXpj7tdTuBq2aq9FSStvYcjMe2wr0y0DXF4wSvZ11L/APp+jzaI5Mm2sJ6nk02ZNFl2366aUGGaOaUZlO+rbNVYp09WiVHtrH3hYHb7Km0PF0Zy++1QerZNP0dHbez1jnkQM6iO1+rVWEVhdTiEBFN92v8A8ODs671D1RRY8/8A2i5q0LBmXDNs94qPc0/5829n9tTesZdP0tJfez0mMdoXlWACaKX/ABTRquHjtEGZpx1HqrDEm/R/jYqqgtrNhtrRaNNF/Zl1UWCKGOom1My4eIFtRIQa6QGNLJu9Hd91aLRpov7MuqgJoY5ANmZb0ueCJsu7dBqoO8MbONjFRcfYXjhjRztKrY0ciqtzc2HXT5o0OcWa67aXMqnLrW42UyGJMjG7Ll1E0JHijZx+YrrpSsaAqMq2GwdlOMi2fe1baBWNQQMoIHV2UyaNMr7wttpC0MZKbt12VomhjMf9pXVTFUUFtRsNtHQwxpfblW1GPRpoztW2o1YahQ+Jfn9ui0SaL+zLqrLNGkg7GF6K6KPKTcjLtpWZVLLsNtlF4oY0c7Sq2NGPRJoztXLqpWKqWXdNtlGRoYzIRbMVF6Vgi3UZQbbBRdoYy5FixUXoMEXMBlvbXbs/CD4l+f2ffxRyW/uW9aMIoTZltqoaOGNLbMqgWpToIrrsOQaqD5RnAsGtrpxkWz72reoRvFG0Y2KV1UciKt+wUXihjRjtKqBRkSGNZDtYLrrSiGPS/wB+UX76Z2giLNqJKjX9hlWGMSH8wXXTOqgM20220M6q1jcXGw1pMoz2tmtrtTJo0yNvLl1Ghooo0tqGVbVpTDFpf78ovWlMMZl/vy66DyQxs42MV10ryRIzLsJW5FZUUKvYB/FdiB764qc1cVOauKnNXFTmripzVxU5q4qc1cVOauKnNXFTmripzVxU5q4qc1cVOauKnNXFTmripzVxU5q4qc1cVOauKnNXFTmripzVxU5q4qc1cVOahaRN4dftripzVxU5q4qc1cVOauKnNXFTmripzVxU5q4qc1cVOauKnNXFTmripzVxU5q4qc1cVOauKnNXFTmripzVxU5q4qc1cVOauKnNXFTmripzVxU5q4qc1cVOauKnNXFTmripzVxU5qFpE3h1+2uKnNXFTmripzVxU5q4qc1cVOauKnNXFTmripzVxU5q4qc1cVOauKnNXFTmripzVxU5q4qc1cVOauKnNXFTmripzVxU5q4qc1cVOauKnNXFTmripzVxU5q4qc1XGv8AGD4l+f8AQR8S/P8ArQ+Jfn/QR8S/P8fKINUuU5ffQyRZMei9JZNTE/5qOdY/vHfR6O/5r7KxMcOF0mg3jnt1XqCX1cjDSkKJC2vX7KxEGHwukaEi5L2GyoZcIliZQjhjrBvsqOFYA2KYZimfUo99YiSSErLAQHjv2+2khbBkPKLxdPb7+ysTJNEUkgOVkBv7tdEzxLH2ZXzX/AD4l+f2RRRNleaQR5uyldYvvBrzkm9SiPCnJGzKWz9YpYMTAImcEoQ+a9qbEeqnQIxV2z69trgVHDPBotKCYzmvf31K0GDzrE7K33ltnZUKKvQmj0iPfb7KkYJZA5VTfet10zvhv9Mp1vn1++1PoYtKxw69dhtPXU0k0bJJCcrR7dfVavRwnw+i+8JFnzflNSHDYbSxRmxbPa/bYVhRh4jL6wpZddu+pcuDOeHijSbPd21gWQyZZY2YdLV1bRTzjCHQxsQ5z69R6qU4aASgi9y+WvRkyggNiNh6tRozZc9iBb3mo48Th9EsupGz319hoabDZYC+TPnue6vSb2kbQorWL6tnV2VAZcMY4ZzZXz67+0fxj4l+f2ej/W8mgu98+zZXpU4U/wCiyfd9l7a7VhoIItLMYg1s2UAe+pmnjaOWEgNHt27LVHHisPodLqQh82vsNYow4YvhwrLpM2v9hWDwzLbPhwytfb7KkYLlQOVU33rddTDDYYyxxdFmzW1+ztr0OOn0iR0WsNh29tDTYbLAXyZ89z3U2Fiw5cqAxbNYAVjVXDkRoJEZy3WKwWkwxWBlVNJm6/dUvq8GlSI2c5ra/Z21FJg4RMrjN0ny0JApXqKnqP8ANYouZrahe16w0kmH9XWElrswJPs1VNlN8PEdJbskIr0gzL0ZSMnt6NYOHJ97GyFhcarGvSOhg0y5l2MAb5fbRAAbEGbTlQfbe1JjI4CxaPI8WYXGvurHSGMCefKFjvsA9tYKVV6EYfMey4r0g5w+lWVlyrcdIWqe8ZhhYjJCWzZe38APiX5/YNG2WVGDoT2ilWXBZO19ICKxiJ93M8jshv2msLMMGIFQMHOcFibddYjD6P71may3H91YCRV6EebMezVWKWHD6QGeTK2cC2vrrCJEw9aiYCP2k7ajhXYgtWKVsKJZmYlJmcbOwdlHERwaSPQhCMwBvesTKwVMRJIsipe9suwVg5Hw2iSJyWu4J2VNBDBpVZi0b5wLX7a9HgdJIY3Vm9pr0iWXVK1017ejXowulhDCyvrGo6qxMBT719JYX7SbVDpcP6xAIguTOAFb29tYCNowGixBdgDsGumy7cyW5hWH0sGhjhfSE5gcx9lASYUPiRKGM5caxm6q9K5U48YEevbqrAqq3MciM2vYB/GPiX5/Zg5oYTKIs2YAgbR7a9ISaIRNPHlWIEbe09VQ4iKLS/ciKSPMAfeKxMz5Y8RIysi3vbLsvWH00GgjhbObsDmPstU2CjgDqcwSXOLWPbWCy9HGR5VQe21iKjhX8gtWIiigEqSOXR8wGW/bXotWTXCTn1jVqNASYUPiRIGM5caxm6qxExX7tkUA99Y2Nk6cjSFRfbfZWDhCfeRmPML7LbanLej48Wsj5w3RuPZrqD/SiXCiO2gDABW/zRjlQIc7GwOq1/54jhQIvYPtkdFs0hux7fww+Jfn/IYRLYMxY+80szIDKosG7P5uSVcy3vb+WPiX5/yFmZAZVFg3Z+H6JAPtFb6cn1rfTk+tb6cn1rfTk+tb6cn1rfTk+tb6cn1rfTk+tb6cn1rfTk+tb6cn1rfTk+tb6cn1rfTk+tb6cn1rfTk+tb6cn1rfTk+tb6cn1rfTk+tb6cn1rfTk+tb6cn1rfTk+tb6cn1rfTk+tC7JvD8vt99b6cn1rfTk+tb6cn1rfTk+tb6cn1rfTk+tb6cn1rfTk+tb6cn1rfTk+tb6cn1rfTk+tb6cn1rfTk+tb6cn1rfTk+tb6cn1rfTk+tb6cn1rfTk+tb6cn1rfTk+tb6cn1rfTk+tb6cn1rfTk+tb6cn1rfTk+tb6cn1rfTk+tb6cn1rfTk+tC7JvD8vt99b6cn1rfTk+tb6cn1rfTk+tb6cn1rfTk+tb6cn1rfTk+tb6cn1rfTk+tb6cn1rfTk+tb6cn1rfTk+tb6cn1rfTk+tb6cn1rfTk+tb6cn1rfTk+tb6cn1rfTk+tb6cn1rfTk+tb6cn1rfTk+tb6cn1rfTk+tb6cn1rX+MHxL8/6CPiX5/jyTqArPhcFnh6meTLm9wrX/DBLoX+9Yr0deX2n7UiJ+8e5Ue6pV0brkNrsNTe78APiX5/YHWPSMWCAXttqR58LYKLgRPnJ8KvWgv97lz29n2QYfLxQxzX2W/hxMWW2hIF77dX8lJsuTNfVe/X9iwk/eMMwHs/gSIn7x7lR7qlXRuuQ2uw1N7v4R8S/P7MNDlvps2u+ywrDQ5b6bNrvssP45sPl4ahs19t/wCJoQ33igEj7Uj0bnMCcwGofzMSse8YzUTxHoZRasYMWufRMFRD+UW21g43dmQYworX1lddT4cp/p9Gr6L8tz11g1d2sMVkzX12uRWEGFGTShhIo69W2vRP/cn/APKppsWuklErL0vyWOwVi58Phxnh1GcvYgjsrAGaJH0kTFrjbsr0w0RynPGM3YLCsHJgxlkaUIbHfHXevSTSqWImfLr3fdWBxMkYxUYi6cTG1/8AdUTw8MqMvu/mD4l+f2R5TY6ZLH96xnrEySdDVljy/wCaXEzQjE4ZYtaX1p/uFI+iQq2H0guOu+2vSd9VpZa9DH/6ZvkKwuLwuGESvMo0ufpOCeyjPi4RLG8gyS31x+y1NZgcu2x2VhcXhcMIleZRpc/ScE9lekhiFz2ZeiTq3dtZIzpUinYBXbiIOq9YPDxo2HgeVklS/WPy1BFhIlRJpQHAbKD+9TiJIsJHJFlyo97N27KxOCSEYXGGPfU3De2pomw64WVAC+vokdt6w6BrRyyqjsD1VhUwgyCUNpEGy1ttNO/FUOQ99aa+qocbi4BiIdAM6XsUPWwrDsYkZXgLaxt2Wr0hKwLMknR16h0ah19SD/8AsKxSYsZ1hy5Izs1jbWCRoUKmNtRHZa1emGiOU50GbsFhWDkwYyyNKENjvjrvXpJpVLETPl17vurDO5uzICT9g+Jfn9no4QuI3u9mK36q9H+sTrLv2tHl/L76MywResljacynMhv7vCnTEDOPV1uvUTc1iJ+kZoGbRuTrWx1WqWPFjOkcalEOzXtNTQK7aJMWqRtfYLivR2HUFYiZLgE69VYiKRLxJCgCX1ddDDSxnEHTvHGhO23bXpONBoQjJYK2bR322r0cYBlLTC9jvattYpjBG8okZFkaUho+y2rVUcczqcRlGYA1im0KZlRXGrr166fGzH/VWZtLfWh7KgnjJSeeEesWG6P769HJBuLE+XwpMXiF0mJLXLH8pvs/mF9FYtrOVioP7Cg0kfSta4YjV+1RLoxliN0A1WppgPvGGUn2VBDBFeMTh3Unq69tFok6R1XJJ+dRIsfRibOms6jRlaPpnaVYi/vtUjSRXz72s2P7VGJE4e6QxBFSnJxd+/XQeKOzDULkm3u7KlCLYSEs2vaTSIUOVFygB2GqgqCyjUB/MHxL8/sCyi4BDfuKaKUXRhYis0iE6rbxt3VG7p0o90gkU0jxXZt7WbH9qhKpwVyJr2CgRDsbMOkdR9nZWmKXe+bWxtf3bKK3zFmLMe0mgRDsbMOkdR9nZTyNF033mDEE0kRSyJuhSVt3V6uYl0XZTxZM0bbQ7FvnTqqtZxY3djTqIz094liT300UfQDkZySWLDsuaMcihkO1TRaJOkdVySx8aFodQ12zGx9466zSoSdm8bH9qjMia490gkW7qkZFsZDmb2mmvDvG9sxt9KDyp0xqDBip8KjV0P3e70iCP3qU5OLv366DxR2Yahck293ZUoRbCQlm17SaWOMWRRYD7B8S/P7I5WF3jvlPZeo5WW7x3ynsoyGM5jrOViL/ALUZsv3hXLf2VJBk+6e5YXPXS6RNaiwIYg94pIdGBGpzADtqOVhd475T2U0wX7xgATWQx9HPpN43zdt6m0EAJkHSW+/WHYYQ4aOJs13kzk+wa9lGR4znO0qxW/vtUs17lwFHsApZ2X71fzAkUZDFrJzEXNifdsqR8nSkFmJ6xUJROECqazqBrTaOz3zGzEAn3f0YfEvz/oI+Jfn/AC70k0YIVxcX/pw+Jfn/AEEfEvz+2Z42KuLWI99YaEYqfJOraS7dnZ2Vj41d3MUiqjNrIzWpGSLF6Gx0mncH3Ea6fHetzLMyZ+i3RHstWVHxjTLHe0LWC+016Oi0hjOIUs7rt1dlQYeGaUaeWxdmzEC3Veo4FlkkimjY2kbNlI9tejcKrtGjRs7FTYm3VWPw6zSMq4fSozN0l/esBP6xM7SOqOGbom/s/pg+Jfn/AEEfEvz+14ZCwVuyoZiWzRXt+9YnPdhiN8H3Vf1jESC1srsCPlUmFw0eN6RsI2Fo19t6ZxJMmdQrhGsHqGC7jQ7jg9IVo5pZpOlmDsekp9lGRnkllIy55DrAqCJWkUw7kgPSFToWkdpxZ5GPSNQIxa0LKy/t/TB8S/P+gj4l+f4/Xf8AY2ra/Oa2vzmtr85ra/Oa2vzmtr85ra/Oa2vzmtr85ra/Oa2vzmtr85ra/Oa2vzmtr85ra/Oa2vzmtr85ra/Oa2vzmtr85ra/Oa2vzmtr85ra/Oa2vzmhrfeH5z21tfnNbX5zW1+c1tfnNbX5zW1+c1tfnNbX5zW1+c1tfnNbX5zW1+c1tfnNbX5zW1+c1tfnNbX5zW1+c1tfnNbX5zW1+c1tfnNbX5zW1+c1tfnNbX5zW1+c1tfnNbX5zW1+c1tfnNbX5zQ1vvD857a2vzmtr85ra/Oa2vzmtr85ra/Oa2vzmtr85ra/Oa2vzmtr85ra/Oa2vzmtr85ra/Oa2vzmtr85ra/Oa2vzmtr85ra/Oa2vzmtr85ra/Oa2vzmtr85ra/Oa2vzmtr85q34wfEvz/oI+Jfn+PmdN5UJFYPEPidMJigZGQDe7LVo5JLNs3TYfvspRM9i2wAEnwrHTJNHljkARmGoDV2UomezHYACT3CvWNKuh/uoRxyfeHXlKkGmyTA5RmOo6qYRPdl2ggqfGgdNqPXlNh7+yhHLJaDQ5rWvc3r1jDSx5cwGZwe2gsr9I/lALHuFabXktm2UMR6wBmkC6N4zlUE9RtrNOjydJN4BSbUJ2kGiOxu2jHDJeIQZrFbWa/fWHfEzJmlGoqDY0zRPfLtuLWoDTbTYdE6/d21oWf7zsCk2/hHxL8/sDIQuZwmc7Fv11JNPiWxCWuOh//mlnkJjBte4Oon21hxDIhikDbQbm3ZXG67XynV7+yl0z2LbAAST3UxgcOFNjaskr9PbYKT8qmiZo8qKGtruPfQGm2mw6J1+7tp0eTpJvAKTag8ZzKdYIopJLZht1E29/ZSCWQDOLr13otC2YA2Oq1qEcslodDmta92vTTJJeNdp7KbRPrXaCCD41I+EnjzKA12VrDXTQhvvFAYi3VTSNJZFfRknqam+91jqym/d10JIWzIeun9af/TOuaM22EbVoPij94/Sy/wBo7KyTSZWte1q0TSWa9t02v79lSRq3Tj3h2VpIWzIeu32j4l+f2YKNT0JM+Yduqs8rZRsp5FfopvXFiP2orE/SGuxUqfGsRoJrTKDY5dV/fsoO3Zc0gE2/sNjbvqVHdNGkWktY5h7aRVm1vumxsf3rLK/S22Ck/KgyEMp1gitDpLve2pSbH31klksw22BNvf2VgFif7qXNf26qyNLrBsTY2B9+yskslntmtYm9aSFsy0FlfpHXYKWPhSTNMuic2DdVMsT3ZdoIIPjWE+8CRM5D37LUwie5XaCCCO+tHHJ09oBUi/up4o5RphcWsdRFYXSOplmW4yg2NTBn1wrmfUdQq2mGy+w6/d20xha+XURaxH7fZif+NvlXozF5ncdBWDtmAuNo7Kx0ckxiKXCwBLlh20JsUcsckCqkh2e0V6XZAQDMCLi39tTy4s5EkRcjnZq2imxWRvVvWxLlt+Xtt79dYNoGzjRv0hsoSwr0rnq2dLbSsMQcQDAenlAG3qpoG4rZwI7a3N+qsMkmt0wYB9969JD/AOrT/wDGsU2LOQS5dG52WtsoOmtSLisD/wAy/wDnXpPV+df/ABr0ZPJfQRSPn/27bGmeHpJ6tbN1HXXoK/Y/yr0qkO+2HX99tYSOHeWWPo23NfXTtg57zu4EmGtfN7fZ/CPiX5/YfWiNE3ROYaqxS4C5wWj1f25/ZWEjBDFHiR17NeysD8En+Kxur/1fmaSXFHKkmHRUkOy/WKx7KCFM/WLdQp5sNiMuLsAYbX0nZXpNYx942GXV31hI4d5ZY7rbc19dek9X51/8ah/+75msTBi9Uxkc5ba5L7LdteiI5h01if8AbZXpH/8Aj+VJJNqT1e2a2oa69IY3DLeJygU21HtaswxBxAOHbp5QBt6qFv7R/wCVO+IORJIQFY7CQdlSmxs2P2MP9wqI2/8A25+dY7/uXpsPG2VMOMxb/wCZ1UpWZ8PKhyyhQD0v3qPOc7Lht4/FWMWSYo6EgYdU6u01HNALtiE9XPv6j86jiTdQW+0fEvz+z0dJMwRAXuT7qwuIw+IOghY6R4xfJcajWLxmFxDYyXKAdQt4CojHijPeF+llAA91PhGH+oRMrR21g9tN/wAf+Kjwia8Q8YVY7a79tYwHWRgfOocJDrxLKoCW1g9tYr1jGPhhJYq2VbNq7SKRIJC6bVY0mFnbR4kNYqdrG+2sXHizlkaUuLjiA7LV6HSQZW+91Hq1U+CmB9asymK2tyeusOkuuRMHY++9ekP+f/ArFti2yCXKY3OywGyonKlY5ceHRSOqoPbA3zFej3cEqJSTqv1UcTgxpVigYErsY9Qr0dIcSZW0nSQJYIbbK9KHr0z/ACr0NiJejCsZVm7LivTLpfKYBY226jXofUN8f+NYz/jT/P8AIIik0b9TWvWnxM2llAyrZcoA+1Ic2fLfXa3X/KNjao/W8TpUjbMFWPLc+3+IfEvz/jBw+IWLtBjzUwzF3ds7ses/YbGxqP1vE6VI2zBVjy3Pt/BCeRywTcTqU9v8A+Jfn/Gy9otUUObNkXLftqSO9s6lb1FFe+RQt/6gPiX5/wBBHxL8/td8MFaRdeU9dYVMHlbSDSOT+VfOizGwHXTNpo7LtOYaqDiaMoTYNmFr0qMyhm2C+s/1IfEvz/oI+Jfn9rzSbqi9ffqq+udMW/K39tYrTvCU0TbiEHZ76wQSGIvNlF32XttNelMPniJKobxCwDV604I0SCKx/u/N/Uh8S/P+gj4l+f22kVWG3WL0M6K1jcXHXRDC4PUa0TRoY/7SNVN6msMcpAUHL1Usa6+sses9v4e7ED31xU5q4qc1cVOauKnNXFTmripzVxU5q4qc1cVOauKnNXFTmripzVxU5q4qc1cVOauKnNXFTmripzVxU5q4qc1cVOauKnNXFTmripzVxU5q4qc1C0ibw6/bXFTmripzVxU5q4qc1cVOauKnNXFTmripzVxU5q4qc1cVOauKnNXFTmripzVxU5q4qc1cVOauKnNXFTmripzVxU5q4qc1cVOauKnNXFTmripzVxU5q4qc1cVOauKnNXFTmripzULSJvDr9tcVOauKnNXFTmripzVxU5q4qc1cVOauKnNXFTmripzVxU5q4qc1cVOauKnNXFTmripzVxU5q4qc1cVOauKnNXFTmripzVxU5q4qc1cVOauKnNXFTmripzVxU5quNf4wfEvz/oI+Jfn/AFofEvz/AKCPiX5/j8R/xt8q9H+oFPXOhn0Z6vzZq9JSNpGETLqLX6ursrEmeJY921nzX106xpeJNRkvtbsFJDDHpZ31hb2sO0msYBFosTEvSGbYO0Gh9ysTNrOVr39tZsPhs2HzW0jPa/tAqU4bDaWKM2Zs9r222FejpYz0Hicjwpp4sKXwq/nz6yBtIFJDh4dKXi0qtmsLU+ZNHJG2R1vexpoMLDpnQXe7ZQtKY8KHOW7fe2t7KwkkMTSesGwF7WqaPEx6GSJc56WYZe2lk9WyYZtedn127bUk7QWwjGwkza/fapcNHhyREwDPm1AW/jHxL8/s+6DsMwLqm0r11jHwCqv3ZDAarauyvRakvrw/93R2DaKfFJhC2GGxs+s+23ZSGKLSO2G2Xt19tTSwx6OaJsjgtuedAzIEfsDZqllySyf6kx2Z7nb1eVaDEwaJmXMhz5r0Hhw3+mJ4jPYn22qdmgKwQlg8mbsqEYjD6JJjZDnvr7DWaXD2w+bLnz6/fangw8Ak0ds5L5dvZUiYaDS6LfJfL+wpJo91xf8AAD4l+f2YRI9/Mzr7wtQxx/roZGt2AX+dqwpghEpMYvd8oGqvWNC1xJo2S+sG9qwU2KTQWjlJGa9tlRu0BEkrWjjzaz7+ypxi49E8S5yA2YEeysDpsNolbEIQc9++pX6eq242U7e2jhYcPpHyB757CjK0bCQPotF15+yp58RhlXRrcASXv4VHfDESSm0SFto7T2VNG0FsRHryBtR/enixMOikVNJqbMCKOIkhEeGyZw+e5t7qhabD6OGY2Vs9zr2XH82ZE1syEAVgGijAxEJXNa2z8wr0i5w+lWVlyrcdIWrGxxwmNJMujgLg5e2miiW+DfpDXwz2VHi8OmlshjZL2NvZWPlePLLNHo0jvsHtNKrbctjS4U4fSRobLKHG77RU0EOHEqsxaN84Fr9tYBR0o4o3V29ppsCkAYa0WbMLW9o21EVH3KYbRZvbesYzrYSS5l9osKnmhh08c1iQGAKke+s02F08TIMqFxaNvbXoxWTXC7Z9ezbWJuLRS4fR5vbrpcLicNYZchlVxbZ31HDL6MikK6tMMuv29tY13WyyMpU9ur+MfEvz+y8MOlN93NasZO0WiMkOiWPMLn2mvR+ZOjHAyPr2GwqXCvCLIuXS5hYj3bb0k2X7v1fJf23r0mmWxmkzJr27PKgZIzE39pINMmj6XrektcbuasM9vulR1Y32XqPCyYfMqdESq4tb3baxmHl6Blkcj9zqqPP6LijZdsqlbft11Kr4USYjPcTlxsv1dlfc4XLMLZMSHAt/mp3bApjElOYHo3X2a6RVjEQtuDq/AD4l+f2YOQL93HnufeKxefdsUhH+06//AH7qwKywaaJIsrw5xvdvtox6FVPrQkCqRYLesNpEzQqr3N9h6qhGIiSWTDPsY6plrERpgVwbOtgejr7qwobC6PRyqznODf3VLFEuZ2tYfvTzFfuzCFv7b1MyqBKuLM8YJ3hWJjOFaNyllBdTesLIIUmMO2JvzCpxhMEMJKbbCAXHWLitOmCWGPQlbZhctfrqe0BwkMsZVlzA3btsKiWX0XEHXbMuW3v7f6QPiX5/w6TR3N82tiRf3bPxg+Jfn+P6IBPtNbic/wBK3E5/pW4nP9K3E5/pW4nP9K3E5/pW4nP9K3E5/pW4nP8AStxOf6VuJz/StxOf6VuJz/StxOf6VuJz/StxOf6VuJz/AErcTn+lbic/0rcTn+lbic/0rcTn+lbic/0rcTn+lbic/wBK3E5/pQuqbw/N7fdW4nP9K3E5/pW4nP8AStxOf6VuJz/StxOf6VuJz/StxOf6VuJz/StxOf6VuJz/AErcTn+lbic/0rcTn+lbic/0rcTn+lbic/0rcTn+lbic/wBK3E5/pW4nP9K3E5/pW4nP9K3E5/pW4nP9K3E5/pW4nP8AStxOf6VuJz/StxOf6VuJz/StxOf6ULqm8Pze33VuJz/StxOf6VuJz/StxOf6VuJz/StxOf6VuJz/AErcTn+lbic/0rcTn+lbic/0rcTn+lbic/0rcTn+lbic/wBK3E5/pW4nP9K3E5/pW4nP9K3E5/pW4nP9K3E5/pW4nP8AStxOf6VuJz/StxOf6VuJz/StxOf6VuJz/Stf4wfEvz/oI+Jfn+PZ3NlGsmly4fEBG1iRl1H8UPiX5/ZpHVm6QUBdtzRDYeaK3XJb/B/kzxtmGhQOx9lK6brC4+wvIwVRtJqOJj05L5Rb+QrOGILBNXt/kj4l+f2Z5TbXYDaSaynDYmLVe8i2H8DgMCU3gOqlliN0bWD+HeJ91xlNQYbElZYX6Ecg1H3Gsa5kfOpls19Y21gIvWJkV8PmfK2s7KxMpxEyaNzGgRrAW7e2vR0X376VGZzGem1vaaxvHjVcpiaRult16wahxGnmkySXlzNtB1GsVPnOizaNBfVq2n8GPiX5/ZHltm0yWv76mkkWFW1BSjE7T7qw0iYiaTPII3WRr5r9fsrFSSTylY52VUzaqiwgkeOPRmRihsT7L1hcFHNKFkzMzlrtYdV6xWHWaR09XMqlmuyH316OlGLn0k5VHu1xrHZWLw4lkePQ6Rc7XKn30mO9anM6xh9bdE+y1ekXF1b1VT7tRrA4YyyIpw+ldlPSb96jg0uLdiSVVHOdv3rGLM014JcozNrtq2227a9HRJJKUbPfM5N9VSYs4maOS7ZArWVbHsrA3lkjWTDl3CG19lY/DwSO7xOMhJ6VjrtenEbT5lPSWckstF8W2IXC6sjxNZV+KvSClyVUplF9mqsHBpnBnlkDSX12BOqlVJZTeZNbtmtr9tQxCaWSOZGJEjXsR/IHxL8/swWfdyPl+KsSykhhGxBHurAMJGDM8VzfbWML4iURQupCBtW7WFkw7Yto5ZMhaVugwPYK9INpJugw/UP9vXXovEvK7I33cl27dhqSdGktiMQIo7dS+y/71YR4kYYrr07hrN7NZ/Cstytxa6mxpZZJpp2Td0h2VMNJMscuto1bo37ahkBa8UejHuqfRx47M+1Il6Eh99YWKUsssI1Oh1qakglnmkD7WYi/yoxRQmVpeh7B7TUcKbEFvwY+Jfn9iq5YAMH1eymjkXMjaiKR3lmm0e4JGvlqXIWOkcyG/bSMWdJE3XQ2IpFklmZ0OZZb9IGpgzySPKuVpGPStWGju9sOQV/btqacZjI0WjtWGE7T5coLQk9G9TvdrzJo291QKGkRoRZJFPSqMmefSx3tLcZtfVsrEQ3dknOZrtrvWHd5ZXeG9ixGu9PaSZI5Dd4lbomo5hcFEyADZap2SWVGmIYlTstTkM7u5uzvtNHSTTGNtsV+iaMyySxMwyto2tmFJhxnCo2ZGB6Smsks88nTD3Yjq/aopyWzxggdmv8AkD4l+f2ZZgdWsEGxU9oo58RiJlIy5ZG1VErTTssTBkBbdtWIfWdPvA+61Q/ezssLZowW1LTzrJIpffQHomvUrvogLXvrpcKQdGoAHbVziJ5dVvvCPL+oD4l+f8lgjBipsbHZ+IHxL8/60PiX5/addvbUEYxTYmOW41xZQD7DbXTJiMQY5QT/AKcpYW6rHrpDFmVc3TdVzFB22rAPHjDIDOvTCr30mEjxNhoczOUBO2seyKhfThE1W1m22ptJjWYlP7FFqwLLOTpGjWxUah2Vh4Q33bIxI7qnxk0oZULIseXb0rC9QrpJp1k1PmgKZPdq/Bj4l+f9aHxL8/tkibY65TWFebFZ/V9gEduq1RSYnECQREsgEeXvoaCURH2pmvQjWX70S6bPl/NfspcS8gZxFoz0bX17axayObTvn1bVP/sUy4nECVSLao8teqvPfIQYmCWK22e+o8TPiNI6qVsEsKkwsjZ1csb2ttN6GlxQkjHVo7Hv/Bj4l+f9aHxL8/6CPiX5/jxo8179Vfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+Nfq+NLe97f8ATn//xAArEAACAQMCBQMFAQEBAAAAAAABEQAhMfFBUWFxgcHwEJGhIDBAULHh0WD/2gAIAQEAAT8hK0FuG/BPJO88k7zyTvPJO88k7zyTvPJO88k7zyTvPJO88k7zyTvPJO88k7zyTvPJO88k7zyTvPJO88k7zyTvPJO88k7zyTvPJO88k7zyTvPJO88k7zyTvPJO88k7zyTvPJO88k7zyTvPJO88k7zyTvPJO88k7zyTvPJO88k7zyTvPJO88k7zyTvPJO88k7zyTvPJO88k7zyTvPJO88k7zyTvPJO88k7zyTvPJO88k7zyTvPJO88k7zyTvPJO88k7zyTvPJO88k7zyTvPJO88k7zyTvPJO88k7zyTvPJO88k7zyTvPJO88k7zyTvPJO88k7zyTvPJO88k7wAeQALujPhf/NHjtk+F/wDNHjtk+F+gEQzoIonbI+WPHGAl0qGw4KHzpgNH/IVwdxG8xZZEwRQBGQlVDLlBYiKwFRtGLkK2qcHMLGCxlygN9xlcg/7DqNs1HwiBOVRqubi6CQYo4uGXh20eRlzUxBRh4UDJ9fBDh8noIZBRNA6KhzhgGEervygAGDgdoW/omgl+0oBKBYKzsB9JoAwfyMvRqkA39QB24LPzeKquNYcTFKHDV39hAORcVur/AM9AgG1YDvCuMboRgBoACrEBf7AQ2lEZJwg9YIVjXnAGpctfC6xRqi6EC8+IDmQBFYbA38xf5iL3HCCLN6ob6QrIVlY8PaAkESxCPP2Mtas0P5xgawDIx75VI5EKjpDaAQYcdVE6oaFDJxfwQ56AZ0ygCNKv+xGZ6DGYNATTW0B+q4YSr/yHtaua0tCF7AFSdhNKgEAtvSOzI6b+Q/WoQUcfaCTR0QcTxgMlUaQE6BCRX1fCEITQf6pCRdeQpe1OAjwGAGdQbf2BkAxcDadKcoFN2h6AFGCos7CZB/ESyttORvGtgK8WjECFsQSohIU/hEWESp/4ho4ECiUBBiTCg4vmIHg4DaCOH1+O2T4X6DR4BFrNUcpwb5wp50mlx7df8MVtP4Ugg8Ub2E9/edfLgtyzDCFwK3VhcviDeE6xgkHEEORwA64E7hiAhqEOEq4gDSNYDDqM3nScLAcK/wDRDXVQ2HHxAIHcAH3M42kDeh86w5sgLkX+iUMaxSPVBgAKb7ea3K1wX+H0rSESAuBi5OBBbfMAVKgPmXeUTzQgWO0U/hDwIYDyJhooAcDsI89vS+DZV8HvEiIAINiEiiRf70E+cqT6xu+AB6x9oLdC+Vw94HUAJsBhBq4akGMeFeqtY+7WsOsrOpdX4oPSH1PPmK/1ItCOAJQ1hAEhrSRgSFM5nuCwXX/kvND3JV3RaIQG9r5ziqQV91Ar6SUu1I/2eHylOFli88QXgEZQTQukMSK8TFYEDBfJbY+3xKaBGaoC3aCaXOMEjwT42UmF2ha7bn8H2n/Mchgq4zbS67emvPWC/wAM10hc0oKbUDK5PM3/AET5P+zzG5nhuHogqKSRuBHk+OnP6/HbJ8L9JtBMB1mzOM9id7FhkKW9FapR2gkGvP2hpDQkjoVnCKjRQjgVzRR5pQzgXCVdbYA6FAW5iBu2rwhE4nXVm1DwBLHR/tkGWjQAIRRQ1V6QIAWfm8AE35hW5/WAwmDSIvp7+g93bEtuiTCFOF4YWQT0SHzlYiEgl/vFwEQajeMqqRTSHsBpxUcveBqdNLU09AGQgSEPmDSkFVqSnAXgEPBN31qGEcIwd3j3RonF+sK/vO/GDTYtclCECNUwwBADc+6FXISqucpYtFYYshjKjLWohP8AZXHIQex8IBYaGJEOTUBKPwFtqAj3qowEAELMUA2UXLnI+6EskmphqZS6gRN0ykEZb1EJ/s2tW1ekEdEFUYYBPAJnJ/sOqAJFpye8vJGhNXCEcCuaKHYCtEAxRTGkq+GAC+vvN3eFFjlApFYFkYqAQQ1Nb+g+btMCDpWZWDqL/vlL1V1Fua7Tr+5wtYWXSDiQEGBXrA7UKyuh0IKqIm3m8h9fjtk+F/8ANHjtk+F/80eO2T4X/wA0eO2T4X/zR47ZPhf/ADR47ZEYpKMYZnMzmZzM5mczOZnMzmZzM5mczOZnMzmZzM5mczOZnMzmZzM5mczOZnMzhBcXVMzmZzM5mczOZnMzmZzM5mczOZnMzmZzM5mczOZnMzmZzM5mczOZnMzmZzM5mczOZnMzmZzM5mczOZnMzmZzM5mczOZnMzmZzM5mczOZnMzmZzM5mczOZnMzmZzM5mczOZnMzmZwgIQASDRUS1z/AC/M7P0Pmdn53wJa5/l+Z2egZhuwELlXgwfWVpGaDC7LcCyosDL2Qjx0Mi5IBoMBgEUdIRjgUxVh6uHCMpHAAiuCN4CEAQXI7xrFxNovYv4lTBgU1qVYqfL6DUZzylZLkeEe0h2j2g+JEVp1bqMg6aZthKTE3FcRnApgjyr97zOz0OWFEAgg6wiQqYFAjr4YNIJFhUjaABTBC+UPAKF2DwJgTY2SM8BW8PS26nUGUKkEsh2EAbcGxzWsPgilYUW7cI+UyBFW1UO0UERRXJ4QwgBVCCruEgMaAVlDqENB1gWRfRTuoQrUXzYMG6iRfHu6vu3AdoNhB8oQ6QiKglWCqKEsgCFiHA/X8CWuf5fmdnoS1fhuf4iJRsUHwC9woTvUvhN7WRinkovxnji6XununvWs6wUXsC29/UYx1+0FtRQAE5E0hx0gmqYmIO60iSwHt9X7ITpmpbwUCM0CBZtUZWeljWFuE4VN++P3nmdnpU+gfExQKiHco8zsIZU/uqIofYpHyNO1rAYpCAN4cDUFKOwPEAOseYQlYOrD3ni8TBCf9WfEFWnuZvic6r1i1IY7n9tfhzTukcpoT31ELxzTxUfFTyOM87sJ5zhDFDBegwpBMr1gEXY0P1/Alrn+X5nZ6CQIoGw9USPSHKbpF71FcKKIqxBEfakEi5YRoMQkEEVIRjgVxRBaOPGDbICmiKx5wkJAkuQ3gWmEHSb2CWzwhQaF3McxyAICcRKZo0+Iy95psLFdFIWJ7gkoglwsQbqkPSmNrztknGNR+SSV/veZ2egoYQAOLdAwoabNNghzGSvI8FLgArw4nWEhlG7A4kQBAgS09UrxflgNCottQbWuoQGykDUPALLHnD5pXmIMtRZZHH3hq9gUEvEIQS7KvjwUIkrAR3c40t1X9iC6rd6NjAe9zzJlY5Ak9opaHSCR6xO0CIBijoQk1lOSLoRGYz2avr+BFMaKzEmYkzEmYkzEmYkzEmYkzEmYkzEmYkzEmYkzEmYkzEmYkzEmYkzEmYkzEmYkzEmYkwJBunzMSZiTMSZiTMSZiTMSZiTMSZiTMSZiTMSZiTMSZiTMSZiTMSZiTMSZiTMSZiTMSZiTMSZiTMSZiTMSZiTAkG6fMxJmJMxJmJMxJmJMxJmJMxJmJMxJmJMxJmJMxJmJMxJmJMxJmJMxJmJMxJmJMxJmJMxJmJMxJjOuRMBIZxDmLzF5i8xeYvMXmLzB5i8xeYvMHmDzF5i8xeYvMXmLzF5i8xeYvMXmLzF4OgNC3bMXmLzF5g8xeYvMXmLzF5i8weYPMHmLzF5i8xeYvMXmLzF5i8xeYvMXmLzF5i8xeYvMXmLwdAaFu2YvMXmLzF5i8xeYPMXmLzF5i8xeYvMXmLzF5i8xeYvMXmLzF5i8xeYvMXmLzF5i8AAACA/M8Ft/Q+C2/ns9y3kpLkUMIGt8SEZhIFhpoHsPvBUTjJIUXJqnvA0HKAQmhEB4oBaDZkke14UiiAQjUWQqY3CGXr1VhG21WtAK06qH1TWW8Yu0FElAEcoKHvCVjr3t1rvtK7ewAIFcA0NeXGLNIeD/AHvBbfQw1cq7zV5a1BJqgFrNoZuoCBVyETGbLFRUpK1IcN9ZBB6v6o2ziEXMj7wRFNAKHqhb5miGSp0SEML2BuiBE/2GklEySlYKnQ8DHSSJU+Isy1CSfV1Z6AwAcAEU5lQNOMdLlVFbQgxUsE3q/qhWwdCG0P4HgtvoIRWIhHFREgUcCQO6OnvCKkDAEF0ifYowsEySXVUmvRwAFYsmrraKHIrAgvAWfGFR7Ryy2LgS8DvDSp/H4y5JFqfAEqvMiPNm5QSrmqNF2BrSGGdSJGoEoSVVmNVV9cK5qbUgJK1uUAeCwcQLp7w8m56m6hQbXxTdDyaStoYyQXS31g1wQzg12nzA1c3EDmDX2hhCMYKFB21gk5P0ITR1+94Lb6fCgHkNImqFwKtAIO4BBqEB17RB0VUr9yFShY6GBM6QaHKcHodUERVeQFSj3haehvKYdYZf0rWjVraA1oAIgpAfJhhN1R2FYS8OQbdQaBqqw5JogIQwJe38jUZO5PVTykFI4YUCSgcbrwoS8PwPBbfQoWuLhpfWA6gOZKsXN8osXiJCEI1Je0e7gDRTQqg4uAvCDjKUF2C0eGUtdpD7Bo4EjbExFQB9pc1nDnvtylr8851EBgfkERSRLMreD8DwW39D4Lb+eFfAk7zLyz8snLLyz8snLJyycsnLLyy8snLJyy8svLLyy8svLLyy8svLLyy8svLLyy8imA4u1xmXll5ZeWXln5ZeWXll5Z+Wfll5ZOWTll5Z+WTln5ZeWXll5ZeWXll5ZeWXll5ZeWXll5ZeWXll5FMBxdrjMvLPyycsvLLyz8s/LJyy8svLLyy8svLLyy8svLLyy8svLLyy8svLLyy8svLLyy8svLLyIkCSHA/meC2/ofBbfzzMMDbAQ9u4HVoA/Ri0b+o0YtUU1VAIdftJMyuprP6/BbfQ0ViA+JoIWhhJgCSHQLk8oCGsAMXMHqIdmAEMk6CAHGyYIlg/SaEMwCDCCJDXsRK7xpCLFa8vQdj2WgIAAQWD9ApwIIBck2FxCtgBgNfpOgwMrARJpjpMH7Xgtvo6lAI6XoBg8BlgkWxBqPUgBJKErWPLYPrs+WErTSOfJMaA2r0P1OJcy2Nsfu+a3Q++M5BjqN3w3iJ4LRFEgoHGCzAAUBVIpZp7xwewWKNRAftSCrHq48aBRq5MeYHANSJPDMWkO4lLBu6jhCCkaIsSAD+wEw+TOwrx3cG0wjB7Af5A8UYCCIqHrXlWC4gEwncFnSHfAIQAWAO7eVhTgBm8s1EMJ004VCvqquUGpZIyWHNf8l7wEXOw6pGoKgQVwESTcEFDoqQBay+HrWL6KkCU0VQwqhU1IvHXJJnYU47uBaiMDaibTlWHdBg2JH0eC2+gkBYALULODQl19QRrW8CabO2TZfUQJ4tQti7Q+m0NT3NAISxo1gFcKNGkuw2gLA1kTUlGbjTnSQAs1EDdDCpYUYi9Lyo00qdhP9EoT8UHQAGgCHzBNfC+ARI0oZWUVjULLSsE+pWgHQoYcWYYYAU6BRZRoW3tKtEeAL0eCGCwtRFVWn+wZ2B/zPcmqh5EQoqhktpXRQekqUUFDlYR/wApSKFXXpEMUiHQrIadIBRHXiDao0h5otH7Q+x4Lb6DAAKo5UCID4yHESK11WGUkJADBjU67xk1ORAQUQJbaawY0SX3Ho+XGmcRQMoFBacBwWmgIViOkCmOIaKJCI9tjBFExJuINAjWAdICmgaixF+GMfVQB2cl3tAzjAUAaNTAuIMqquUjsYYGCIdJ8wvCg8dhAVXdDZQVRBiVb1DWEr62gIBpe+sqrALUMoLT5pePHDUrtjpH/scIOgAGm+kFkS8AsvY7ygEYhQDIgCHYAFYpZ3oen18F0DTCj301JoK0ocwElsoMr8RBdBNWSLpfjEtHlKAAyH4bQUmgAoFo37S5LqPaOqcso6Qmj1UCiUoq44iGZKMHAqVPtNULWioALjaD0gip9gjUQqEbSQAsA1us1YqoyVRqDKh50M1wGN4hpABP8YgOEu36sGvWDRGREJyyGCnQx/hhIWaB+G0OmBWIrAqvhtCFywBFNwYZkowcCpU+03g8ppWvWaVlRVHD6PBbfVgcFk+Qj7TQ8BANam83wEEKpfQ/2CZu2Qg7q9Rox/s0mnE6BiwdQrB1SKB/U94njaABZP3g4vY0VC1GK9YQIEZWIANtLKH48bWNekClrOiCuV+Iycgq7hNTSWt/V1P4iQWZRETjaImOQY9d7RcZAOpi/EesOopXqDQ5GHEjAUC+oDtW3zEeESI9g6qcYTil4rFq8b/H2fBbfTXa6q0vpNqLtEQbdI2SYBQYRBGoMUSAlBts+XN/E4CcS4mrBNuAjel+M/r0oa9Yx/xYDLBbjvD7nBjUFo+ENR28T143gSJRr00kBaXJXGDRKQbctROXyTiFMuV8UvGuUzWXfdaA6uO8F3LHRnTowrQ9hCX0gAjq7CBxgqSUVuyY/wCQwoBgBJcmtwUopuZcMs4bxklCoGNA0AUZRIAXCFnet4gQbR7G1b7D9F4Lb+h8Ft/PCriSd5g5YOWHlh5YeWDlg5YeWDlh5YeWHlh5YeWHlg5YeWHlh5YeWHlg5YeWHlh5YeQTCcHa4TDyw8sPLDyw8sHLDyw8sHLByw8sPLByw8sPLBywcsHLDyw8sHLBywcsHLDyw8sPLDyw8sPLDyw8gmE4O1wmHlg5YOWDlg5YOWHlg5YeWDlh5YOWDlh5YeWHlh5YOWDlh5YeWHlg5YOWDlh5YeWHlh5CQAJE7n8zwW39D4Lb+eB7RCb2ARAhCB0INOuG8QIHIQoCXpB1A8Ikm73C0oSxglQagFwFwTQaopCCO6HLvLvSkn5ODlBACA9TLi/fRO8BBDFpdXV48wlEZaQDTVVHabuQCq76FLmD64xJ5gj7VaIqC0NUtfJcjyEKV5jRzOUulBlHchq6ihN0JCFv/wCxD4ELQ35OE1vQkABahtSUQQV7BshlLetQi5lK1GYisE1T08Vt9BWmX/MIiCSkSARVCpLxehlQGx7zZBULO1ZbgRBcwgKCYLgH/aAr6UitELre0sYO4uYaQlQxQ0Ls8INFJZAH2qisvz4XOQvCjvctj7fieC2+laAYeoGaC5lrMzju114/PD6kuhDJxmNZBAnhDlmI0czlBlF2VdyAog6kAuQIi2KgJez2lovKg5iWwkKQ6S0vdAfIRBkrF8W/ofhW4CvSUpKeALWC3Mu5tiZ2gLu3ANiYQkoiVGbAbxYk6lFG6hgcsTvS8s0GIR9JsvKXScMDtN9BwgAILH2IAwdJR2CRfSVsXNyuXRz2Io1DIZAbogw21HeDj0VFYJF9BKGVsx8k0bcB4uAqS6VKSTrFcS1KXcp6ViYDgWA36pwBXANza0qcJYRA2Bo55feAkEyipw+ISwiAMDSGqs+CehjhWAXAPX4sV7OwFdNqkwWMti7Ffk+8GJUd8wmyim1AgLAMcddYT/hvboj4hkV/hblH+zTWqWloQyPX1Ar0EKWyRPSeC2+nwpVOEH1uEHTWyIYAiLccjKFTLINaDB1EuYE+ZcQuHOEaK4U1lcuFU0lQoaKarIqnFiGg7ELD4YQiHOuqRFRsV7QhwyAn2/ieC2+gSCpGg1ITAyqkRySdVWsK+BVkCC/hnsNTUXZQZusANNdxi90AFdNqkyhUGbd28Ibni7UvRww5buhaKP5Wu8OazcQLP7DBxLaI8RiGBFzDU4wyI1QkH3Bp74fF3cdEkg32ewgYxMNRWaY6GyqGuUImaW4fxKwXBoqaNKGZxf0rtdzcZ0uL5XFtLpLhn+iBUtob85U1j/eoDFq6xgowfAEj6y/zaglx3gEdUYKPjBJiAIMgWDgOFEIEDd7wnJFYp/hAI6owUfGWVUhrycB09TDp2l03JuQfS3KlSczB9SVKZXJ4w6H6EFdjvCJtdAL7jaEphKUcURrAQSQAIDnGalgRwmwgEAMpIrfvvEfvxBG1w4RFdRKaM3Y1lOsxgJ5dpVobVL8oFngIEILAw2Ebwm5qALAbR1LsQKCABADSeS2+v8VHxtAoElgMAesdTSWIhYkdB7R903gS90dJaUypOZlS1UpM6liXlIlT7bRhGAkQ2cAhqIXsDhSNN6iIbEwMUqEE4m34ngtvoIACWKX3lGA0Ao2UvHpN6LqEhJzOsFekLE+gANnAIAZGK3b7xQcUxBcJpbgKwwLS+j9Q8yJaVSYLrCgWVw/7UBqZtENidYAAEKCXcDCg+sXhpdSWZlj5VpGo4zzOgntNa+Sgw3Y1hA0koEBuBAw0FQXzbwXCliH5ywl4yHWWcHdyBggFLJAdPqWm2ZKYFMCmBTApgUwKYFMCmBTApgUwKYFMCmBTApgUwKYFMCmBTApgUwKYFMCjKFWg7ZgUwKYFMCmBTApgUwKYFMCmFTApgUwKYFMCmBTApgUwKYFMCmBTApgUwKYFMCmBTApgUwKOoVaDtmBTApgUwKYFMCmBTAphUwKYFMCmBTApgUwKYFMCmBTApgUwKYFMCmBTApgUwKYFAASBqF+Z4Lb+h8Ft/deC2/ofBbfzycMEeyUgoarxJUkmzjWAT6QgNSKBZaV00j/iMUIkGxS/D5hmB8hDY9r1cKMAM4Frq/CKaUiKKbTetYcikK+Jle0uc2PoRGoV+IRFACmi9tvWBCw21FUbCxCAWljDmh+B4Lb6HhCkbiakjigY6+eojO5LrKditVtADjTk5S/Wm1BYI1izKfQisCo9oaiCV0rgFQrnCCCCIM3DX4i4vCoum4h7yXhKOSrhVsABio5NusGZ0wERax/xAUGjl3sLVsS8nIANg0CMMNPrjIbKq6QbHW20u74j7hyCgBqrWiukBcgMCqtBU13hB5TdCCQVfiB0f+Q/hgFQHcIBIPURpmCaUaA7wosxALTQqH3hLECARASUCUt1gt4I/WUC2cYj4hwECDFCj5/X4Lb6eNCQ4NWGAGSDelaVQHOgxU1QfgDFydRq4k2JEDVYCPvDDhaQRAIJTUDnpKFLU8ADT2M11TwlHJVw9wCnOioFWdIN6PwCBbIS1EAiAkoEpbrA0FMSFyfbrB5VipBsLns4ERW0tgg9p3c1T8XoGQKP8SrlGRA9jWH3BJvgiiPj7qsWxajZwmPJjvhIxpX4lD9NtiI9gT1iZBcmNj+zpGJDDVqF9tTCkcigEOVwE2hPCM7i41MCC211iSRyNfR2O8YEFOFgv5HikFtUG/W8LBHBPEMMB7fgeC2+gXEPdQb3DSEDgShDeI1+Jb7aFqBYtDbwkSLiBr/s1ebeAWFWrR1C7hcogRYsAAtg9nCOxA5YBwqfaWJC251MS+4QD0AblTQcYBmcIrIaPyspQnQUmHp8zUsoWGGFp81gaK2Q9oTWhOjgvaoQFjTm4hjZChB0rN1CDoIONjabXwauoW1EDoRMYDuQPJvaCAgJTax7iaO1yzgIBOCqAgBNK6qHQyPGu4xTSkJrBRysGOnWK/vU3H1+C2+jvsdawLhKwoeiQBqai5WOIABVBDTeCqIJQJsCG9feFO+soQQBsV1gBIKipNF3WUx6m2fwBPtLEgW33MToNk1QN77OL8nqy03rfSHUzPGu4xTSkSqb8VIqp1iFitKHhhImhdF3SAJhnwfctr2m8FUquQaBpEofHgKhcPvEMIwPI14nqs8zRqAQ+PxvBbfsIKQmS7hrHlIapDh92yMqhFQWLcvt+C2/YeUhqkOH44F7qHeZ1GdRnUZ1GdRnUZFGdRnUZ1GdRnUZ1GdRnUZ1GdRnUZ1GdRnUZ1GdRnUZ1GdR0EkrpGdRnUZ1GdRnUZ1GdRnUZ1GdRnUZ1GdRnUZ1GdRnUZ1GdRnUZ1GdRnUZ1GdRnUZ1GdRnUZ1GdRnUdBJK6RnUZVGdRnUZ1GdRnUZ1GdRnUZ1GdRnUZ1GdRnUZ1GdRnUZ1GdRnUZ1GdRnUZ1GdRnUZ1DJSTwp+Z4Lb+h8Ft/PMmAmSdBGyHthhug05qOQRHb6NIQdbSmhIZSlPn1SPCgNRd/Y2U6iULlr+B4Lb6ArE5vkrowXFRL9gEihCGLGU91YnUm/S/nooadfp55+lbW0+wbTXmBpEQv09K/2oGy5fX6ErwoDUXf2WddRKFy1+nwW3011gWry2s13gWry2v12F9WCi6fU2wmxoDb+H1MjWkT0J+4LYkSANaQaolSaUtBSnM0qkG5ZrwjdC201FfcQtsEBihiCm9IaCmNgIleUEnA1igDAhu9eM8JvCzFgRK0AaaHrCZ5DQ/rUe0LWNSABH8wKRCguYBI5AmVLPQL/c3cbWOEqwAXsPGMCTrIQKNCecCyQYA6fceC2+gGIBwkDRXSLJTtH5QZ0wMqakFjTrSBXEkuJXMoB2Kk9KQBSwIZiAjwrYFpY8TAJ53r6AcB7bwAT+qxuMGBPhWwLSx4mDICjSKLN+MRQTEAMIBeLQieKKITqGhO0JnrhSmhqTQELUIBY6IhFrKAGklg2U3u+MV+r3ql814UZrwq+PFAdYknkssFC7uj4wpJDT2AlwaQLhFNrICx/tJw7qkF3tCXigWajIG9ZbD+iC5sA2xhXWtOkGZJLDSpygUgBJcwCRyEqWegX+5u42scJVgAvYeMMW32CvTwW30IlNEI5WITA5K6X3Ie4KgwhUVoCVUQTTPO8hrAxEVnSFYFtSDMXHSqjroIBEG4E2gHgTKq+gVws3rKiCIUWPe0t1S+hm7YCAKoMXAFqIc+ERjgBdSrc8eMNLcwrRD7DesFShrwbErZyqhsOMtzUhbdVYBSUGySURBGNs2bhnwQj/AKW1CqgzBoySQFRstvuGk6qscSARzYKqTsLBjnCsgOmDAWnMxaUVk1C1OsF4coCok6uNobaBserYEihwiVChvNb8TCwAr2niD6wJErSib1J8bwpY9EBcFwOxJWsSKVY8ImKiRL2Y/CXSpluJ7Omsko16wf0VAUA+54Lb6JM+BkVGLS655EMdIPloBFkBoQKPWaeSRo2oailoJts1zWRiaJJVVlTjYXltADoCLofwhKx1Z8SqrpLA6amGaQaAIHREXQ/hKtKdDxXBtS0Jg74wQheE7593d8YdpktwdSJm3FT3mTSIPBAI0C1RfzAzEnAELYj4QNt0BSE9gTLjZkSolBBNVN2LqlNdAgsHECj1m7EjeBkKUtKtJRk0F2lCKZoR3Aa6IQSQ0ENmQMP6C+OgBcFsSVrEilWPCJipiXsx+EulTLcRX+nmh6eC2+mo7SNhGajpo3BGCOD0XPcgUYAHRDc2FpTcFuMSZq3CZHKjkNmAyjBOWIQFg+8rO0cbgjEynnNQGqdTCSvFQACuDMdJSkyWhBqT/Y/qKykhUKrhaAKKHuNA+spXJFbW92YVypBkGxANesGzPWghdj0iTiMcJRpwEKABrm1gqeEJyAj85wIFH9N4Lb+h8Ft+2YKWgcVMoCH+u8Ft/Q+C2+oHeM0RRCq90JJAH5dIaHly2oTdM3mlgubTqKrRClY8ilSAHRYOd4bBCKzLDCAeRdpbEi0ksWjcqzIvVhBbl8xFRiMNGoKqLiWvzkVh0vAJzBAS1C1aOCEkaghHoH6zwW39D4Lb6riGydaF9oncxEGhRF+0SI8CVSiU9oNELQMPgT1gfGuOv2LapnlDpVBgAQdH7KEcF3n3BheYoOoWJABSid2B2AQAEFsGbG9VL4gy/HBAlsh7QXWgiGTa6frPBbf0Pgtv54lF1P8AE8H7zwfvPB+88H7zwfvPB+88H7zwfvPB+88H7zwfvPB+88H7zwfvPB+88H7zwfvPB+88H7zwfvPB+88H7zwfvPB+88H7zwfvANgej4zwfvPB+88H7zwfvPB+88H7zwfvPB+88H7zwfvPB+88H7zwfvPB+88H7zwfvPB+88H7zwfvPB+88H7zwfvPB+88H7zwfvPB+88H7zwfvPB+88H7zwfvPB+8A2B6PjPB+88H7zwfvPB+88H7zwfvPB+88H7zwfvPB+88H7zwfvPB+88H7zwfvPB+88H7zwfvPB+88H7zwfvPB+88H7zwfvPB+88H7zwfvPB+88H7xBVTcv8AM8Ft/Q+C2/nk+RG4gQ7zqjkALOPeEQRLY2BRLjWFtYWroBMKYGtlW5GbmH0BZdDdBKgSiBWukL9ISCOGqIEE6JWkarT4hAyBHgboAY4CFy+aEupQIDMuu2aDNNIDFCpxqAIIAbhzQGwmN0EwI2O+BkkcryudUCQQAMjiq6SvxkUqGyhat4EHUitVkryvGBPNyCAFINJNIOvYEPaJJCQkPnBqISINI9EyVUl0QIIqANQLMgIdfp8lt9COokFhJNB+oFCx7K+0VMTTrAMK87QpKtBnTYlz6QjI0udCTVSXVCwdgegExxsUBoU+8DjQQsSNyhQ5xGlYADnUrKkBQaR6JkqpLolfDIpUNlC1bwfkPQCJtljE5wC6oQCkplIVle4l6uURFsQaiVBNAuoaIM00g+jAUQeAi4hUTEbHoboAYTQLCgiAqg3W0ZgdBQrH4g7KPiAxL/bSjDsmv8kfRAL7QKfEqiFkAFuo7iHWCGgA63TFh01hJDVEKx7SzlPZR/UeuOAoioMQLYBAYGitfXwW30SPPRCxxFpNSjJOwAqTOIrZzJVEJOI2WG6AUgGAGCI8Fgx4RoaVnSBJGilObChA8IcdRiC4Floqc4GoUBETahPhAkgJUkDcgChxMEPNgwRKoBgYH7BAIdYSKhil8QHygqxbVECHCMKhxWS2hRPeCTmoTA4IVg4GcppI7EG0JCAEWG6A0gxjeMeeloUsE0q3QCnGO8hEBVp/qnZFv0AGAhxIFAfEQH0hWGvaQq6Wga07+wyQxS+sRSA1y142NoUV9EkADiS6JVZzRGcSr6ea3QGKoOGpB0Ei0TdrJHeSCVxCU01IwEOpxYMDUMGOJQVEPHoqq6XcPAdNayIRkEQQQkVVqA6/7B8S2TVUYJjVD+QVU71i0QB34wBRI2lglxaVlUFRyAYKKgYusAB4ph1BU/P+wsFSNx6NFHIMhPJIhhWwSGIE4CFvqUirtOt4AqOrAGqaANUVzhBE2oU2bR7aI2ITWjW1Pp8lt9DkKS4dUd46wSQJsPwUOr4MiRkJ47aLZVJnn/hNC+oQOpuWDCL0EDmBQQhu6MWK7qaiEKAaA30yvsICbUKbNoUdGQ/CeyICTzGiIhItyEJeQOD7HS0pCLVdXlyGNqd50tL/AMDMoonUB/ECOrqWLRAHfjFQQGY80mtF7gHzVEBBwQhoCjcEogd/p/7KCAsFD2lP6B3Cnpc84V+RVguKD4YcC0VACTqQgJuQCSBCMQStWFGnUY3/AMosDEenr4Lb6aDE1CVYRgXVAEHjprGyzxQRoUJpmOcRg9qUICvzD8AazQNeTVz5yB4loMF2NXDKoAT1l4wHzFF0jVwpFb+BhExUI04xIjkHdl8N4LeWHkE2Nwd4r90IflGyh0lcNKSIHQEQglWQ6NG4LblMwSclwUMWqUkBsJ1IETu6rjKIYpkZ241PWCiC4JktUIUq6rheHVu4zIITrY+8K4NBHjuTfAmBBgMMnohtqMNDCn7R752Il0cIj0AmnHASNTn7Ho3o+k39ZlroM1pv6Ga4zdGRt1+0BImCKHaNIQgohYky/j6vBbfrDYAEin5EajihE/g9AJEwFDtGgIQUQsSZfx+Ek/K4AQrxH6PBbfrrinNNAyoqjhOG6BphTgj4TQVv2Hgtv6HwW31CZJAk03HOGEKGpOdTpBoAmSoAIQkLgaUBs4hPSObHvHoSeARdDX9l4Lb+h8Ft9TCJ5x4CAYUWBvmvkfgy1VkdSCUpKBpPZvvCGgU0ClEBmtB7Q8XNBa/sH7LwW39D4Lb6gY7KAQMawZpmorcOMGkGRAwRAsNgBUrytDP6BpHRsyhClEw7oapL8dabZkpgUwKYFMCmBTApgUwKYFMCmBTApgUwKYFMCmBTApgUwKYFMCmBTApgUwKOoVaDtmBTApgUwKYFMCmBTApgUwKYFMCmBTApgUwKYFMCmBTApgUwKYFMCmBTApgUwKYFMCmBTAo6hVoO2YFMCmBTCphUwqYVMKmBTApgUwKYFMCmBTApgUwKYFMCmBTApgUwKYFMCmBTApgUABIGoX5ngtv6HwW3914Lb+h8Ft/PYb/cQxCmbkaRY0veIy4ETIJFRUQwF2OCaoQ3A5lqA1W8WZBpMF9BD3qs3wopX4hxA4Nk7ihWcbgTQooFj2hip5UZbFVdI5YRul0OPLLEBpA1F9dJSXrUZrSmnvKwSJNA2OorKAKEr6waNekpoQiDNlK/EsMsgIkTX2hgeIQ5sFDaWYBAbTFHvA6IIi2SgS2trE0EHBDPnw+vwW30UQo6J+gSokhYkQK5WMEOLjRaNArfeAq8SqB2sU8KHH0FYC+sEU3qizFqbh7zgc9nuhLAHUAWpe3yicAwIAALugRjzCQRGxbdRGKL0L7Rc/7NUglaGAqltzFcpkIkGUKNq7w4wE6G4CL+IZZULwTsFlLaaPkO/wCB4Lb6N2RTG6I+Y2p5CPP4QMuN0QaoyqgJvzFvB4mjBXEJ7pfuAaNAZuoHia5DUkNtoQZSM6QVD7xpEfa1ZDDwhClREkVKO0LYKwINSw958cBK50fMIIjZWps/1FxOEpCbEKNjpLXwuPaKFYZFi9xiU9zDUgNODsVHzP3QHcUwkRcU2QEqma/5Bgigtqg363h0x2QDU2g9npEM1ZcXkMYxIOQiwSNLwWROxJA+AyTDgyAAdIbygFFWpViJoNkPaE1oTo4PSpgBY0vvEkoTEJuuoAMeMCBhZsvK0pBg0LsYbmnE0tgItEOgW5omvMOJnnKdBC87iHQwURI1aL6iNMAuiYoYH/EOTsGZA3g3SpcUhQBB+vwW30DTFgQA1uHSEP59gLWoKaq8teKaVhLjY2lLn++dFAOWgvcb6V4GoBHhaPbdNUfTAdRSbiF8Uu+0GF0bWAqe83SfS0klcoNRtWDRhUg9vsECNf8ACaziZq4A3ooqSqAmjTqw21ojErxdAyqW2kABGgXDT8DwW30fWGThQgAp7xGwa3WIS+SBCz+lYVCKqCh94F9hqgNPNJYkqmcA39hNbUFSJ8Da+ohC4SpEm99GBAw5vFAN0051muaQAdG8onLuLCKXWUjSCSkmLOsvOOEeh/sfQIEhECNTR0EJUNpsOA0fvAmmSmUGzfesDy2/TWAhAUUxVioNH+P1Hgtv0gi0KgO7gR/j8zwW388g9lDtM6jKoyKM6jOozqMijOozqM6jOozqM6jOozqM6jOoyqMqjIozqM6jOozqM6jOo6CSV0jOozqM6jOozqMijOoyKM6jOozqM6jOozqM6jOozqM6jOozqM6jOozqM6jOozqM6jOozqM6jOozqOgkldIzqM6jOozqM6jOozqM6jIozqM6jOozqM6jOozqM6jOozqM6jOozqM6jOozqM6jOozqM6hkpB4V/M8Ft/Q+C2/nhACsaCBEAiQBe7HUfleC2+gkDkBgkRC5EWRzQp9z7LsRC0Z210hbmMZKh9L8LmgOsOLF4Kqpr9gfYdTckPs+C2+jowKQcCA1MSqUBSexP0EXDAZ11iBboCH+O411GxhesokkBgPIXEPYATHQKI8IQ4WkVzW/GN79G02Go3rCzJwMjYMCvu6QhpdURYAGH1OsCwQTkjRlkKEbR/kQ9uzmfj8PwW30K+qFQGt5YB/hKGWFnKUj6ewGoXpLXYXo4jW9NoburmOgGjpC+PMqSwq6/ELmp1CKcWIwsdoGlYCFeCqQTFrAKKuglwUTo3WHneNugSCiURdRJJaBatWYTxWHcxmhzECYcS0gcv8AhDVwXzHd4duCkQSAA2m1XL2Sh52bXvFfb2fAma3RMoXJOirVlEbpkjVBxVTSOZcBENplzjgBOITrQCNOlzzNbRZ4wIio2vb7HgtvoYRx3ydnDQ0ARBaxgX0wzYFN7uKHuItN8OHGI462BDcLHQCCmxIEoL0HWMgSMxB1nFgB8YEcQEbXRjQCV7hAbu640GZWv4oCo1oDkYwVVOQ+oAArDTNkNBFex/KlFjmSEaL0vQQWC3YpLlKcai0qzsR6xGG/WKAIulmm0MDKI8cXdpujVudT+H4Lb6D7DnFyYgDwLGohZJYQclL8S4fPgGZbcKRkT7srjlH5AoRwxAXRRcg2jQsKIe0J69eGSCFk6e4KDNONYBrBN9WoId9GoV4wwAhAHal6mDB3UwCWyNtpo/xUlxWLpDtKNSoCoPRwIwU3RCqhBuQgmCm+jD4EQOKZcHLTpEuduBIFSnDVyqUZGdIWhzNQKtLo/mDg1CABWdP4obswUSCTQ9TBdRDeMmBRFFTC4uob9vseC2+gNWD9uBoZXOkgih4ACDAHDyGUAp0q4AlcDaUsRYIxByjS1ubMD2kAA0BAkJvrpKMiIFLVtq8PzVgQKxB3h+2oBQHsH7DwW36zS/olTJY2x9BW343gtv7rwW31Y1UXWHGOqDFABgiAB1MpIowTWQ914bsgRwkXsisfhUCTRFcQ/VXlArAs7cIjgjlBAApe8axCwhcKdKuDZd2HKIU/2LZL+KkFK9TBLO0NVQQr7QUc2IAhJgktNKu/4fgtv7rwW31NGQcQXDgNSRWCQblb8fiAiFGJkKpl34RB9NSoHJiEQSjYa90cImWCCiqStOULUAiQQQCRhCFsMcyWe0XIq0hXVP8AEC3DaJWqVaE9FwGBnwcQeqol5t2H4fgtv7rwW39D4Lb+f/aG1+WkkkkkkkkkkkkkLR1A/oSSSSSSSSSSSSSSSSQtHUD+cSSSSSSSSSSSSSSXA5bu/wDzn//aAAwDAQACAAMAAAAQEMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMU80w0+044w48808ww0ww0420ww0800408w4w84w4008888U8kMTAJ03W3fn808O9RQqc8gUwcgoccA4cw/3JVXCM8888U888888888888888888888888888888888888888888888U888888888888888888888888888888888888888888888U88888888888848888888888888888888888888888888wU888888888888o44w+/04000888888Ux08w4w48844888AU888888888888otOAM1fGuZf8APPPPPFDP5suRwF/iV/PPAIAAAAAAAAAAAAFAAAAAAAAAAAAAAAAKAAAAAAAAAAAAAAPBrNAziZfPPPPPKNjCC7mTQhPPPPPPPFDBCIPPPPPPPPPPPHsQcobc/PPPPPKDoEM8oCMUfPPPPPPFBOMMIfPPPPPPPPPPLPDDPDPPPPPPKPPPPPLHLPPPPPPPPFLPPHPPPPPPPPPPPAkiAJyCCSDBBfKBPLdMNCUtwDVePPPFLRIQNAfiBJQhvPPAqhk4MIYUOoNfKPCPPgDAQILoPPPPPFM9ocEAQAHkWCPPPPPPPHPPPPPPPPKPPPPPPPPPPPPPPPPFPPPPPPPPPPPPPPPCtxcofPbB6K+mGehOtAH6fPPPPPPPPFMsBM+CJenMHUfPPOMAIEOcEEMEMoBIIALMKMMMMMMMMMMGEIFDUEMAEDLEMMPPPPPPPPPPPPPPKPPPPPPPPPPPPPPPPFPPPPPPPPPPPPPPPLi4zPk/PPPPPPKBidjnBHGEvARAvfPFHxOzgWIQCfPPPPPOkMMMMMMMMMMMIMMMBPMMMMMMMMMMMEPMMPMMMMMMMMMMPNsPGPOvPPPPPPKKnKgvMvPPOsPPOvPFDPPPCPPPPPPPPPPOlTjPGyofPPPPKBuCJbOhUO7ABT2SpVDfHQkHRQDifPPPPPPPPPPPPPPPPPKPPPPPPPPPPPPPPPPFJAWIauSPPPPPPPPPPPPPPPPPPPPPKPPPPPPPPPPPPPPPPFPMEuEIU/PPPPPPPLDDDDDDDDDDDDCDDDDDDDDDDDDDDDDBDDDDDDDDDDDDDDDCMEqQrM+NFyIfKL87czGfg/jl8YVKfFN/DELZVTPRTpClvPPPJrjPPPPOPPKPPPKrrPPPPPPPPLPFPjShafPPPPPPPPPPPPPPPPPPPPPPKPPPPPPPPPPPPPPPPFKJiGfPPPPPPPPPPLDDDDDDDDDDDDGDDDDDDDDDDDDDDDDJDPPPDDDDDDDDDDPNjBTBCTRqRMfPKBXTAMQ8TOvPPPPPPFNrRRxHWBdfPPPPPOmERzZUUMK+fPKPICKc70YHfPPPPPPFAIwXdEIvXfPPPPPLLDDDDDDDPDDDCDDLDDPDDDDDDDDDDBDLDDLDDPDDDDDDPEtVhLPPPPPPPPKAjBxlcFfiGTOAfPPFPjTFyfPPPPPPPPPDpJcofPPPPPPPKAjskAuEkMkvMDPPPFDglEvPPPPPPPPPPPPPPPPPPPPPPPKPCC/LjuPPPPPPPPPFPPPPPPPPPPPPPPPMMMMMMMMMMMMMIMMMMMMMMMMMMMMMMEMMMMMMMMMMMMMMPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPP/8QAJBEAAgICAQUAAwEBAAAAAAAAAAEQESFBMSAwUFFhQGDRcJH/2gAIAQMBAT8Q8h8jUfejkTKEajk4NRzk1cfOldC6fvbXJWo2fIRYhcVC4o0Pmz+jeCsGzVHw9DV5hYFCEejYsC9HqzQ8mqHm2P2ekL/JPvaqeZXNS8F/hoWlK4R8EL1C7GA+WkehcCwjSEqdmqLzZl/0rybndd2oWTVzfZai+8ijdxWBdrVGqLNVFCXZblOvNPib6am+ispR8KzUWfJSNdTXFTRoUPt12K6U+ijcrrubL800aTHiFxYti0PBxCNidoQlGyuBZLz23CyLooc3x2fnXwL8xeU3Ou0oRweh8ChmzZofw10PQhHpG4f9Ni/SH+Y4vEVFdj5CwbHmPQ8lj5ncJRY4UaPpuyvDJXCOIRf7K+IqGqHs9mhcXBm5RYi8RxL5N0PAx8lZ6dWehZFChDHH0J34HmPosCXi1h2IXmmsCyKV2mauH3ayJ4udX228UJ1G76V1vJ86K7jUaNUbsvza7aPYoWULJVyx4Fnpq3RZs576ZXfWIvxO42aH+7f/xAAnEQACAQQBBAICAwEAAAAAAAAAAREQITFBMCBQUWFAcWChcIHBkf/aAAgBAgEBPxDuHumzUm46JI1XdUybmD0LMU90xX6PTp7PuqPo3FPZPBk900kbmqtYaG7zR5k2LEC/wShmzUG5F5PMCemJWHg+iDcjy/Y9oyh3H5MK3mhWNyK0IWENTI/4d+6wR5Ip63yu1yKOymqI+H7Ht0lfomUxO6ZPkm8jHfgsE8Mizo7pnkd4G5NQK3/IFnuaNT0MjgwNUgfk3HIr0j4E0zknhkmmoG5c0bJ4USInvSuz30eEQRSOpEGFSCKwI0NX6lcgg0RGaxescU3TpMOk9WBOskk2iruLgkkY6SJ0nufmiUyQQqP0LIlWOjYijsQa5TUEGxKWjY6RaaJZ5cdGenJn8JVqWvy7o/R5Ylh1UCHn+xZHnpWD7Hgd5YiBW/VH+S+B0kvw7k1A2pkd0WiBHkkVNEmC43LonBNJo7kmoJHfs0EEUfapN97yuZQ7RTcEXIsLJAlYV3BroS/wfkjIsCWx5IsYECu4osC10asbHZCQNG+hsVx2GuXHxcDIHfPa4HdGw33pXZA7cjsK5FyNiI5NSNa6vfDJmrck0d7nvqVidkyoMKKSJ8Uk3kkyM9UknuqzT65NqnijsOw6oEpuRDgjpm0kUa5liPgNSNzSaTSeuaT8tZuPCo8Ddxfm3//EACsQAQEAAgEEAQMFAQEBAQEBAAERACExQVHB8GEQcYEgMECRobFgUNFwgP/aAAgBAQABPxACJgMoKcprb/zXXr169evXr169evXr169evXr169evXr169evXr169evXr169evXr169evXr169evXr169evXr169evXr169evXr169evXr169evXr169T4fMgClilj3//AJ2MkDJAxppHVKsD+3JsabVzVhXnpv4MqlYYcmgNgxO+0JvSLEwfILXo9+gy5FnJgVFbVenExDvaYDUFROnR0wyqRigjYl0XX9YU+5BooyB5+eNxx9eIsahsJ0TjlMoCbCCYBNSojx1xFlSsEENBeTt98TwxYIAOx0ld8PcRBqpoogaOHb0mKpsngjwATUheemc2tZOlWr+JuhZcqEMkL1DvPtw6Jie62hzmwNJeTp84kTsBRKIQNaf/ALg4UFFn0Dux/AvxjFalMnNAT87+HeKxoSNoCB2R265uKDxyakg+bfjH8HBryaDux/pfhOjSEj3aSITe9/GH7Zp1FecN99YLSIdAdodyJOqfOJBrQsagH4cz5x862IVIiKOkri7wozXgo42if5gqUMALDSNOgJ1w9AtgE8GjTTiff6cy6vL3IQN0DrK5XaCAOmgl+TY9cjOuWIV0BbBo5MBoJEVdABKkKmQyMdwg4Dup2wqkdnHxNB91+MOvLuksZKIFt6sVHkUoNyHdi344ccWssjaaQBzdthw4OrUVlKmkeF1wEjFdTbICSf7jWwBEOnAEKuV5MgAEIQ7QivwJwZARVKDBeaCibcQOBQUDsTleDtlnRwwuYgnbrua640bRpSxaicicdHeLXqBycigBt4B4d48TMQiUZA1p/wDuJBDURorIGgFm3XOcy+rA8kDq+Z84CaApCKXTNz7Y/iAxIIICjo5XFoVN+SBLdOv4xMHBBCFAAht5XOprZlyF32d+Qm9Xir+jY6czW37Y11vBw3qjs4jmEoiryEWDibwQYDSD1EA+evDxg64MyYhsT8TlM21RFUSMJFXXcwNDhUxNcE5LMv8A0kg0jSm6VdX8cDk9sNKALwYGxzZpqMb9gEOQ8uJOMvCU2hZTpv6MUYWKF2XQaee3Jq7legyzarogCsO0V4fstarmny1zPnBMq3UECQUSOunxiHqXvKChf6x4IarKUAoJrqL85vi4KgS04cnfEANhfhrq35s+Mq8wYwHYI6R45m8IhrZVXbiuuwb/AHJAxHA2DwLQf7TCwkkeqCJ8dPxhNiALnZ1O0H+2F52g0bCV+39GcODw9St/ymHGIM7H8Cz+GUTon9k4njzQxVIqlOpZqlwCuCURE+XD+Lh6EaBAo8IjD8YJz6AYiLKDOOZstEVulJFsTpOJnAgkAsBjE2SiPBlVfE16IHGuRJq0uKztT4Yqx+yvyZq2JZzu7O0/sM3C2HSMnzo/gdcNqAHZKGSDsS5EYH3f8YFFNHBQ3+QwpRZVNngKD3wT5EEWlaQdiE+M0/XW5ewel+gvGZgHSGcl2N2fCvoSrqwguuhfNzdRQbohr+ItyAxcnyP/ANA/GdGlpQ52A3kFc90Un/MB+Do5If8As/t1+gsSrhreJh5OEfyf0zXi4FXQZ04/MymJqNLQqArU0jS7ykJvR3A0FIx46YVJpCwVqgnw+Mj+fI7X9i2dL8YZjYkiobOHTH564sRjM4FmgGx6CUxhTAgnBQLopPnAqTyQgB2Bai8dcXSzHxln5P7uU5vPkBV+YX8sGmwVFBXA20/rNwuANEQvWGrmtPJmdPK63zTkZ26ctGldxREu4jvqZQ3BtfIFZFcaRGGBnODejvh/eMqjA7EtE7ciYcZ9JlBasE0aqOBw4pcehJf8xkhoKnArGF4ZA6Um5n+v/wAyOHkeU2qdo/0+M4MaRCqQqBAjEXneI1qAoyyncpcsIZrpvcs6OXka6y7eAwCC7eH+cKBHpAgo8IjD8Z7fsY1Ygj35w4tRdOI/pX+Gc65jtWD8EPxhNIBSh1oAseur9NHNKNhI/u4FEH4CX/gmBLvIjVdHzcTEq/Mf+Ye77vqoi/y/GHK8ik3SiKEDjWHDNWatd9xBpWI/uSBgoiLTYmDARPiXKN/MvfAK2V+TuxDq8R2724yfVbN91V+ZL1xUiNEpEi2T8dOc6TRIWAWlrpxOuNEoh0Kp2WPfnAzAAUBVUN2b74CQjoI+FW8dehlx2MCioLYm5IMDeSHMUxAEIqxDe/tM0K3BKFRsK1ym3WN1TlEXLRFdHK4/j9rb7Vbvvrpk7gPD7qqOunMwsoCCXYOn/fnATF1gF0Yq3vvCaHAwQVqKt264kzW6IHojqZWe5t1zsdvc3hypIgBZQgO3I/SEK06oHkR0nvOczSBOG1Vd0tI4RAvqM3Fq7v2MOSwGKOGlr06a1jur3sSS7T/J8YHjZwNVWI2nNzgs5Rh50I/7gxBsyBeQgO3I4ISxYtQ0ICk5Hg+hgBEAEIur9sF+UcRQgBIE6f8Ad4gJVrRAkVSxY4ZEUcC8iq83pHAKDbFhrgE68OBxgdAVWb6NfdytUYaRqvyHd++VjeZSIO1fnmVxWs7Kfna9OBL1x5MgMV68D/MtVwKFNorXA3QsCkkRiLzeeQxx0ncA7AKsAA26MPL8UgA50rC6M0O96SAoAjy55XEwxeE3sBEYpz1+2UqKwttYiLt5a4q6Q/Gg/HVcEgoarcRE4n3zScFC7hCIEXje1t3iTBy1/kp/mMwUVVaq9Vzi8QHeqFE/uYo2jyt6hXfTb9sOJ8UgA5YrC6MPwk8TdDbQdN3ne3FhOMkN2tW7eEybCiBHBXKmeUQDdESSpb0y3/U49xiRoO7s+9BIR8EfCreOvQzYBPk26tk3xOhh2s0BRJatddJ9sHocUNVUSxNuA6ZtvKqhMorAZujy5cDkCqiNBHheuBUIkA0Ia3u3v9N5i/uayif3HK0EsyqNJXkOswsTd4a99p/k+MCJY0AQRWI9e+aCWpHsdUlm9d8PYIEBCotXe3/8xsEkhDLSo8HAYI3Ui/ssmu35w6ojqQQiIEnbElVpADsAa6//AOz5AyQMkDJAyQMkCl6mMhsBZU/vPafGe0+M9p8Z7T4z2nxntPjPafGe0+M9p8Z7T4z2nxntPjPafGe0+M9p8Z7T4z2nxntPjPafGe0+M9p8Z7T4z2nxntPjPafGe0+MLpyhUyrA45VD857T4z2nxntPjPafGe0+M9p8Z7T4z2nxntPjPafGe0+M9p8Z7T4z2nxntPjPafGe0+M9p8Z7T4z2nxntPjPafGe0+M9p8Z7T4z2nxntPjPafGe0+M9p8Z7T4z2nxntPjPafGe0+M9p8Z7T4z2nxntPjPafGe0+M9p8Z7T4z2nxntPjPafGe0+M9p8Z7T4z2nxntPjPafGe0+M9p8Z7T4z2nxntPjPafGe0+M9p8Z7T4z2nxgY32UignT/wA2AYN/jf8AP5wBq6nVAO7ieZC1nDcQm6gYnB5nr8Dg0rOG4mtsw/cEVW8B95MoC4ABytUdb5H4wveLDoKFWBuhvvlQt0kVJ1GI3y/vAFAoGK0IacWNNxwe6ogQEAKDHcX75EYnyWcmB5/LjGofWDYyrCKWomJiR0BUgIBeqljh18ARbQARVEKtNbyD0j4V3ubOXanfELUnfSWKvAyfnB1wmH5IcB3UM4SdACAEHV776XPyqJ0EVV3Z2H+AGeDIg9lqITiDvtjReDlwVKJR1Dbti39QgIVhab5Y/GIxwqZ6o0F4VLjz5ZFlIQSoUd9LmvOIuOUq9U1ow6Dxw6waEF6oZTnGVloRB0LzwOFg4mZqkAduXesGTimQqgMGo+6DMNANBAKQcWalvxjcb/AC1JAO0r8YJzye6NHof8x04JS6AOVemaexIOGN1peoJ+M2zVGNyhAPulwOqlpwWRRQY2ad6clGSYEqbBQddFwqOyQkqTfprGprKa4EQMQnpSiU7YrexGrgE2qAct4MdKuheFRbaa0/H6/8b/n84Awg4BXdV+ynL4z4+HYk1J0mNXw5pjS0hHSW8ac12Y05ixwLRDousBf+qN/dO/4z2tTyl+Jn/czuj7KW9bh5tOjo7l6B18pntezNMEhgNNboT6Is4xvfYatTTaN8adbN2+xBodFs0DTce+NmSbQCr/HE+bgIVSN+9DJodrrGJ3B11DZvdM7EKJiKNrp8m+ec+A/5PvoSdt3+AG6EFa0aIfdmsPRRByRK/F19HjVwQvR4LuSWas+M87URLNyyzczyWDr0JO27iC82k0JBaiqh1y596CRTYAVV+O+V/tAvbWxiI9s/046wDX1FH/R/rE1vjkiIPcYP3M/68M6PxcX843XpMttNZh/XZ5Iv5tvzct9wX4C9J26zCl4ux7uL4Oeme/8AL6LPUd8EZgu7srkpv4y3lLxWB/uah0O/6/8AG/5/OANDOCqJ4RiJsSmLkVTh0FlT4VwjuOhAhgITi1+XDiHRl8RkQ1QNabg4vABeS4GtWWdcb3iw6CAEo7q77ZpC3ZFS9Bid8v6w4BKolAGQEGyfE1i51RFgBQAsNwPthNcQrFdEI3iuTkC1AIFg1U2orXd3gxKCItAAnXaR+cHK4kYHYktTebN42FzEmotSkUWOsYgIapOo2S9bOemOEHmqYECdygOBkFfA0SlUKzoSZzsnSdRiEEg3he/8AMkGw5HAOErvBPugOUogBewYMNMC8yD8dqw5wprQ0ecRFq1HElBSa6IwChoNdJk9eMJFCEEg75dY/wCwBNGNFE7SdMdBbMGgECV21a9s2g5qUwCUjVsnTG6oljYrsA0rNfe4lG/JPtoAXboY2kLkEAFAIABNBhsPzgyqCeX74UYwWwUid1Oc3gynBWthQvZDOcfDUbQET7jj8woq9EtSoLOh2xInKlA2AiuoS1yN/wBZBAkBDXDX5ys2PiQpAQIQa/LnJwpXpCQHgR+bg53uAcoWAXsH6/8AG/5hDtTAU4XonbPZPOeyec9k857J5z2TznsnnPZPOeyec9k857J5z2TznsnnPZPOeyec9k857J5z2TznsnnPZPOeyec9k857J5z2TznsnnPZPOeyecLADgPIU69zPZPOeyec9k857J5z2TznsnnPZPOeyec9k857J5z2TznsnnPZPOeyec9k857J5z2TznsnnPZPOeyec9k857J5z2TznsnnPZPOeyec9k857J5z2TznsnnPZPOeyecLADgPIU69zPZPOeyec9k857J5z2TznsnnPZPOeyec9k857J5z2TznsnnPZPOeyec9k857J5z2TznsnnPZPOeyec9k857J5z2TznsnnPZPOeyec9k857J5z2TziaOqnyGAzJoEL9nPXPGeueM9c8Z654z1zxnrnjPXPGe+eM9c8Z654z1zxnvnjPfPGeueM9c8Z654z1zxnrnjPXPGeueM9c8Z654z1zxnrnjPXPGeueMZGNw4EU46mvznrnjPXPGeueM988Z654z1zxnrnjPXPGeueM9c8Z754z3zxnvnjPXPGeueM9c8Z654z1zxnrnjPXPGeueM9c8Z654z1zxnrnjPXPGeueM9c8Z654z1zxnrnjPXPGMjG4cCKcdTX5z1zxnrnjPXPGeueM9c8Z654z3zxnrnjPXPGeueM9c8Z654z1zxnrnjPXPGeueM9c8Z654z1zxnrnjPXPGeueM9c8Z654z1zxnrnjPXPGeueM9c8YIAEAIB9scPqfTX0msDWdM64G/jA/kZXj69c7/TrnOT+Dl+P13+MGCElkkT5ZhhQrwiB2RUAJOXAkpzCWA1ijcpQGsAm2gLOBCm3egV1nWl0Bl32x0oiItza7+uBiFQUCo3Mm/h4NbENQcSOxlT9F/yQVSlTl4gusM9kEmVAlIUDXTBz6kkjoBWHVR1N5zlTPw6dAFXQCrh7FolaQULURV3tByJ81LSK2/KI0TYw7gzBSgoiNEUT+BlSGB8kzqmk1eK5tl8n6EiiaAVsmX0g5TUmZSiiUphGZElRaaIFlCMVJmuMKGlZ6iimsazApYeJi7VIicEbcfuUJOS2INNQ0BVmB3V1HUFAR5rA3ZhefrXswiMYiidHGrqAaZS7Vd47Xc0OVQgjVRhd8H7ZOsBCRAa6nWOByS0oLG1aXiTr0w1gARWMOQheHTB1dCcal7eEBK2g5DDGX0l6VS7HSkf4WWYBhJKijBwkAcJomykQNSDdw63hWanAgi6Bs05qZeMTNCgdKQR3h2uIHJ1e10EiWNye/4kBbotF3xmy0MVO0ISbFFpLuHHr5EQGQEUFEDpdP8AGdDDMg3BQX84isbD1Awi7RpCW4rmjKutxbpJacXCJAaTUSKokUQUzpYQAQXTMALOMTnVJgr2Y0LIeTLwwGKlFQANPA8sJwR0gCBPZkfhwJOrDKH0lgtI1TBsCnyMLTSxS7uJ7h4IQTFECBZoOPk+GJkq2KgEHs3igNQBJ1N9AsWOEtfSHFQSFBjp/fymBQO7DxpcZEVi2y1uNOc0vy9PSRL9wznjDSog8IUY2lXXG8V2uFccBEohUsZhz5q7IsTi0Zdkx66DKTtiQIpaUw8y7C9nhtkEHVSpk4j6lOqkNAOJzASssWkECI7ESYJ7NFUDl0NsNncxnDslECCpQWWpkHHsfmFhUrodnFZiKWKQIkFUUFC6cUdABqJEFjBdxyvjXDMomyiU6jhh/Ays6dLa7fIUEvKaxrpYrRwEWhukujENIW/kLaig0M54w0NZ1xhNBtBG6yUs7XawUFEUWk5y75sbhaECBNxawFxQkLJSwIpaB1S4o/EhBQSa3YZxvjBPtmH8b7YfQ+nV+hhRCU7iREDfCPR5DEM+iQ0BQACsABf4OXt+jp9Ic51zp9OmdM6/o+38LK51+Ppfq5qfTv8AxLEiywT+wf71/llKzQpWaNGjQoUaNChQoUKFChQoUKFChbtWvQeae3g6XmG//glChQpWKFClasUaNClZpWKFChQoUKFChQoUKFChbtWvQeae3g6XmG/5xSs0KFK1ZoUKFChQoUKFChQoUKFChQoUKFHAKC7kezKf0v7t/j5b/wDYy6TqGsVWBWAuQNyJzLo32i/TZtvtgEg2c/qiaS2YiKjoUEXXc+vX6rhl+mjLjmaw5KcXBv0ef1ZRysKrUAA2qoTD9oEoIiGoSB4ezhWYIwIRB+J1x36noBtXtgftiluETSYp5yxBywFfwZqXnC6dgrQzix3lQwG+0WgJtHHT6RhgCfurxhFgUTYn0753x0xRsLhMgOxTnWBzIpQOxHPnOv12DUMxKsNuhx9V0UajEEojsw5/byovdiYjCmhHHzjOC9DE+EPqJYdq6DCmhAk+E5zrv6arJeWkGgvKf3iFlxLfuiN6Ddby7+kw++OQILtyEWDFMdHDs0/RPp0+j+wiErPYoqIuIbiUsyWSGo5huyOyokKAwiWksW3IYm12ua6ESKIDCqCIB0wXC18oitSCMRtJi34SF4Y7QANxpuhJ+IuYGa1GtNgEMtUTMpW9qF+LlfpCDxxGECNI83B359CokEZqCR0u8qMkDzhh7BbsUUM2FQeQAMsKOAR4wA/gBuw2OBbWkhMfHq+UwAYiCAmxvOMG6MMOlSQncKkYgkCyspCaDstSGlXB7weKgAJkWEKE04w9Rba3YJ0CutaYL5WRANql0BRBjl0xjbggDEbMBCYLzdUHHkYQI1Hm5B52TADB6wNOSroAZEi6AUPi/qyrGIgbcUNBR1NhmnVOkBIhHSRBXW8FTEBsEGmGicnTGpTEMXbgupqUKKwIVuEIkACOAQqUQmLixxgBgItUCijcKMaEK1V/oPgMoqq3ITxEBRAVRmAItQ7RUjiIIhLzBR7g0bkjvc6fXB22dXCBS0dLQEmFFks9cx2EQREYmKlWzHtIlZ1VE5cZp4ClDwkBgGvGF0l5YENCuIiC6zg9AwUWAC0N0FhZjCNKAA1NA7IKsLCZNpFsgFmVKNIFopDPqGSlTSwA1Bbxh+AUokzVhhIs2u8a0JNQhaVoOWE4xFD1c9bTR1nUbOsZP0w2wAsSaRpTLfnpuFToEIfjH9nLa8Yh0GkrzucFcriaBRDHYkCwsGYY7GqKqI6gLeSjAzewpOSHqV2AxdS4hAIqI1qMEoiV1AmLeLpgdACGwAFC0or/AFyJUVoCpAtNka4E6CJEpWoJKB1xa8SXPOhUOgYIRygJa2syAIycfCO8m8vDAAXRpYpHePOalVlRZRogCyu+JhFa5clQQQQNKwuakDmCPUFDkUTluMStp1qIQiFg1R2stuYNgXomq1HhDWANB+kchGVKpUJZMMgUiaGpC0uyEbCmdKSdYGgjAcjetyzZ5GkITUS1AAC0c7klGCggksA4QM3JFigqopEHSfOsqkiCVcpSLg2Rz+v+zZBqlLLZc6ZmPHq2ZZZXIVc4h3em2IKxbJjEA1ChKJe46rtmo1cIR0ByDYXnWDj+QYSKVNKhVPvW+JReRNn5BZ0ySnrB3L4PuMvXEebRxBEToiCfJkxRlqREikLICtmf/tSIldN7rnjIKkUTRWnJwI0ImMAgoNQvQVYpVVcIo8EOpCsAol2dc27oO0CUg6VVWEhrDAnbrVaLHcjULeMt3ZM2b7bvTCT5xR0cB4kSVQYXH3zWBIVGotW0rE1NBIfgAPGUb3lLlwOZcgUtaiaInXJmzbEiJFIWQFbM5EOwjGlaS3VvBjIjXnGS7M+1f15X3ggJ3uWJNR67uIcTQCqBAAkKdtXN/qamIJiAx0x25wIL4tobUojIl4WI7xJRgIVRpFWqpWcGsSoyJ/CNloqIQlLBEcQWSFKO6ltw6fEd4O0+AykjqC1Wvc4yzrqdvbcCsTgxuFcxqvFCAQANAGnBVU/pk3bU+Db0wMYtKtoNkeCLvtF1bBc2nRXau93E+FPNDyE4mj98WXBAEY2vBN1zxkSCRbcMGgau8M25iQ8l1IQDA04ETBKBrbSpS2aUb11hlcPaAYtI5VaKq6JGNXGtQ7U2jYIzGY3RdqQACq0J/jD9nK4pG8f6FGnPDfjnH6Rf9yovRz1xApAR2EoC5KOiJlCxkF2p9Vq0mx6TB7R6miIxLNY0ZrnPskvcXla7fZiwfQhrF2bfgSdcHCbqpGTuAEKT5mUoE7bsgCOoagzcqKcHW7lCK10BqdblU1ubw+6p6IHZknt/uaIrSCidTqY9CCm+MIdraxGQwBsWEAgVCgCrJwGN8aLTY9Sad0/Gb7ZOdQ2FQjWdnFnaHB6EaC3B2kwf7BHWLEKDSQHS72pnEvleVVdkUE5x5Q4QacF1ogSvOMd9C0elSFCvWrcUMAWjqhzU7JCAVcf2oY4TaQdlNW5P2rrLv6dv0T9HfLh9Zk19Lh+zl6/Tp9DLnX9H3zrlz8Z1+kwx7YfuZXOv6Ov6X6zf06/X/mdcXD9ViQbJL/RP86fy2zYoWLNmxRsUKFChQo2KFChQo2LFChRt0rHqHdHZydLzTX/wShQoUKNihRs2KFGxQo2bNihRs2bNihQoUKFChRt0rHqHdHZydLzTX84o2bNmzYo2KNijZsUKFCjZsUKFGzZsUKFCggEAlFe7AP8AD/zmXKDVREpd1SzjeMmUxIWuyMjY7wMRQJPuLQvO79sSK9nd0dJwXTucY8RGKrPCCy8ZIShjUGiqF42hznBRF5Ga27Caz5NA17UK/bG+BWJLBAc4+DYfdU6jjDSVbHphbeoDHUFT85O3qqRLEkAbU67MCLTVIbt1DhAdzjIIyAnqg0PvkS8DMWZhMjEebuYexTbX3EX+scBIpACDumigvBTNWuhGybXr1q4MPkNIZdSF1eLjY0WVt12/xc1vqSvzC4qCBSWRAjoGNYYgF/AK8gGtLw2axi/zpuaJn5xPXjoJIFqiIhwk+sftjVhFufE4brbemN4yBt7nuDp1nOJGGRN1phsa53nX+jlkALjVA3txuOT7JQqfnN4MlZ1ero+MCAo9sQG1ChnCJi2njx8aFfyxCDFAt8yGjbxG5D9ovQIV3qdGzvkwdx1+KtXpMFsZ7WoTbNG8W9cP4uXlc8wclBagAnVus1/tBRAYiJZK1k5mDM1jBwpNsEWcY+MHoaAlUFnV4OMUCAhICDumigvApi++grZNr1driXArBE2FQpXpcTcQeIWPNGy85QUWkl6Cp+cuoPRf3LT+sj3zfz3Wv9YPhQALtL/4wa5fedLDuWn9Y4HFcou5ewdemFMsWAvUFldOjs4d1mrfJEH4uENdcgybEgoHOJgEbAKCaqChZNmOGECiPEbV+2Tx1ug4ja/1nKgcvO1Cv2xBXx/2YL+MEMpRNj+rpnMxiIgMa5lyEgN8GKXTRe54W7sJ1x/9Rz7xu9+t5wtlZuAo8DIbq8AYAnqh0wuQgBvQTHXuC7NsHbIHbt4wjcghGDeYBoIR1hOmvBCkRzVAUQcYZERiHCQOA/ywrV1K2Hcd4133hzEIBgwp9MsX6jJvaGxhby75wZncAxMp0+MjjdWtBBABAl3Ya2X+OkvRo8sXfzj0MXAYknYGASLghAotwMOrAvyw5RSBTQdhbA0KuSDYIOGJEIlQCNOKGOMSAZemgD2xo60XSeM6b2dLhlIpuk8Q91ZN4jA2g7lOQmjtiCFc5VNfpl65/uYIipSXjpwkxiQQKIsIgilVxUE7EEFEokrtY4yvQEmBAbBBO2IkS+NGIpPRiUHWNNfokPEchAhH/rkvGVZiKGwQT5wWF5S7JyYhrdwNrQFECrTKpeGPJlVPKBtXRQJEgYGsteMPKtnL/FypM51GgiREpZri4d9UwKC02hBGfDgqQ0NyFHV0d5lNpPvHg73Y6Orrdzel+AA6PQPXr84lTlQGJJ2BwEi4AxPACQVqoL848BMZYNRyhOuzjFI/la614/Mu8gNxV1KTPy/zcUNA8obOwIGwTccqQVcBQCRookKyzL1F1Dsk+bxgOp1m2VTq/LzcNBMPY1aNK7DesJwmFGQidRNZHx4j+CEvC8xTrjEFx4MYPYIOxcUw00XQM1eHvE7mKY2nuZzfY3ckylqpNtdF8I01jiBzJlrKrEREGbg5goICiApQC8YjDYW9EN9gD8frHA0YEBUFUAr0MM4gACFVGZtVdbXAxrCWqAqFYdLrOCX40Qgoeo89cOxJaCCCJxNEmsM4iACFVGZtVdbXOFqXWvQGfjD0bUSLZZpd6w5vBBTihSdMmf41QSQF/ODM1YXLEFXVdvXAToVE7LmhXTo3kZY6kRChsClN7cUZAKhFkiUFU258LMn5CKHOvnGIoSmnYHQNGtHbC3gABiKZskG2zAMRACaMFLB6NYAwk7rblE9Vt64YbwLvZpRrgmExSZJS2yWq2dbjAc2A4gNgaB4OM3jOb38gX85qljt1urGq2m7vAOmCgDUDp9UrEjxn4h9PtmvVvjnefKatFABLiyOoNZaCKaF2R2y7Vkokq3RpkplwsbaW6AXeCuCbB1SEVdtNu8R+DHZI3zRpnTWPmQ9KSmVJqXJgvgae6a0aNaO2Xz4UMlhU6S4KTg1TQRStzj+NlRwlJ32wzAYxILp8MnxJivXVACKAlNM5xJ1m0SpU0qqzq3EjWYK0UcgUNcMMZeMMEIpm6AK2hnbMsvxGQhohrE2qUwRAwKBo7GU0V3Z9AXe8oxTaf3JX+8TFigEvNj/rL0BpN1RRxpwkAGgkMrTneRzSV/vI6flE0iKwULxhY0uTpFuBuJswNwusLq9/bcsuXV3giilEu2jcYiKlnDAEFBQ5Q7YoEKEE6k7fnOTiAROJN/3Izn0W8RFP7z/WXvSCn4x7rKJc1g1yr939QpfYCL2r9nPUfOeo+c9R856j5z1HznqPnPUfOeo+c9R856j5z1HznqPnPUfOeo+c9R856j5z1HznqPnPUfOeo+c9R856j5z1HznqPnPUfOeo+cOldZWhF56A37Z6j5z1HznqPnPUfOeo+c9R856j5z1HznqPnPUfOeg+c9R856j5z1HznqPnPUfOeo+c9R856j5z1HznqPnPUfOeo+c9R856j5z1HznqPnPUfOeo+c9R856j5z1HzgkrcVQReeAFfgz1HznqPnPUfOeo+c9R856j5z1HznqPnPQfOeo+c9R856j5z1HznqPnPUfOeo+c9R856j5z1HznqPnPUfOeo+c9R856j5z1HznqPnPUfOeo+c9R84nAQiER6n/8Dy5ct+l/j5b9b+t/gi9WFgqu9NzFs1ug8sqPRBRhrLyXWjet0K8jgXNwPaBvIl3To1UUMtn6yqMhj05djI40sNU6OzjVCEhVKGDPIKeGiTUJRCINmEfusH2a4sALW9lwnQ0mKAQiCTQtCGBS+AtaUbAiz4ldYOHHKWKAIbkJumsozKIIFvCn2fh/hZeo7/FK3wnZRwAwZ6566T1uvjKcBYRqPArFLBArGSwIgeLNgA8OrvWMH9OS6+AlqhULLlLe0kxEE0MEc71jGJsN5Qu0KjAoCtiOFkbJA86BHl69s6h7l5UQiAG+LcBEmmSgnpF3qysyOoAXGqFDYAJXpBQFcWVjAgdRhzsJiXGr58yCDTUSWLMU9LuJZF1jaFEHNAF2hlyhhFXaMArmlfYVEFduonIsXOQaJiBtdAMRHT0Rp4CCuDoFaw0LLldyEaeA3Km+A+c7IZFsF1EPxhKYmo4HTU2nWTXOP4PeIQELAyIpLkZQ8xTyCYUaUpzKtjVn3G/k2lsJMFNg4RMU7Ai6UMOP2Mrkex1bxya5k+cYzY8Q6daWwcUZrLk2CABcIroAVbxFwHq3YqSgbAYdbJiLkl6A6FIGSGJcr6ElQ5srtC1BxOX12H9bSDStF4mN1vJWVEIQJvi3KqGVBp1VQNRdC4oJrKUbnR0FI7upgao3YtZBKGmlKcykTlg0oOSIFaeAXNbDygAQKEXggV3GbCtCVQFGNbNlC4+qkdYCSgHdRdC7gNogqYIOxV4kI1NV4jYinemmK31Jk4/cNI9GA40MveY7EhAKTIJpVOExal/RDXdxA6O/ObCsDSB6Gmibmfi4lCvIgPC3pcipE6xu0JHMaJw3CaXLm1ONABYU6Zsiow4/o2EjSRUmUfCHlwiJi2MNAuaLbZUDVa1XA/OCKLMyL3hE0mz5uM04AMGCASIFCdP4WVDkgFigDdCr75BtRcdQG/gQ98gMoTbDYaTi7F2awNTLpQIJtBq7UDGFXXZE/AqHafh1lT91rW1Wtdas66xxSBFsVgwd6pNQeRanw5qZzQz2AvGMpfgqNnytfzjs3ClhbURpEau2LWXmhpGDKWoQRUTHUiaFq/SoqlDhZgKSlZBA0Soc0jQC5LDDTI1DYbNHZyFKzAW0TUREGHMzeQlp8Regm53xmDQpHQF2dlGtuQl/N9NDFE2ku5iU1LEF8ASBBFQ3tbCor4pSkkG47CIcG78nBWblmFaMrTSulJUqEmEcFYrgKiSLAAysHju4urm3qQsG+2ax7WQb1QZ8KvS4cfsZUMXg2Cwkd3r0xQQeKHAgYGlANuOzHYM6CPaEU6IudEEvxgpVslCJZkz0PdoQwqVhYExyzAp0l46NCLKhUOk7cEcWLShRnKzGVvephs+Vr+cbkUW2yjqcE0PTIRL5ITOuoOp398LAOBQ0KiSLAAysFXF/K+O1JHIDeubGlj0UowtOUTrMehEvhOxjBcLelyxBlWlOi7EU6YmDhwpBjcCGkFIoNyWJdmJudiSg9w4/eJgo9MYgaAdraq1V6qrk+lHjY0LUsIA1P52XkNU1V3GV6cYhkBKi17Be5ua4yfuI7hfCtqh0hnWfw8qGQEqLXbQvc3NcZP4xQuOVM+wN/wAsmTJkyZPmTJkyZMmTJkyZMmTJkyZMmT3pGkG8N5aGL3Na5/aJkyZMmTJkSNP48SZMmTJkyZMmTJkyZMmTJkyZMmT3pGkG8N5aGL3Na5/ZJ0yZMmTJkafxYkyZMmTJkyZMmTJkyZMmTJkyc6ISohe4K/8AX9D+gP4uXpiZP0dc6/u9Mms6fuZev81I4uODav4zkvnvHI1dFVrgxJUDdWOP0uLE5I6dKXXCH1zSDeX6KPHFtBdCEjS7uuuJNRN2h2tCxe5ly5f3svbIKgykJuoV7YfqkqtOp43l4ynQj1D74m3cnop4k5ZLcuM/23O203fkSdf0v+MnivQ0s5bLrj6X9NxRObN/4AJHO3GrMuLVOT8oaEIjrd/S/SL8xbQXQhI5d3XXEZmTdodrQsXuZcv6Mrin88PwKduOSc74xf8A8niKduOSc74+t+l+lw4zVtPBqdVben0uX6tOjPD0VSN6Cyb6fS4IXgt1eXpbo6xy/t8zrRdlD7lPzklXiZIKnCcJ8ZbUwFh3hF7k0EmEepsC0FqJttQ5zi22lTLhBnyrzvBF61gub0QgNprGjsGHkikSdTQr9BLAv+4wsTURAVpuMJVKHoJENCKVU3VyPEBkb7uZY7XGTJfwr8oD0l6ZspXYO8q2HPUS3eD+dNQAxlmo2wHRgY10pRs0wSRyyLgGNhbAg1eDXL+9lirIHSS6UHcpeMQWaFK9atbrtJ1yvz082VFYuwcHpgU3VhA3dEl5JkbRVpDQt4oj+cROOnYouICqzXEaoKm0hokwuue0VdST5beQ3LOImRckcJ2cUURGuI1QVNpDRJhqGktnEs4QWyalwQTSiMS3fFoxdYpkGjfq35YEJqzCIJcSgQRaINNdcoDJXjiNxCm2DyZsp2F9BZTBpF5ZhUBA2IBTmVA97iyfDLewHA6B4+WAdjhFLbAI0C6K5vmU0dqOoiQlVtuabHlksoiOyg4PTLnAe9AW7oodQxk16ozAYohUWAZ3Km3yLH3I/wBYeBX6e0FNUjNDIRsYCUVzCy93GSl/wr8oo9JembKV2DvKthz1Et3gfnTUAMZZqNsB0Y3sJcsavy851frl46dAULdylOSW5L0iN+Vdl12k63AtWBTgl6qEJzy4JtSOsChpWXi3mYRutN8kdRCda26xT7ptykDEIC2TUuBFljIi1VsBVSTpiLmjQJOtCN7rXHuu+EkQEoILZV53i6cCQpB2NfI8EFDAZOuLLVABYAEs4uCidABFiqEzfe295czgtMD0A0ClXnBUDSUADo1W5m6zoirQeiRX4wP1bfDSOrEdO6bypKBpQqEk4pscFpSaUsldVWr1W4PnXxsHdZCIM3b+27zQPw68lEe9N9cRmPE510fFRjCWlKYEEDDQ03m02sVKjaG1wXebhPKSw5KpjvozlnMK9oFOiHxlgl1llNNPaVN8aMsf9pFxBT8HO31XylgdOTCW3AcfaC0BoQjXc3cWVKEF1qIESAXrm0mBp8gwOknWuMmwN0gjqsoGiB0wbUgABxJn8sHp2CAQA7fu5XrnC3loBNixBnDl7dFtOSoT8OJi69NYSJ8HGi8zCg1LYNqa4wnKHQDQmGnCi6O2UxaF4gwsoC06wKY2BibqbbQg8ImsVdHgfMLQDsSh2Zsyt90psw2AV0GJzLgRN1dtoAeETWOygkAEInQdlLLvPgEm7mlOF67uHQHbt3vPyq7W9cHKpJs4YiQkSTWKqzjj2i0fZMYNcmJRaQdkEcH7ZxHUIQeTBYYdelgg418QScYXFS8niMfAZkCycBGmwPkro7ZbRSZnASZeh5xg7SQjKEHRtRhrO1qnQVFZoGoaxEKZsja7cXqRa93EJABFc1g+FmaDpHzIgJiQa763E1WhBSaiBEgA9cuTCtPkGB0k61xk2BukgOrqgaIHTN2pgRkCqr+X9GVzaVCrgRjTWxnSYwhChVxIxprYzpg4XoLei37qK9ckE5zTBsnK9Lkf+V7IRVXSTpMVcpo3nQD1LMZQHI0hEV5Ntebio0wKuJGNNbGdMvIMGrQ2hOQLveKbhrYqAFVdIJrjWbRSDogDUFqK22tcRkAwAxwSaSjSGFqMXoNaC11y1rjOkb1icFrakdchNVmUCZBUEBFYBwQ9ooGznBNqdYM4IAhCVSC6AGq7xabg6ohSmhuwIQwDekJDQO3DUb1z4/iz/wCply8fS44J9TOFRsSeyAJU2Cl13cpvOuP/AI7LlcTUqi6emneJ1FMQ9RoBK5s0OpOI7yR13f8ARINwXzBZggafURwHaKAjhrNc11SNH4BgNEtyzB12UiuZaJNCLVdKSHNdy3SmwGTDORF9OhI6S2KTpEAbEkIZQCEVLJMTqJYpA+6bUjDSY+pri79WUCqm943196SzmjEQHW7Vw3/47LlMjCAcGAiicjpg9QPpFAiutInzcnKKKZHUE0G1R2TGZmFE/ZDoKcHXoqFKlATsElk7AHCEoRuCGq1MBOtTCiQksUREeph5GAUKFGTUOrbXFN03KamAXbCqFswZ4uwXsUG7FDDWLmAzagDoAsABeMT4VcQhao9YD2TA/wDH5ct/TcX6dfn6OOX+AMJBta/tDP5bt27du3bt27du3bt27du3bt27du3bt24HcSaReefZ5HZv/wCC7du3bt27du3bt27du3bt27du3bt27du3bt27duB3EmkXnn2eR2b/AJzt27du3bt27du3bt27du3bt27du3bt27duyEsEKKfK1fvl/wDN5cunBxjEox07Mnu6pQbaVVGiDxilLSUCDQ9QcnczZhsJTlJApWQxk9wKVBavSUWMDSvUy7uRAOrId8cHpXHjJ3t1JbrnEWfuACpQN6ULuWOLhqtAIW2jUnJGhN4LqEc3CkGcyYIgNyQsDbGavSPCYpBYOAhsbfSkFmrlq9AjpVu8BCKWG8vFZsjToC9ZMh0ZxVtCVrpLjNoJ2FHYS0HbhjLwVW4kZ0C8CxbrBrS2J6Q0p6AK5J5TwgF3QGmUbOHHXW8F7JR3AgrwPGWl+4rmHNG9hTZlVhcA4DrRNtDlhvHZ5R66/VpKL+pL3ya58dqKlA7sqXWICmY/Y4TTdQqs4UuhjuwAhup05UMqHcGkVQBWsURo3gEgkkOmdQCFl5KY6k6gISowClZN84cdowKIqFYLOGjsTA8RTO8OUV3Br4zqyU/LQFuEVI2atBRcI4BuYm0gbYbxnYPS3SM6BeBYt1gHbrVXCOGIg5x8Xu5ua3gORw5kamuANt0O8ubAQL0ITZpDN518UQlm20uhZq42qaUTlINxpLswpuGarFIadyazXE5MePEcGxRQM1ZFcpSiRqut1iQegYBpTip/ZZvBdpiQsKLzILSkHLULAKoxFREREQTDFGUKlQBQlKrQcWciYjbqColWq3DDSXufASqOisLJvBCxKyOFqLTTW8t5C2bRUBE6lOeudUYjkKAGUd8PJ+nLAfJE0tqUjvUvXNLJJSfACjoArnIhuHpWU0bKbOLhCPj49BUa1QmBbO4yyU2a2X4wZwBLxyWGBbIq4IogymyI6S459AsIolyoC0OuK4KFHQoWOebUdS6xCktuPLhqeA07wCgxiRRHqZuRVoiAqeppEyQtCY3CkDrWa3xmgrci9YKAt0nzrBf7qC4HTxpDsyGQ6xqUsqjorCybx5bIpAxAFHUQcZ+2EHlMHRUmEQkdVFYg7lsiR3gHzD0uAgroBMVWXACEVFNIkV1u5CcxIZ4WQ+ZMGhYuDlCHrs63xmwfkok6dBHfDEFdYl1MrH2oIIS74usfyQLRKaEo0U6w6kUDdLUJsI1upcRj345AEFOKYYsgBLUKlB1GAaAKZOYC5glydukOWlwG5xVbS8BgWWdZiaXwsNbAS2lBRuIRex99AlEMt1xgielIXVWIIlhZjsRTVThIjahZF5wx/shgC2NyHTlMCfkJKb40bO0WLgvn/LWAatCKEakySqK7QSH+y9cISDA4qq/dduP5KMTQTBKYu9sPjryxDXPx9M2CERCvCfjblvEVqhoFF1eCj0xAqiaAK0CSBSl1yOAwSa9EaP3MWNUeKhn3Qh981+RSUCCF8gYt1S5yh+nNqwQlaY2w/Sl75TBwV70EQNcusTfvKBFPI5AYMMZjUjTNLh0iOaB0MVtFbo5El+SP6Ml94i1SShyCWfGMiEQkeYBLzsu948HyKYoxEALrqc42ONt2Vfd2fnNYmxohBC+QMW6pXGCrNhU4r22/3iY7lB0AgPg4yiyho8AHZQLJGY7o1bVxFdwn4YTXkOcFUZ3Yf1lTSoipxKhRFYdOuNrOJAZjEQaS22bw08gkotjA2dosXE+WS1Uy/dcOuPJ5JA6WDlOMunVy1FCiiUTLJHGN66/5f250ikHBRuum1fzjsp0UUbexX7AxlrteEQmKUnIMRE2a5wyAKLYBthM3e0stxqDcAIVxrKIPYdfvtT2mAVPl8Er8vP6cp/4VSgCvyofnKkwW4AGmgtQrXOE+cUhKAQRCsJrWMe+1BXJ6MUVGrLtFGDS0cmqvT3zcj0OWD3SKKkmdfxzdz5V6EgP9zDnJ2MWoQjHppwtxsBFlq9HTkmqBq5KIEAh+AALoAaxGXvgaaubYp34xXSNQA4RsJKokm8swu8L5/IE6SYVAvWhYzdHRC3jEcGN2gBD/AGXrgHoV2Bbv5d4CxMK44ACuo7FxDsiCjCopRBNYANEjuCn9K/3l+PxMm+BYokNAvTGIiodAE22Msjq5cGGkZsRqlags1oQI48oQv2r/AHiQEOSXNBoVFdVMhG28SLYCpEHhlKbwY5ceiKT8g/cMAphKaFor30H0mTJkyfQoaoqQhFFpR45GOk5wARuO0HdFIqrRAM6YKJjVdD+wk8ac7lyZP0T6zExOERrox/vIrQ5a+lR3AFL+xln0mT6M7ACT0TcJ90+MYZLMhaw0AAA0BhiImCI10Y/3kXpeNfSo7gCl/Zn0mTJ9J9R3CDTRr25QXgUP2Mrv6y7oosolnXnE/GPMl2Z/bn90yDVKWWy4n4pPatmWWV+hkyfSfon0n0mT6z93pl1+10/dy9f5uWOdegKjERFjeZpwHgBMHSQSLXVBVGYtnzsIqrwBOcED0slqVgJsXk4whh0xTA1FOgtzhcuoVobBtnHXCXD/AMnlymI6SA5XT5FgfLlNxQYCq7N53Yc48P4cmoo0l1O28jXHEFGVVOHVUBOcTPwMxVJBq3fZlYSgFdofCfic/wC/+Uy5bgpUhw2gIlHY84WSgTS4sMHR5MebYwlpEdI3jDQVSgcFmhCa1gUZBgzoSVAnBXpXEbyAj78oqufb+MKX2Ai9q/Zz1HznqPnPUfOeo+c9R856j5z1HznqPnPUfOeo+c9R856j5z1HznqPnPUfOeo+c9R856j5z1HznqPnPUfOeo+c9R856j5z1HznqPnBJW4qgi88AK/BnqPnPUfOeo+c9R856j5z1HznqPnPUfOeo+c9R856j5z1HznqPnPUfOeo+c9R856j5z1HznqPnPUfOeo+c9R856j5z1HznqPnPUfOeo+c9R856j5z1HznqPnPUfOCStxVBF54AV+DPUfOeo+c9R856D5z0HznoPnPQfOeg+c9R856j5z1HznqPnPUfOeo+c9R856j5z1HznqPnPUfOeo+c9R856j5z1HznqPnPUfOeo+c9R856j5z1HzicBCIRHqf+cy5XX1szrj9CZ3wwzq585+P38vX636dc7fRw64n165MmP8ACy6/OHTNdPo4fTrjnTLhj9Jz9L+60Rgk5PbqBrRFoRtq2BtxnVeDxzAsDVOVnGSVtEkHsQT7J2XET7UnsB04NAOoxj7Jc4ugMVAgquPPOkoujaYM0qRkwPGAl4i0VtaP3cBisJA7EwoxVM0YpaecQiLrG0KILjrnIIx4Xc2J3HKOGdQTgSkUqJDiufTg1RupEoQVQTrirDkkQdIUAjC5rnTUVrWLBYaHKXIN8HO2vdk5gabyaAxU0lE0wtIV3Jg8FMFroppQ0I981BYPDuBcHUN41MOdXSgfDTXa0EUxt+KAIgStKRdFUofs5bBnkHt4jU6DUp1wDKkW1kiFdwvzMP4PkoetF9DE3puoShGQwm6PWqG8MP5z2NMMOmhVTXaGrXCNVrCgGjVdJi1MtWBdNcn21gkAlV+rAAfg47sU8XgeSiEIps5i4auTglTc3TVRNzitP+5AjCYiAvAIK7i5pTApkSNFIFIpj05GzmgcqO8HZgNmHKVKJJtqLq3D/hggGJdEkmmwtsT1QzQXkTuNH5M6fwcoQg9g+A/OFGhjk+D2v91ybOaPvEK3UOjZhaHVLoVAiHZxabLmsvAA6qAKk0XbBeVWtrBKKKDeDg1t1hYAtxaCgWoREZ3ubpf2wrIlh1EaRRlMFaryR9A53ppTrhgDrVAMhsRBVeAFxrbUzEcQR0ihN64wyLLXyJFmug3rFRhiGuYQhVNuNVhf8/ane0KDQiOnVIXYOQs2KGCTqRcMIByg3CNysIInOLR5wFKIuKEgoM/d3OZIKoFUCvV1gu5YhjLARWVFEusGEsTIveETSbPm5R5gqhdwcUKDsWY3lMt3Tha85BjbBuFNgMQNJQNilHnBfWC4wAlwsUACubrAQaSHjEHttiSKQkxARmnCgA0sjUNhxo7OQF0oAWInRSIMOZhhm6Q4Q8IgIobK46N+bJWbdBbJ84/jvOgIKmwjHWERfZoHuiHBonGBD5cbzcy1NSAgdwulIUNIR0WEqXYRl87EQmTbgJsjxjcOip0LQLrUS/GEwSNO6RNZUjXrGmzZwVsQaRE2HxrHrh+vL1I3FTUYnjSmOVIQaMQSsDaHMx5sS7oVA9QWjXPGdjNssJHYIRAu68M8ZcChyugtk+bmllQwKKjyQ3JzxvE0gSWOuVV508czjH/CtC36d0t6S6xM4SAooE1s2BCby7MwQd2gA0QHZzvKl5ctiadcKaZrWI4cRCtEPNBBCXbraYXfgZaNJEgaWq7Bo3wORgAGlg3kuqeySHgiBTRHVROuFe11y7Q6O12a/hZQsybJjprewZN4Ta37pNpZd5GcJMIyy4yBUDASs2BxFrQIrlU0AkQeg4wlKHhQ0C1REQQTfTOVFwEus3K1D4G5VJ1wAFqByGu9a2WKNWhIq8l4cAHcR0IcNK7QGhd4+g5nTbZeBuTfOLlADpVEdCClEKGDdXxT5BcAhtF7GQiaUFiUAULqnJziIqh6hBEaANo1rnLF1JJK0ighXBWKGLWTfyFyaulsnXEvbY3PXd1LEI9dX93Rnb6HP6D/ADOuQv0Amv0dfr2wy7/cy8ztmqtKG7E0+vX6uH0751/j5ev1XD6T6v074fTp+4UbiIhn3Fv+WTp8yZMnzJkSZMmTJkSZOnT5kyZMmTJ60jSreGcNLB7G98f/AASZMmTJ8yfMmTJkyZMmTJkyZMmTJkyZMmTJkyZPWkaVbwzhpYPY3vj+cTJkSZMmTI8yZMmTJkyZMmTJkyZMmTJkyZO8EJRQPYUP+H/nMuVSJ3YEVX4hcbc+D5R52OIXFn0d/Q+mrh/EyhU1kIAAcp1wNNABtkKr12B9Lv8AQ9c65d4dSwiyvgqS6TtLjx2SVFRjE09TLkaOoO9BVA6H5zl6qgnwCGu6Xp+jrnf6dcKKIBIVmpqu+v3zt+1lAhIrQ4OKnQMLJCAQTVUOzSDz2Y/RyW15NhADYzYPTF6WU0cWIJx1MNB9P+/xAIQaozRj3ji2UKn/AGMagNybN44xIATWNICSSHGBFFbYc+Up3zigly2jqA6OKwVKRADApaFBgBsUKggBpcVW9A+CgBKKKIaZI0PRxowKikhnONyvGYGmpVi8yMP4mXRYWSrrCBQvMFnTA7aGpjPUg9bNzL4g1M0VaRwkgiTLfeGJC9QHBZGi5pEMgJIbG1dHjZipvE0TuhUbtBROcuwnkEwbQ0Sqio4pbSANVQeEAt2q44nGTEyNGhXTxgQkAowN7sNKqd3piLZOqiImxHqcJiwX6SjO42kEXWy5HEINitQLG0qgrxktAmb2SiAiqih5Li6amyCltQOy6OkwlHxhTXy4q1k1hi/6NI2Gq0CIUErkZ3RqLfMRKF2b0OMLDaFDS1ibEUbp6YhgFufC2tUAwzW8iclY6s2Au2cu875DVQTRAHaAyQzg6f8A4CksHc4uObXvbe85iEQ7Bl/Zypiwg4P+d4uvOJe+MUghsR3cOxTI7FDRWxt63FXIEsptt1soVKWIapaSUGgCCIkHnWOiX6M1dCbq2ABwZcViSpmVEWFZGCnaOmrYG5KgqLoyyGUDEoJQ0LBBA3nb+IhSSRTqhsfnAOkGuiINRqosXIORwB0FBXabHkTWIWruA58j1QhzrNyErAE2BehDtW6szqjGx4yJtERENjiNuEUwEAFH9sD4MwggoSArqqgG3ITov7L7iq/nJ/EyvFEAKWlElN9Z2xSReM/6fbtlQlWHSUAWNUU64tMoA6IkBNEGvzjPUR4OoRFQoiYs16UlKDEU4E5HEYSXpIEABVAi7RwExkLL6AiLYG+Jlfp4RbBEtKOU41jJWDQREycl7OmG6qAAI8xHNTjWHvUweELQIKKHtktLQJS6xUNcJrHW0MpAoLaNrv41jrNWNk1RhxJ83OQP0Byld4EevLmsvfgy6LSQiEusKLmDIJbJBTZkAFESBRAAAAATBX0k9DSaxgoEevLbCsGEgKkQUFIHnNzEehIYSQ2NNNwn40MmBDYb1XvhPi5ABCCW6SJ+f2srbQIgnAYhen5uADi2DxtJTVa7e7jxL/HQAaQ6oNCc4ojLAdSAAghurvA9qDYcIGwzgGhN5QYYClogCcA0o9Vx4d4iA0AYjMRyMjTKJECDTrkH0dSLQsflr/FmOPX66/j5blw+t3iBUB9JEYeU7o4dmnLvECqnx9Ohj9OmXP8Av1f4GXph0x0f/Xy83pef5XGjlzZ+cStiKCJQ03nNSwuzUX4ESM5IG80/jvarA3YFjBWOEhl7WdSSKSAtp2rL6qdQACEOoKhcGoAzy4kZUq1Qlkhxwc8tsjYgwlGiJcCbEgHaYoiFVE0mbsg5b50pOAQ73B5nJbQVwYQFCtW5fiCvlKG5Q1o3Tf8Ax+XKl3kdART5zSWFh7wN5jDIJFuCv0AGCMgLQUx+MH6jMkcNR3o5Opkw9VlA6IeOt3nCVS6D2Oicvvk6Pg4Lo1EIw7TGN9Ib+QEs1oHWYxWYam0EEQF5F4tzUrLrjQgZdVW04CZr6oemTbFCPcswHTBeiwTYvCyj/wDw3Lly/BNe0PM3OP8AP5ckkkkkkkkkkkkhgVIURpE/ND7f/BkkkkkkkkkkkkkkkkMCpCiNIn5ofb+dJJJJJJJJJJJJJJP7uvwbt3f/ADn/2Q==" width=726></div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>5. </span> Smoking is known to increase the risk of all of the following diseases except </p><ol class=mt-3 type=A><li>Osteoporosis</li><li>Bladder cancer</li><li>Alzheimer's disease</li><li>Peptic ulcer disease</li></ol><button aria-controls=explanation-NX4 aria-expanded=false class="btn btn-secondary" data-target=#explanation-NX4 data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-NX4><p class=correct-answer><strong>Answer:</strong> C</p>1. Tobacco use is a major individual and public health problem. Dependence develops rapidly. Major consequences include premature death and morbidity caused by coronary artery disease, lung cancer, COPD, and other disorders. Smokers should be offered smoking cessation intervention.<br>2. Smokers typically live 5 to 8 years less than nonsmokers. They have an increased risk of cancer of the lung, mouth, throat, esophagus, pancreas, kidney, bladder, and cervix.<br>3. Furthermore, they have an increased risk of heart diseases and chronic lung disease.<br>4. In addition, they are at increased risk for the development of peptic ulcer disease and osteoporosis.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>6. </span> A 53-year old woman presents to the physician with bilateral joint pain, easy fatigability and swelling in her hands for the past 6 months. Her symptoms are worst in the morning. The pain is associated with mild fever.<br><br>Which of the following is the appropriate confirmatory test for this patient? </p><ol class=mt-3 type=A><li>Anti-cyclic citrullinated peptide assay</li><li>ESR</li><li>Rheumatoid factor</li><li>X-ray</li></ol><button aria-controls=explanation-6DD aria-expanded=false class="btn btn-secondary" data-target=#explanation-6DD data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-6DD><p class=correct-answer><strong>Answer:</strong> A</p>1. <span style="text-decoration: underline;"><strong>Rheumatoid arthritis</strong> </span>(RA) is a chronic systemic inflammatory disease of unknown cause.<br>2. An external trigger (eg, cigarette smoking, infection, or trauma) that triggers an autoimmune reaction, leading to synovial hypertrophy and chronic joint inflammation along with the potential for extra-articular manifestations.<br>3. In most patients with RA, onset is insidious, often beginning with fever, malaise, arthralgias, and weakness before progressing to joint inflammation and swelling.<br>4. Rheumatoid arthritis is an erosive arthritis involves the <strong>MCP</strong> and <strong>PIP</strong> joints.<br>5. Joint disease is symmetrical and non-migratory.<br>6. Narrowing of joint space and juxta-articular bony erosions is the characteristic x-ray finding in rheumatoid arthritis (RA).<br><strong>7. ESR is always elevated</strong><br>8. Rheumatoid factor is present in most cases (80%) of rheumatoid arthritis<br><strong>9.The presence of anti-CCP (cyclic citrullinated peptide) is more specific than RF. <br>10</strong>.<strong>Anti-cyclic citrulinated peptide</strong> <strong>(anti-CCP) is the single most accurate test for RA.</strong> . <br><br><br></div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>7. </span> A 25-year-old male comes to the doctor with diarrhea. He just returned from a trip to South Africa, where he developed foul-smelling stools, abdominal cramps and bloating. His temperature is 37 C , blood pressure is 102/68 mm Hg, and pulse is 90/min. Physical examination is unremarkable. What is the most appropriate treatment of choice? </p><ol class=mt-3 type=A><li>Ampicillin</li><li>Metronidazole</li><li>Amoxicillin</li><li>Ciprofloxacin</li></ol><button aria-controls=explanation-7BH aria-expanded=false class="btn btn-secondary" data-target=#explanation-7BH data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-7BH><p class=correct-answer><strong>Answer:</strong> B</p>1. <strong>Giardiasis</strong> is infection with the flagellated protozoan Giardia duodenalis (G. lamblia, G. intestinalis).<br>2. Infection can be asymptomatic or cause symptoms ranging from intermittent flatulence to chronic malabsorption.<br>3. <span style="text-decoration: underline;">The most common symptoms</span> are foul-smelling stools, fatty stools, bloating, flatulence, nausea, malaise, and abdominal cramps.<br>4. Places where giardiasis is widespread include: sub-Saharan Africa – all the countries south of the Sahara desert, such as South Africa, Gambia and Kenya <br>5. <strong>Transmission</strong> can also occur by ingestion of contaminated food and by direct person-to-person contact, especially in mental institutions and day care centers or between sex partners.<br>6. <span style="text-decoration: underline;">The major source of giardiasis is waterborne transmission</span>, including via fresh-appearing mountain streams and poorly filtered municipal water supplies.<br>7. <strong>Diagnosis</strong> Giardia is best diagnosed with an ELISA stool antigen test. A single stool antigen test has 90% sensitivity.<br>8. <strong>Treatment</strong> is with metronidazole, tinidazole, or nitazoxanide or, during pregnancy, paromomycin.<br>9. Empiric treatment should also be given with a course of <strong>metronidazole</strong>. <br><br><strong>Prevention requires</strong><br>1. Appropriate public water treatment<br>2. Hygienic food preparation<br>3. Appropriate fecal-oral hygiene</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>8. </span> Which of the following conditions is associated with Raynaud's phenomenon? </p><ol class=mt-3 type=A><li>Scleroderma</li><li>Sjögren syndrome</li><li>Fibromyalgia</li><li>Ankylosing spondylitis</li></ol><button aria-controls=explanation-0Y3 aria-expanded=false class="btn btn-secondary" data-target=#explanation-0Y3 data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-0Y3><p class=correct-answer><strong>Answer:</strong> A</p>1. <span style="text-decoration: underline;"><strong>Scleroderma</strong></span> is a disorder characterized by diffuse fibrosis of skin and internal organs.<br><strong>2. Raynaud' s phenomena are seen in most patients with scleroderma.</strong><br>3. Scleroderma is more common in women. <br>4. Presents with arthralgias, myalgias, hand swelling, Raynaud phenomenon (i.e., blue distal extremities caused by arteriolar spasm), skin thickening, esophageal dysmotility, intestinal hypomotility, dyspnea, possible arrhythmias or heart failure.<br>5. Scleroderma patients have positive ANA and Anti-Scl-70 antibodies <br><br><br><span style="text-decoration: underline;"><strong>Treatment</strong></span> <br>1. There is no available treatment for scleroderma.<br>2. Steroids for acute flares.<br>3. Penicillamine can be used for skin changes.<br>4. Calcium channel blockers for Raynaud’s.<br>5. ACEIs for renal disease and malignant hypertension</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>9. </span> Which of the following is the most common cause of chronic pancreatitis? </p><ol class=mt-3 type=A><li>Ischemia</li><li>Alcohol consumption</li><li>Malignancy</li><li>Gallstones</li></ol><button aria-controls=explanation-CRC aria-expanded=false class="btn btn-secondary" data-target=#explanation-CRC data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-CRC><p class=correct-answer><strong>Answer:</strong> B</p>1. An alcoholic patient with chronic abdominal pain and diarrhea is classic for chronic pancreatitis. <br><strong>2. Chronic alcoholism is the most common cause (&gt;80% of cases).</strong><br>3. Chronic pancreatitis is commonly defined as a continuing, chronic, inflammatory process of the pancreas, characterized by irreversible morphologic changes.<br>4. The endocrine and exocrine functions of the pancreas are impaired <br>5. <span style="text-decoration: underline;"><strong>Clinical features</strong></span>: recurrent epigastric pain, steatorrhea, weight loss, nausea, constipation <br>6. <span style="text-decoration: underline;"><strong>Labs</strong></span>: Mildly increased amylase and lipase, glycosuria; low fecal elastase.<br>7. Abdominal radiograph may show pancreatic calcifications; CT may show calcifications, pancreatic enlargement, or pseudocyst</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>10. </span> A 83-year old man brought to the emergency room with sudden visual loss in his right eye. The patient also complained of fever and right sided headache. Erythrocyte sedimentation rate is 91 mm/h.<br><br>Which of the following is the appropriate confirmatory test for Giant cell arteritis ? </p><ol class=mt-3 type=A><li>Temporal artery biopsy</li><li>P-ANCA</li><li>MRI</li><li>CT Brain</li></ol><button aria-controls=explanation-MO8 aria-expanded=false class="btn btn-secondary" data-target=#explanation-MO8 data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-MO8><p class=correct-answer><strong>Answer:</strong> A</p>1. <strong>Temporal Arteritis</strong> (Giant cell arteritis) is due to subacute granulomatous inflammation of the large vessels, including the aorta, external carotid (especially the temporal branch), and vertebral arteries.<br>2. The most feared manifestation is blindness <br>3. Risk factors: include polymyalgia rheumatica (affects almost half of patients), age &gt; 50, and female gender. <br>4. Presents with headache and pain in one or both temples, visual problems (decreased vision or blurry vision) and polymyalgia rheumatica (proximal stiffness in neck, arms, hips). <br><strong>5. Temporal artery biopsy can be done within several days after treatment, for confirmation of the disease. </strong><br>6. Any delay in the treatment may result in visual loss.<br>7. Giant cell arteritis must be treated immediately with high dose glucocorticoids once the clinical diagnosis is made.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>11. </span> A 30-year-old woman with a history of tonic-clonic seizures complains of double vision, thickened gums, and<br>growth of facial hair since starting a new medication. Which of the following anticonvulsant medications is most<br>likely responsible for her symptoms? </p><ol class=mt-3 type=A><li>Phenytoin</li><li>Carbamazepine</li><li>Ethosuximide</li><li>Phenobarbital</li></ol><button aria-controls=explanation-OL5 aria-expanded=false class="btn btn-secondary" data-target=#explanation-OL5 data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-OL5><p class=correct-answer><strong>Answer:</strong> A</p>Diplopia, gingival hyperplasia, and hirsutism are classic side effects of <span style="text-decoration: underline;"><strong>phenytoin</strong></span>.<br>Other side effects include nystagmus, sedation, ataxia, and enzyme induction. Phenytoin is used in the<br>treatment of grand mal and tonic-clonic seizures. It is not used for absence seizures.<br><br><strong>Carbamazepine</strong> does produce diplopia, but not the other symptoms in this vignette. It can also<br>produce ataxia, enzyme induction, and blood dyscrasias. It is useful in tonic-clonic and partial seizures and tic<br>douloureux. <br><br><strong>Ethosuximide</strong> causes gastrointestinal distress, headache, and lethargy as side effects. It is used<br>exclusively for absence seizures. <br><br><strong>Phenobarbital</strong>, which is used for grand mal and partial seizures, causes sedation, enzyme induction,<br>and dependence.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>12. </span> A 70-year-old man presents to the clinic with weight loss and fatigue. Lab shows an elevated white cell count. Physical examination reveals splenomegaly.  Which of the following is the most likely diagnosis? </p><ol class=mt-3 type=A><li>Chronic myelogenous leukemia</li><li>Iron deficiency anemia</li><li>Hodgkin’s lymphoma</li><li>Anemia of chronic disease</li></ol><button aria-controls=explanation-D9U aria-expanded=false class="btn btn-secondary" data-target=#explanation-D9U data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-D9U><p class=correct-answer><strong>Answer:</strong> A</p>Chronic myelogenous leukemia (CML)<br><br>1. CML is a disorder characterized by massive over production of myeloid cells.<br>2. Philadelphia chromosome t(9,22) or BCR-ABL fusion gene.<br>3. Seen in middle-aged adults ( 40–60 years ) and can be associated with radiation exposure.<br>4. Patients frequently have splenomegaly with LUQ pain and early satiety.<br>5. Constitutional symptoms (weight loss, anorexia and fever)<br>6. It is characterized by leukocytosis, Basophilia, anemia and marked splenomegaly (Lymphadenopathy is not a feature of CML).<br>7. Labs: Elevated WBCs ( more than 100,000/ml), small numbers of blasts and promyelocytes and Decreased leukocyte alkaline phosphatase activity</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>13. </span> A 52-year-old male presents with epigastric pain that improves with meals. Endoscopy demonstrates a 2 cm<br>ulcerated area located 3 cm distal to the pyloric junction. Basal acid output is within normal limits. Which of the<br>following is most likely to have made the strongest contribution to the development of this disease? </p><ol class=mt-3 type=A><li>Smoking</li><li>Chronic antacid use</li><li>Aspirin use</li><li>Helicobacter pylori infection</li></ol><button aria-controls=explanation-LWZ aria-expanded=false class="btn btn-secondary" data-target=#explanation-LWZ data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-LWZ><p class=correct-answer><strong>Answer:</strong> D</p>The patient has a duodenal peptic ulcer. The strongest risk factor for duodenal peptic ulcer is <strong>Helicobacter pylori</strong> <strong>infection</strong>, which is found in almost 100% of these cases (contrast to 70% infection rate in gastric peptic ulcer). The basal acid output is normal in many patients with duodenal ulcer.<br><br><strong>Aspirin use</strong> and <strong>ethanol</strong> use are more strongly implicated in gastric ulcer disease than duodenal ulcer disease.<br><br><strong>Chronic antacid</strong> use is seen as a result of peptic ulcer disease, not as a cause of it.<br><br><strong>Smoking</strong> may also be a lesser contributing factor to the development of peptic ulcer.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>14. </span> A pregnant 32 year old paraplegic woman underwent a cesarean section. A week later she developed a deep venous thrombosis in her left lower limb. If the thrombus breaks, which of the following would first receive the detached thrombus in its capillaries bed? </p><ol class=mt-3 type=A><li>Lungs</li><li>Heart</li><li>Left Kidney</li><li>Brain</li></ol><button aria-controls=explanation-GLO aria-expanded=false class="btn btn-secondary" data-target=#explanation-GLO data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-GLO><p class=correct-answer><strong>Answer:</strong> A</p>1. <strong>Deep venous thrombosis</strong> (DVT) is clotting of blood in a deep vein of an extremity (usually calf or thigh) or the pelvis. <br>2. DVT is the primary cause of pulmonary embolism. DVT results from conditions that impair venous return, lead to endothelial injury or dysfunction, or cause hypercoagulability. <br>3. DVT may be asymptomatic or cause pain and swelling in an extremity; pulmonary embolism is an immediate complication. <br>4. <strong>Diagnosis</strong> is by history and physical examination and is confirmed by objective testing, typically with duplex ultrasonography. <br>5. d-Dimer testing is used when DVT is suspected; a negative result helps to exclude DVT, whereas a positive result is nonspecific and requires additional testing to confirm DVT. <br>6. <strong>Treatment</strong> is with anticoagulants.(Treatment initially is with an injectable heparin (unfractionated or LMWH) followed by oral warfarin or perhaps a LMWH; the role of oral factor Xa and direct thrombin inhibitors is evolving.)<br>7. <strong>Prognosis</strong> is generally good with prompt, adequate treatment. <br>8. Common long-term complications include venous insufficiency with or without the postphlebitic syndrome.<br>9. Deep venous thrombosis usually begins in venous valve cusps. Thrombi consist of thrombin, fibrin, and RBCs with relatively few platelets (red thrombi); <span style="text-decoration: underline;">without treatment</span>, <span style="text-decoration: underline;">thrombi may propagate proximally or travel to the</span> <strong>lungs</strong>.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>15. </span> Which of the following is associated with rigidity, stiffness, masked facies, unilateral resting tremor and micrographia? </p><ol class=mt-3 type=A><li>Benign essential tremor</li><li>Parkinson disease</li><li>Alzheimer's disease</li><li>Wernicke’s encephalopathy</li></ol><button aria-controls=explanation-DA6 aria-expanded=false class="btn btn-secondary" data-target=#explanation-DA6 data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-DA6><p class=correct-answer><strong>Answer:</strong> B</p>Parkinson Disease <br><br>1. Results from a loss of dopamine containing neurons that are located in the pigmented substantia nigra and the locus ceruleus in the midbrain. <br>2. Onset is usually after age 50 years.  Parkinson disease is essentially a clinical diagnosis <br>3. Manifestations : Bradykinesia, Rigidity, Instability and Pill-rolling tremor at rest.<br>4. Other manifestations include masked facies, memory loss, and micrographia (small handwriting).<br>5. Autonomic dysfunction ( Constipation, orthostatic hypotension)<br>6. Personality changes.<br>7. Rigidity is characteristic "Cogwheel rigidity"<br>8. No cure : The goals are to delay disease progression and to relieve symptoms. <br>9. The most effective symptomatic therapy of Parkinsonism is L-dopa. <br></div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>16. </span> Which of the following is associated with adenocarcinoma of the esophagus? </p><ol class=mt-3 type=A><li>Peptic ulcer</li><li>Zenker's diverticulum</li><li>Barrett's esophagus</li><li>Tracheoesophageal fistula</li></ol><button aria-controls=explanation-SAJ aria-expanded=false class="btn btn-secondary" data-target=#explanation-SAJ data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-SAJ><p class=correct-answer><strong>Answer:</strong> C</p><span style="text-decoration: underline;"><strong>Esophageal cancer</strong></span><br>1. The two major histological types are squamous cell carcinoma (SCC) and adenocarcinoma. <br>2. The risk factors for adenocarcinoma include Barrett's esophagus, chronic GERD, smoking, obesity, high dietary calorie and fat intake. <br>3. The major risk factors for squamous cell cancer of the esophagus are smoking, alcohol.<br>4. Presents with progressive dysphagia (initially solids, later solids and liquids), weight loss, odynophagia, reflux, GI bleeding, vomiting, weakness, cough, hoarseness.<br>5. Weight loss is very common with cancer.<br><strong>6. Barrett esophagus (intestinal metaplasia of distal esophagus secondary to chronic GERD) commonly precedes adenocarcinoma.</strong><br>7. Complications: poor prognosis; local extension and metastases are frequently present by time of diagnosis</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>17. </span> Which of the following is the drug of choice of patient with trigeminal neuralgia? </p><ol class=mt-3 type=A><li>Phenobarbital</li><li>Carbamazepine</li><li>Valproic acid</li><li>Prednisone</li></ol><button aria-controls=explanation-8HV aria-expanded=false class="btn btn-secondary" data-target=#explanation-8HV data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-8HV><p class=correct-answer><strong>Answer:</strong> B</p>1. <span style="text-decoration: underline;"><strong>Trigeminal neuralgia</strong> </span>(TN), also known as tic douloureux, is a distinctive facial pain syndrome that may become recurrent and chronic.<br>2. It is characterized by <strong>unilateral pain</strong> following the sensory distribution of cranial nerve V (typically radiating to the maxillary or mandibular area in 35% of affected patients) and is often accompanied by a brief facial spasm or tic. <br>3. Usually idiopathic in origin. <br><strong>4. Brief (seconds to minutes) but frequent attacks of severe, lancinating facial pain </strong><br>5. Involves the jaw, lips, gums, and maxillary area (ophthalmic division is less commonly affected) <br>6. Recurrent attacks may continue for weeks at a time. <br>7. No motor or sensory paralysis <br>8. <strong>Drug of choice is carbamazepine (</strong>usually effective in relieving pain); other choices <br>9. Consider surgical decompression if medical therapy fails.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>18. </span> Which of the following is the most common cause of death in dialysis patients? </p><ol class=mt-3 type=A><li>Renal disease</li><li>Stroke</li><li>Cardiovascular disease</li><li>Respiratory disease</li></ol><button aria-controls=explanation-5RU aria-expanded=false class="btn btn-secondary" data-target=#explanation-5RU data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-5RU><p class=correct-answer><strong>Answer:</strong> C</p>1. Sudden cardiac death is the most common cause of death in dialysis patients and is usually preceded by sudden cardiac arrest due to ventricular tachycardia or ventricular fibrillation.<br>2. Cardiovascular disease is also the most common cause of death in renal transplant patients. <br><br><br></div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>19. </span> A 62-year-old man presents to the physician with cough for the last 7 months. He also complained of hemoptysis, weight loss and constipation. He is a chronic smoker with a 40-year history. Laboratory tests reveal hypercalcemia. Chest x-ray shows hilar mass in the right lung.<br><br>Which of the following is the most likely diagnosis? </p><ol class=mt-3 type=A><li>Tuberculosis</li><li>Adenocarcinoma</li><li>Squamous cell carcinoma</li><li>Small cell carcinoma</li></ol><button aria-controls=explanation-4WZ aria-expanded=false class="btn btn-secondary" data-target=#explanation-4WZ data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-4WZ><p class=correct-answer><strong>Answer:</strong> C</p><span style="text-decoration: underline;"><strong>Lung cancer </strong></span><br><br>Pathologic types are divided into two subgroups:<br><strong><br>A-Non-Small Cell Lung Cancer or NSCLC (75-80% of Lung Cancers)</strong><br>1. <span style="text-decoration: underline;">Adenocarcinoma</span> (40%): <strong>Peripheral</strong> Lung Cancers<br>2. <span style="text-decoration: underline;">Squamous Cell Carcinoma</span> (25%): <strong>Central</strong> Lung Cancers most often<strong> associated with Tobacco smoking</strong><br><strong><br>B-Small Cell Lung Cancer or SCLC (15-20% of Lung Cancer)</strong><br><br><strong>1. Adenocarcinoma is the most common in both smokers and nonsmokers. </strong><br>2. Symptoms present in 90% of Lung Cancer patients at the time of diagnosis<br>3. Presents with cough, hemoptysis, dyspnea, wheezing, pneumonia, chest pain, weight loss, and possible abnormalities on respiratory examination (crackles, atelectasis). <br>4. Suspect squamous cell carcinoma of the lungs in a patient with a significant <strong>smoking history</strong>, <strong>hypercalcemia</strong> and <strong>a hilar mass.</strong> <br>5. <span style="text-decoration: underline;"><strong>Diagnosis</strong></span>: Biopsy; peripheral ones by CT guided biopsy, and central ones by bronchoscopic guided biopsy or mediastinoscopy. <br><br><span style="text-decoration: underline;"><strong>Mangement</strong></span>:<br>Non-Small Cell Lung Cancer: Surgical resection<br>Small Cell Lung Cancer: Unresectable (radiation and chemotherapy)</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>20. </span> Which of the following is the most common cause of superior vena cava obstruction? </p><ol class=mt-3 type=A><li>Malignancy</li><li>Wegener's granulomatosis</li><li>Tuberculosis</li><li>Sarcoidosis</li></ol><button aria-controls=explanation-V9H aria-expanded=false class="btn btn-secondary" data-target=#explanation-V9H data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-V9H><p class=correct-answer><strong>Answer:</strong> A</p><span style="text-decoration: underline;"><strong>Superior Vena Cava Syndrome</strong> </span>(Superior Vena Cava Obstruction)<br><br>1. Superior vena cava syndrome (<strong>SVCS</strong>): obstruction of venous drainage through superior vena cava and associated head swelling and CNS symptoms It<span style="text-decoration: underline;"> is a medical emergency and most often manifests in patients with a malignant disease process within the thorax.</span> <br><strong>2. More than 80% of cases of SVCS are caused by malignant mediastinal tumors.</strong><br><strong>3. Dyspnea is the most common symptom, observed in 63% of patients with SVCS.</strong><br>4. Other symptoms include facial swelling, head fullness, cough, arm swelling, chest pain, dysphagia, orthopnea, distorted vision, hoarseness, stridor, headache, nasal stuffiness, nausea, pleural effusions, and light-headedness.<br>5. The characteristic physical findings of SVCS include venous distention of the neck and chest wall, facial edema, upper extremity edema, mental changes, plethora, cyanosis, papilledema, stupor, and even coma. <br>6. Bending forward or lying down may aggravate the symptoms and signs.<br>7. <strong>Treatment:</strong> Radiation</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>21. </span> A 50-year-old man presents to the emergency room with fever, productive cough and dyspnea for the last 2 days. His temperature is 39.1 C, blood pressure is 120/80 mmHg, pulse is 112/min and respirations are 22/min. Examinations shows decrease breath sounds and crackles over the left lower lobe of the lung. Which of the following is the most likely diagnosis? </p><ol class=mt-3 type=A><li>Community acquired pneumonia</li><li>Asthma</li><li>Pneumocystis pneumonia</li><li>Pulmonary edema</li></ol><button aria-controls=explanation-4NO aria-expanded=false class="btn btn-secondary" data-target=#explanation-4NO data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-4NO><p class=correct-answer><strong>Answer:</strong> A</p>1. Community-acquired pneumonia develops in people with limited or no contact with medical institutions or settings.<br>2. The most commonly identified pathogens are Streptococcus pneumoniae, Haemophilus influenzae, atypical bacteria (ie, Chlamydia pneumoniae, Mycoplasma pneumoniae, Legionella sp), and viruses. <br>3. P. aeruginosa is an especially common cause of pneumonia in patients with cystic fibrosis, neutropenia, advanced AIDS, and/or bronchiectasis.<br>4. Symptoms and signs are fever, cough, sputum production, pleuritic chest pain, dyspnea, tachypnea, and tachycardia.<br>5. Pneumonia may manifest as upper abdominal pain when lower lobe infection irritates the diaphragm. GI symptoms (nausea, vomiting, diarrhea) are also common.<br>6. Signs include fever, tachypnea, tachycardia, crackles, bronchial breath sounds, egophony<br>7. Diagnosis is based on clinical presentation and infiltrate seen on chest x-ray (may be normal very early &lt;24 hours)<br><!--24-->8. Treat patients with mild or moderate risk pneumonia with empiric antibiotics without testing to identify the underlying pathogen.<br>9. Hospitalize patients with multiple risk factors<br>10. Empiric outpatient treatment of healthy patients includes doxycycline or macrolides. Patients requiring hospitalization should be started on an extended-spectrum fluoroquinolone (eg, levofloxacin, moxifloxacin) or a beta-lactam plus a macrolide <br>11. Prognosis is excellent for relatively young or healthy patients, but many pneumonias, especially when caused by S. pneumoniae, Legionella, Staphylococcus aureus, or influenza virus, are serious or even fatal in older, sicker patients</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>22. </span> A 66-year-old female presents with a history of low-grade fever, malaise, and joint pains and stiffness. You suspect polymyalgia rheumatica. Along with an elevated erythrocyte sedimentation rate, which of the following provides additional support for this diagnosis? </p><ol class=mt-3 type=A><li>Proximal muscle weakness</li><li>Proximal muscle tenderness</li><li>Calcified cartilage visible on x-ray</li><li>Bony erosion on x-ray</li></ol><button aria-controls=explanation-F9S aria-expanded=false class="btn btn-secondary" data-target=#explanation-F9S data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-F9S><p class=correct-answer><strong>Answer:</strong> B</p>1. <strong>Polymyalgia </strong>rheumatica is a syndrome closely associated with giant cell arteritis (temporal arteritis).<br>2. It affects adults &gt; 55. It typically causes severe pain and stiffness in proximal muscles, without weakness or atrophy, and nonspecific systemic symptoms. <br>3. ESR and C-reactive protein are usually elevated. <br>4. Diagnosis is clinical. <br>5. Treatment with low-dose corticosteroids is effective. <br>6. A dramatic and rapid response to low to moderate doses of prednisone or methylprednisolone supports the diagnosis.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>23. </span> Which of the following is the most common cause of acquired angioedema? </p><ol class=mt-3 type=A><li>ACE inhibitor</li><li>Beta blockers</li><li>Chlorpheniramine</li><li>Angiotensin II receptor blockers</li></ol><button aria-controls=explanation-RLW aria-expanded=false class="btn btn-secondary" data-target=#explanation-RLW data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-RLW><p class=correct-answer><strong>Answer:</strong> A</p>1. <span style="text-decoration: underline;"><strong>Angioedema</strong></span> is the swelling of deep dermis, subcutaneous, or submucosal tissue due to vascular leakage.<br>2. Acute episodes often involve the lip, eyes, and face; however, angioedema may affect other parts of body, including respiratory and gastrointestinal (GI) mucosa. Laryngeal swelling can be life threatening.<br>3. <strong>Peripheral</strong> <strong>swelling</strong>: skin and urogenital area (e.g., eyelids or lips, tongue, hands, feet, scrotum, etc.) <br>4. <strong>Abdomen</strong>: Abdominal pain (sometimes it can be the only presenting symptom of angioedema) <br>5. <strong>Larynx</strong>: Throat tightness, voice changes, and breathing trouble (indicators of possible airway involvement), potentially life-threatening. <br>6. The primary goal of medical treatment for angioedema is to reduce and prevent swelling, as well as to reduce discomfort and complication.<br>7. <strong>Epinephrine</strong> should be used when laryngeal angioedema is suspected. <br><br><span style="text-decoration: underline;"><strong>Angioedemas with identifiable etiologies include those caused by the following:</strong></span><br>1. Hypersensitivity (eg, food, drugs, or insect stings) <br>2. Physical stimuli (eg, cold or vibrations) <br>3. Autoimmune disease or infection <br>4.<strong> ACE inhibitors (ACE inhibitors are the most common cause of acquired angioedema )</strong><br>5. NSAIDs <br>6. C1-INH deficiency (hereditary and acquired)</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>24. </span> Which of the following is the most likely cause of anemia in a patient with end-stage renal disease? </p><ol class=mt-3 type=A><li>Renin levels</li><li>Vitamin B12</li><li>Iron deficiency</li><li>Insufficient erythropoietin</li></ol><button aria-controls=explanation-LNP aria-expanded=false class="btn btn-secondary" data-target=#explanation-LNP data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-LNP><p class=correct-answer><strong>Answer:</strong> D</p>1. Anemia of chronic disease (ACD) is seen in patients with chronic illnesses and is usually normocytic. <br>2. <strong>Anemia of chronic kidney disease</strong> is due to <span style="text-decoration: underline;"><strong>erythropoietin deficiency</strong></span>.<br>3. Erythropoietin is produced by the kidneys, and in chronic renal failure, erythropoietin levels are low <br>4. Treating the underlying cause of ACD will often improve the anemia.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>25. </span> Which of the following is frequently seen in a patient with scleroderma? </p><ol class=mt-3 type=A><li>Chronic renal failure</li><li>Atopic dermatitis</li><li>Interstitial nephritis</li><li>Raynaud' s phenomena</li></ol><button aria-controls=explanation-ISA aria-expanded=false class="btn btn-secondary" data-target=#explanation-ISA data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-ISA><p class=correct-answer><strong>Answer:</strong> D</p>1. <strong>Scleroderma</strong> is a disorder characterized by diffuse fibrosis of skin and internal organs. <br>2. Also called systemic sclerosis; characterized by inflammation that leads to progressive tissue fibrosis through excessive deposition of type I and type III collagen.<br>3. Commonly manifests as CREST syndrome <br><strong>4. Raynaud' s phenomena are seen in most patients with scleroderma.</strong><br>5. Scleroderma patients have positive ANA and Anti-Scl-70 antibodies. <br>6. Scleroderma is associated with anti-centromere antibodies in up to 90% of patients. <br>7. Examination may reveal symmetric thickening of the skin of face and/or distal extremities. <br><br><span style="text-decoration: underline;"><strong>Treatment</strong></span><br>1. There is no available treatment for scleroderma.<br>2. Corticosteroids for acute flares; penicillamine can be used for skin changes. <br><strong>3. Calcium channel blockers for Raynaud’s phenomenon</strong><br>4. ACEIs for renal disease and for prevention of a scleroderma renal crisis.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>26. </span> Syndrome of inappropriate antidiuretic hormone (SIADH) is often associated with which of the following lung cancers?<br><br> </p><ol class=mt-3 type=A><li>Adenocarcinoma</li><li>Large cell carcinoma</li><li>Squamous cell carcinoma</li><li>Small cell carcinoma</li></ol><button aria-controls=explanation-WSO aria-expanded=false class="btn btn-secondary" data-target=#explanation-WSO data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-WSO><p class=correct-answer><strong>Answer:</strong> D</p>1. SIADH (syndrome of inappropriate secretion of anti-diuretic hormone) is a common paraneoplastic syndrome that affects the endocrine system. This syndrome is most often associated with <strong>small-cell lung cancer</strong>; however, other cancers such as brain tumors, leukemia, lymphoma, colon, prostate, and head and neck cancers can lead to SIADH. SIADH is caused by the inappropriate production and secretion of arginine vasopressin or antidiuretic hormone (ADH) by tumor cells. <br><strong>2. Syndrome of inappropriate antidiuretic hormone (SIADH) is often associated with cancer. Approximately 67% of SIADH cases are reported to be caused by cancer, the majority of which (70%) are linked to small cell carcinoma of the lung </strong></div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>27. </span> Which of the following medications is associated with gynecomastia? </p><ol class=mt-3 type=A><li>Penicillamine</li><li>Cimetidine</li><li>Metformin</li><li>Cyclophosphamide</li></ol><button aria-controls=explanation-9O5 aria-expanded=false class="btn btn-secondary" data-target=#explanation-9O5 data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-9O5><p class=correct-answer><strong>Answer:</strong> B</p>1. Breast enlargement in males due to increased 􏱿estrogen compared with androgen activity.<br>2. Physiologic (not pathologic) in newborn, pubertal, and elderly males, but may persist after puberty.<br>3. Other causes include cirrhosis, hypogonadism (eg, Klinefelter syndrome), testicular tumors, and drugs (<strong>Spironolactone</strong>, <strong>Hormones</strong>, <strong>Cimetidine</strong>, <strong>Ketoconazole</strong>)</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>28. </span> What of the following condition is associated with glossitis, weight loss, paresthesias and diarrhea? </p><ol class=mt-3 type=A><li>Iron deficiency anemia</li><li>Multiple myeloma</li><li>Thalassemia</li><li>Pernicious anemia</li></ol><button aria-controls=explanation-EKJ aria-expanded=false class="btn btn-secondary" data-target=#explanation-EKJ data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-EKJ><p class=correct-answer><strong>Answer:</strong> D</p>1. <span style="text-decoration: underline;"><strong>Pernicious anemia</strong> </span>(PA) <strong>is the most common cause of megaloblastic anemia</strong> (common in elderly). <br>2. In Pernicious anemia (Vitamin B12 deficiency is due to reduced intrinsic factor (IF) secondary to gastric atrophy.<br>3. Patient present with fatigue, weakness, dyspnea on exertion, memory loss; pallor, tachycardia, tachypnea, increased pulse pressure, possible systolic murmur, symmetric paresthesias, loss of vibration sense, ataxia, possible dementia.<br>4.Weight loss occurs in about 50% of patients and probably is due to anorexia,<br>5. The diagnosis of PA is confirmed by achlorhydria, decreased serum Vitamin B12, positive IF antibodies, and extremely elevated LDH.<br>6. Labs: decreased Hgb, decreased Hct, increased MCV, decreased vitamin B12 <br><strong>7. Pernicious anemia is associated with increase risk of gastric cancer.  </strong></div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>29. </span> A 62-year-old Type 2 diabetic patient presents with complaints of malaise, myalgias, respiratory distress, and<br>increased somnolence. If laboratory examination reveals an anion gap of 26 mmol/L, HCO3- of 17 mmol/L and an<br>arterial blood pH of 7.27, the patient is most likely receiving which of the following? </p><ol class=mt-3 type=A><li>Repaglinide</li><li>Glyburide</li><li>Troglitazone</li><li>Metformin</li></ol><button aria-controls=explanation-8NK aria-expanded=false class="btn btn-secondary" data-target=#explanation-8NK data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-8NK><p class=correct-answer><strong>Answer:</strong> D</p>1. <strong>Lactic acidosis</strong>, characterized by elevated blood lactate, decreased arterial blood pH, decreased bicarbonate, and electrolyte imbalances with an elevated anion gap (normal = 10 - 12), <span style="text-decoration: underline;">is a rare but serious complication of metformin administration.</span><br>2. The onset of lactic acidosis is usually accompanied by several non-specific signs and symptoms including malaise, myalgias, respiratory distress and increased somnolence.<br>3. There may be associated hypothermia, hypotension, and resistant bradyarrhythmias as the condition progresses. <br>4. <strong>Glyburide</strong> is a sulfonylurea associated with the development of hypoglycemia and cholestatic jaundice (a rare complication). <br>5. <strong>Repaglinide</strong> is the non-sulfonylurea moiety of glyburide; it is commonly associated with hypoglycemia, nausea and vomiting.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>30. </span> Which of the following is the treatment of choice for a patient with pyoderma gangrenosum? </p><ol class=mt-3 type=A><li>Reassurance</li><li>Corticosteroids</li><li>Surgical excision</li><li>Antibiotics</li></ol><button aria-controls=explanation-DYJ aria-expanded=false class="btn btn-secondary" data-target=#explanation-DYJ data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-DYJ><p class=correct-answer><strong>Answer:</strong> B</p>1. <strong>Pyoderma gangrenosum</strong> (PG) is an uncommon neutrophilic dermatosis that presents as an inflammatory and ulcerative disorder of the skin.<br>2. More than 50% percent of patients with PG have an associated systemic disease, <span style="text-decoration: underline;">most commonly inflammatory bowel disease,</span> arthropathies , and hematologic disease or hematologic malignancy.<br>3. <strong>Extraintestinal manifestations of inflammatory bowel disease</strong>: Rash (<span style="text-decoration: underline;">pyoderma gangrenosum</span>, erythema nodosum), eye inflammation (episcleritis, uveitis), oral ulcerations (aphthous stomatitis), arthritis (peripheral, spondylitis). <br><strong>4. The ulcerative variant of PG represents the vast majority of cases of PG.</strong><br>5. Ulcerative PG typically begins as a tender, inflammatory papule, pustule, or vesicle that develops on normal-appearing skin or at a site of trauma. <br>6.<strong> The lower extremities and trunk are the most common sites of involvement</strong>, though lesions may occur in other areas<br><strong>7. Treatment typically requires local or systemic corticosteroids.</strong></div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>31. </span> A 62-year-old man presents to the physician with cough for the last 7 months. He also complained of hemoptysis and weight loss. He is a non-smoker. Chest x-ray reveals a 2.5-cm irregular nodule in the peripheral right upper lung.<br><br>Which of the following is the most likely diagnosis? </p><ol class=mt-3 type=A><li>Solitary pulmonary nodule</li><li>Wegener's granulomatosis</li><li>Osteosarcoma</li><li>Adenocarcinoma</li></ol><button aria-controls=explanation-LJG aria-expanded=false class="btn btn-secondary" data-target=#explanation-LJG data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-LJG><p class=correct-answer><strong>Answer:</strong> D</p><span style="text-decoration: underline;"><strong>Adenocarcinoma of the lung <br></strong></span><br>1. Lung cancer is the second most common malignancy in men after prostate cancer.<br><strong>2. Adenocarcinoma is the most common in both smokers and nonsmokers. </strong><br>3. It has the least association with smoking history.<br>4. Adenocarcinoma is usually located peripherally and may present as a solitary nodule, with or without symptoms.<br>5. <strong>Clinical features</strong>: cough, sputum (salty suggests bronchoalveolar), hemoptysis, dyspnea, chest pain, wheezing, dysphagia, brachial plexus, hoarseness, Horner’s syndrome, superior vena cava syndrome.<br>6. <strong>Metastasis symptoms</strong>: bone pain, jaundice, seizures, head aches, adrenal lesions, skin lesions <br>7. <strong>Diagnosis</strong>: Biopsy; peripheral ones by CT guided biopsy, and central ones by bronchoscopic guided biopsy or mediastinoscopy. <br>8. Any type of lung cancer infiltrating the sympathetic chain will cause Horner’s syndrome, and is called Pancoast tumor.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>32. </span> What is the best initial treatment for a patient with the syndrome of inappropriate antidiuretic hormone secretion (SIADH)? </p><ol class=mt-3 type=A><li>Fluid resuscitation</li><li>Antibiotics</li><li>Steroids</li><li>Fluid restriction</li></ol><button aria-controls=explanation-OXM aria-expanded=false class="btn btn-secondary" data-target=#explanation-OXM data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-OXM><p class=correct-answer><strong>Answer:</strong> D</p>1. <strong>Syndrome of inappropriate ADH secretion (SIADH)</strong>: Excessive ADH secretion leading to oliguria with a high urinary Na content and osmolality. <br>2. This disorder is caused by the nonphysiologic release of vasopressin from the posterior pituitary or an ectopic source.<br>3. Common causes of SIADH include <strong>neuropsychiatric disorders</strong> (e.g.,meningitis, encephalitis, acute psychosis, cerebrovascular accident, head trauma), <strong>pulmonary diseases</strong> (e.g., pneumonia, tuberculosis, positive-pressure ventilation, acute respiratory failure), and <strong>malignant tumors</strong> (most commonly, small cell lung cancer). <br><br><span style="text-decoration: underline;"><strong>SIADH is diagnosed by the following:</strong></span><br>1. Hypoosmotic hyponatremia<br>2. Urine osmolality &gt;100 mOsm/L<br>3. Euvolemia <br>4. The absence of conditions, which stimulate ADH secretion, including volume contraction, nausea, adrenal dysfunction, and hypothyroidism <br><br><span style="text-decoration: underline;"><strong>Treatment of SIADH depends on the severity of illness. </strong></span><br>1. <strong>Mild disease</strong> (no symptoms): fluid restriction <br>2. <strong>Moderate disease</strong> (moderate confusion): saline and loop diuretic <br>3. <strong>Severe disease</strong> (seizure, coma, profound confusion): hypertonic (3%) saline; conivaptan/tolvaptan <br>4. <strong>Chronic disease</strong>: tolvaptan or demeclocycline</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>33. </span> Which of the following is associated with tall, peaked T waves in ECG? </p><ol class=mt-3 type=A><li>Hyperkalemia</li><li>Hypophosphatemia</li><li>Hypernatremia</li><li>Hypercalcemia</li></ol><button aria-controls=explanation-9PC aria-expanded=false class="btn btn-secondary" data-target=#explanation-9PC data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-9PC><p class=correct-answer><strong>Answer:</strong> A</p><span style="text-decoration: underline;"><strong>Hyperkalemia</strong></span> <br>1. Serum potassium  (&gt;5.0) mEq/L<br>2. <strong>Causes</strong>: metabolic acidosis, aldosterone deficiency, tissue breakdown, insulin deficiency, adrenal insufficiency, renal failure.<br>3. <strong>Clinical features<span style="text-decoration: underline;">:</span></strong> weakness, nausea, vomiting; arrhythmias; paralysis or paresthesia in severe cases <br>4. <strong>ECG</strong>: tall, peaked T waves <br>5. <strong>Management</strong>: calcium gluconate, dialysis may be required in severe cases.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>34. </span> Which of the following is the most appropriate management to stop bleeding in a patient with von Willebrand's disease? </p><ol class=mt-3 type=A><li>Cryoprecipitate</li><li>Vitamin K</li><li>Fresh frozen plasma</li><li>DDAVP</li></ol><button aria-controls=explanation-NEL aria-expanded=false class="btn btn-secondary" data-target=#explanation-NEL data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-NEL><p class=correct-answer><strong>Answer:</strong> D</p><span style="text-decoration: underline;"><strong>von Willebrand Disease<br></strong></span><br>1. <strong>Autosomal dominant</strong> disorder characterized by deficiency or defect of factor VIII-related antigen (vWF) <br><strong>2. The most common inherited bleeding disorder </strong><br>3. The most common signs of von Willebrand disease (vWD) include nosebleeds and hematomas. Prolonged bleeding from trivial wounds, oral cavity bleeding, and excessive menstrual bleeding are common.<br>4. Von Willebrand's disease is the most frequently diagnosed inherited bleeding disorder in adults. <br>5.Labs would show an increase in bleeding time with an increase in PTT.<br>6. PT will be normal. Platelet count is normal.<br>7. vWF Level is decreased in Von Willebrand disease<br><br><br><span style="text-decoration: underline;"><strong>Treatment</strong></span>:<br>1. DDAVP (desmopressin)—induces endothelial cells to secrete vWF.<br>2. Bleeding episodes can be treated with DDAVP; menorrhagia can be controlled with OCPs. <br>3. DDAVP increases the release of factor VIII von Willebrand factor multimers from endothelial storage sites. <br>4.Cryoprecipitate is not recommended as treatment for vWD because it carries the risk of viral transmission. <br>5. Avoid ASA and other inhibitors of platelet function.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>35. </span> A 52-year-old man with peptic ulcer disease has been on drug therapy for 3 months. While on this regimen, he<br>noticed changes in his bowel habits, increasing headaches, dizziness, skin rashes, loss of libido, and<br>gynecomastia. The drug most likely responsible for these effects is </p><ol class=mt-3 type=A><li>Metronidazole</li><li>Omeprazole</li><li>Cimetidine</li><li>Famotidine</li></ol><button aria-controls=explanation-IN7 aria-expanded=false class="btn btn-secondary" data-target=#explanation-IN7 data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-IN7><p class=correct-answer><strong>Answer:</strong> C</p>1. <strong>Cimetidine</strong>, an H2-receptor antagonist, can produce all of the side effects exhibited when taken in high doses over a long period of time. In addition, cimetidine can alter the hepatic metabolism of several drugs.<br><br>2. Famotidine is also an H2-receptor antagonist, but it does not have the side effects of cimetidine. <br><br>3. <strong>Metronidazole</strong> is an antibacterial and antiprotozoal drug that may present with the adverse effects of headaches, dizziness, diarrhea, and rashes, but not gynecomastia. <br><br>4. <strong>Omeprazole</strong> and sucralfate are a proton pump inhibitor and a physical barrier to gastric acid, respectively. Neither have reported effects on sexual function or breast development.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>36. </span> Which of the following is associated with oral candidiasis? </p><ol class=mt-3 type=A><li>Aspirin</li><li>Decongestants</li><li>Inhaled corticosteroids</li><li>Epinephrine</li></ol><button aria-controls=explanation-3P4 aria-expanded=false class="btn btn-secondary" data-target=#explanation-3P4 data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-3P4><p class=correct-answer><strong>Answer:</strong> C</p><strong>Oral candidiasis</strong> “Thrush": appears as curd like patches over erythematous base and presents with painless white plaques that cannot easily be scraped off. <br><br>Oral candidiasis is common in:<br>1. Denture wearers<br>2. Diabetics<br>3. Immunosupressed individuals.<br>4. Use of antibiotics or inhaled glucocorticoids. <br> <br>Leukoplakia : These are localized, plaque-like lesions that have a granular appearance and are hard to remove.  <br>Hairy leukoplakia is a white, painless lesion that appears "hairy" and is often found in AIDS patients.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>37. </span> A 83-year old man brought to the emergency room with sudden visual loss in his right eye. The patient also complained of fever and right sided headache. Erythrocyte sedimentation rate is 91 mm/h.<br><br>Which of the following is the most likely diagnosis? </p><ol class=mt-3 type=A><li>Giant cell arteritis</li><li>Scleroderma</li><li>Meningitis</li><li>Systemic lupus erythematosus</li></ol><button aria-controls=explanation-R9K aria-expanded=false class="btn btn-secondary" data-target=#explanation-R9K data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-R9K><p class=correct-answer><strong>Answer:</strong> A</p>1. <span style="text-decoration: underline;"><strong>Temporal Arteritis</strong></span> (Giant cell arteritis) is due to subacute granulomatous inflammation of the large vessels, including the aorta, external carotid (especially the temporal branch), and vertebral arteries.<br><strong>2. The most feared manifestation is blindness </strong><br>3.<strong> Risk factors:</strong> include polymyalgia rheumatica (affects almost half of patients), age &gt; 50, and female gender. <br>4. Presents with <strong>headache and pain in one or both temples</strong>, visual problems (decreased vision or blurry vision) and polymyalgia rheumatica (proximal stiffness in neck, arms, hips). <br>5. <strong>Temporal artery biopsy</strong> can be done within several days after treatment, for confirmation of the disease. <br><strong>6. Any delay in the treatment may result in visual loss.</strong><br>7. Giant cell arteritis must be treated immediately with <strong>high dose glucocorticoids</strong> once the clinical diagnosis is made.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>38. </span> Which murmur is associated with mitral stenosis? </p><ol class=mt-3 type=A><li>Mid diastolic</li><li>Early systolic</li><li>Holo systolic</li><li>Mid systolic</li></ol><button aria-controls=explanation-KFM aria-expanded=false class="btn btn-secondary" data-target=#explanation-KFM data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-KFM><p class=correct-answer><strong>Answer:</strong> A</p><span style="text-decoration: underline;"><strong>Mitral Stenosis  </strong></span><br>1. Almost all cases are due to rheumatic heart disease. (Patient may not recall a history of rheumatic fever.) <br>2. Long-standing mitral stenosis can result in pulmonary HTN and ultimately can result in right ventricular failure <br><br><span style="text-decoration: underline;"><strong>Heart murmurs </strong></span><br>1. <strong>Mitral Stenosis:</strong>Cardiac auscultation reveals a loud S1 and a mid diastolic rumbling murmur at the apex.<br>2. <strong>Aortic regurgitation</strong>: An early decrescendo murmur. <br>3. <strong>Mitral regurgitation</strong>: A holosystolic murmur that radiates to the axilla or to the carotids.<br>4. <strong>Mitral valve prolapse</strong>: A midsystolic or late systolic murmur with a preceding click.<br>5. <strong>Aortic stenosis:</strong> A harsh systolic ejection murmur that radiates to the carotids.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>39. </span> A 24-year-old male patient presents to your clinic with an ulcer on his penis. Painless bilateral inguinal lymphadenopathy is present. Which of the following is the most likely diagnosis? </p><ol class=mt-3 type=A><li>Granuloma inguinale</li><li>Herpes genitalis</li><li>Chancre</li><li>Basal cell carcinoma</li></ol><button aria-controls=explanation-1MC aria-expanded=false class="btn btn-secondary" data-target=#explanation-1MC data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-1MC><p class=correct-answer><strong>Answer:</strong> C</p><strong>Syphilis</strong> is caused by the spirochete Treponema pallidum and is characterized by 3 sequential clinical, symptomatic stages separated by periods of asymptomatic latent infection. <br>Common manifestations include genital ulcers, skin lesions, meningitis, aortic disease, and neurologic syndromes. <br><br>Primary syphilis is the first stage after infection. Papules become painless ulcers with rolled edges (chancres) which appear 2–3 weeks after contact at the site of infection, most commonly the vulva, vagina, or cervix. Darkfield microscopy of lesion exudate is positive for the spirochete, but the nonspecific serologic tests VDRL or rapid plasma reagin [RPR] test) are not yet positive. Without treatment the chancre spontaneously disappears.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>40. </span> Which of the following is the most common cause of hypernatremia? </p><ol class=mt-3 type=A><li>Diabetes insipidus</li><li>Hypovolemia</li><li>Hypervolemia</li><li>Diabetes mellitus</li></ol><button aria-controls=explanation-45P aria-expanded=false class="btn btn-secondary" data-target=#explanation-45P data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-45P><p class=correct-answer><strong>Answer:</strong> B</p><span style="text-decoration: underline;"><strong>Hypernatremia</strong></span> <br><br>1. Serum Na &gt;155 mEq/L <br><strong>2. The most common cause of hypernatremia is hypovolemia.</strong><br>3. Presents with oliguria, thirst, weakness, lethargy, decreased consciousness, mental status changes, seizures <br>4. Hypernatremia is most often due to water loss, but can also be caused by the intake of salt without water or the administration of hypertonic sodium solutions. Hypernatremia due to water loss is called dehydration.<br>5. Hypernatremia can occur in the absence of increased water losses if there is primary hypothalamic disease impairing thirst (hypodipsia), sometimes associated with concurrent diabetes insipidus (adipsic diabetes insipidus). In such patients, forced water intake is usually sufficient to maintain a normal serum sodium concentration, although in patients with adipsic diabetes insipidus, desmopressin must also be given.<br>6. <strong>Treatment: </strong>gradual hydration with normal saline for inadequate fluid intake or excess fluid loss (maximal Na reduction= 12 mEq/day) <br>7. Rapid correction of hyponatremia leads to central pontine myelinolysis.<br>8. <strong>Rapid correction of hypernatremia leads to brain edema. </strong><br>9. Complications: seizures, CNS damage; too rapid hydration can cause cerebral edema</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>41. </span> Which of the following is the best initial step in the management of mildly obese patient with sleep apnea? </p><ol class=mt-3 type=A><li>Weight reduction</li><li>Tracheostomy</li><li>Surgical resection of the uvula, palate, and pharynx</li><li>Acetazolamide</li></ol><button aria-controls=explanation-OTF aria-expanded=false class="btn btn-secondary" data-target=#explanation-OTF data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-OTF><p class=correct-answer><strong>Answer:</strong> A</p>1. <strong>Obstructive sleep apnea</strong> (OSA) is a disorder that is characterized by obstructive apneas and hypopneas due to repetitive collapse of the upper airway during sleep. <br>2. Episodic cessation of airflow during sleep leading to desaturations and frequent arousals <br>3. <strong>Risk factors:</strong>obesity, sedative use; males more than females <br>4. Patient presents with fatigue,excessive day time sleepiness, snoring, gasping or choking during sleep, morning headaches or confusion, impaired daytime function because of sleepiness; obesity common, anatomic abnormalities of palate or pharynx may be visible.<br><strong><br><span style="text-decoration: underline;">Types</span></strong> <br> 1. <strong>Obstructive</strong>: obstruction of upper airway during sleep with continued respiratory effort; most often associated with obesity or abnormal pharyngeal anatomy <br> 2. <strong>Central</strong>: loss of central respiratory drive leads to cessation of airflow and respiratory effort <br> 3. <strong>Mixed</strong>: combines both obstructive and central characteristics  <br><br><span style="text-decoration: underline;"><strong>Management</strong></span> <br>1. The treatment of a mild to moderate disorder usually starts with weight reduction, avoidance of sedatives and alcohol.<br>2. If this is not effective, surgical resection of the uvula, palate, and pharynx can be performed.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>42. </span> A patient with tuberculosis develops bright orange-red urine and calls his physician in a panic because he is<br>afraid he is bleeding into the urine. The patient has no other urinary tract symptoms. Which of the following<br>medications is most likely to produce this side effect? </p><ol class=mt-3 type=A><li>Pyridoxine</li><li>Ethambutol</li><li>Isoniazid</li><li>Streptomycin</li><li>Rifampin</li></ol><button aria-controls=explanation-BGK aria-expanded=false class="btn btn-secondary" data-target=#explanation-BGK data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-BGK><p class=correct-answer><strong>Answer:</strong> E</p>Urine color changes as a result of medications can be very distressing to patients. These changes are consequently worth learning so that you can warn<br>patients when you prescribe the medicine. <br><span style="text-decoration: underline;"><strong>Rifampin</strong></span> is a safe drug that is used both for prophylaxis and for active tuberculosis therapy. In addition to discoloring urine, rifampin and its metabolites can discolor feces, saliva, sweat, and tears (and apparently can stain soft contact lenses).<br><br><strong>Ethambutol</strong> is an antituberculosis agent that is added if isoniazid-resistance is suspected and does<br>not alter urine color.<br><strong>Isoniazid</strong> remains the principle antituberculosis agent and does not alter urine color.<br><strong>Pyridoxine</strong> is used principally in prophylaxis against tuberculosis and does not alter urine color.<br><strong>Streptomycin</strong> , which must be given intramuscularly, is sometimes used as an adjunctive agent very<br>early in antituberculosis therapy and has sometimes been lifesaving in critically ill patients. It does not cause a urine color change.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>43. </span> What is the mode of inheritance of Huntington’s disease? </p><ol class=mt-3 type=A><li>Autosomal recessive</li><li>X-linked Dominant</li><li>Multifactorial Inheritance</li><li>Autosomal dominant</li></ol><button aria-controls=explanation-B3H aria-expanded=false class="btn btn-secondary" data-target=#explanation-B3H data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-B3H><p class=correct-answer><strong>Answer:</strong> D</p>Huntington’s Disease (HD)<br><br>1. It is caused by a defect in an autosomal-dominant gene on <strong>chromosome 4.</strong><br>2. Lack of family history of HD makes the diagnosis unlikely.<br>3. The inset is between 30 and 50 years of age. <br>4. Gradual onset of chorea, altered behavior, and dementia and antisocial behavior.<br>5. Chorea is characterized by sudden, jerky and irregular movements of the extremities. <br>6. CT /MRI shows : Cerebral atrophy of the head of caudate nuclei.<br>7. Haloperidol for psychosis; reserpine to minimize unwanted movements.<br>8. <strong>Treatment</strong> is symptomatic and there is no curative treatment.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>44. </span> Which of the following symptoms is associated with typhoid fever? </p><ol class=mt-3 type=A><li>Confusion</li><li>Shortness of breath</li><li>Abdominal pain</li><li>Pruritus.</li></ol><button aria-controls=explanation-7TM aria-expanded=false class="btn btn-secondary" data-target=#explanation-7TM data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-7TM><p class=correct-answer><strong>Answer:</strong> C</p>1. Typhoid fever, also known as enteric fever, is a potentially fatal multisystemic illness caused primarily by Salmonella enterica, subspecies enterica serovar typhi.<br>2. The incubation period (usually 8 to 14 days) is inversely related to the number of organisms ingested. <br>3. The protean manifestations of typhoid fever make this disease a true diagnostic challenge. The classic presentation includes fever, malaise, diffuse abdominal pain, and constipation. <br>4. Untreated, typhoid fever is a grueling illness that may progress to delirium, obtundation, intestinal hemorrhage, bowel perforation, and death within 1 month of onset. Survivors may be left with long-term or permanent neuropsychiatric complications</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>45. </span> A 70-year-old male presents to the physician with cramping and nausea. He was diagnosed with small cell lung cancer 3 months ago.<br><br> <table class="table table-responsive table-sm table-striped"> <tbody> <tr> <td>Sodium</td> <td>122 mEq/L</td> </tr> <tr> <td>Potassium</td> <td>3.7 mEq/L</td> </tr> </tbody> </table> <br>Which of the following is the most likely diagnosis?<br><br> </p><ol class=mt-3 type=A><li>Cushing's disease</li><li>Primary aldosteronism</li><li>Addison's disease</li><li>Syndrome of inappropriate ADH secretion</li></ol><button aria-controls=explanation-9D0 aria-expanded=false class="btn btn-secondary" data-target=#explanation-9D0 data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-9D0><p class=correct-answer><strong>Answer:</strong> D</p><span style="text-decoration: underline;"><strong>Syndrome of inappropriate ADH secretion (SIADH) </strong></span><br>1. Nonphysiologic release of ADH, resulting in hyponatremia.<br><strong>2. Hyponatremia results from an excess of water rather than a deficiency of sodium.</strong><br>3. Caused by CNS pathology, sarcoidosis, paraneoplastic syndromes, psychiatric drugs, major surgery, pneumonia, or human immunodeficiency virus (HIV)<br>4. SIADH is commonly seen in patients with intracranial hemorrhage &amp;<strong> lung carcinoma</strong>. <br>5. ADH is characterized by <strong>hypotonic hyponatremia</strong> with <strong>euvolemia</strong> (without hypertension or edema).<strong> Low plasma osmolality</strong> (high urine osmolality (&gt;100-150 mOsm/Kg) in suspected patients is diagnostic.<br>6. <strong>Water restriction is the initial treatment of choice.</strong> <br>7. Rapid correction of serum sodium levels can lead to central pontine myelinosis.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>46. </span> Which of the following is associated with amenorrhea, headaches, blurring of vision and galactorrhea ? </p><ol class=mt-3 type=A><li>Conn syndrome</li><li>Asherman syndrome</li><li>Prolactinoma</li><li>Cushing's syndrome</li></ol><button aria-controls=explanation-0K0 aria-expanded=false class="btn btn-secondary" data-target=#explanation-0K0 data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-0K0><p class=correct-answer><strong>Answer:</strong> C</p>1. <strong>Prolactinomas</strong> are the most common hormone-secreting pituitary tumors.<br>2. Based on its size, a prolactinoma can be classified as a <strong>microprolactinoma</strong> (&lt; 10 mm diameter) or a <strong>macroprolactinoma</strong> (&gt;10 mm diameter).<br>3. <strong>Men</strong>: Presents with impotence, decreased libido, and occasionally gynecomastia.<br>4. <strong>Women</strong>: Amenorrhea and galactorrhea in the absence of pregnancy.<br>5. Most accurate diagnostic test is an <strong>MRI of the brain</strong>. <br>6. Treatment is indicated if mass effects from the tumor and/or significant effects from hyperprolactinemia are present.<br>7. <strong>Dopamine agonists</strong> (e.g. cabergoline or bromocriptine) are the mainstay of the treatment for <br>8. most patients with prolactinomas (microprolactinoma as well as macroprolactinoma).<br>9. <strong>Bromocriptine</strong> is generally considered to be the agent of choice in the treatment of prolactinoma because of its long track record and safety.<br>10. Surgically, transsphenoidal pituitary adenomectomy is the preferred treatment in patients with microprolactinoma and in most patients with macroprolactinoma.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>47. </span> Which of the following is mostly associated with dermatomyositis? </p><ol class=mt-3 type=A><li>Inflammatory bowel disease</li><li>GERD</li><li>Underlying malignancy</li><li>Melanoma</li></ol><button aria-controls=explanation-22P aria-expanded=false class="btn btn-secondary" data-target=#explanation-22P data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-22P><p class=correct-answer><strong>Answer:</strong> C</p><span style="text-decoration: underline;"><strong>Dermatomyositis<br></strong></span><br>1. Autoimmunee disorders characterized by proximal muscle weakness, and ultimately wasting. Facial or ocular muscles are never involved. <br>2. Dermatomyositis involve typical skin changes: Heliotrope dusky rash around the eyes associated with periorbital edema, and Gottron's papules, which are red scaly patches over the metacarpophalangeal joints. <br>3. <strong>Occult malignancies are often associated with dermatomyositis or Polymyositis such as: breast, lung or colon cancer. </strong><br>4. Anti Jo-1 antibodies are positive in polymyositis and dermatomyositis.<br>5. Specific diagnosis is usually made by muscle biopsy.<br>6. Inflammatory myopathies are best treated with corticosteroids</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>48. </span> Which of the following is the drug of choice in treating patient with pseudomembranous colitis? </p><ol class=mt-3 type=A><li>Penicillin</li><li>Doxycycline</li><li>Metronidazole</li><li>Acyclovir</li></ol><button aria-controls=explanation-9Q1 aria-expanded=false class="btn btn-secondary" data-target=#explanation-9Q1 data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-9Q1><p class=correct-answer><strong>Answer:</strong> C</p><span style="text-decoration: underline;"><strong>Pseudomembranous colitis</strong> </span>(antibiotic-associated colitis)<br><br>1. <strong>C. difficile</strong> toxin is responsible for pseudomembranous colitis. Patients usually have bloody diarrhea, and most cases are <strong>associated with prior antibiotic use</strong>. <br>2. Patient usually presents with profuse watery diarrhea (usually no blood or mucus), crampy abdominal pain and toxic megacolon <br><strong>3. Watery diarrhea is the cardinal clinical symptom of C. difficile infection</strong><br>4. Demonstration of C. difficile toxins in stool is diagnostic.<br>5. Discontinue the offending antibiotic, if possible. <br><strong>6. Metronidazole is drug of choice (cannot be used in infants or pregnant patients) </strong><br>7. Oral <strong>vancomycin</strong> used if patient is resistant to metronidazole or cannot tolerate it.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>49. </span> A 32-year-old woman comes to the doctor with joint swelling and stiffness and fatigue for the last 6 weeks. Her symptoms starts every morning and improve at night. On examinations the wrist, MCPs and PIPs are swollen bilaterally.<br><br>Which of the following is the most likely diagnosis? </p><ol class=mt-3 type=A><li>Osteoarthritis</li><li>Polymyalgia rheumatica</li><li>Rheumatoid arthritis</li><li>Fibromyalgia</li></ol><button aria-controls=explanation-DFH aria-expanded=false class="btn btn-secondary" data-target=#explanation-DFH data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-DFH><p class=correct-answer><strong>Answer:</strong> C</p>1. <span style="text-decoration: underline;"><strong>Rheumatoid arthritis (</strong></span>RA) is a chronic systemic inflammatory disease of unknown cause. <br>2. An external trigger (eg, cigarette smoking, infection, or trauma) that triggers an autoimmune reaction<br>3. Immunologic tissue injury occurs in rheumatoid arthritis.<br>4. Rheumatoid arthritis is an erosive arthritis involves the MCP and PIP joints.<br>5. <strong>Morning stiffness</strong> (present in all patients)—improves as the day progresses. <br>6. Joint stiffness lasts for &gt; 30 minutes and affected joint show signs of inflammation. <br>7. Joint disease is <strong>symmetrical</strong> and non-migratory.<br>8. ESR is always elevated.<br>9. Rheumatoid factor is present in most cases (80%) of rheumatoid arthritis.<br>10. Positive anti-citrullinated peptide antibodies (ACPA) is 90% specific for RA <br>11. Positive antinuclear antibodies (ANA) in 40% of patients <br><br><span style="text-decoration: underline;"><strong>Signs and symptoms of rheumatoid arthritis may include the following:</strong></span><br>1. Persistent symmetric polyarthritis (synovitis) of hands and feet (hallmark feature) <br>2. Progressive articular deterioration <br>3. Extra-articular involvement <br>4. Difficulty performing activities of daily living (ADLs) <br>5. Constitutional symptoms<br><br><span style="text-decoration: underline;"><strong>Treatment</strong></span>: NSAIDs combined with a disease-modifying antirheumatic drug (DMARD).<br><br><br></div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>50. </span> Which of the following is the most appropriate screening test for a woman at high risk of developing osteoporosis? </p><ol class=mt-3 type=A><li>Serum phosphorus</li><li>Dual-energy x-ray absorptiometry</li><li>X-ray of the pelvis and spine</li><li>Serum calcium</li></ol><button aria-controls=explanation-4EM aria-expanded=false class="btn btn-secondary" data-target=#explanation-4EM data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-4EM><p class=correct-answer><strong>Answer:</strong> B</p>1. <span style="text-decoration: underline;"><strong>Osteoporosis</strong></span> is characterized by low bone mass, microarchitectural disruption, and skeletal fragility, resulting in decreased bone strength and an increased risk of fracture.<br>2. It is the most common cause of pathologic fractures in thin, elderly women and men. <br>3. It is the most common metabolic bone disease.<br>4. Osteoporosis generally does not become clinically apparent until a fracture occurs.<br>5. Usually asymptomatic until fractures (e.g., Colles, femoral neck, and vertebral) and neurovascular impingement occur <br>6. <strong>DEXA is currently the gold standard</strong> and most widely used investigation for detecting osteoporosis and osteopenia. <br>7. DEXA focuses mainly on 2 areas i.e. <strong>spine</strong> and <strong>pelvis</strong>.<br>8. T-score of –1 to –2.5 SD indicates osteopenia <br>9. <strong>T-score of less than –2.5 SD</strong> indicates <strong>osteoporosis</strong> <br>10. T-score of less than –2.5 SD with fragility fracture(s) indicates severe osteoporosis <br>11. Prevention and treatment with calcium and vitamin D supplementation. <br><strong>12. Bisphosphonates inhibit bone resorption and are first-line treatment </strong><br>13. <strong>Smoking cessation</strong> (smoking accelerates bone loss) and weight-bearing exercises help maintain and even restore some bone density.<br>14. Selective estrogen receptor modulators (e.g., raloxifene) help increase bone density with fewer adverse effects than classic hormone replacement therapy.<br>15. <strong>Fracture</strong> is the most devastating consequence of low BMD/osteoporosis.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>51. </span> Which one of the following is true about Alzheimer's disease? </p><ol class=mt-3 type=A><li>It is associated with tremor, ataxia, and muscle rigidity.</li><li>It is usually reversible.</li><li>It is not familial.</li><li>It is associated with microscopic senile plaques, neurofibrillary tangles, and granulovacuolar degeneration of neurons in the brain.</li></ol><button aria-controls=explanation-9IU aria-expanded=false class="btn btn-secondary" data-target=#explanation-9IU data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-9IU><p class=correct-answer><strong>Answer:</strong> D</p><span style="text-decoration: underline;"><strong>Alzheimer’s disease</strong></span>, which is the most common degenerative disease of the brain, usually occurs in patients in their late fifties and older. The disease is highlighted by progressive dementia, which begins with memory deficits and personality changes and progresses to involve disorders of cerebral function, including aphasias, agnosias, and apraxias. Pathological changes in the cerebral cortex include neuritic (senile) plaques, neurofibrillary tangles within nerve cells, and granulovacuolar degeneration of neurons. <br><br><br>Risk factors:<br>1. Age<br>2. Family history <br>3. Down syndrome</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>52. </span> A 30-year old man presents to your clinic with high-grade fever, rigors and headache. His symptoms started 5 days ago. The patient has recently traveled to Africa . Which of the following is the most likely diagnosis? </p><ol class=mt-3 type=A><li>Malaria</li><li>Hepatitis E</li><li>Viral Encephalitides</li><li>Yellow fever</li></ol><button aria-controls=explanation-XN8 aria-expanded=false class="btn btn-secondary" data-target=#explanation-XN8 data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-XN8><p class=correct-answer><strong>Answer:</strong> D</p>1. Yellow fever is a mosquito-borne flavivirus infection endemic in tropical South America and sub-Saharan Africa.<br>2. Symptoms may include sudden onset of fever, relative bradycardia, headache, and, if severe, jaundice, hemorrhage, and multiple organ failure.<br>3. Diagnosis is with viral culture, reverse transcription PCR, and serologic tests.<br>4. Treatment is supportive.<br>5. Prevention involves vaccination and mosquito control</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>53. </span> What is the mainstay of Parkinson's therapy? </p><ol class=mt-3 type=A><li>Anticholinergic</li><li>Monoamine oxidase inhibitor</li><li>Dopamine agonist</li><li>Levodopa</li></ol><button aria-controls=explanation-5GG aria-expanded=false class="btn btn-secondary" data-target=#explanation-5GG data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-5GG><p class=correct-answer><strong>Answer:</strong> D</p>Parkinson Disease <br><br>1. Results from a loss of dopamine containing neurons that are located in the pigmented substantia nigra and the locus ceruleus in the midbrain. <br>2. Onset is usually after age 50 years.  Parkinson disease is essentially a clinical diagnosis <br>3. Manifestations : Bradykinesia, Rigidity, Instability and Pill-rolling tremor at rest.<br>4. Other manifestations include masked facies, memory loss, and micrographia.<br>5. No cure : The goals are to delay disease progression and to relieve symptoms. <br>6.  The most effective symptomatic therapy of Parkinsonism is L-dopa.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>54. </span> A 55-year-old obese man is complaining of daytime sleepiness. He says that he frequently falls asleep during meetings. His past medical history is unremarkable.<br><br>Which of the following is the most likely cause for his symptoms? </p><ol class=mt-3 type=A><li>Obstructive sleep apnea</li><li>Idiopathic hypersomnia</li><li>Narcolepsy</li><li>Primary insomnia</li></ol><button aria-controls=explanation-NZJ aria-expanded=false class="btn btn-secondary" data-target=#explanation-NZJ data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-NZJ><p class=correct-answer><strong>Answer:</strong> A</p>1. <span style="text-decoration: underline;"><strong>Obstructive sleep apnea</strong></span>(OSA): A condition in which airflow ceases as a result of obstruction along the respiratory passages.<br>2. <strong>Risk factors</strong>: male gender, obesity, prior upper airway surgeries, a deviated nasal septum, a large uvula or tongue.<br>3.OSA is strongly associated with snoring. <br>4. OSA is associated with arrhythmia and pulmonary hypertension. <br><br><span style="text-decoration: underline;"><strong>Clinical features </strong></span><br>1. Snoring <br>2. Daytime sleepiness due to disrupted nocturnal sleep <br>3. Personality changes, decreased intellectual function, decreased libido  <br><span style="text-decoration: underline;"><strong><br>Diagnosis</strong></span>:<br>1. Polysomnography (sleep study) <br>2. Multiple (&gt;5/hour) periods of apnea/hypopnea (severe disease &gt;30/hour) <br><br><span style="text-decoration: underline;"><strong>Treatment</strong></span> <br>1. Lifestyle modifications (weight loss, exercise, decrease alcohol)<br>2. Positive airway pressure: continuous positive airway pressure (CPAP) <br>3. Surgical correction of the narrowed airway</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>55. </span> A 40-year-old man is brought to the emergency room with of sudden onset of fever, headache, and nausea. His temperature is 39.4 C, blood pressure is 94/63mmHg, pulse is 115/min, and respirations are 20/min. Examination shows a stiff neck.<br>Examination of the cerebrospinal fluid reveals: <br> <table class="table table-responsive table-sm table-striped"> <tbody> <tr> <td>WBC</td> <td>1800</td> </tr> <tr> <td>Protein</td> <td> 300mg/dL</td> </tr> <tr> <td>Glucose</td> <td> 23 mg/dL</td> </tr> </tbody> </table> <br>Which of the following is the most likely diagnosis? <br><br><br> </p><ol class=mt-3 type=A><li>Tuberculosis meningitis</li><li>Bacterial meningitis</li><li>Viral meningitis</li><li>Guillain-barré syndrome</li></ol><button aria-controls=explanation-9JA aria-expanded=false class="btn btn-secondary" data-target=#explanation-9JA data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-9JA><p class=correct-answer><strong>Answer:</strong> B</p>1. <strong>Meningitis</strong> may be classified as acute, subacute, chronic, or recurrent. It may also be classified by its cause: bacteria, viruses, fungi, protozoa, or, occasionally, noninfectious conditions.<br>2. Acute bacterial meningitis is particularly serious and rapidly progressive. <br>3. Viral and noninfectious meningitides are usually self-limited. <br>4. Subacute and chronic meningitides usually follow a more indolent course than other meningitides, but determining the cause can be difficult.<br><br>Symptoms and signs of the different types of meningitis may vary, particularly in severity and acuity. However, all types tend to cause the following (except in infants):<br>1. Headache<br>2. Fever<br>3. Nuchal rigidity (meningismus)<br>4. Patients may appear lethargic or obtunded.<br><br>Nuchal rigidity, a key indicator of meningeal irritation, is resistance to passive or volitional neck flexion. Nuchal rigidity may take time to develop. Clinical tests for it, from least to most sensitive, are<br>1. Kernig sign (resistance to passive knee extension)<br>2. Brudzinski sign (full or partial flexion of the hips and knees when the neck is flexed)<br>3. Difficulty touching the chin to the chest with the mouth closed<br>4. Difficulty touching the forehead or chin to the knee <br><br>Diagnosis is mainly by CSF analysis.<br> <table class="table table-responsive table-sm table-striped"> <tbody> <tr> <td> </td> <td><strong>WBC count</strong></td> <td><strong>Glucose</strong></td> <td><strong>Protein</strong></td> </tr> <tr> <td><strong>Normal</strong></td> <td>0- 5</td> <td>40-70</td> <td>&lt;40</td> </tr> <tr> <td><strong>Bacterial meningitis</strong></td> <td>&gt;1000</td> <td>&lt;40</td> <td>&gt;250</td> </tr> <tr> <td><strong>Viral meningitis</strong></td> <td>100-1000</td> <td>40-70</td> <td>&lt;100</td> </tr> <tr> <td><strong> Tuberculosis meningitis</strong></td> <td>5- 1000</td> <td>&lt;10</td> <td>&gt;250</td> </tr> </tbody> </table></div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>56. </span> What is the most likely causative organism of pseudomembranous colitis? </p><ol class=mt-3 type=A><li>Giardia lamblia</li><li>Campylobacter jejuni</li><li>Escherichia coli</li><li>Clostridium difficile</li></ol><button aria-controls=explanation-TWD aria-expanded=false class="btn btn-secondary" data-target=#explanation-TWD data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-TWD><p class=correct-answer><strong>Answer:</strong> D</p>1. Toxins produced by <strong>Clostridium difficile</strong> strains in the GI tract cause pseudomembranous colitis, typically <strong>after antibiotic use.</strong><br>2. C. difficile is the most common cause of antibiotic-associated colitis and is typically hospital-acquired, but community-acquired cases are increasing.<br>3. <strong>Risk factors</strong> for C. difficile–induced diarrhea include (Extremes of age, Severe underlying disease, Prolonged hospital stay and living in a nursing home)<br>4. <span style="text-decoration: underline;">Antibiotic-induced changes</span> in GI flora are the dominant predisposing factor. Although most antibiotics have been implicated, cephalosporins (particularly 3rd-generation), penicillins (particularly ampicillin and amoxicillin), clindamycin, and fluoroquinolones pose the highest risk.  Symptoms are diarrhea, sometimes bloody, rarely progressing to sepsis and acute abdomen.<br>5. <strong>Diagnosis</strong> is by identifying C. difficile toxin in stool.<br>6. <strong>Treatment</strong> is with oral metronidazole or vancomycin.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>57. </span> A 22-year old male dies while exercising. He had a family history of sudden death collapses. Which of the following is the most likely diagnosis? </p><ol class=mt-3 type=A><li>Myocardial infarction</li><li>Restrictive Cardiomyopathy</li><li>Pericarditis</li><li>Hypertrophic cardiomyopathy</li></ol><button aria-controls=explanation-26T aria-expanded=false class="btn btn-secondary" data-target=#explanation-26T data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-26T><p class=correct-answer><strong>Answer:</strong> D</p>Hypertrophic cardiomyopathy (HCM)<br><br><br>1. It is an autosomal dominant disease (chromosome 14). <br>2. It is more common in younger patients especially African-Americans.<br>3. Ejection-type systolic murmur at the left lower sternal border that decreases with an increase in preload (e.g. squatting) is classic for hypertrophic cardiomyopathy <br><br>Signs and symptoms of HCM can include the following:<br><br>1. Sudden cardiac death (the most devastating presenting manifestation)<br>2. Dyspnea (the most common presenting symptom)<br>3. Syncope and presyncope<br>4. Angina<br>5. Palpitations<br>6. Orthopnea and paroxysmal nocturnal dyspnea (early signs of congestive heart failure [CHF])<br>7. CHF (relatively uncommon but sometimes seen)<br>8. Dizziness<br> Diagnosis: Echocardiogram and positive family history.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>58. </span> Which of the following is medications is associated with drug-induced lupus? </p><ol class=mt-3 type=A><li>Digoxin</li><li>Penicillin</li><li>Metoprolol</li><li>Hydralazine</li></ol><button aria-controls=explanation-S8Q aria-expanded=false class="btn btn-secondary" data-target=#explanation-S8Q data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-S8Q><p class=correct-answer><strong>Answer:</strong> D</p>1. <span style="text-decoration: underline;"><strong>Drug-induced lupus erythematosus</strong></span> (DILE) is a variant of lupus erythematosus that resolves within days to months after withdrawal of the culprit drug in a patient with no underlying immune system dysfunction.<br>2. Patients often present with constitutional symptoms, pho­ tosensitive rash, arthralgia, myalgia, and serositis. <br>3. Subacute cutaneous lupus also may be present.  <br><span style="text-decoration: underline;"><strong><br>Several broad drug categories have been linked to DILE, including the following:</strong></span><br>1. Antihypertensives - Hydralazine, methyldopa, and captopril<br>2. Antipsychotics - Chlorpromazine<br>3. Anticonvulsants - Valproate, ethosuximide, carbamazepine<br>4. Antiarrhythmics - Procainamide and quinidine<br>5. Cholesterol-lowering agents - Lovastatin, simvastatin<br><br><span style="text-decoration: underline;"><strong>Treatment</strong></span>: Discontinue the offending agent.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>59. </span> Which of the following is <strong>not</strong> associated with cushing syndrome? </p><ol class=mt-3 type=A><li>Hypotension</li><li>Moon face</li><li>Trunk obesity</li><li>Easy bruising</li></ol><button aria-controls=explanation-NGT aria-expanded=false class="btn btn-secondary" data-target=#explanation-NGT data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-NGT><p class=correct-answer><strong>Answer:</strong> A</p>1. <strong>Cushing syndrome</strong> results from excessive levels of glucocorticoids (cortisol is the principal glucocorticoid) due to any cause. <br>2. Cushing disease results from pituitary Cushing syndrome (pituitary adenoma). <br><br>Causes<br>1. <span style="text-decoration: underline;">Iatrogenic Cushing syndrome</span> is the <strong>most common cause</strong>, and is due to prescribed prednisone or other steroids. Androgen excess is absent (because the exogenous steroid suppresses androgen production by the adrenals). <br>2. ACTH-secreting adenoma of the pituitary (<span style="text-decoration: underline;">Cushing disease</span>) is the second most common cause and leads to bilateral adrenal hyperplasia. Androgen excess is common. <br>3. Adrenal adenomas and carcinomas (10% to 15%). <br>4. Ectopic ACTH production (10% to 15%).  <br><span style="text-decoration: underline;"><br>Cushing's syndrome clinical features include :</span><br>- Moon facies<br>- Truncal obesity<br>- Impaired growth (Cessation of linear growth is characteristic in children)<br>- Striae<br>- Delayed puberty and amenorrhea<br>- Hyperglycemia<br>- Hypertension (common)<br>- Masculinization<br>- Osteoporosis with pathologic fractures<br>  <br>1. <strong>Diagnosis</strong> is usually made by elevated nocturnal serum or salivary cortisol levels, or 24-h urinary free cortisol, and a dexamethasone suppression test.<br>2. Pituitary causes are distinguished from non-pituitary causes by ACTH levels.<br>3. <strong>Treatment</strong>: Remove tumor; if no response, remove adrenals; other tumor-specific protocols</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>60. </span> Which of the following is the most common cause of acute pancreatitis? </p><ol class=mt-3 type=A><li>Gallstones</li><li>Hyperlipidemia</li><li>Trauma</li><li>Mumps</li></ol><button aria-controls=explanation-Q86 aria-expanded=false class="btn btn-secondary" data-target=#explanation-Q86 data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-Q86><p class=correct-answer><strong>Answer:</strong> A</p><table cellpadding=2 cellspacing=2 class="table table-responsive table-sm table-striped"> <tbody> <tr> <td> </td> <td><strong>Acute Pancreatitis</strong></td> <td><strong>Chronic Pancreatitis</strong></td> </tr> <tr> <td><span style="text-decoration: underline;"><strong>Risk factors</strong></span></td> <td><br><strong>Acute pancreatitis is most commonly secondary to gallstones or alcohol abuse. </strong><br>Trauma, hypercalcemia, hyperlipidemia, drugs</td> <td>Chronic alcohol abuse, congenital defect</td> </tr> <tr> <td><span style="text-decoration: underline;"><strong>Clinical presentation</strong></span></td> <td>Acute epigastric pain radiating to back, nausea, vomiting, Grey Turner sign (ecchymosis of flank), Cullen sign (peri- umbilical ecchymosis), fever, tachycardia; hypotension, shock if severe</td> <td>Recurrent epigastric pain, steatorrhea, weight loss, nausea, constipation</td> </tr> <tr> <td><span style="text-decoration: underline;"><strong>Labs</strong></span></td> <td>Increased amylase and lipase</td> <td>Mildly increased amylase and lipase, glycosuria</td> </tr> <tr> <td><span style="text-decoration: underline;"><strong>Imaging</strong></span></td> <td>1. CT scan is diagnostic for pancreatitis <br><br>2. ERCP is the investigation of choice for patients with recurrent attacks of pancreatitis without obvious cause.</td> <td>Abdominal radiograph may show pancreatic calcifications<br><br>CT may show calcifications, pancreatic enlargement, or pseudocyst</td> </tr> <tr> <td><span style="text-decoration: underline;"><strong>Treatment</strong></span></td> <td>Hydration, pain control with opioids, na- sogastric suction, make patient NPO, stop offending agent; debridement of necrotic tissue</td> <td>Stop alcohol use, opioid analgesia, enzyme supplementation, dietary modification (small, low-fat meals); surgery may be required to repair ductal damage</td> </tr> </tbody> </table></div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>61. </span> A 42-year-old man comes to the physician with fever for the last 3 days. Since returning from a family trip to Sudan two weeks ago, he has been lethargic with abdominal pain, constant nausea and headache. His temperature is 38.5 C, blood pressure is 120/60 mm Hg, pulse is 119/min, and respirations are 19/min. <br>Which of the following investigations will be most helpful in establishing the diagnosis? </p><ol class=mt-3 type=A><li>PCR</li><li>Peripheral blood smear</li><li>KOH Prepration</li><li>Clinically</li></ol><button aria-controls=explanation-7PQ aria-expanded=false class="btn btn-secondary" data-target=#explanation-7PQ data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-7PQ><p class=correct-answer><strong>Answer:</strong> B</p>1. Malaria is a parasitic infection by caused by plasmodium spp. (P. vivax, P. falciparum, P. ovale, P. malariae) transmitted by Anopheles mosquito.<br>3.Symptoms and signs include fever (which may be periodic), chills, sweating, hemolytic anemia, and splenomegaly.<br>4. Diagnosis is by seeing Plasmodium in a peripheral blood smear.<br>5. Treatment and prophylaxis depend on the species and drug sensitivity and include the fixed combination of atovaquone and proguanil, artemisinin derivatives, doxycycline, mefloquine, chloroquine, and quinine.<br>6. Patients infected with P. vivax and P. ovale also receive primaquine to prevent relapse</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>62. </span> Which of the following is the most specific test for tuberculosis? </p><ol class=mt-3 type=A><li>PPD</li><li>chest radiograph</li><li>AFB culture</li><li>CT scan</li></ol><button aria-controls=explanation-JN0 aria-expanded=false class="btn btn-secondary" data-target=#explanation-JN0 data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-JN0><p class=correct-answer><strong>Answer:</strong> C</p>Tuberculosis (TB), a multisystemic disease with myriad presentations and manifestations, is the most common cause of infectious disease–related mortality worldwide.<br><br>Classic clinical features associated with active pulmonary TB are as follows (elderly individuals with TB may not display typical signs and symptoms):<br>1. Cough <br>2. Weight loss/anorexia <br>3. Fever <br>4. Night sweats <br>5. Hemoptysis <br>6. Chest pain<br>7. Fatigue <br><br>Diagnosis<br><br>Screening methods for TB include the following:<br>1. Mantoux tuberculin skin test with purified protein derivative (PPD) for active or latent infection (primary method).<br>2. Acid-fast bacilli (AFB) smear and culture using sputum obtained from the patient: Absence of a positive smear result does not exclude active TB infection; AFB culture is the most specific test for TB <br>3. HIV serology in all patients with TB and unknown HIV status: Individuals infected with HIV are at increased risk for TB <br><br>Other diagnostic testing may warrant consideration, including the following:<br>1. Specific enzyme-linked immunospot (ELISpot) <br>2. Nucleic acid amplification tests <br>3. Blood culture</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>63. </span> Which of the following is associated with recurrent parotitis, xerophthalmia, conjunctivitis, xerostomia, positive ANA and RF?<br><br> </p><ol class=mt-3 type=A><li>Sjogren syndrome</li><li>Systemic lupus erythematosus</li><li>Behcet’s disease</li><li>Reactive arthritis</li></ol><button aria-controls=explanation-T1T aria-expanded=false class="btn btn-secondary" data-target=#explanation-T1T data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-T1T><p class=correct-answer><strong>Answer:</strong> A</p>Sjogren syndrome<br><br>1. It is an autoimmune disorder resulting in chronic dysfunction of the exocrine glands.<br>2. The <em>most common symptoms</em> of Sjögren’s syndrome are dry eyes (due to decreased production of tears) and dry mouth (due to decreased production of saliva).<br>3. Parotid enlargement may be chronic or relapsing.<br>4 Lip biopsy is the most specific test for Sjogren' s syndrome.<br>5. Non-Hodgkin lymphoma is a complication of Sjogren's syndrome.<br>6. Anti SS-A (Ro) and anti SS-B (La) are more frequently positive in patients with Sjogren' s syndrome.<br>7. There is no cure for Sjögren’s syndrome<br><br>Treatment <br>1. Artificial tears for dry eyes <br>2. Good oral hygiene</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>64. </span> Café au lait spots are associated with which of the following disorders? </p><ol class=mt-3 type=A><li>Peutz jeghers syndrome</li><li>Dysplastic nevus syndrome</li><li>Addison's disease</li><li>Neurofibromatosis</li></ol><button aria-controls=explanation-693 aria-expanded=false class="btn btn-secondary" data-target=#explanation-693 data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-693><p class=correct-answer><strong>Answer:</strong> D</p><br> <table class="table table-responsive table-sm table-striped"> <tbody> <tr> <td><strong>Neurofibromatosis (von Recklinghausen's disease)</strong></td> <td>Café au lait spots</td> </tr> <tr> <td><strong>Peutz jeghers syndrome</strong></td> <td>Hyperpigmentation around the oral cavity, hamartomas of the intestine</td> </tr> <tr> <td><strong>Dysplastic nevus syndrome</strong></td> <td>Multiple pigmented nevi</td> </tr> <tr> <td><strong>Hypoadrenocorticism (Addison's disease)</strong></td> <td>Hyperpigmentation of the gingiva, areola of the nipples, labia, and linea alba of the abdomen</td> </tr> </tbody> </table></div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>65. </span> The most clinically useful marker for the presence of acute or chronic hepatitis B infection is: </p><ol class=mt-3 type=A><li>Antibody to hepatitis B surface antigen</li><li>Hepatitis B surface antigen</li><li>Hepatitis E antigen</li><li>Hepatitis B core antigen</li></ol><button aria-controls=explanation-J4I aria-expanded=false class="btn btn-secondary" data-target=#explanation-J4I data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-J4I><p class=correct-answer><strong>Answer:</strong> B</p>1. The hepatitis B virus (HBV) is commonly transmitted via body fluids such as blood, semen, and vaginal secretions.<br>2. Antibody to hepatitis B surface antigen indicates the development of an immune response to the virus, via either immunization or natural infection. <br>3. Hepatitis core antigen is not detectable in the serum. <br>4. Hepatitis E antigen occurs during periods of high viral replication and may not be present in the chronic carrier state. <br>5. High titers of E antigen correlate with infectivity. <br>6. The most clinically useful marker for hepatitis B infection is the hepatitis B surface antigen.<br><br><br>- Serologic tests for hepatitis B surface antigen (HBsAg) and hepatitis B core antibody (anti-HBc) immunoglobulin M (IgM) are required for the diagnosis of acute hepatitis B virus (HBV).<br>- HBsAg is positive in both acute and chronic HBV infection; however, the presence of IgM anti-HBc is diagnostic of acute or recently acquired infection.<br>- Antibody to HBsAg (anti-HBs) is produced after a resolved infection and is the only HBV antibody marker present after vaccination.<br>- The presence of HBsAg and total anti-HBc, with a negative test for IgM anti-HBc, indicates chronic HBV infection; the absence of IgM anti-HBc or the persistence of HBsAg for 6 months indicates chronic HBV infection. <br>- The presence of anti-HBc alone might indicate acute, resolved, or chronic infection or a false-positive result.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>66. </span> A 26-year-old male comes to the office and complains of a chronic cough, fever and night sweats. <br>His chest x-ray reveals right upper lobe fibrosis and his sputum is positive for acid-fast bacilli. Which of the following is the most appropriate management? </p><ol class=mt-3 type=A><li>Isoniazid -Rifampin -Pyrazinamide -Ethambutol</li><li>Isoniazid - Rifampin -Pyrazinamide -ethambutol- streptomycin</li><li>Isoniazid -Rifampin -amikacin -streptomycin</li><li>Isoniazid -Rifampin -amikacin - ethambutol</li></ol><button aria-controls=explanation-GED aria-expanded=false class="btn btn-secondary" data-target=#explanation-GED data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-GED><p class=correct-answer><strong>Answer:</strong> A</p>1. Tuberculosis properly refers only to disease caused by Mycobacterium tuberculosis (for which humans are the main reservoir). <br>2. Most (about 95%) primary infections are asymptomatic and followed by a latent (dormant) phase.<br>3. TB results almost exclusively from inhalation of airborne particles (droplet nuclei) containing M. tuberculosis. <br>4. They disperse primarily through coughing, singing, and other forced respiratory maneuvers by people who have active pulmonary TB and whose sputum contains a significant number of organisms (typically enough to render the smear positive). <br><br>Classic clinical features associated with active pulmonary TB are as follows (elderly individuals with TB may not display typical signs and symptoms):<br>1. Cough <br>2. Weight loss/anorexia <br>3. Fever <br>4. Night sweats <br>5. Hemoptysis <br>6. Chest pain <br>7. Fatigue<br><br><strong>Diagnosis</strong><br>Screening methods for TB include the following:<br>1. Mantoux tuberculin skin test with purified protein derivative (PPD) for active or latent infection (primary method) <br>2. Acid-fast bacilli (AFB) smear and culture using sputum obtained from the patient: Absence of a positive smear result does not exclude active TB infection; AFB culture is the most specific test for TB <br>3. HIV serology in all patients with TB and unknown HIV status: Individuals infected with HIV are at increased risk for TB<br><br><strong>Management</strong><br>Physical measures (if possible or practical) include the following:<br>1. Isolate patients with possible TB in a private room with negative pressure <br>2. Have medical staff wear high-efficiency disposable masks sufficient to filter the bacillus <br>3. Continue isolation until sputum smears are negative for 3 consecutive determinations (usually after approximately 2-4 weeks of treatment) <br><br>Initial empiric pharmacologic therapy consists of the following 4-drug regimens:<br>1. Isoniazid <br>2. Rifampin <br>3. Pyrazinamide <br>4. Either ethambutol or streptomycin</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>67. </span> Which of the following is the most common cause of cyanotic congenital heart disease? </p><ol class=mt-3 type=A><li>Pulmonary atresia</li><li>Hypoplastic left heart syndrome</li><li>Coarctation of the aorta</li><li>Tetralogy of Fallot</li></ol><button aria-controls=explanation-8ZF aria-expanded=false class="btn btn-secondary" data-target=#explanation-8ZF data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-8ZF><p class=correct-answer><strong>Answer:</strong> D</p><strong>Tetralogy of Fallot</strong> "TOF" <strong>is the most common cause of cyanotic congenital heart disease.<br></strong>TOF Characterized by 4 anomalies that result from deviation of the infundibular septum in utero: <strong><br></strong>1. Right ventricular outflow tract obstruction (pulmonary stenosis or atresia)<br> 2. Right ventricular hypertrophy 3. Overriding aorta 4. Ventricular septal defect (VSD) <br><br><span style="text-decoration: underline;"><strong>Clinical Presentation </strong></span><br>1. Cyanosis at birth (severe RVOT obstruction) <br>2. Murmur<br>3. Paroxysmal hypercyanotic attack (Blue or Tet spell) <br><br><span style="text-decoration: underline;"><strong>Chest radiography </strong></span><br>Boot­shaped heart (Coeur en sabot)<br><br><span style="text-decoration: underline;"><strong>Treatment</strong></span> <br>1. Cyanosis in newborn: Prostaglandin E in neonates with severe obstruction <br>2. Surgical correction electively within first year of life</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>68. </span> Response to iron therapy can be documented by which of the following? </p><ol class=mt-3 type=A><li>Ferritin</li><li>Hct</li><li>RBC</li><li>Reticulocyte count</li></ol><button aria-controls=explanation-3NJ aria-expanded=false class="btn btn-secondary" data-target=#explanation-3NJ data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-3NJ><p class=correct-answer><strong>Answer:</strong> D</p><strong>A reticulocyte test</strong> is used to determine the number and/or percentage of reticulocytes in the blood to help evaluate conditions that affect red blood cells (RBCs), such as anemia or bone marrow disorders. Reticulocytes are newly produced, relatively immature red blood cells. They form and mature in the bone marrow before being released into the blood. <br><br>Monitor patients with iron deficiency anemia on an outpatient basis to ensure that there is an adequate response to iron therapy and that iron therapy is continued until after correction of the anemia to replenish body iron stores. Follow-up also may be important to treat any underlying cause of the iron deficiency.<br><br><strong>Response to iron therapy can be documented by an increase in reticulocytes 5-10 days after the initiation of iron therapy.</strong> The hemoglobin concentration increases by about 1 g/dL weekly until normal values are restored. These responses are blunted in the presence of sustained blood loss or coexistent factors that impair hemoglobin synthesis.<br><br><span style="text-decoration: underline;"><strong>The reticulocyte test may be used:</strong></span><br>1. As a follow up to abnormal results on a complete blood count (CBC), RBC count, hemoglobin or hematocrit, to help determine the cause<br>2. To determine if the bone marrow is functioning properly and responding adequately to the body's need for red blood cells<br>3. To help detect and distinguish between different types of anemia<br>4. To monitor response to treatment, such as that for <strong>iron-deficiency anemia</strong><br>5. To monitor bone marrow function following treatments such as chemotherapy<br>6. To monitor function following a bone marrow transplant</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>69. </span> A 30-year-old woman comes to the doctor for skin tightness and painful fingertips with exposure to cold. Examinations shows thickened skin. Labs shows positive ANA and Anti-Scl-70 antibodies. <br><br>Which of the following is the most likely diagnosis? </p><ol class=mt-3 type=A><li>Behcet's disease</li><li>CREST syndrome</li><li>Systemic Lupus Erythematosus</li><li>Scleroderma</li></ol><button aria-controls=explanation-PRW aria-expanded=false class="btn btn-secondary" data-target=#explanation-PRW data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-PRW><p class=correct-answer><strong>Answer:</strong> D</p>1. <span style="text-decoration: underline;"><strong>Scleroderma</strong></span> is a disorder characterized by diffuse fibrosis of skin and internal organs.<br><strong>2. Raynaud' s phenomena are seen in most patients with scleroderma.</strong><br>3. Scleroderma is more common in women. <br>4. <strong>Presents</strong> with arthralgias, myalgias, hand swelling, Raynaud phenomenon (i.e., blue distal extremities caused by arteriolar spasm), skin thickening, esophageal dysmotility, intestinal hypomotility, dyspnea, possible arrhythmias or heart failure.<br>5. <strong>Scleroderma patients have positive ANA and Anti-Scl-70 antibodies </strong><br><br><br><span style="text-decoration: underline;"><strong>Treatment</strong></span> <br>1. There is no available treatment for scleroderma.<br>2. Steroids for acute flares.<br>3. Penicillamine can be used for skin changes.<br>4. Calcium channel blockers for Raynaud’s.<br>5. ACEIs for renal disease and malignant hypertension</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>70. </span> Which of the following conditions occurs due to tumor invasion of the paravertebral sympathetic chain in a patient with lung cancer? </p><ol class=mt-3 type=A><li>Eaton–Lambert syndrome</li><li>Phrenic nerve palsy</li><li>Syndrome of inappropriate antidiuretic hormone secretion</li><li>Horner's syndrome</li></ol><button aria-controls=explanation-RIC aria-expanded=false class="btn btn-secondary" data-target=#explanation-RIC data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-RIC><p class=correct-answer><strong>Answer:</strong> D</p><span style="text-decoration: underline;"><strong>Pancoast tumors</strong></span>: Superior sulcus tumors (mostly squamous cell carcinoma) invading and compressing the paravertebral sympathetic chain and brachial plexus.<br><br><strong>Pancoast tumors most commonly present with shoulder pain</strong>. Other findings include <strong>Horner's syndrome</strong>, weakness and atrophy of the hand muscles, pain and/or paresthesias in the arm or forearm, and enlarged supraclavicular lymph nodes.  <br><br><span style="text-decoration: underline;"><strong>Horner’s syndrome presentation: </strong></span><br>1. <strong>Ptosis</strong>: Due to paralysis of superior tarsal muscle. <br>2. <strong>Miosis</strong>: Due to paralysis of dilator pupillae muscle. <br>3. <strong>Anhydrosis</strong>.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>71. </span> A 19-year old girl presents to the physician with band-like headache around the head. Which of the following is the most likely diagnosis? </p><ol class=mt-3 type=A><li>Subdural hemorrhage</li><li>Tension headache</li><li>Migraine Headache</li><li>Cluster Headache</li></ol><button aria-controls=explanation-I37 aria-expanded=false class="btn btn-secondary" data-target=#explanation-I37 data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-I37><p class=correct-answer><strong>Answer:</strong> B</p><span style="text-decoration: underline;"><strong>Tension headache</strong></span><br>1. Band-like headaches that occur <strong>bilaterally</strong>.<br>2. Associated with tightness of the posterior neck muscles.<br>3. It may persist for several days.<br>4. Treatment with acetaminophen, NSAIDs and muscle relaxants. <br><br> <table cellpadding=1 class="table table-responsive table-sm table-striped"> <tbody> <tr> <td> </td> <td><span style="text-decoration: underline;"><strong>Migraine</strong></span></td> <td><span style="text-decoration: underline;"><strong>Cluster</strong></span></td> <td><span style="text-decoration: underline;"><strong>Tension</strong></span></td> </tr> <tr> <td><strong>Patients</strong></td> <td>10–30 yr of age, female &gt; male</td> <td>Young men</td> <td>Female &gt;male</td> </tr> <tr> <td><strong>Pathology</strong></td> <td>Poorly understood; likely due to neuronal dysfunction</td> <td>Poorly understood, likely extracerebral cause</td> <td>Poorly understood</td> </tr> <tr> <td><strong>Precipitating factors</strong></td> <td>Stress, oral contraceptives, menstruation, exertion, foods containing tyramine or nitrates (chocolate, cheese, processed meats)</td> <td>Alcohol, vasodilators</td> <td>Stress, fatigue</td> </tr> <tr> <td><strong>Pain characteristics</strong></td> <td><strong>Unilateral</strong>, throbbing</td> <td>Severe, <strong>unilateral</strong>, periorbital, recurrent (“in clusters” over time)</td> <td><strong>Bilateral</strong>, tightness, occipital or neck pain</td> </tr> <tr> <td><strong>Symptoms</strong></td> <td>Nausea, vomiting, preceding aura (visual abnormalities), photophobia</td> <td><strong>Horner syndrome</strong> (ptosis, miosis, anhidrosis), lacrimation, nasal congestion</td> <td>Anxiety</td> </tr> <tr> <td><strong>Duration</strong></td> <td>4–72 hr</td> <td>30 min–3 hr</td> <td>Variable</td> </tr> <tr> <td><strong>Treatment</strong></td> <td>NSAIDs, ergots, sumatriptan; IV antiemetics useful for severe cases; prophylaxis includes tricyclic antidepres- sants, 􏰉-blockers, calcium channel blockers, ergots</td> <td>100% O2, ergots, sumatriptan; prophylaxis similar to that for migraines</td> <td>NSAIDs, ergots, sumatriptan, relaxation exercises</td> </tr> </tbody> </table></div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>72. </span> What is the most controllable risk factor for developing crohn's disease? </p><ol class=mt-3 type=A><li>Family history</li><li>Alcohol</li><li>High Fiber Diet</li><li>Smoking</li></ol><button aria-controls=explanation-CML aria-expanded=false class="btn btn-secondary" data-target=#explanation-CML data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-CML><p class=correct-answer><strong>Answer:</strong> D</p>1. <span style="text-decoration: underline;"><strong>Crohn disease</strong> </span>is an idiopathic, chronic inflammatory process that can affect any part of the gastrointestinal tract from the mouth to the anus.<br>2. The characteristic presentation in Crohn disease is abdominal pain and diarrhea, which may be complicated by intestinal fistulization or obstruction.<br>3. Site of involvement : Entire GI tract may be involved with multiple “skipped” areas; distal ileum most commonly involved; entire bowel wall affected (Terminal ileum is the most common)<br><strong>4. Cigarette smoking is the most controllable risk factor for developing Crohn’s disease. It also leads to more severe disease and greater risk of having surgery.</strong></div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>73. </span> Which of the following is the most common cause of superior vena cava syndrome? </p><ol class=mt-3 type=A><li>Carcinoma of the lung</li><li>Pericarditis</li><li>Tuberculosis</li><li>Aortic aneurysm</li></ol><button aria-controls=explanation-SXN aria-expanded=false class="btn btn-secondary" data-target=#explanation-SXN data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-SXN><p class=correct-answer><strong>Answer:</strong> A</p>1. <strong>Superior vena cava syndrome</strong> (SVCS) is obstruction of blood flow through the superior vena cava (SVC).<br>2. It is a medical emergency and most often manifests in patients with a malignant disease process within the thorax.<br>3. A patient with SVCS requires immediate diagnostic evaluation and therapy.<br>4.<strong> More than 80% of cases of SVCS are caused by malignant mediastinal tumors</strong>.<br>5. Bronchogenic carcinomas account for 75-80% of all these cases, with most of these being small-cell carcinomas.<br>6. Non-Hodgkin lymphoma (especially the large-cell type) account for 10-15%.<br>7. As the syndrome advances toward total SVC obstruction, the classic symptoms and signs become more obvious.<br>8. <strong>Dyspnea is the most common symptom</strong>, observed in 63% of patients with SVCS. <br>9. Other symptoms include facial swelling, head fullness, cough, arm swelling, chest pain, dysphagia, orthopnea, distorted vision, hoarseness, stridor, headache, nasal stuffiness, nausea, pleural effusions, and light-headedness.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>74. </span> Which of the following murmurs is associated with mitral stenosis? </p><ol class=mt-3 type=A><li>Holosystolic murmur</li><li>A diastolic, mid to late, low-pitched murmur</li><li>Systolic crescendo/decrescendo murmur</li><li>Austin Flint murmur</li></ol><button aria-controls=explanation-ET6 aria-expanded=false class="btn btn-secondary" data-target=#explanation-ET6 data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-ET6><p class=correct-answer><strong>Answer:</strong> B</p>Mitral stenosis<br><br>1. Almost all cases are due to rheumatic heart disease <br>2. Cardiac auscultation of reveals a loud S1 and a mid diastolic rumbling murmur at the apex.<br>3. Echocardiogram is the most important test to confirming the diagnosis. <br> <br>Symptoms:<br>1. Exertional dyspnea<br>2. Orthopnea<br>3. PND <br>4. Hemoptysis <br>5. Palpitations<br>6. Chest pain <br><br> Systolic murmurs:  <br> 1. Aortic stenosis: Harsh systolic ejection murmur; radiation to carotids.  <br> 2. Mitral regurgitation: Holosystolic murmur; radiation to axillae or to  carotids.  <br> 3. Mitral valve prolapse: Midsystolic or late-systolic click.  <br><br>Diastolic murmurs: <br> 1. Aortic regurgitation: Early decrescendo murmur.  <br> 2. Mitral stenosis: Mid- to late, low-pitched murmur.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>75. </span> A 45-year-old male comes with weakness, abdominal pain, and arthralgias. Initial blood tests show a mild elevation in AST/ALT. In reviewing the family history, the patient's father had hemochromatosis. What would additional blood test be most specific in screening for this patient? </p><ol class=mt-3 type=A><li>Amylase</li><li>Transferrin</li><li>Renal function test</li><li>Glucose</li></ol><button aria-controls=explanation-GOJ aria-expanded=false class="btn btn-secondary" data-target=#explanation-GOJ data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-GOJ><p class=correct-answer><strong>Answer:</strong> B</p>1. <strong>Hereditary hemochromatosis</strong> is a genetic disorder characterized by excessive iron (Fe) accumulation that results in tissue damage.<br>2. The effects of iron overload are similar in all types and include liver disease (leading to cirrhosis), skin pigmentation, diabetes, arthropathy, erectile dysfunction, and sometimes heart failure. Manifestations can include systemic symptoms, liver disorders, cardiomyopathy, diabetes, erectile dysfunction, and arthropathy.<br>3. Diagnose by measuring serum ferritin level; if elevated, confirm by demonstrating elevated serum iron, transferrin saturation, and genetic testing.<br>4. Once diagnosis is made, do liver biopsy to identify cirrhosis and determine prognosis; consider genetic testing and screening of first-degree relatives.<br>5. Treat with phlebotomy and moderation of alcohol consumption.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>76. </span> Which of the following is associated with T-wave flattening, ST depression and U-waves in ECG? </p><ol class=mt-3 type=A><li>Hypokalemia</li><li>Hypophosphatemia</li><li>Hypercalcemia</li><li>Hypernatremia</li></ol><button aria-controls=explanation-C3Y aria-expanded=false class="btn btn-secondary" data-target=#explanation-C3Y data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-C3Y><p class=correct-answer><strong>Answer:</strong> A</p><span style="text-decoration: underline;"><strong>Hypokalemia</strong></span> <br>1. Serum potassium<strong> &lt;3.5 mEq/L</strong> <br>2. Due to poor dietary intake, metabolic/respiratory alkalosis, hypothermia, vomiting, diarrhea, hyperaldosteronism, insulin excess (e.g., treatment of diabetic ketoacido- sis), diuretics (loop, thiazide), or renal tubular acidosis types I and II.<br>3. <strong>Clinical features</strong>: Fatigue, weakness, paresthesias and/or paralysis; hyporeflexia, arrhythmias <br>4. <strong>ECG</strong>: T-wave flattening, ST depression, U waves <br>5. <strong>Treatment</strong>: treat underlying disorder; give oral or IV KCl<br>6. <strong>Complications</strong>: rapid replacement can lead to arrhythmias</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>77. </span> A 71-year-old man presented to his primary care physician with paresthesias, glossitis and diarrhea. Laboratory tests show a macrocytic anemia. Which of the following is the most likely diagnosis? </p><ol class=mt-3 type=A><li>Beta thalassemia</li><li>Acute myeloid leukemia</li><li>Sickle cell anemia</li><li>Pernicious anemia</li></ol><button aria-controls=explanation-9ZC aria-expanded=false class="btn btn-secondary" data-target=#explanation-9ZC data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-9ZC><p class=correct-answer><strong>Answer:</strong> D</p>Vitamin B12 deficiency anemia<br>1. <strong>Pernicious anemia</strong> specifically refers to anemia resulting from vitamin B12 deficiency caused by an autoimmune metaplastic atrophic gastritis with <span style="text-decoration: underline;">loss of intrinsic factor</span>. <br>2. Pernicious anemia or anemia resulting from inadequate vitamin B12 intake, ileal resection, bacterial overgrowth in GI tract, or Diphyllobothrium latum infection (a worm) <br>3. <strong>Clinical features</strong>: fatigue, weakness, dyspnea on exertion, memory loss; pallor, tachycardia, tachypnea, increased pulse pressure, possible systolic murmur, symmetric paresthesias, loss of vibration sense, ataxia, possible dementia <br>4. <strong>Labs</strong>: decreased Hgb, decreased Hct, increased MCV, decreased vitamin B12 <br>5. <strong>Blood smear</strong>:macrocytic RBCs, hypersegmented neutrophils<br>6. <strong>Treatment</strong>: monthly intramuscular vitamin B12 injections, dietary supplementation of vitamin B12, intranasal vitamin B12</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>78. </span> Which of the following is the most common cause of endocarditis following a dental procedures? </p><ol class=mt-3 type=A><li>Streptococcus pyogenes</li><li>Staphylococcus aureus</li><li>Viridans streptococci</li><li>Staphylococcus epidermidis</li></ol><button aria-controls=explanation-6OC aria-expanded=false class="btn btn-secondary" data-target=#explanation-6OC data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-6OC><p class=correct-answer><strong>Answer:</strong> C</p><span style="text-decoration: underline;"><strong>Endocarditis</strong></span> <br><br>1. Bacterial infection of endocardium (i.e., inner lining of heart), with or without valve involvement.<br>2. <span style="text-decoration: underline;"><strong>Subacute endocarditis</strong></span> caused by viridans streptococci, Enterococcus, fungi, and Staphylococcus epidermidis <br>3. <strong>Clinical picture</strong>: fever (very high in acute form), chills, night sweats, fatigue, arthralgias; possible new murmur; small, tender nodules on finger and toe pads (i.e., Osler nodes); peripheral petechiae (i.e., Janeway lesions), subungual petechiae (i.e., splinter hemorrhages), retinal hemorrhages (i.e., Roth spots)<br>4. <strong>Viridans group streptococci</strong> (most commonly S. mutans) are <strong>the most common cause of endocarditis following dental procedures.</strong></div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>79. </span> Which of the following is associated with chronic myelogenous leukemia? </p><ol class=mt-3 type=A><li>t(2;5)</li><li>t(1;11)</li><li>t(15;17)</li><li>t(9,22)</li></ol><button aria-controls=explanation-4W5 aria-expanded=false class="btn btn-secondary" data-target=#explanation-4W5 data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-4W5><p class=correct-answer><strong>Answer:</strong> D</p><span style="text-decoration: underline;"><strong>Chronic Myelogenous leukemia (CML)</strong></span><br><br>1. CML is a disorder characterized by massive over production of myeloid cells.<br>2. Philadelphia chromosome t(9,22) or BCR-ABL fusion gene.<br>3. Seen in middle-aged adults ( 40–60 years ) and can be associated with radiation exposure.<br>4. Patients frequently have splenomegaly with LUQ pain and early satiety.<br>5. Constitutional symptoms (weight loss, anorexia and fever)<br>6. It is characterized by leukocytosis, Basophilia, anemia and marked splenomegaly (Lymphadenopathy is not a feature of CML).<br>7. Labs: Elevated WBCs (more than 100,000/ml) <br><br></div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>80. </span> A 22-year old man with café-au-lait spots, freckling of axilla, and optic glioma. Which of the following is the most likely diagnosis? </p><ol class=mt-3 type=A><li>Hyperkinetic disorders</li><li>Myasthenia gravis</li><li>Neurofibromatosis</li><li>Guillain-Barré syndrome</li></ol><button aria-controls=explanation-RMD aria-expanded=false class="btn btn-secondary" data-target=#explanation-RMD data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-RMD><p class=correct-answer><strong>Answer:</strong> C</p>Neurofibromatosis<br><br>1. It is the the most common neurocutaneous disorder. <br>2. There are two types: Neurofibromatosis 1 (NF1, or von Recklinghausen’s syndrome) and neurofibromatosis 2 (NF2). <br>3. Both are Autosomal dominant disease (Caused by NF1 gene on chromosome 17).<br>4. Neurocutaneous disorder characterized by café-au-lait spots, cutaneous neurofibromas, optic gliomas, pheochromocytomas, Lisch nodules.<br>5. Optic glioma occurs in 15% of patients with neurofibromatosis type 1.<br>6. Initial signs are freckling, café-au-lait spots, Lisch nodules, neurofibromas, axillary or inguinal freckling and bone abnormalities.<br><br></div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>81. </span> Which of the following is associated with ipsilateral lacrimation, rhinorrhea, red eye and horner's syndrome? </p><ol class=mt-3 type=A><li>Cluster headache</li><li>Giant cell arteritis</li><li>Tension headache</li><li>Migraine headache</li></ol><button aria-controls=explanation-7PD aria-expanded=false class="btn btn-secondary" data-target=#explanation-7PD data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-7PD><p class=correct-answer><strong>Answer:</strong> A</p>Cluster headache<br><br>1.Usually occurs in middle-aged men ( Males are affected more often than females).<br>2.Presents as excruciating, unilateral periorbital headache that lasts 30 minutes to 3 hours.<br>3.Almost always unilateral<br>4.Accompanied by ipsilateral lacrimation, facial flushing, nasal stuffiness and discharge and <strong>May present with Horner syndrome.</strong><br>5.100% oxygen (treatment of choice) is an effective and rapid method to abort an acute attack of cluster headache.<br>6.Prophylactic therapy: prednisone and ergotamine</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>82. </span> A 50-year-old man presents to the doctor complaining of palpitations and shortness of breath. On examination, he is found to have an irregular heartbeat of 130 bpm.Which of the following is the most likely diagnosis?<img alt class=img-fluid height=176 src=data:image/gif;base64,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 style=undefined width=531> </p><ol class=mt-3 type=A><li>Atrial fibrillation</li><li>Ventricular fibrillation</li><li>Premature ventricular contractions</li><li>Ventricular tachycardia</li></ol><button aria-controls=explanation-XXR aria-expanded=false class="btn btn-secondary" data-target=#explanation-XXR data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-XXR><p class=correct-answer><strong>Answer:</strong> A</p>1. Atrial fibrillation (AF) is a rapid, irregularly irregular atrial rhythm.<br>2. Symptoms include palpitations and sometimes weakness, effort intolerance, dyspnea, and presyncope.<br>3. The most common causes of atrial fibrillation are hypertension, ischemic or nonischemic cardiomyopathy, mitral or tricuspid valvular disorders, hyperthyroidism, and binge alcohol drinking (holiday heart).<br>4. Atrial thrombi often form, causing a significant risk of embolic stroke.<br>5. Diagnosis is by ECG.<br>6. Treatment involves rate control with drugs, prevention of thromboembolism with anticoagulation, and sometimes conversion to sinus rhythm by drugs or cardioversion</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>83. </span> Which of the following is associated with auer rods on blood smear? </p><ol class=mt-3 type=A><li>Acute lymphoblastic leukemia</li><li>Chronic lymphocytic leukemia</li><li>Acute myeloid leukemia</li><li>Chronic Myelogenous leukemia</li></ol><button aria-controls=explanation-HF1 aria-expanded=false class="btn btn-secondary" data-target=#explanation-HF1 data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-HF1><p class=correct-answer><strong>Answer:</strong> C</p>Acute myeloid leukemia (AML) <br><br>1. AML is the most common type of acute leukemia in adults. <br>2. Risk factors: prior exposure to alkylating chemotherapy, radiation, myeloproliferative disorders, Down syndrome <br>3. Presents with fatigue, dyspnea on exertion ,easy bruising, frequent infections, fever and hepatosplenomegaly.<br>4. Auer rods are associated with AML.<br>5. AML is characterized by the presence of Auer rods, myeloperoxidase and esterase.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>84. </span> A 70-year-old male presents to the physician with cramping and nausea. He was diagnosed with small cell lung cancer 3 months ago.<br><br> <table class="table table-responsive table-sm table-striped"> <tbody> <tr> <td>Sodium</td> <td>122 mEq/L</td> </tr> <tr> <td>Potassium</td> <td>3.7 mEq/L</td> </tr> <tr> <td>Blood glucose</td> <td>100 mg/dL</td> </tr> </tbody> </table> <br><br>Which of the following is the best initial treatment of choice for this patient? </p><ol class=mt-3 type=A><li>Fluid restriction</li><li>Mannitol</li><li>Dexamethasone</li><li>Normal saline</li></ol><button aria-controls=explanation-JIQ aria-expanded=false class="btn btn-secondary" data-target=#explanation-JIQ data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-JIQ><p class=correct-answer><strong>Answer:</strong> A</p>1. The syndrome of inappropriate secretion of antidiuretic hormone (<strong>SIADH</strong>) is a disorder of impaired water excretion caused by the inability to suppress the secretion of antidiuretic hormone (ADH).<br>2. If water intake exceeds the reduced urine output, the ensuing water retention leads to the development of hyponatremia.<br>3. The SIADH should be suspected in any patient with hyponatremia, hypoosmolality, and a urine osmolality above 100 mosmol/kg. In SIADH, the urine sodium concentration is usually above 40 meq/L, the serum potassium concentration is normal, there is no acid-base disturbance, and the serum uric acid concentration is frequently low.<br>4. <span style="text-decoration: underline;"><strong>SIADH is characterized by</strong></span> hypotonic hyponatremia with euvolemia (without hypertension or edema). Low plasma osmolality (100-150 mOsm/Kg) in suspected patients is diagnostic. <br>5.<span style="text-decoration: underline;"><strong>Caused by</strong> </span>CNS pathology, sarcoidosis, paraneoplastic syndromes, psychiatric drugs, major surgery, pneumonia, or human immunodeficiency virus (HIV)<br>6. SIADH is commonly seen in patients with intracranial hemorrhage &amp; lung carcinoma. <br><br><span style="text-decoration: underline;"><strong>Treatment</strong></span>: <br>1. <strong>Water restriction is the initial treatment of choice.</strong><br>2. Loop diuretics and hypertonic saline if symptomatic; demeclocycline may help maintain normal Na levels <br>3. Rapid correction of serum sodium levels can lead to <span style="text-decoration: underline;">central pontine myelinosis</span></div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>85. </span> Which of the following conditions is associated with pyoderma gangrenosum? </p><ol class=mt-3 type=A><li>Diverticulitis</li><li>Inflammatory bowel disease</li><li>Irritable bowel syndrome</li><li>Ischemic colitis</li></ol><button aria-controls=explanation-SEG aria-expanded=false class="btn btn-secondary" data-target=#explanation-SEG data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-SEG><p class=correct-answer><strong>Answer:</strong> B</p>1. <strong>Pyoderma gangrenosum</strong> (PG) is an uncommon neutrophilic dermatosis that presents as an inflammatory and ulcerative disorder of the skin.<br>2.<strong> Ulcerative colitis (UC)</strong> and <strong>Crohn’s disease (CD)</strong> collectively are called inflammatory bowel disease (IBD).<br>3. <strong>Extraintestinal manifestations of inflammatory bowel disease</strong>: Rash (<strong>pyoderma gangrenosum</strong>, erythema nodosum), eye inflammation (episcleritis, uveitis), oral ulcerations (aphthous stomatitis), arthritis (peripheral, spondylitis). <br><br><span style="text-decoration: underline;"><strong>Both are idiopathic disorders presenting with: </strong></span><br>1. Abdominal pain and diarrhea <br>2. Blood and mucous in stool <br>3. CD can have fever and palpable abdominal masses  <br><span style="text-decoration: underline;"><strong><br>Both UC and CD can have: </strong></span><br>1. Joint pain <br>2. Erythema nodosum/pyoderma gangrenosum <br>3. Uveitis/episcleritis <br>4. Sclerosing cholangitis (more common in UC)</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>86. </span> Which of the following conditions is associated with markedly elevated serum iron and serum ferritin? </p><ol class=mt-3 type=A><li>Hemochromatosis</li><li>Gilbert's disease</li><li>Wilson's disease</li><li>Cirrhosis</li></ol><button aria-controls=explanation-AA3 aria-expanded=false class="btn btn-secondary" data-target=#explanation-AA3 data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-AA3><p class=correct-answer><strong>Answer:</strong> A</p><span style="text-decoration: underline;"><strong>Hemochromatosis </strong></span><br><br>1. <strong>Autosomal recessive</strong> disease of iron absorption.<br><strong>2. The most common cause of hemochromatosis is a genetic defect resulting in the overabsorption of iron from the duodenum. </strong><br>3. Excess iron absorption causes iron deposition in liver, pancreas, heart, and pituitary, leading to eventual fibrosis. <br>4. Presents with abdominal pain, polydipsia, polyuria, arthralgias, impotence, lethargy; pigmented rash (bronze hue), hepatomegaly, testicular atrophy; may see symptoms and signs that resemble DM and CHF.<br>5. <strong>Best initial tests:</strong> Elevated iron and ferritin levels and decreased total iron binding capacity (TIBC).<br>6. Liver biopsy is the most accurate test.<br>7. <span style="text-decoration: underline;"><strong>Treatment</strong></span>: Phlebotomy until normal iron</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>87. </span> Which of the following is the most common cause of acute mesenteric ischemia? </p><ol class=mt-3 type=A><li>Obesity</li><li>Hypertension</li><li>Diabetes mellitus</li><li>Embolic occlusion</li></ol><button aria-controls=explanation-MEJ aria-expanded=false class="btn btn-secondary" data-target=#explanation-MEJ data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-MEJ><p class=correct-answer><strong>Answer:</strong> D</p><strong>Acute mesenteric ischemia</strong> refers to the sudden onset of small intestinal hypoperfusion, which can be due to acute embolic occlusion of the intestinal blood supply, <strong>most commonly the superior mesenteric artery (SMA).</strong> Acute ischemia can also be related to acute thrombotic occlusion, typically of an already diseased mesenteric vessel (eg, atherosclerosis, dissection).<br><br>1. Patients present with sudden onset of severe abdominal pain out of proportion to the exam <br>2. <strong>The most common cause is an embolus from the heart</strong> (e.g. in case of AF).<br>3. Progression to bowel infarction causes peritoneal signs and the passage of bloody stool. <br>4. <strong>Mesenteric angiography</strong> is the <span style="text-decoration: underline;">gold standard</span> for arterial occlusive disease.<br>5. The mortality rate for acute mesenteric ischemia is &gt; 50%.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>88. </span> A 42-year-old man comes to the physician with fever for the last 3 days. Since returning from a family trip to Sudan two weeks ago, he has been lethargic with abdominal pain, constant nausea and headache. His temperature is 38.5 C, blood pressure is 120/60 mm Hg, pulse is 119/min, and respirations are 19/min. <br> Which of the following is the most likely diagnosis? </p><ol class=mt-3 type=A><li>Malaria</li><li>Giardiasis</li><li>Hepatitis A</li><li>Meningitis</li></ol><button aria-controls=explanation-PWJ aria-expanded=false class="btn btn-secondary" data-target=#explanation-PWJ data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-PWJ><p class=correct-answer><strong>Answer:</strong> A</p><strong>Malaria</strong> is one of the most common causes of fever in the returning traveler. <br>1. Parasitic infection by Plasmodium spp. (P. vivax, P. falciparum, P. ovale, P. malariae) transmitted by Anopheles mosquito <br>2. <strong>Clinical features</strong>: chills, diaphoresis, headache, myalgias, fatigue, nausea, abdominal pain, vomiting, diarrhea; periodic fever at approximately 1- to 3-day intervals, splenomegaly; P. falciparum infection can include decreased consciousness, pulmonary edema, and renal insufficiency <br>3. <strong>Labs</strong>: polymerase chain reaction (PCR) for Plasmodium is highly sensitive <br>4. <strong>Blood smear</strong> : Giemsa stain shows Plasmodium spp. <br>5. <strong>Treatment</strong>: antimalarials (e.g., chloroquine, primaquine, quinine); atovaquone-  proguanil or mefloquine used in chloroquine-resistant P. falciparum</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>89. </span> A 40-year-old man is brought to the emergency room with of sudden onset of fever, headache, and nausea. His temperature is 39.4 C, blood pressure is 94/63mmHg, pulse is 115/min, and respirations are 20/min. Examination shows a stiff neck.<br>Examination of the cerebrospinal fluid reveals: <br> <table class="table table-responsive table-sm table-striped"> <tbody> <tr> <td>WBC</td> <td>1800</td> </tr> <tr> <td>Protein</td> <td> 300mg/dL</td> </tr> <tr> <td>Glucose</td> <td> 23 mg/dL</td> </tr> </tbody> </table> Which of the following is the best next step in management of this patient?<br><br><br> </p><ol class=mt-3 type=A><li>Peripheral smear and reticulocyte count</li><li>Empiric antibiotics</li><li>Magnetic resonance imaging of the brain</li><li>CT scan</li></ol><button aria-controls=explanation-AER aria-expanded=false class="btn btn-secondary" data-target=#explanation-AER data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-AER><p class=correct-answer><strong>Answer:</strong> B</p>1. This patient presents with signs and symptoms of acute bacterial meningitis. Meningitis may be classified as acute, subacute, chronic, or recurrent. It may also be classified by its cause: bacteria, viruses, fungi, protozoa, or, occasionally, noninfectious conditions.<br>2. Acute bacterial meningitis is particularly serious and rapidly progressive. <br>3. Viral and noninfectious meningitides are usually self-limited. <br>4. Subacute and chronic meningitides usually follow a more indolent course than other meningitides, but determining the cause can be difficult.<br><br>Symptoms and signs of the different types of meningitis may vary, particularly in severity and acuity. However, all types tend to cause the following (except in infants):<br>1. Headache<br>2. Fever<br>3. Nuchal rigidity (meningismus)<br>4. Patients may appear lethargic or obtunded.<br><br>-Diagnosis is mainly by CSF analysis.<br>-Empiric antibiotics must not be delayed while awaiting results of computed tomography scan or performing lumbar puncture to diagnose bacterial meningitis.<br> <table class="table table-responsive table-sm table-striped"> <tbody> <tr> <td> </td> <td><strong>WBC count</strong></td> <td><strong>Glucose</strong></td> <td><strong>Protein</strong></td> </tr> <tr> <td><strong>Normal</strong></td> <td>0-5</td> <td>40-70</td> <td>&lt;40</td> </tr> <tr> <td><strong>Bacterial meningitis</strong></td> <td>&gt;1000</td> <td>&lt;40</td> <td>&gt;250</td> </tr> <tr> <td><strong>Viral meningitis</strong></td> <td>100-1000</td> <td>40-70</td> <td>&lt;100</td> </tr> <tr> <td><strong> Tuberculosis meningitis</strong></td> <td>5- 1000</td> <td>&lt;10</td> <td>&gt;250</td> </tr> </tbody> </table></div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>90. </span> A 42-year-old female with a history of chronic corticosteroid therapy comes in with complaints of easy bruising, muscle weakness, depressive symptoms, and amenorrhea. Examinations reveal hirsutism, truncal obesity, striae, elevated blood pressure, and hyperglycemia. Which of the following is the most likely diagnosis? </p><ol class=mt-3 type=A><li>Addison disease</li><li>Cushing's syndrome</li><li>Hyperthyroidism</li><li>Hyperprolactinemia</li></ol><button aria-controls=explanation-2ZC aria-expanded=false class="btn btn-secondary" data-target=#explanation-2ZC data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-2ZC><p class=correct-answer><strong>Answer:</strong> B</p><strong>Cushing syndrome</strong> is a constellation of clinical abnormalities caused by chronic high blood levels of cortisol or related corticosteroids.<br><br>Clinical manifestations of Cushing syndrome include<br>-Moon face with a plethoric appearance<br>-Truncal obesity with prominent supraclavicular and dorsal cervical fat pads (buffalo hump)<br>-Usually, very slender distal extremities and fingers<br>-Muscle wasting and weakness are present. <br><br>1. Cushing disease is Cushing syndrome that results from excess pituitary production of adrenocorticotropic hormone (ACTH), generally secondary to a pituitary adenoma.<br>2. Typical symptoms and signs include moon face and truncal obesity, easy bruising, and thin arms and legs.<br>3. Diagnosis is by history of receiving corticosteroids or by finding elevated serum cortisol.<br>4. Diagnosis is usually made by elevated nocturnal serum or salivary cortisol levels, or 24-h urinary free cortisol, and a dexamethasonesuppression test.<br>5. Treatment depends on the cause.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>91. </span> Which of the following is the gold standard test to diagnose pulmonary embolism? </p><ol class=mt-3 type=A><li>Chest X ray</li><li>D-dimer</li><li>Transthoracic echocardiogram</li><li>Pulmonary angiography</li></ol><button aria-controls=explanation-CPR aria-expanded=false class="btn btn-secondary" data-target=#explanation-CPR data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-CPR><p class=correct-answer><strong>Answer:</strong> D</p><span style="text-decoration: underline;"><strong>Pulmonary Embolism (PE)</strong></span><br>1. Suspect pulmonary embolism in any patient who presents with sudden onset of shortness of breath, pleuritic chest pain, normal lung exam, hypoxic, and have tachypnea, tachycardia and hypotension. Pulmonary vascular disease includes PE. <br>2. The most typical findings of a pulmonary embolism on arterial blood gas sampling are hypoxemia and hypocarbia. <br>3. Source: <strong>Most common source is DVT in the lower extremities</strong>, which could be explained by Virchow’s triad: Flow stasis, endothelial damage and hyper-coagulable state. <br>4. <strong>Clinical picture</strong>: Sudden dyspnea, hyperventilation and pleuritic chest pain in a patient with normal <br><strong>5. Presents as a hospitalized or immobile patient who suddenly develops unexplained respiratory distress few days after surgery.</strong><br>6. The most common ECG finding is sinus tachycardia.<br><strong>7. Gold standard for diagnosis: Pulmonary angiography. </strong><br>8. Patients with PE have normal chest X ray. <br>9. <strong>Treatment</strong>: Heparin is the first step, followed by warfarin for 3–6 months (Target INR = 2–3). <br><br></div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>92. </span> A 28-year-old man is placed on haloperidol after he is diagnosed with schizophrenia. A few days later his<br>concerned mother brings him back to the psychiatrist because he is exhibiting strange movements. The physician<br>observes movements that consist of sustained contractions and twisting motions of his limbs and trunk, with his<br>eyes tonically deviated upward for several minutes. Which of the following adverse reactions is occurring in this<br>patient? </p><ol class=mt-3 type=A><li>Tardive dyskinesia</li><li>Dystonia</li><li>Akathisia</li><li>Neuroleptic malignant syndrome</li></ol><button aria-controls=explanation-ZWT aria-expanded=false class="btn btn-secondary" data-target=#explanation-ZWT data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-ZWT><p class=correct-answer><strong>Answer:</strong> B</p>This patient is exhibiting dystonia, an acute extrapyramidal side effect that can be a<br>consequence of neuroleptic therapy. <strong>Acute dystonic reactions</strong> generally occur within the first few days of the<br>initiation of neuroleptic therapy, tend to occur more frequently in children and young adults, and occur in males<br>more often than females. The sustained eye deviation described in the question is a form of dystonia called an<br>oculogyric crisis. These reactions are reversible with antihistamines (e.g., diphenhydramine), anticholinergic<br>drugs (e.g., benztropine), or diazepam. All of the other answer choices can also be consequences of<br>neuroleptic therapy.<br><br><strong>Akathisia</strong> is an extrapyramidal syndrome characterized by a feeling of restlessness, frequent,<br>repetitive stereotyped movements and an inability to sit still for more than a short period of time. It usually<br>occurs during the first few months of drug use.<br><br><strong>Neuroleptic malignant syndrome</strong> a rare, but potentially fatal syndrome that usually occurs within 10<br>days of starting neuroleptic therapy. Clinical manifestations include fever, encephalopathy, muscle rigidity,<br>dystonia, diaphoresis, tachycardia, and labile blood pressure. <br><br><strong>Tardive dyskinesia </strong>is an often irreversible syndrome characterized by involuntary, choreoathetoid<br>movements in patients treated with antipsychotic medications. The frequency of tardive dyskinesia increases<br>with age and with the length of therapy. This disorder would be unlikely to occur within a few days of the<br>initiation of drug therapy.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>93. </span> A 40-year old man presents to the physician with big sweaty hands, large jaw, large tongue and feet. He also complained of headaches. His temperature is 36.3 C, Blood pressure is 150/80 mmHg, pulse 100/min. Which of the following is the most likely diagnosis? </p><ol class=mt-3 type=A><li>Gigantism</li><li>Acromegaly</li><li>Hypothyroidism</li><li>Prolactinoma</li></ol><button aria-controls=explanation-OH4 aria-expanded=false class="btn btn-secondary" data-target=#explanation-OH4 data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-OH4><p class=correct-answer><strong>Answer:</strong> B</p>1. Acromegaly is a syndrome of excessive secretion of growth hormone. In children this is called gigantism.<br>2. Acromegaly is an insidious, chronic debilitating disease associated with bony and soft tissue overgrowth, and increased mortality.<br>3. Acromegaly is caused by pituitary adenomas, usually a macroadenoma in 75% of the cases that produce growth hormone.<br><br>In addition to enlargement of the hat, ring, and shoe size from head, hand, and foot size, other abnormalities of acromegaly are: <br> 1. Cardiomyopathy <br> 2. Increased sweating: sweat glands enlarge <br> 3. Colonic polyps, including increased risk of colon cancer <br> 4. Nerve entrapment such as carpal tunnel from surrounding tissue pressing on the nerves <br> 5. Joint pain: bones and joints grow out of alignment <br> 6. Obstructive sleep apnea <br><br><strong>Diagnosis &amp; management </strong><br>1. The gold standard test for making a diagnosis of acromegaly is measurement of growth hormone levels following an oral glucose load.<br>2. Most patients with acromegaly are unable to suppress growth hormone levels following an oral glucose load. <br>3. Radiologic studies such as CT scanning and MRI are used to localize the tumor but should be done only after GH excess is documented biochemically.<br>4. MRI is superior to CT scan. MRI will show a tumor in 90% of people with acromegaly. <br>5. Octreotide is the best medical therapy for acromegaly. <br>6. Dopamine agonists such as bromocriptine and cabergoline are used if surgery is not curative <br>7. The most common cause of death in acromegaly is cardiovascular mortality.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>94. </span> A 53-year old woman presents to the physician with bilateral joint pain, easy fatigability and swelling in her hands for the past 6 months. Her symptoms are worst in the morning. The pain is associated with mild fever.<br><br>Which of the following is the most likely diagnosis? </p><ol class=mt-3 type=A><li>Systemic lupus erythematosus</li><li>Juvenile rheumatoid arthritis</li><li>Osteosarcoma</li><li>Rheumatoid arthritis</li></ol><button aria-controls=explanation-B6D aria-expanded=false class="btn btn-secondary" data-target=#explanation-B6D data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-B6D><p class=correct-answer><strong>Answer:</strong> D</p>1. <span style="text-decoration: underline;"><strong>Rheumatoid arthritis</strong></span> (RA) is a chronic systemic inflammatory disease of unknown cause.<br>2. An external trigger (eg, cigarette smoking, infection, or trauma) that triggers an autoimmune reaction, leading to synovial hypertrophy and chronic joint inflammation along with the potential for extra-articular manifestations.<br>3. In most patients with RA, onset is insidious, often beginning with fever, malaise, arthralgias, and weakness before progressing to joint inflammation and swelling.<br>4. Rheumatoid arthritis is an erosive arthritis involves the <strong>MCP</strong> and <strong>PIP</strong> joints.<br>5. Joint disease is symmetrical and non-migratory.<br><strong>6. Narrowing of joint space and juxta-articular bony erosions is the characteristic x-ray finding in rheumatoid arthritis (RA).</strong><br><strong>7. ESR is always elevated</strong><br>8. Rheumatoid factor is present in most cases (80%) of rheumatoid arthritis. <br><br><span style="text-decoration: underline;"><strong>Signs and symptoms of rheumatoid arthritis may include the following:</strong></span><br>1. Persistent symmetric polyarthritis (synovitis) of hands and feet (hallmark feature) <br>2. Progressive articular deterioration <br>3. Extra-articular involvement <br>4. Difficulty performing activities of daily living (ADLs) <br>5. Constitutional symptoms <br><br><span style="text-decoration: underline;"><strong>Treatment</strong></span>: <br>1. <strong>NSAIDs</strong> are the drugs of choice for pain control.e.g., acetaminophen, phenacetin, salicylates and indomethacin. <br>2. <strong>Steroids</strong>: Provide relief and may slow the progression of the disease. <br>3.<strong> Anti-Tumor Necrosis Factor (TNF):</strong> e.g., Infliximab, Adalimumab and Etanercept.<br>4. Disease modifying anti-rheumatoid drugs (<strong>DMARDs</strong>): Now the <strong>first line of therapy</strong> once there is any X-ray changes in the joint.<br>5. DMARDs should be started early and include methotrexate (the best initial DMARD to start with).</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>95. </span> Which one of the following conditions is most associated with pulsus alternans? </p><ol class=mt-3 type=A><li>Hypertrophic obstructive cardiomyopathy</li><li>Mixed aortic valve disease</li><li>Severe left ventricular failure</li><li>Cardiac tamponade</li></ol><button aria-controls=explanation-DYG aria-expanded=false class="btn btn-secondary" data-target=#explanation-DYG data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-DYG><p class=correct-answer><strong>Answer:</strong> C</p>1. <strong>Pulsus alternans:</strong> Sign of left ventricular systolic dysfunction  <br>2. <strong>Pulsus bigeminus</strong>: Sign of hypertrophic obstructive cardiomyopathy  (HOCM)  <br>3. <strong>Pulsus bisferiens:</strong> In aortic regurgitation  <br>4. <strong>Pulsus tardus et parvus</strong>: Aortic stenosis  <br>5. <strong>Pulsus paradoxus:</strong> Cardiac tamponade and tension pneumothorax  <br>6. <strong>Irregularly irregular</strong>: Atrial fibrillation</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>96. </span> Which of the following is associated with eating undercooked or raw meat? </p><ol class=mt-3 type=A><li>Giardiasis</li><li>Schistosomiasis</li><li>Trichinellosis</li><li>Hookworm Disease</li></ol><button aria-controls=explanation-Y6Z aria-expanded=false class="btn btn-secondary" data-target=#explanation-Y6Z data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-Y6Z><p class=correct-answer><strong>Answer:</strong> C</p>1. <strong>Trichinosis</strong> (trichinellosis) is the result of infection by a parasitic nematode belonging to the genus Trichinella. <br>2. Humans become infected with Trichinella by eating raw, undercooked, or underprocessed meat from infected animals most commonly pigs, wild boar, or bear.<br>3. Trichinellosis typically presents with gastrointestinal complaints (eg, abdominal pain, nausea, vomiting) followed by the characteristic triad of periorbital edema, myositis, and eosinophilia (hallmark of the disease).<br>4. Other findings include fever, subungual splinter hemorrhages, and conjunctival or retinal hemorrhages. <br>5. <strong>Diagnosis</strong> is clinical and with serologic tests.<br>6. Muscle biopsy may be diagnostic but is seldom necessary.<br>7. <strong>Treatment</strong> is with mebendazole or albendazole and, if symptoms are severe, with prednisone.<br>8. Trichinosis is <span style="text-decoration: underline;">prevented</span> by cooking pork or meat from wild animals until brown (&gt; 71° C throughout).</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>97. </span> What is the characteristic ECG finding of pericarditis? </p><ol class=mt-3 type=A><li>Saw tooth pattern</li><li>Low-voltage, diffuse ST-segment elevation</li><li>Normal ECG</li><li>QT interval prolongation</li></ol><button aria-controls=explanation-0OJ aria-expanded=false class="btn btn-secondary" data-target=#explanation-0OJ data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-0OJ><p class=correct-answer><strong>Answer:</strong> B</p>Acute pericarditis<br><br>1. It is an inflammation of the pericardial sac.<br>2. The vast majority of pericarditis cases are viral. <br>3. The majority of patients recover within 1 to 3 weeks. <br>4. Chest pain is the most common finding (often severe and pleuritic )<br>5. Presents with pleuritic chest pain with inspiration , dyspnea, cough, pain decreased with leaning forward,fever, friction rub (best heard when leaning forward).<br>6. Common associated signs and symptoms include low-grade intermittent fever, dyspnea/tachypnea (a frequent complaint and may be severe, with myocarditis, pericarditis, and cardiac tamponade), cough, and dysphagia. <br>7. The best initial test is the ECG.<br>8. The best initial therapy is an NSAID (e.g indomethacin, naproxen, aspirin, ibuprofen)</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>98. </span> Which of the following is the most common cause of osteomyelitis in children and adults? </p><ol class=mt-3 type=A><li>Pseudomonas aeroginosa</li><li>Staphylococcus aureus</li><li>Escherichia coli</li><li>Staphylococcus epidermidis</li></ol><button aria-controls=explanation-JHX aria-expanded=false class="btn btn-secondary" data-target=#explanation-JHX data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-JHX><p class=correct-answer><strong>Answer:</strong> B</p><span style="text-decoration: underline;"><strong>Osteomyelitis</strong></span><br>1. Bone infection via hematogenous spread or local extension<br>2.<strong> The major cause of bone infections is Staphylococcus aureus</strong> (consider Salmonella in patients with sickle cell disease)<br>3. Osteomyelitis is often diagnosed clinically with nonspecific symptoms such as fever, chills, fatigue, lethargy, or irritability. The classic signs of inflammation, including local pain, swelling, or redness, may also occur and normally disappear within 5-7 days.<br>4. Labs shows􏰀 increased WBC, ESR, and CRP; cultures needed to define appropriate antibiotic therapy.<br>5. <span style="text-decoration: underline;"><strong>Treatment</strong></span>: IV antibiotics for 4 to 6 weeks</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>99. </span> Following a total gastrectomy, which of the following digestive enzymes will be produced in inadequate amounts? </p><ol class=mt-3 type=A><li>Lipase</li><li>Pepsin</li><li>Amylase</li><li>Trypsin</li></ol><button aria-controls=explanation-MHI aria-expanded=false class="btn btn-secondary" data-target=#explanation-MHI data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-MHI><p class=correct-answer><strong>Answer:</strong> B</p>1. Pepsin is secreted (in an inactive or zymogen form as pepsinogen) by the chief cells of the stomach. Pepsinogen is activated by contact with stomach acid. Although protein digestion usually begins with the actions of hydrochloric acid and pepsin, pancreatic enzymes complete the job as the food passes into the small intestine. <br>2. Vitamin B12 deficiency is common after a total or partial gastrectomy.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>100. </span> Which of the following is associated with persistent vomiting? </p><ol class=mt-3 type=A><li>Hyperchloremic metabolic alkalosis</li><li>Hypochloremic metabolic alkalosis</li><li>Hyperchloremic metabolic acidosis</li><li>Hypochloremic metabolic acidosis</li></ol><button aria-controls=explanation-8DR aria-expanded=false class="btn btn-secondary" data-target=#explanation-8DR data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-8DR><p class=correct-answer><strong>Answer:</strong> B</p>1. Persistent vomiting can cause hypochloremic metabolic alkalosis. <br>2. Repeated vomiting may be a clue that the patient has severe gastroesophageal reflux or pyloric stenosis.<br>3. Metabolic alkalosis is an acid-base disorder in which the pH of the blood is elevated beyond the normal range of 7.35-7.45. This metabolic condition occurs mainly due to decreased hydrogen ion concentration in the blood, leading to compensatory increased levels of serum bicarbonate, or alternatively, as a direct result of increased bicarbonate concentrations. An elevated PaCO2 is often present as a result of compensatory alveolar hypoventilation.<br>4. Hydrogen loss can occur from the gastrointestinal tract or in the urine. In the presence of vomiting and aspiration of gastric contents, the normal stimulus to the production of the bicarbonate is eliminated which in turn leads to increased levels of bicarbonate in the blood and thus the resulting metabolic alkalosis.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>101. </span> A 35-year-old woman comes to the doctor with dry eyes and mouth. She also complained of difficulty in swallowing solid food. Examinations shows bilateral parotid enlargement. <br><br>Which of the following is the most likely diagnosis? </p><ol class=mt-3 type=A><li>Scleroderma</li><li>Dermatomyositis</li><li>Sjögren's syndrome</li><li>Fibromyalgia</li></ol><button aria-controls=explanation-Q4A aria-expanded=false class="btn btn-secondary" data-target=#explanation-Q4A data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-Q4A><p class=correct-answer><strong>Answer:</strong> C</p>1. <span style="text-decoration: underline;"><strong>Sjögren’s syndrome</strong></span> is an autoimmune disease most common in women. Lymphocytes infiltrate and destroy the lacrimal and salivary glands. <br>2. It is characterized by dry mouth, dry eyes (keratoconjunctivitis, with burning, itching, and foreign body <br>3. sensation), nasal dryness, vaginal dryness, chronic bronchitis and reflux esophagitis.<br><strong>4. Parotid enlargement may be chronic or relapsing.</strong><br>5. Anti SS-A (Ro) and anti SS-B (La) are more frequently positive in patients with Sjogren's syndrome.<br>6. Sjogren' s patient with positive anti SS-A usually have extra glandular manifestations. <br>7. <strong>Lip biopsy is the most specific test for Sjogren' s syndrome.</strong><br><strong>8. Lymphoma is the most dangerous long-term complication of Sjögren. </strong><br><br><span style="text-decoration: underline;"><strong>Treatment</strong></span> <br>1. Artificial tears and saliva, sour sugar-free candy <br>2. Pilocarpine and cevimeline increase salivary secretions <br>3. Hydroxychloroquine for arthralgias</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>102. </span> Which of the following is contraindicated in patient with hypertrophic obstructive cardiomyopathy? </p><ol class=mt-3 type=A><li>Atenolol</li><li>Acetaminophen</li><li>Digoxin</li><li>Aspirin</li></ol><button aria-controls=explanation-BH1 aria-expanded=false class="btn btn-secondary" data-target=#explanation-BH1 data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-BH1><p class=correct-answer><strong>Answer:</strong> C</p>1. <span style="text-decoration: underline;"><strong>Hypertrophic cardiomyopathy (HCM)</strong></span> is the most common cause of sudden death in the young. The most important predictors of sudden death are a family history of sudden death and recurrent syncope. Mortality in children with HCM is twice as high as adults. The condition is usually progressive and the symptoms depend on the age and mode of presentation.<br>2. This disorder is caused by a mutation in cardiac sarcomere protein genes and is most frequently transmitted as an autosomal dominant trait.<br><br><span style="text-decoration: underline;"><strong>Signs and symptoms of HCM can include the following:</strong></span><br>1. Sudden cardiac death (the most devastating presenting manifestation)<br>2. Dyspnea (the most common presenting symptom)<br>3. Syncope and presyncope<br>4. Angina<br>5. Palpitations<br>6. Orthopnea and paroxysmal nocturnal dyspnea (early signs of congestive heart failure [CHF])<br>7. CHF (relatively uncommon but sometimes seen)<br>8. Dizziness<br><br><span style="text-decoration: underline;"><strong>Management</strong></span><br>1. Beta-blockers are helpful in the medical management by reducing the heart rate and thereby prolonging the diastolic time. However, these agents have no effect on the degree of LV outflow obstruction or sudden death. <br>2. Digoxin and other inotropic agents and ACE inhibitors are contraindicated in HCM as they worsen the obstruction, though they may have a role in the end-stage dilated thin-walled HCM hearts with impaired LV function. <br>3. Diuretics are also usually contraindicated as they reduce the preload and enhance the LV obstruction.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>103. </span> A 48-year-old man presents to the physician with episodic productive cough of yellow sputum for the last two years. He denied any fever or chest pain. Examination shows digital clubbing.<br><br>Which of the following is the most likely diagnosis? </p><ol class=mt-3 type=A><li>Sarcoidosis</li><li>Tuberculosis</li><li>Asthma</li><li>Bronchiectasis</li></ol><button aria-controls=explanation-Q84 aria-expanded=false class="btn btn-secondary" data-target=#explanation-Q84 data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-Q84><p class=correct-answer><strong>Answer:</strong> D</p><span style="text-decoration: underline;"><strong>Bronchiectasis</strong></span><br>1. Combination of airway obstruction and infection, leading to abnormal persistent dilatation of the bronchi. <br>2. <strong>Most common sites</strong>: Bases of the lungs.<br>3. Occurs secondary to chronic airway obstruction, chronic tobacco use, TB, fungal infections, severe pneumonia, or cystic fibrosis <br>4. Presents with persistent, productive cough; hemoptysis, frequent respiratory infections, dyspnea; copious sputum, wheezing, rales, and hypoxemia <br>5. <strong>Diagnosis</strong>: 􏰀 multiple cysts and bronchial crowding seen on CXR; CT shows dilation of bronchi, bronchial wall thickening, and bronchial wall cysts <br>6. <strong>Treatment: </strong>pulmonary hygiene (e.g., hydration, sputum removal), chest physical therapy; antibiotics given when sputum production increases; inhaled 􏰅2-agonists and corticosteroids may reduce symptoms; resection of severely diseased regions of lung indicated for hemorrhage, substantial sputum production, or inviability</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>104. </span> A 25-year-old male comes to the doctor with diarrhea. He just returned from a trip to South Africa, where he developed foul-smelling stools, abdominal cramps and bloating. His temperature is 37 C , blood pressure is 102/68 mm Hg, and pulse is 90/min. Physical examination is unremarkable. Which of the following is the most likely diagnosis? </p><ol class=mt-3 type=A><li>Cryptosporidiosis</li><li>Amebiasis</li><li>Salmonella</li><li>Giardiasis</li></ol><button aria-controls=explanation-X1O aria-expanded=false class="btn btn-secondary" data-target=#explanation-X1O data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-X1O><p class=correct-answer><strong>Answer:</strong> D</p>1. <strong>Giardiasis</strong> is infection with the flagellated protozoan Giardia duodenalis (G. lamblia, G. intestinalis).<br>2. Infection can be asymptomatic or cause symptoms ranging from intermittent flatulence to chronic malabsorption.<br>3. <span style="text-decoration: underline;">The most common symptoms</span> are foul-smelling stools, fatty stools, bloating, flatulence, nausea, malaise, and abdominal cramps.<br>4. Places where giardiasis is widespread include: sub-Saharan Africa – all the countries south of the Sahara desert, such as South Africa, Gambia and Kenya <br>5. <strong>Transmission</strong> can also occur by ingestion of contaminated food and by direct person-to-person contact, especially in mental institutions and day care centers or between sex partners.<br>6. <span style="text-decoration: underline;">The major source of giardiasis is waterborne transmission</span>, including via fresh-appearing mountain streams and poorly filtered municipal water supplies.<br>7. <strong>Diagnosis</strong> Giardia is best diagnosed with an ELISA stool antigen test. A single stool antigen test has 90% sensitivity.<br>8. <strong>Treatment</strong> is with metronidazole, tinidazole, or nitazoxanide or, during pregnancy, paromomycin.<br>9. Empiric treatment should also be given with a course of <strong>metronidazole</strong>. <br><br><strong>Prevention requires</strong><br>1. Appropriate public water treatment<br>2. Hygienic food preparation<br>3. Appropriate fecal-oral hygiene</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>105. </span> A 34-year-old female present with complaints of weakness and paresthesias of her left leg and right arm. She has noticed these symptoms for the past 3 to 6 months and they seem to come and go with no reason or pattern.<br>Her physical exam shows a very mild but definite weakness in the left leg and right arm. Which of the following is the most accurate test for the diagnosis of multiple sclerosis? </p><ol class=mt-3 type=A><li>CT scan</li><li>EEG</li><li>Lumbar puncture</li><li>MRI</li></ol><button aria-controls=explanation-93F aria-expanded=false class="btn btn-secondary" data-target=#explanation-93F data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-93F><p class=correct-answer><strong>Answer:</strong> D</p>1. <strong>Multiple sclerosis</strong> (MS) is characterized by disseminated patches of demyelination in the brain and spinal cord.<br>2. Common symptoms include visual and oculomotor abnormalities, paresthesias, weakness, spasticity, urinary dysfunction, and mild cognitive symptoms.<br>3. Typically, neurologic deficits are multiple, with remissions and exacerbations gradually producing disability.<br>4. Diagnosis requires clinical or MRI evidence of ≥ 2 characteristic neurologic lesions that are separated in both time and space (location in the CNS).<br>5. <span style="text-decoration: underline;">Most accurate diagnostic test is MRI</span> <br>6. Treatment includes corticosteroids for acute exacerbations, immunomodulatory drugs to prevent exacerbations, and supportive measures.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>106. </span> A 66-year-old is hospitalized for pneumonia. The patient has fluctuating levels of attention, changes in awareness, and marked disturbance of the sleep-wake cycle. Her past medical history is unremarkable. Which of the following is the most likely diagnosis? </p><ol class=mt-3 type=A><li>Senile dementia</li><li>Dementia</li><li>Delirium</li><li>Psychosis</li></ol><button aria-controls=explanation-NLK aria-expanded=false class="btn btn-secondary" data-target=#explanation-NLK data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-NLK><p class=correct-answer><strong>Answer:</strong> C</p>1. <strong>Delirium</strong> is an acute, transient, usually reversible, fluctuating disturbance in attention, cognition, and consciousness level.<br>2. Delirium, which is very common among hospitalized elderly patients, is often caused by drugs, dehydration, and infections (eg, UTI) but can have many other causes.<br>3. The clinical hallmarks of delirium are decreased attention or awareness and a change in baseline cognition. Delirium often manifests as a waxing and waning type of confusion. <br>4. Causes include almost any disorder or drug. <br>5. Diagnosis is clinical, with laboratory and usually imaging tests to identify the cause.<br>6. Treatment is correction of the cause and supportive measures.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>107. </span> A 65-year-old male presents with complaints of difficulty with urination. He reports that he has difficulty initiating urination and that his urinary stream has less force than it used to have. He has some dribbling and awakens three times each night to urinate. His exam reveals an enlarged prostate with no masses. Urinalysis is normal. Which of the following is the most likely diagnosis? </p><ol class=mt-3 type=A><li>Benign prostatic hypertrophy</li><li>Varicocele</li><li>Acute epididymitis</li><li>Prostate cancer</li></ol><button aria-controls=explanation-U13 aria-expanded=false class="btn btn-secondary" data-target=#explanation-U13 data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-U13><p class=correct-answer><strong>Answer:</strong> A</p>1. Benign prostatic hyperplasia (BPH) is nonmalignant adenomatous overgrowth of the periurethral prostate gland. <br>2. Symptoms are those of bladder outlet obstruction—weak stream, hesitancy, urinary frequency, urgency, nocturia, incomplete emptying, terminal dribbling, overflow or urge incontinence, and complete urinary retention.<br>3. Diagnosis is based primarily on digital rectal examination and symptoms; cystoscopy, transrectal ultrasonography, urodynamics, or other imaging studies may also be needed.<br>4. Treatment options include 5 alpha-reductase inhibitors, alpha-blockers, tadalafil, and surgery.<br>5. Use of alpha-adrenergic blockers (eg, terazosin, doxazosin, tamsulosin, alfuzosin), 5 alpha-reductase inhibitors (finasteride, dutasteride), or, if there is concomitant erectile dysfunction, the phosphodiesterase type 5 inhibitor tadalafil<br>6. Avoidance of anticholinergics, sympathomimetics, and opioids</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>108. </span> Which of the following is associated with fever, recurrent abdominal pain, bloody diarrhea, erythema nodosum, ankylosing spondylitis, elevated ESR and positive P­ANCA?<br><br> </p><ol class=mt-3 type=A><li>Celiac disease</li><li>Wilson’s disease</li><li>Ulcerative colitis</li><li>Pseudomembranous Colitis</li></ol><button aria-controls=explanation-KA5 aria-expanded=false class="btn btn-secondary" data-target=#explanation-KA5 data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-KA5><p class=correct-answer><strong>Answer:</strong> C</p><table class="table table-responsive table-sm table-striped"> <tbody> <tr> <td> </td> <td><span style="text-decoration: underline;"><strong>Crohn’s Disease</strong></span></td> <td><span style="text-decoration: underline;"><strong>Ulcerative Colitis</strong></span></td> </tr> <tr> <td><strong>Location</strong></td> <td>Anywhere except the rectum; most common in ileocecal segment</td> <td>Anywhere in the colon; most common in the rectum</td> </tr> <tr> <td><strong>Microscopy</strong></td> <td>Skip lesions and cobblestoning<br>Non-caseating granuloma</td> <td>Crypt abscesses and ulcers</td> </tr> <tr> <td><strong>Effect of smoking</strong></td> <td>Worsens symptoms</td> <td>Improves symptoms</td> </tr> <tr> <td><strong>Symptoms</strong></td> <td>Abdominal pain, diarrhea and mass in the RLQ of abdomen</td> <td>Abdominal pain and bloody diarrhea</td> </tr> <tr> <td><strong>Barium enema</strong></td> <td>String sign</td> <td>Loss of colonic haustrations</td> </tr> <tr> <td><strong>Treatment</strong></td> <td>Sulfasalazine, mesalamine or steroids Fistula: Treated by Metronidazole or Infliximab. If failed, perform fistulotomy</td> <td>Sulfasalazine, mesalamine or steroids</td> </tr> <tr> <td><strong>Malignant transformation</strong></td> <td>High, need annual colonoscopy</td> <td>High, need annual colonoscopy</td> </tr> <tr> <td><strong>Extra-intestinal manifestations</strong></td> <td>Possible, but not as common as in ulcerative colitis.</td> <td>Arthritis, Scleritis, uveitis, pyoderma gangrenosum and sclerosing cholangitis. If any patient with IBD develops jaundice, do ERCP to rule out sclerosing cholangitis</td> </tr> <tr> <td><strong>Lab</strong></td> <td><strong>ASCA</strong>:Positive<br><strong>ANCA</strong>:Negative</td> <td><strong>ASCA</strong>: Negative<br> <strong>ANCA</strong>: Positive<br><strong>P-ANCA</strong> is present in 60-80% of the patients</td> </tr> </tbody> </table></div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>109. </span> Which of the following is true about pseudogout? </p><ol class=mt-3 type=A><li>Lack of response with the use of anti-inflammatory medication</li><li>High uric acid levels</li><li>Calcium pyrophosphate crystal deposition in the large joints</li><li>Lack of response with the use of colchicine</li></ol><button aria-controls=explanation-SHR aria-expanded=false class="btn btn-secondary" data-target=#explanation-SHR data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-SHR><p class=correct-answer><strong>Answer:</strong> C</p><span style="text-decoration: underline;"><strong>Pseudogout</strong></span> <br><br>1. Calcium pyrophosphate dihydrate crystal deposition in joints <br>2. Familial condition associated with other endocrine diseases (e.g., DM, hyperparathyroidism) <br>3. Similar presentation to gout but less severe symptoms; knee and wrist most commonly initially affected joints <br>4. <span style="text-decoration: underline;"><strong>Labs:</strong></span> joint aspiration shows positively birefringent, rhomboid crystals <br>5. <span style="text-decoration: underline;"><strong>Radiology:</strong></span> X-ray may show chondrocalcinosis (i.e., calcification of articular cartilage in joints) <br>6. <span style="text-decoration: underline;"><strong>Treatment:</strong></span> NSAIDs, colchicine</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>110. </span> Which of the following is associated with Hodgkin lymphoma? </p><ol class=mt-3 type=A><li>Schistocytes</li><li>Target cells</li><li>Reed­ Sternberg cell</li><li>Giant cells</li></ol><button aria-controls=explanation-CBH aria-expanded=false class="btn btn-secondary" data-target=#explanation-CBH data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-CBH><p class=correct-answer><strong>Answer:</strong> C</p><strong>Hodgkin lymphoma</strong><br><br>1. A predominantly B-cell malignancy with an unclear etiology. <br>2. Characterized by Reed-Sternberg cells (seen in the lymph node biopsy)<br>3. Bimodal distribution ( young adulthood and &gt; 55 years)<br>4. More common in men <br>5. Hodgkin is associated with EBV.<br>6. Non-Hodgkin is associated with HIV and autoimmune diseases.<br>7. Presents with painless lymphadenopathy (mostly cervical and supraclavicular), weight loss, pruritus, night sweats, fever, hepatosplenomegaly.<br>8. Treatment Radiation, Chemotherapy.<br>9. Good Prognosis.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>111. </span> Which of the following test results indicate Graves' disease? </p><ol class=mt-3 type=A><li>Decreased thyroid-stimulating hormone</li><li>Decreased thyroxine (T4) levels</li><li>Decreased radioactive iodine uptake</li><li>Decreased triiodothyronine (T3) levels</li></ol><button aria-controls=explanation-9CJ aria-expanded=false class="btn btn-secondary" data-target=#explanation-9CJ data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-9CJ><p class=correct-answer><strong>Answer:</strong> A</p>1. Graves disease is an autoimmune disease characterized by hyperthyroidism due to circulating autoantibodies.<br>2. Thyroid-stimulating immunoglobulins (TSIs) bind to and activate thyrotropin receptors, causing the thyroid gland to grow and the thyroid follicles to increase synthesis of thyroid hormone.<br>3. Graves' disease is the most common form of hyperthyroidism.<br>4. Patients usually present with symptoms typical of thyrotoxicosis. Hyperthyroidism is characterized by both increased sympathetic and decreased vagal modulation.<br>5. Tachycardia and palpitation are very common symptoms.<br>6. In elderly individuals, fewer symptoms are apparent to the patient. Clues may include unexplained weight loss, hyperhidrosis, or rapid heart beat.<br>7. Ophthalmopathy is a hallmark of Graves disease. Approximately 25-30% of patients with Graves disease have clinical evidence of Graves ophthalmopathy.<br><br>Lab results:<br>1. All forms of hyperthyroidism give an elevated T4 level. Almost all give a suppressed TSH level. <br>2. RAIU is Elevated.<br>3. Positive thyroid-stimulating antibodies.<br>4. Note: T4 levels are usually elevated, but in rare cases may be normal with increased T3 levels.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>112. </span> A 45-year-old woman complains of difficulty speaking, chewing, and swallowing. She experiences generalized<br>weakness that increases with effort and as the day goes on. Symptoms are significantly improved after taking<br>neostigmine. Autoantibodies responsible for causing the patient's condition are directed against </p><ol class=mt-3 type=A><li>Myelin</li><li>Double-stranded DNA</li><li>Acetylcholine receptors</li><li>Dystrophin</li></ol><button aria-controls=explanation-M0Z aria-expanded=false class="btn btn-secondary" data-target=#explanation-M0Z data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-M0Z><p class=correct-answer><strong>Answer:</strong> C</p>The patient has <span style="text-decoration: underline;"><strong>myasthenia gravis</strong></span> (MG), which typically produces weakness worsening over the course of the day. It often affects the eye muscles and can produce diplopia. Neostigmine, an acetylcholinesterase inhibitor, would temporarily improve the patient's condition, which is associated with antibodies against nicotinic acetylcholine receptors present on skeletal muscle. <br><br><strong>Antibodies to double-stranded DNA</strong> as well as anti-Smith antibodies are found specifically in systemic lupus erythematosus. Peripheral nuclear staining is observed on immunofluorescence. <br><br><strong>Antibodies to dystrophin </strong>are not a recognized pathology. Abnormal or absent dystrophin, resulting from mutations in the X chromosome, is associated with Becker's and Duchenne muscular dystrophy, respectively. Pelvic girdle weakness and ataxia are classic symptoms. <br><br><strong>Antibodies to myelin</strong> may play a role in multiple sclerosis, which is presumed to be of autoimmune etiology. This demyelinating disease is characterized by the spontaneous appearance and remission of symptoms such as hyperreflexia, weakness, spasticity, dysarthria, tremor, ataxia, and visual disturbances.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>113. </span> A 41-year-old man returns from a week-long trip to Egypt. For the past two days he has been passing frequent bloody diarrhea associated with crampy abdominal pain. Abdominal examination shows diffuse lower abdominal tenderness but there is no guarding or rigidity. His temperature is 37 C , blood pressure is 134/86 mm Hg, pulse is 86/min, and respirations are 16/min. Which of the following is the most likely diagnosis? </p><ol class=mt-3 type=A><li>Staphylococcus aureus</li><li>Giardiasis</li><li>Salmonella</li><li>Shigella</li></ol><button aria-controls=explanation-BH3 aria-expanded=false class="btn btn-secondary" data-target=#explanation-BH3 data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-BH3><p class=correct-answer><strong>Answer:</strong> D</p>1. <span style="text-decoration: underline;"><strong>Shigellosis</strong></span> is a type of food poisoning caused by infection with the Shigella species.<br>2. t is a major public health problem in developing countries where sanitation is poor.<br>3. Shigellosis is spread by means of <span style="text-decoration: underline;">fecal-oral transmission</span>.<br>4. <strong>Symptoms</strong> include fever, nausea, vomiting, tenesmus, and diarrhea that is usually bloody.<br>5. <strong>Diagnosis</strong> is clinical and confirmed by stool culture.<br>6. <strong>Treatment</strong> of mild infection is supportive, mostly with rehydration; <strong>antibiotics</strong> (eg, ciprofloxacin, azithromycin, ceftriaxone) are given to moderate to severely ill and high-risk patients with bloody diarrhea or immunocompromise and may shorten the duration of illness and decrease contagiousness.<br>7. Ampicillin was widely used in the past but is no longer an effective empiric treatment in the United States because of antibiotic resistance. <br>8. <span style="text-decoration: underline;">Avoid antimotility</span> agents because they have the potential to worsen symptoms and may predispose to toxic dilation of the colon.<br>9. Clear liquids followed by a low residue, lactose-free diet are recommended until symptoms of shigellosis resolve.<br><br> <table class="table table-responsive table-sm table-striped"> <tbody> <tr> <td>1-6 hours</td> <td>Staphylococcus aureus</td> </tr> <tr> <td>12-48 hours</td> <td>Salmonella, Escherichia coli</td> </tr> <tr> <td>48-72 hours</td> <td>Shigella,Campylobacter</td> </tr> <tr> <td>&gt;7 days</td> <td>Giardiasis ,Amoebiasis</td> </tr> </tbody> </table></div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>114. </span> A middle-aged man present to the doctor with blurred vision and eye pain. He was recently diagnosed with tuberculosis.<br>What is the cause of his symptoms? </p><ol class=mt-3 type=A><li>Isoniazid</li><li>Ethambutol</li><li>Rifampin</li><li>Pyrazinamide</li></ol><button aria-controls=explanation-SCF aria-expanded=false class="btn btn-secondary" data-target=#explanation-SCF data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-SCF><p class=correct-answer><strong>Answer:</strong> B</p><strong>Ethambutol</strong> side effects:<br>1. Chills<br>2. pain and swelling of joints, especially big toe, ankle, or knee<br>3. tense, hot skin over affected joints<br>4. Blurred vision, eye pain, red-green color blindness, or any loss of vision (more common with high doses)<br>5. fever<br>6. joint pain<br>7. numbness, tingling, burning pain, or weakness in hands or feet<br>8. skin rash<br><img alt class=img-fluid height=407 src="data:image/jpeg;base64,/9j/4AAQSkZJRgABAQIAJQAlAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCALQA8ADASIAAhEBAxEB/8QAHAABAAIDAQEBAAAAAAAAAAAAAAQFAwYHAggB/8QAVhAAAAUDAQUFBgQEAwQGCAILAAECAwQFBhESBxMUITFBUVORoRUiMlJhcSM0gZIIM0JyFmOxJDdishc1c3SzwRg2Q2Z1gqXRJZPC4yZEVFWDoqTD0v/EABsBAQADAQEBAQAAAAAAAAAAAAABAgMEBQYH/8QANxEBAAEDAwQBAgMHBAICAwAAAAECEVEDEhMEITFhBTJBIiNxBhSBkaGx8EJSwdEV8RZDU2Lh/9oADAMBAAIRAxEAPwD6pAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAGOS+zFjuPyXUMsNpNa3HFElKSLqZmfQhxm6Nv1IgyFsUGnvVPSeN+4vctn/AG8jUf6kQz1NWjSi9c2dnR/H9T1tU09PRNVv5R/GeztQD57g/wARLm/Ip9vI3JnzNmUepJfY08/Mh2Gybzo1509UmjPma28E7HdLS60Z9NRd31LJCun1GnqTame7frPh+s6Knfr6dqc9pj+jYwABs8wAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAABy3afta/wNcLVL9i8drjJkb3i91jKlFjGhXy9c9opqalOnG6rw6ek6PW6zU4tCL1eftHj9XUgFTadY/xBbVOq244fjGUu7rXr0Z7M4LPkLYWiYmLwxroq06poq8x2/kAA4ta+3L27dMCjf4e3HFPkxvuN1acn107ss+YpXq0acxFU+XT0vQdR1dNdejTeKIvPeO3nP6S7SAANHGAAAAAAAAAAAA5ltP2tQLKnlTWIaqhU9BLWjebtDRH01HgzyZc8Y6dopXqU6cbqp7Onpek1us1I0tCm9TpoDiNi7bpVx3PAo71BbQctzQTrck/cLmZng088EXeQ2HaftagWVPKmsQ1VCp6CWtG83aGiPpqPBnky54x07RnHU6c0779nZX8J1tGvHTTR+OYva8eM3+38XTQHEbF23SrjueBR3qC2g5bmgnW5J+4XMzPBp54Iu8h24X09WnVi9Dm634/X6CuNPqItMxfzE/2AABo4wAAAAAAAGulelDcupi3Y0xMmqOEs1Ns+8lrSkzPWroR8unM/oNiERVFXiWmppV6Vt9MxeLxfGQAASzAAAAAAAAAAAGqbRb4p9jUhuZPQ4+88o0MR2zIlOGRZPmfQi5ZP6kORI/iKlb8zXbjJs/KUsyV56P/ACGGp1Onpztqnu9To/het63T5dCi9ObxH8rvogBggPqkwY77jRtLdbStTZnnQZlnGfoNc2lXd/gm2jq3A8b+Mhrdb3dfFnnnSfd3DWqqKad0+HDpaFetqxo0ReqZtH6tqAfP3/pG/wDut/8AUf8A9UH/AKRv/ut/9R//AFQ5/wB80f8Ad/d6/wD8a+S//F/Wn/t9AgPn7/0jf/db/wCo/wD6odTue8vYWzxN0cBv9TLDvDb7T/MNJY16T6au7njsF6Oo064maZ8ObqPhut6aqijVotNc2jvHef5tuAfP3/pG/wDut/8AUf8A9UMjX8RbJke+tlxJ9mmaSv8A/WQp++aP+7+7pn9mvko/+r+tP/bvoDmli7YqBdM9mnuNvU2oOnpbbfMjQ4r5UrLt+hkWewdLG9GpTqRembvL6rpNbpK+PXpmmfYAALuYABQ31cP+FbUn1rheL4UkHud5u9WpaU/Fg8fFnp2CKpimLyvpadWrXGnRF5mbR+sr4BzXZXtR/wAe1SbD9j8BwzJO6+K3ur3iLGNCcdR0oVo1KdSN1Phr1XSavR6k6OvFqo/5/QAAF3OAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAD56/icux4pMS2IjppZ0FJlkk/jMz9xJ/Qsav1LuGHYrslp9aozVeudC32HzVw0QlGhJpI8a1GRkfMyPBdMc+eRom3Rxbu1WvGsz91baSz2ETSB9TbO20NWDbaW8afZ0c+XbltJmY8zSpjW6iqa+9n3PXa1fxnxGhp9NO2a+8zHnvF57/xiP0hqN2bGLXq1KdbpUNNMnpSe5eaUrTqxyJSTMyMvUcm2RWre9FvOFUI1FmMxUObqXvjJlK2jPCviMtXeWM8yIfU4Dqr6WiqqK47Ww8Lp/n+q0tCvp9T8cVf7rzbP+faYBpF2bUbWtiUuJOnKemIPC48VG8Uj7n0I/oZ5ETbjdb9q2Q45AWbc+a4UVlZdW8kZqUX1IiMi+pkOEbG9nZX3UJcipPutUyKZE4bZlrdWrJkkjPOO8zwfZ35Kmv1FUVxpacXlt8X8RoanTVdd1tU06cdu3mf8ns7TSNuNn1CQll1ybA1HglymSJP6mg1Y+5jpkZ9qVHbfjOoeYcSS0ONqJSVEfQyMupD5+2p7F6bSLak1e2nJKVw0G69HeWSyW2XxGk+RkZFk+3JEI38M92yGqs9bMp1S4j6FPxSUed24nmpJfQyyf3T9TFaNfUo1I09aPP3b9V8T0fUdHV1vx1U2p80z5/z7+4dVuvajbdrVlyl1Z2UmUhKVmTbJqLCiyXMfl17U7XtlSGpsp1+WpCXOGjI1rSRlktXMiSeMcjPPMcD/iL/AN6Ez/sGf+Qh0PZrsfodUtGJVblTJmT6i2UjO+Ugm0q5pxg+ZmWDMzz1FY19avUq06Ijs1r+J+O6bpNHq+pqqtVEXiPvMxftiIb3ZW1C2rumFDp770ecosojykEhSyIsnpMjMjMu7ORDurbDaluz3ITr8idJbPS4mE2SyQfaRqMyLP2M8D5cumnKtm76lAiSHMwZS0NPJPSvBH7p5LoeMdB9AW1sMoCrTZTWeIXWH2ta5DbppJlRlkiSnoeOXUjzz6CNPqNfVvTTEXht1vw/xfQzRr61dU6ddrRHnN74tMe2+WVf9v3lvEUaUriWy1LjvJ0OEnvx0MvsZ47RY3dc1OtOke0qup1MXeJby2jUeTzjl+g+RtmMl+kbT6ETazS5x6Iq8dpLVoUXkZjv/wDEp/u2P/vjX/6QvpdTVXo1Vz5hydd8Ho9N8jo9PTMzRqW/Xzae6+p21C1ZtBlVjj1R4Md0mVKfbNKlLMsklKSyajx3CgibdrPfmkw57RjtmZFv3Y5aPv7qjV6DjmxGx4971iUiquvFS4CScW02rGta+RFnsySTyZc+RCz292BSLQOlS6ChxliUa23GVuGsiUnBkZGeT55PyGf7xrzp8sRFndHw3xVHWz0NdVU1z4xHa9r/AHn7+LO/3NfNvW3So8+pVFrcyU646WfxFPl1ygi6l9en1Gr0TbdaFUnIjLdmQDWrSlyW0SUGfZlSVHgvqePqOU7Dtn0a9Sk1C4XHnqZCxGZYJxSdSj94yz1JJas4LHNXnS7cLOgWbdMePSN4mFKjk8ltxRqNtWo0mRGfMy5EfPnzCvqdbZGrERtV6f4T42eoq6CuuqdWL947RH3t+sRa76+IyMiMjIyPmRkKi5bkpFswil1yc1EZUeE6smpZ9yUlkz/Qhr+xypLmbK6HMmOGZtsLQpavlbWpBZ/RJD5lr9Uqe0raAnSozcmPkxFbUeEst590v0Lmf1yN9bqdlFM0x3q8PL+N+D/eep1dPVqtRpX3T+kz/wBX9O8K292iUjdk1VVI8Uo6dP8Az59Bv1rXVRbqhqkUKe1KSjGtBZStvPzJPmX/AJjnTewK2ipJMOS6gqdo5yiWRFqx1JGMYz2Zz9Rwxh+rbMtoLiW3P9qp72hwknhL7Z4PB/RSTI/pku0hlOvraMxOrEWnDv0/ifjPkqa6Pj66o1KYv+LxP+f07dn17dVwQbXor1UqqnExGlJSo20ajyoyIuX3MUFD2nWvWKXUai1NVHhwNBPuSUGgiNWdJEXUzPSfIuYpNu8pqdseky46tTMg4zqD70qWky9DHCtj1oFe1xLp0yS8zS2G+KkJbVg1mR6UkXYR+8fPuz3i+t1FdOrFFEXu5/jvh+l1+gr6rqKppmmZvbEWv2z9v1dvPbxZ5S9ySambfjlHLR5atXoOj0Ks0+vUxqoUiU3KiOfC4jv7SMj5kf0PmODbatldDt60zrNvoejKjOIS82pxTiVpUenPvcyPJl9B7/hVqD3E16nGozj6G5CU9iVZNJmX3LHkQijX1adXi1bd8LdV8X0Or8fPXdDNUbZtMVfwv/eJw+hQAa9tDky4di1+RTjUmU1CdUhSTwacJPKiPvIsmX2HbVO2Jl8zpac6upTpx95iP5zEf8qO6NrNp27MXEkTlypTZmTjcRG80GXYZ5JOfpnJYFTTNulnTXkNvKqEIlHjXIYLSX30KUPnvZw7aqLhNV8NSHacbZ6d2asE5ksGvT7xljPTtxyHWK3s+sO8mI3+AqvToM/WWps31K3iMeGo9RH06EXbkedR1OtqRuot+n3fZ9R8L8d0dUaXURqePrj6Y/lEu8wpcefEZlQnm34zySW262rUlRH2kY5Hted2douhkr0YmuVLhUaDYNend6l4+EyLOdQ3DZdZsmyKG7TX6sdRaU5vWy3O7JozL3iL3jyR8j7Oee8cM/ie/wB4cX/4c3/4jg26nUmNHdVHft2nu8z4TpNPU+SnR0tSdtqrVU/hmY7f5L6Lso6aq06UdCS4mlmwnhiczqJHZnPMVF67R7cs94o9UlrcmGWrho6dbhF3n0JP6mQgWhU/YuxCDUyJKlRKSb6Uq6KUlBmRfqeCHzVY9Bl7QL6aiTJThrkrXIlyT5q0lzUf3M8EX3EavUVUU0U0R3lp0Hw+l1Or1Gt1NUxp6czfM95+/wCn8ZmX0pae121blnNwmJD8KW4eG25qCRrPuJRGac/TPMfN2y//AHo0H/v6f9R227th1vnbshVvokx6ow0a2lKeNZPKIs6VEfIs9MljA4dsn57Srdz/APxiP9Rza86u+iNTP2/g9v4mjof3bqdTopm00zExV5i0Vf0l9qPOtstLdeWltpCTUpazwSSLqZn2EOY1jbjZ9OlKYacnT9KtJriMkaP0NSk5L6kNY/ieuZ+LEp9vRHVNplJORJ0njUgjwhP2ySj/APlIVOxvZjbtatdFZuZzfLlKWTMcn92SEJM06jwZHkzI+3GMDp1NeudTi0rdsvD6L4rpdPoo67r5qtVNoinz/naf4Ou2dtHtq7X+HpU40zMGZRpCd24ZfTsV+hmNwHx9tVthqwrvirt+as4ziSkxnCcI1sqJXMsl3GRGR9xj6jsOuHcln0mrKIicksEbhF01l7q8fTURi/T69VdU6dcd4c/y/wAVpdNpafV9LVM6defMT/l/5L4AHKf4i7mfoVnNQYLqmpNTcNk1pPBk0ksrx98pL7GY31K406Zrn7PK6Lpa+s16NCjzVP8Ak/yT7j2y2jQ5jkU5Eie82elZQmyWkj7tRmST/QzEu09q9q3NMbhxJjkWY4eG2ZaN2az7iPJpM/pnJjjGw7Z7RroiTKrcjuqK07uGoxPbvWokkalKMuePeLGDLtELbbYlMtCTAm29IM4Uo1INo3dZtLTgywfXBl388kOD9414p5ZiNuH1f/h/iquonoKaq+X/AHfa9r2x/lrvpy567CtqhyatVFOJhx9Os0J1K95RJLBfdRD432lVqNcV81aqwVLVFkOJNs1pwekkJTzL9B9G2E61tO2RIhV5x5ajUUWU42oiWpTa0rSeTI+ZkSDP7mPm7aJRo1v3pVaVANw4sV0kNm4rKsaSPmeC7xXra6q6Kao+mf7uj9l+n0um6nV0a78tN4nG28f1v/R3y2b+2cQ4JPwKchl6lxkuKeTT0k4kjNLRmSupmZuER95GY4PtKrUa4r5q1VgqWqLIcSbZrTg9JISnmX6D6IpGxa12qa+lLlSxOjIady+nprQ5y93l7yE/pkfOe0SjRrfvSq0qAbhxYrpIbNxWVY0kfM8F3jPqo1Y04iuIt6dXwNfQ19XqVdNVXNVv9WL9/wCr6Q2ZXFYtZnRafblNZbqUONvCdOElCkkREhRkvGcnqx9cmNsvG9qDaDKFVuaTbrhZbYQWtxZd5JLs+p4Ia5aFgW9YbT9xQlzTcRBUbu9dJSdGCWrBaS5+6PnSlIlbSNo7KapLNtdQfUp10z5NNpI1GSc8uSU4L9B01a1ejRFMxG6f5PF0Pjel+R6jU1qa6uGiLzM96r95mI89vu77B272fJk7p0qlFRnG9ejkafv7qlH6DplNnxKpBZmU6Q1JiulqQ60olJUX3HGbz2PWmi15blBeVHqUZlTja1StZPGks6VEfLn9Mc8DVf4ZrlfiXK/b7rhqhzW1OtIM/gdSWTMvukjz9iE06+pRqRRq274Z6/xfRdT0lfVfHzVE0eYqxmP7vpSVJYiRnZEp5tlhpJrW44okpSRdTMz6EOZVTbnZ8GSpppc+cST0muMwWnzWpOS+w0j+J+5pBz4FuR3FIjJaKVIJJ41qMzJJH9CIjPH1LuEnZLsfo1XtSLWLjJ996YRrbZQ4aEtoyZEZ45mZ9evcJr19SrUnT0vtlHS/FdHodFT1vyEzarxFP+er/o6bZ+0u2bsklFps025p/DHko3a1cs+72K7eRHnkMO1y7adbVsyY09x5uTUoshmKbSDP39GOZ9nNRcxyC5NiNfhXZm0DM6cWl5iS9IShbK8/DkveyRlkjIuhl25HT9pVoN3HYSJdzKV7VpNPefzEcw2p7dkaj5pyZZQXcEamtVRVFUWmP5K6nSfG6XU6Gppak1adU94/1RPa1/42vfv5fPGyO4INr3zDqlVU4mI0hxKjbRqPKkGRcvuY+ubXuKn3NQ2qtTFrOG4aiJTqdB+6ZkeS/QfIeye3YV1XvDpNTN4orqHFKNlRJVlKDMuZkfaQ7ztMoybK2JVCmW8uQUZCkpWta8rJDjpauZEXI84+xmMOjqro06qv9MX/AFu9b9pdDp+o6vT0YmY1atsf/rtmZ/qsq9tos+kSXGEy357iORnCbJac9xKMyI/0PAx0XbZZ1TkIZckyoCl9FS2dKc9xqSaiL7nyHBdlLtjomyyvxp5RHp4Zfvm0nrq1Ej3s9MdS6jolZ2WWnd0uM9YFcp8VOD4hhLxvH9FEk1aiPrkj5dOgtR1GtXG6m36fdj1Hw/xnS18OvGpHb6/9Pj1EvoFC0uIStCiUhRZJRHkjLvH6NesK3n7WtiLR5FRVUeHyTbymt2ZIM8knGT5Fzxz6YLsGwj0aZmYiZiz43VppormmirdET2nMZBpF2bUbWtiUuJOnKemIPC48VG8Uj7n0I/oZ5ETbjdb9q2Q45AWbc+a4UVlZdW8kZqUX1IiMi+pkOEbG9nZX3UJcipPutUyKZE4bZlrdWrJkkjPOO8zwfZ35Lk1+oqiuNLTi8ve+L+I0NTpquu62qadOO3bzP+T2dppG3Gz6hISy65NgajwS5TJEn9TQasfcx0yM+1KjtvxnUPMOJJaHG1EpKiPoZGXUh8/bU9i9NpFtSavbTklK4aDdejvLJZLbL4jSfIyMiyfbkiEb+Ge7ZDVWetmU6pcR9Cn4pKPO7cTzUkvoZZP7p+pitGvqUakaetHn7t+q+J6PqOjq6346qbU+aZ8/59/cNd27XvSrzmUhVFcfW1FbcJe9bNGFKNPT9o2DY3cVixqDAotZprMmszJJtqU7CS6SjWvSgjUZdMY9RrW3CyKVZNQpTNGVJUiS0ta9+slHkjIixgi7xu2xPZrQ6xblIuSWuaVRakm6kkOkSMtue7y0/wDCWeY5aI1Z6ibxF/v/AEe91NfQ6fxFG2quNO/4bdpv+K17fa7v4qrlt6l3NTfZ9bi8VE1k5u94pHvF0PKTI+0WoD15iJi0vzqiurTqiuibTH3hzap7ILGYpst1qh6XENLUk+LfPBkRmX9Y+atm9MiVi+aNT6k1voch8kOt6jTqLB8skZGX6GPtKs/9Tzv+wc/5THxzsf8A95lu/wDei/0Meb1enTTqUREf5eH3H7P9Xr63SdVVqVzMxHa8zNvw1eH0l/0OWH//ACL/APzH/wD/ALEXbpGZhbHahFjI0MMFGabTkz0pS6giLJ8+hDpQ53/ED/uprH9zH/jIHXq6dNGnVti3Z850HV6/UdboRrVzVaqPMzP39uIfw/27SbluufFrkNEuO3CU6lClKLCt4gs8jLsMx3h3ZJY7jakHQWiI+1LzpGX6kofKlo1ivUWoOv2w7IalraNCzYaJw9GSPoZHyyRDaX792k7pe9n1VCMc1cKScfro5DztDW0qKLV03n9H2fy3xvXdT1U6nT68UU2jtumP6Qpdp1AjWpfVRpdMfWuOwpC2jNXvI1JJWkz7yzjI+wrTkSJdq0aROzxb0Jlx7PXWaCNXrkfHVlS6G7drUy+HJsiKpzeOKSW83i85y4Znk09+MmY+1IchiXEZkQ3W3ozqCW242eUqSZcjI+4dHQREzVVH3+zyf2sqro09DQ1ImZpjvVbtM2iO395ZgAcy/iGr8ih7P1twnDbfqD6YprSeFJQaVKVj7knT/wDMO7UrjTpmqfs+U6Ppqur16NCjzVNmS49tFo0SauLv5VQdbPSs4TZLSk+7UpREf6GYo9oN+0C8dk9xFRpZnIbQ0pcZ5Oh1Jb5HPHaX1LI5rsP2dRb0kzZtYU6VMhmlG7bVpN1wyzjPUiIsZ+5C+22bK6ZbVCKuW4TzLDbiW5EdbhrIkqPBKSZ8+uCMjM+v0Hnzq69enNcxG2X19Px/xXS9bp9LTXVy0zHf7X7TacX9eOzH/Cx/60Vn/uZf85Dr127T7ctWsKplXclJlJQlwybZNRYPpzHIf4WP/Wis/wDcy/5yFF/Ef/vNf/7qz/oYjT1atLpoqpy06v4/S+Q+cr0da9tsT27eIh3C59rtr289HZkuypMh1tDptRmyUbaVkRp1ZMiI8GR4zkWhbQaCdl/4pJyR7K1Egz3JkslatOMdvPtLkOObNtjUa6bWarddqU1p6ZqUyhnTyIjMiUo1Eec4M8FjljmNz2tURi29hKqRFVraibhvXpxrVvCNSsdmTMz/AFG9OrrbZ1KoiIteHl63QfGRrafSaNVVVe+Kap+1vvbt/Budk37RLzdlt0Rb6lRUpU5vWjRyVnGPIxa3VcEG16K9VKqpxMRpSUqNtGo8qMiLl9zHDP4U/wDrC4/+yY/1WOg/xDf7rKl/2rP/AIiRfT1qqtCdSfPdzdX8Zo6PytPRU32TNMee/fz3XllX/Q7zflM0RyQpcZKVub1o0cjMyLHkLyvVqnW/TXJ9YltxIiORrWfU+4iLmZ/QuY4F/Cp/1xcH/YNf8yhQfxG3FIqd9OUrViFS0pQhJHyUtSSUpR/XmSf/AJRn+9TGhGpPmXXPwGnqfK1dFpzMUUxEzPmbWj/mXVUbebPVM3JpqaW8435xy0ffBK1egv6/tTtaiMwHpExx9ic0bzDkZs3EqSR4PPceew+Y0+yNiNvnbMV24G35VRktJdWaXlIJk1ER6UkXXHeeeY4ptStRdmXU5SEyHH4egpEZSz56FcuZdM5SZfXGRSvX6jSo3VRHf+jq6X4v4jrupnQ0Kqr03vf/AFW+8T6n+cPsO36vFr1Gi1Snms4slOts1p0njJlzL9BqV0bWbTt2YuJInLlSmzMnG4iN5oMuwzySc/TOSwKe25MuH/DqmRTjUmU1S3lIUk8GnGvKiPvIsmX2Hz7s4dtVFwmq+GpDtONs9O7NWCcyWDXp94yxnp245C+r1NVMURFrzHmfDm+P+D0NerqNTU3TTp1TEU0/VPl9CUzbpZ015DbyqhCJR41yGC0l99ClDpsKXHnxGZUJ5t+M8kltutq1JUR9pGODVvZ9Yd5MRv8AAVXp0GfrLU2b6lbxGPDUeoj6dCLtyOm7LrNk2RQ3aa/VjqLSnN62W53ZNGZe8Re8eSPkfZzz3jTRr1ZqtXaYzDi+T6X4+jSivp5qprv3oqib/r4/57/q3IAAdTwQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAfKv8SVDdp9++0tB8NUmUrSvs1oIkKLyJJ/8AzDsOwe6oldseDAJ5BVGnNlHdYNXvaE8kKIu0tOCz35IbRfNp0+8qE5Tamk0lnWy8j42V9ii/8y7SHzPXNlV62vUDdpsaRLQgz3cqnLM1GX9pe+R/pj6mPOrpr6fVnUpi8S+06bX6b5j4+jotfUijUo8TPift6+3aYvftd9U3BWYVAo8mp1N4mosdBqUZ9T7kl3mfQiHAtn+2O6qvdUSlPRYc5E2RpSRp3a2kmeT95PLCU5Pmkz5DRnLT2i3O603UIFflGlWEHUVOESM9uXT5Dumx7ZYizNdSqzjUmtOJ0pNvJoYSfUkmfUz7T/Qu3KNTV1642xNMQpX0Xx/xXS6ka9VOrqVeIj7Y8T2zM39WU/8AFLEcdtSkykJM22JhpXjs1IPBn+31EP8AhXqUY6TWqZrSUtL6ZJJPqpBpJOS7yIy9S7x2O5qHCuOhy6VUka40lGk8dUn1JRfUjwZfYfMVb2WXrZ1XKXQESZiG1HuZlPMycx9UEeouXXqX1E69NenrRrUxeFfi9bp+t+Nq+N1a4oqveJnxPe//AHf+cPofajUo9K2fV9+WtKUrhuMIJX9S1pNKU/Xmf+o+cP4d4bsnajT3mkmaIrLzzh9yTbNH+qyHmTbm0u95LDNVh1h5LZ+6c9JsNt96sKwX6kWR9AbKNn0axaS4lTiZNUk4OS+RYLl0Qn/hLJ8+pnz7iKsbup1aa7WiG1U6Hwvx+r0/JFepqfaO8R2t/a/6y4H/ABF/70Jn/YM/8hD6ZsJJJsW3El0KmxiL/wDKSOEbcbJuSt7QZU2k0eVKiqZaSTrZFgzJOD7R32z470O0qJGktqbfZgsNuIV1Som0kZH+pDTpqZjW1JmP8u5fmtbTr+M6SimqJmI7xeO34fu+QNrP+8m4/wDvix9rERERERYIuwfKO0iwLqqN+VyZBocx+K9KWttxKSwoj7S5j6uEdHTMV13j7/8Aaf2j1tPU6bpYoqibU97TE27U+XxTav8AvXo//wAbZ/8AHIfQX8Sn+7Y/++Nf/pDktu2BdUfaPTJz9DmIiN1Zp9bppLCUE8Rmrr0xzHadvFGqNdsM4dIiOy5XFNr3bZZPBZyYy0KKo0dSJh6PynU6NfyXR101xMR5m8du/wB+/Zo38KCSJm51dpqjF/4v/wBxJ/ir/wCp7f8A+3d/5Uiw/hxtqs26xXyrdPfhG+pg296RFqwTmcfbJeYzfxF25V7iplFbokB6atl5xThNFnSRpLGReKav3Tbbv/8A1yVa+l/8h5d0bb+bxb6M+Hn+Fwi/wDUDxz9puc//AOk0NL/in/8AWijf9zP/AJzHRv4e6FU7fsubFrUJ2HIXUFupbdLBmk22yI/Mj8hqv8RFp124bgpT1FpkiY01FNC1NERkk9ZngNSmr91im3fsdJr6UfP6mrNUbb1d7xbxH38Nu2NR1S9iFPjI+N5iW2X3N50h867LZzNE2kUSTUTJlpqTu3Dc5Eg1EaMn3YM/0wPqHY1TJtH2bUeBVI7kaY1vtbS/iTl5aiz+hkf6jm+1zY1LqFVkVq00trXIUbj8E1Eg9Z9VIM+XM+ZkeOecdxRraVc6enXTHemy3x3yHT0dX1fTa9VqdWarT9vvHn3E9p8O+D4121VKPVtp1afhKS4yS0MktHMlGhCUK+/MjIWCGdqjMEqMiPcyYmndk2TTmkk4xp145JxyxnA3jZLsZlxqnHrN3NoaJhROMQdRKNSy5kpwy5ERddPb246HXVrr6q1FNMxm7b4/pun+CmvqtbWprm1qYpnvP9ZxHqO7Y9q8N2n/AMP8aFIIyejRoTKyPsUk0EfqQ0/+FVJHW68rtKO2Xmo//sOqbbaTOrWzufBpUZyVLW40aWmy5mRLIz9Bo/8ADpatct2p1pyt02RCQ8y2ls3SItRko84GldEx1NFo7RH/AG4+m6mir4TqIqqiKqqpm14v3mmfHlt/8QP+6msf3Mf+Mgcy/hW/9YK5/wB1R/zjrW2mlzqzs5qcGlxnJUtxTJoabLmrDqTP0IxoH8O1qV23q1V3a3TJEJt2OhKFOkREoyVnAnUpmeppm3b/ANq9FradPwevpzVG6Z8Xi/8Ap+3l3YRqjLhwYi3qlIjx4pcluSFkhHPsMz5CSK25aNFuGhTaTPIzjSmzbUacZT2kos9pGRGX1Id03t2fLae2a43zaL97ebOI1bZXZ93VSYqyLijMykfiuRWjJ9lOT/pMjI0lnuyRDnd67KbktGA7UZiY0mA0Za5EZ3OjJkRZJREfUyLkRi4k7PL+sKvcbbjb8nTlLcqCRL1J7ltnk+7JGRlntPAyVg9rF7xSptRp9T4Rai1NLiFFQoyMjI1GZJyRHg+Z45fQePXTTVE7qJir14fpHS62vpVUTpdVRXo9r7pjd7xP6X/i3X+Gu76lVU1CiVR9yUiK2l6O66ZqUhOdJoMz6lzLHdz/AE03+J7/AHhxf/hzf/iODsGxrZ4djUyQ5Odbeq0zG+NszNDaSzhCc9epmZ//AGHPv4gLOuGv3tHl0akyZkZMFts3GyIyJRLWZl5GXmN9WjU/dopq7y8voeq6SfnK9XSmKaLT38RM2i8/bzLbkx3ZX8NxNMEZuex9eC6mSS1H6EY5J/DnPZhbSmEPrSji4zkdBq+bkoi/XSZenaPo7ZzAkQLCokGoMKakNRUtutLLmk8cyMfP+0fZBXKJWnp1rxXptNW4brSY3N2OecknSXM8dhlkNeiunZq0xe1lfi+q6fV/eug1a4p5JqmJ+3mY/TE+e76bq09il0uXPmLJEeM0p1xR9hJLJj402UHnaVbp4IszEci+43Sl25tNvtLNMrr9Ti0hKi3q56TaLBH8pkSnD7s5LOOZDDYuzy5aTtJpch2jTEU6NOI9+sixoIzwo/0FNauvWroqimYiJ/6dPxvT9P8AG9P1GlXrU1V1Uz4nta1UR9+8zfwnfxTRVou+kyzI927B3RH2ZS4sz/5yETZ/sbZvG1otYZuMo6nVLQ4wUPeG0pKjLBnvC7MH06GQ7ltUslq+LbOETiWJzCt7FeUXJKsYNKu3SZdcfQ+eMD59ptG2n2DKfao0KqNpcP3uEYKU0vuVgiUX6mRGGtpRRrTXXTemcHxnyFXUfHU9P02tGnq0dvxWtMd8/r/OF9UditFpk9EKpX/Bhy1oJxLUiKltSkmZkRll4u0j8h3HZxQG7Ys+DSWZ6Kg0ybikyUIJJLJS1K5ERn0zjqPnuj7M71vi4Tn3SmTEacURyJUwiS4aS7EN9enIuREQ+nqRTo1JpcWnwW93FjNpabT3JIsc/r9Rv0lEbpqijbH8Xl/tB1NfFRoV9Ry1eZiIptE/rH6+P4pY4N/FZFWun25LIj3bTr7Rn2ZUSDL/AJDHeRQ3zbMW7rZl0iYo0E6RKbdIsm04XNKi/wDPvIzIdGvpzqac0w8b4nq6ej6zT16/ET3/AEntP93zTsu2WM35RpM1FeKE9Hf3K4/C70yLSRkrOsuR5Mun9JjYavsQpNGcjt1e+4cFUjVuuIiJbJeMZwZu/UvMa83aG0fZ9V3XqJFnGo/d39PRxDbqezKMH/8A3JGX/BW0TaFWmpFfYltGREg5E9BMJaRn+lvBeRF9x5dNNMU7Z05mr+L7zW19arWnWp6ymnRnvFtszHbx3/8Af2td3fZFace0LckRIdYaq7L8k5BPtIJKSyhKcclKz8Oc57R807Z/96Fwf9uX/IkfWtn27EtW3YlIp+TZYSeVqL3nFGeVKP6mZ/8AkPnHapYV01TaDWptPokuRFeeJTbqElhRaSLlzHT1enPDTTTH/Lxf2e6yifkdbW1dTzHmbU37x9vHiPD6fp3/AFfF/wCyT/oQ+Ods/wDvQuD/ALcv+RI+yIKVIhR0LLCktpIy7jwPl7apYV01TaDWptPokuRFeeJTbqElhRaSLlzFuupmrTiIj7/8MP2U1tPS6vUq1KoiNv3mI+/t9D3DFXNsCpxGiM3H6Y60ki65U0ZF/qPjqxqCzc90waO/PKAmUpSEvm3vCJWkzIsZLqZY69TH2/BSpEKOhZYUltJGXceB85bUNj9YiV5+sWgycmI64b+4ZUSXY685PSXLJZ6Y5l0xyyI6zSmrbXEXt5hf9mvkNPR5umrr2TX3pqnxfvH37Ynv5TJf8PbMOK9JlXchmOyg3HHF0/BJSRZMzPe9MCx2X7M6PS7sp9ZpV6wauqLrVw7DScq1IUnqTpmXxZ6dg0WevazcdO9iz4lcdiGZJUh2HuSXjpqcNJai+5mQ6xsU2YOWeTtVrSm11h5BtpbQepLCDMjMs9qjwWTLoXLvFNKiirUjZp2jM3dfX9T1Oh0lcdT1cVVT2immKZvE5+8f8fq5Z/EtGcZ2jJdWXuPw2loP7GpJ+pDu+xqczP2aUFbC0q3TBMLIv6VIPSZH5Z/URtruz9u+qM0lhxDFViGaozqy91WeqFfQ8Fz7DL7jgMKgbTLLkPMUqDWo5OH7/BIN5tfZn3cl+vUTO7p9aqu14nDLT4PmPjNPpo1Io1NP/dNr+Y/t/V9CXjtNt60a41S6uqUT62ieNbTZLSgjMyIlc855ZxjpgT69Uotc2a1efTVqciyqZIW0pSDQaiNtXYoiMfP9r7J7suyvcddKZMSMtwlSZEtf47hdpJSeTzjlk8EX1xgfTD1JjKt9dHZTuYhxTiISn+hGjSRF9iG+jXq6sVTVFo+zyvkem6LoJ0qdGvfXExNUxN47THj/AN+P1fKv8PRkW1Om57Wnv/DUPqi4JVIj05xu4JEFmC+RtrKY4lCFkZcy948GPkp6xb7tSupdgUqp8Uws91KgNqdSfZkjSR4IyPoeOvMh263rTq14bJnKRexzGaoqQt1l+SetxBlzQrBn05mnHLlnoOfpKqqaZ09vfv58PY/aLR0NfX0+s5o2fhj8MxNUd57x3+382nStjlvXMcqTYVysrbaXpWw5+KhBnzIiWXMi/Q/uOdXps9uOxkszKkhrh1Ok23KivZTrwZkXYojwR9hdBsMO1NpWzuqvO0OLKXrLCnIKCkNPJLvTg/r1Ij58hkqtK2pbQnI0asQpxR0L1JTJYKK02eDLUZYLJ4z3nz5dRhXRTVH0TFXrw9bpuo19HUiZ6qivQzVMbrW9W/rDqv8AD1ddQuS15TFWdXIkU91LaX1nlS0KLJaj7TLBlnuwOqjT9ltltWPbSYG9J+Y8vfSXU/CpeCLCc/0kRYL9T7RuA9XQiqnTiK/L4D5TU0dXq9Svp4tRM9v89zdxX+KWI47alJlISZtsTDSvHZqQeDP9vqIf8K9SjHSa1TNaSlpfTJJJ9VINJJyXeRGXqXeOx3NQ4Vx0OXSqkjXGko0njqk+pKL6keDL7D5ireyy9bOq5S6AiTMQ2o9zMp5mTmPqgj1Fy69S+o5NemvT1o1qYvD6D4vW6frfjavjdWuKKr3iZ8T3v/3f+cPofajUo9K2fV9+WtKUrhuMIJX9S1pNKU/Xmf8AqPnD+HeG7J2o095pJmiKy884fck2zR/qsh5k25tLveSwzVYdYeS2funPSbDbferCsF+pFkfQGyjZ9GsWkuJU4mTVJODkvkWC5dEJ/wCEsnz6mfPuIqxu6nVprtaIbVTofC/H6vT8kV6mp9o7xHa39r/rLln8Vf8A1xb/AP2Dv/MkdF/h5/3WU3/tXv8AxFDVP4i7VrlxVOiuUSmyJqGWXEuG0RHpM1FjI3jYlSZ1F2dwYNVjORZaHHTU04XMiNZmXoL6dMx1VU27f+nN1mtp1fBaOnFUbonxeL/6vt5b2AAO98mh1n/qed/2Dn/KY+Odj/8AvMt3/vRf6GPsiqtqdpkxttJqWtlaUkXaZpMfL2zGwbppl/USbPoktiKzIJTji0lhJYPmfMcHV0zOpRMR/l4fW/s7r6en0fVU11REzHa8xF/w1eH1WOd/xA/7qax/cx/4yB0QaRtppc6s7OanBpcZyVLcUyaGmy5qw6kz9CMdWtF9OqIw8D4yqKes0aqptEVR/dxn+Fv/ANd6n/8ADlf+K2Pp0fG0Cwr/AKc6p2n0irRXVJ0mthZoMy7skfTkQnna+1F4t2pi4FErlhUpWP1yrA8/p9erRo2TRMvr/l/itD5Hqp6inqaKYmIi14+38Vj/ABKR6WxfTB00mUSlxiVMQ0REWvUeDVj+oyxn6Y7x1z+HV6Q9sxiFJNRobfdQyZ/Jqz/qai/Qcct3YpdtWqCfa7CabFNWXX33UrWZduEpMzM/vgvqPqGgUiJQaNDpdORoixWybQR9T7zP6meTP6mNelornVq1Zi0S4/neq6fT6DS6DT1OSqm3fz4v/wB2tee0J44n/FNHdXa9HkJIzaamGheOw1IPH/KY7YKm7KDFua3ptIncmZKNOsiyaFdUqL6kZEY69ejk05ph878X1UdH1enr1eInv+nif7uRfwrz2VUOtU7WkpDclMjT2mlSSTn680/pku8bT/EPPYibMJ8d5SSdmOtMtJPqpROJWfkSDHDZtg33ZNd31Ih1BxxBmTUymoU4S0n3knJlntJRC7kWDf14U2XWLpXMU5GYVwkV4y3rqz7Et9EF2nkiM8F9y4KNWuNKdHZN313UdD0tfyFPyP7xTsmYm1+9+3b+dvNrd0z+Fj/1orP/AHMv+chRfxH/AO81/wD7qz/oY3n+He067b1wVV6tUyRDadikhCnSIiUesjwKjbpZVx1y/nptIpEqXFOO0knGyIyyRcy6is0VfusRbvdtp9Vox89Xqb427PN4t4j73s7RstTo2c22WMf7C0fmkjGv/wAQpGeyupmRdHGDP/8ANSNrsOI/AsmgxJjSmZLEFltxtXVKiQRGR/qPd6UBq57WqNHeXuylN6UrxnQsjJSVY+iiIx6E0TVo7Yx/w+P0+op0vkY1qp/DFd/4bpcL/hVeSms19kzLUuO0si7cJUZH/wAxDoH8RslpnZjKbcURLfkMobIz6mStX+iTHDGrO2gWVcSX6XTKiUxozSiTBZN9taT+xGWD7lF9yG0VOw9oF3USXWLselOyY7f+xQD0ktajURGehOEoLGT7zwXYODTrrjRnR2zfu+t6zpenr+So+RnXp2Xpm1+8zHb+XjvNrd0z+FT/AK4uD/sGv+ZQ0PbdEch7UK6lwlfiOpeSZ9pKQk+Xnj9B1b+HS1a5btTrTlbpsiEh5ltLZukRajJR5wNj207NFXqwxPpTjbVYjI3ZJcPCXm8mekz7DIzPB9OZ57yngqr6aIiO8Sp/5TQ6b5yvUqqjZVTEX8xHaMe+0t6tOqR61bVNqMNaVsvsIVy7DxzT9DI8l+g+Zv4j6tGqe0PdRHEuFBiojOKTzLXqUoyz9NZF9yMYqPYe06AtynU1iqQGXT/EJqaTbR/UzJeD/TJih2nWcqyatTqc9J4mU9BTJkLT8OtTjhGSe3BEkuZ9eZ8ugr1GtXqaVppt4u1+H+N6XpOvmvT14rmYq2xHe0fe8+PHaMvpXZTLhwdklCeqUiPHilHMluSFkhHNauRmfIc8q2yuz7uqkxVkXFGZlI/FcitGT7Kcn/SZGRpLPdkiG9bPqJGuDYlS6TUEnw8qGaFGWMp98zJRZ7SPBl9hxmTs8v6wq9xtuNvydOUtyoJEvUnuW2eT7skZGWe08DbV+ijdRem0fq87oLfvXUTpdRx6u6q0TbbPefN/8+8Ke9dlNyWjAdqMxMaTAaMtciM7nRkyIskoiPqZFyIx1H+Gu76lVU1CiVR9yUiK2l6O66ZqUhOdJoMz6lzLHdz/AE0qsHtYveKVNqNPqfCLUWppcQoqFGRkZGozJOSI8HzPHL6DsexrZ4djUyQ5Odbeq0zG+NszNDaSzhCc9epmZ/8A2GXT6c80VacTFP3u7fmOrpn46rS62uivVmfw7e9vHf72+9/5OigAD1XwIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAD5//AIgrduCLW0XLQXZvCONJbkcItZKaUnJEoySfwmWCz2GXPqQ+gAGWtpRq07Z7O747r6ug141qYir7TE/eJfKtqbcLgodIRAlsNVU2zM0SJTqzdwZmeFKyerGeX05DXZSrm2sXhv0xt9Jc0tZaQZMxmy6ZPngiyZ8zyZmfXoPr96lU59w3H4ERxw+qlspMz/UyEphlqO0lthtDTaeiEJJJF+hDlnpK6oimuu8Pep/aLptCqrW6bpop1J+98+v/AEhW9S2qJQqfTGDNTcNhDBKPqrSRFk/v1FgADuiLRaHytdU11TVV5kAAEqgAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAPDyzbZWsuZpSZip9qveG36i0l/lXv7D/0Gtjo0aIqibw59auqmYtKw9qveG36h7Ve8Nv1FeA24qMMOWvKw9qveG36h7Ve8Nv1FeP3BhxUYOWvKf7Ve8Nv1D2q94bfqK/ABxUYOWvKw9qveG36h7Ve8Nv1FeAcVGDlrysPar3ht+oe1XvDb9RXgHFRg5a8rD2q94bfqHtV7w2/UV4/cBxUYOWvKf7Ve8Nv1D2q94bfqK/ABxUYOWvKw9qveG36h7Ve8Nv1FeAcVGDlrysPar3ht+oe1XvDb9RXgHFRg5a8rD2q94bfqHtV7w2/UV4BxUYOWvKw9qveG36h7Ve8Nv1FeAcVGDlrysPar3ht+oe1XvDb9RXgHFRg5a8rD2q94bfqHtV7w2/UV4BxUYOWvKw9qveG36h7Ve8Nv1FeAcVGDlrysPar3ht+oe1XvDb9RXgHFRg5a8rD2q94bfqHtV7w2/UV4BxUYOWvKw9qveG36h7Ve8Nv1FeAcVGDlrysPar3ht+oe1XvDb9RAwPwOKjBy15WHtV7w2/UPar3ht+orwDiowcteVh7Ve8Nv1D2q94bfqK8A4qMHLXlYe1XvDb9Q9qveG36ivAOKjBy15WHtV7w2/UPar3ht+orwDiowcteVh7Ve8Nv1D2q94bfqIGB+BxUYOWvKw9qveG36h7Ve8Nv1FeAcVGDlrysPar3ht+oe1XvDb9RXgHFRg5a8rD2q94bfqHtV7w2/UV4BxUYOWvKw9qveG36h7Ve8Nv1FeAcVGDlrysPar3ht+oe1XvDb9RXhgOKjBy15WHtV7w2/UPar3ht+or8AHFRg5a8rD2q94bfqHtV7w2/UV4BxUYOWvKw9qveG36h7Ve8Nv1FeAcVGDlrysPar3ht+oe1XvDb9RXgHFRg5a8rD2q94bfqHtV7w2/UV4BxUYOWvKw9qveG36h7Ve8Nv1FeAcVGDlrysPar3ht+oe1XvDb9RXgHFRg5a8rD2q94bfqHtV7w2/UV4BxUYOWvKw9qveG36h7Ve8Nv1FeAcVGDlrysPar3ht+oe1XvDb9RXgHFRg5a8rD2q94bfqHtV7w2/UV4BxUYOWvKw9qveG36h7Ve8Nv1FeAcVGDlrysPar3ht+oe1XvDb9RXgHFRg5a8rD2q94bfqHtV7w2/UV4BxUYOWvKw9qveG36h7Ve8Nv1FeAcVGDlrysPar3ht+oe1XvDb9RXgHFRg5a8rD2q94bfqHtV7w2/UV4BxUYOWvKw9qveG36h7Ve8Nv1FeAcVGDlrysPar3ht+oe1XvDb9RXgHFRg5a8rD2q94bfqHtV7w2/UV4BxUYOWvKw9qveG36h7Ve8Nv1FeAcVGDlrysPar3ht+oe1XvDb9RXgHFRg5a8rD2q94bfqHtV7w2/UV4BxUYOWvKw9qveG36h7Ve8Nv1FeAcVGDlrysPar3ht+oe1XvDb9RXgHFRg5a8rD2q94bfqHtV7w2/UV4BxUYOWvKw9qveG36h7Ve8Nv1FeAcVGDlrysPar3ht+oe1XvDb9RXgHFRg5a8rD2q94bfqLOG6b8ZDiiIjVnkX3GuC/pf5Fr9f9TGWtRTTTeIbaNdVVVplKAAHM6QAABil/lXv7D/0GtjZJf5V7+w/9BrY6un8S5eo8wAADdzhdR8435QpR31WZe0SmXTVKI44k6a/Rl5ZjtnywpHUjLlnzH0cOXTtmVdg1moVCxb0mUJue6b0iM6yUhvWfMzTnp1GepEzC+nNpVFm1KGxshuw2a4u6IkNuQoo09txl5lGkz3LuT1dh8yx9BMav86JYVjsUOjR11autIagwCeUTLJYLJqUZmrSWS7c/UWdF2Wt0227ohqq782tXE0pEuoyEf1GRkWEEfQjUZ/qE/ZdxFpWvAZqhxq3biU8HUUM5TqIiIyUgz5pPBcs9gi1S16ZlqFam11zb7YLNxw4sSS2y8ZqhPqcYdI218y1ERkZGXMj+nMepu3gnF1CZSm6D7MhOKQUebMW3Mlkn+ppKUmkiPsJRja07OqxL2g0G7K5cjU6TTkLQthEPdNmSkqLCCJR4+IzMzyZjFA2aVWgHNiWlccen0eW8b5sv05Eh6OZ9SaWZ4IvuRiLVfZN6Pu322KzHuK3qfV4RKTHmMpeQlfVOS6H9SHztteTSHduUlu44NcqED2YhSWKQf4pLyWFGXy4zn6mQ+lYEc4kJiOp5x9TSCSbrhESlmXaZJIiyf0Ic2u3Z1cNQv966bYuxFDlORExDLhN6rQRkZlkzxzMi7OwW1ImaVdOYiZUmx2JQmna5Isei3BAqiIxJT/iFSksOGZngi05PqXPA0XZ2xcDuzy67vZaprtVNqSj2k/Kf4kix75ERe4WCItP17h22y7evSl1dUi5729uwTaUgovBpawszLC9RdxEfL6iFamzh2g7NKvaiqm0+5PJ8ikkyaUo3hY+HPPH3FYont/FbfHf+DnNj3C1s22aU6vTqbAVU6+ttpl5Et0zeLme8kGvJJwajzoLtG7WLtXRWbs/w9VFUd6QuOqQ1Mo8hbrB4zlCiWRKJREWe4TZuy5idYVvUF+oqbn0NSHYs5pojInE9poPqk+XL6C7tq3q7FqLsu469GnpNvdIiw4CIzPPqpXVRq/UiE0xVExH2RVNM3n7tWpd/3dcsCTWrQtqnTKGy+phtuRLUiXJ0qwakERaUl9Fdxir2k1q8U7RLEi0xuHERL1uohSZCySp0ke8l80ZIyTnlpzzF1B2b12hRJdKtO7fZtCkPG8TS4ZOPxzM8mTbmSwX3I+0WN22FPq0y2KjS68bFXoWokSJrBPk/qTgzWRGnn6cwtVMF6Yns1+79q1QpV5SbejMUKnvRWkLXIrT7rTchSiI8NGhJ8s5LKj8h0e0qrIrVAjTpkZiM+4R6m2JKJDf3StJ4Mj8xrl02hX6tKWuPXqc7FebJDkOq0puU0g+WTb6GRGeTwZmLHZrZkexbbKkxpTko1OqfcdWkkEalddKS5JL6Cad27urVt29vLagABooAAAAAAAAAAAAAAAAAAAADy5/LX/af+g9D8UWUmXeWAHzjse2XW/eNrSKrV3aoU7jXmyWxLNBJJKuRkWOou7TvCsWpZV/MSZB1hy1ZW5iuyzMzcQayThZlzPGTMTKDsrva34zkOibREwqet5Tpst08jwajyeDMzPI2EtlkWPs4rdswqg6qZVz3kqpSk61uOakq1GRH05YxkYRTMR2izeqqJnvN3hi9LnTs/n3ZPpNJjw009MuIwl5xTqlGZZJzkREXaWDMx4rm0adTtltuXU3AiLlVR2OhxhSlaEE5qzp555Y7RtTtrNSrA/wvMfNTSoRQ1vNpwfIsaiI/qWcDQpmyeuzrSpVvTbsjrgUt9pyKhEDT7iDPks9WTPny6F1Fp3R4UjbPlfV296s5e7dqWlTYMupNxky5b855TbLKDIjJJaSMzVzIQrc2kVObWr3g1mkR4J25G35JbcNanDLPIzPkZHjkZEXUVG0Vv/D20aHXqa/VaXNeipjyJqaUc6G8giwSVJQrUSywXZjkI2ym3JlWrm0GpzuPOmVxrhmJU1k2XH85yskH0Tz5EIvVey1qdt3u0bikWjsXkXpJiP1ap1WSqY+lJn/WoySaj54QkiF9s72hVO5asxHfTbUqM63rN2lVBRuMHjJJW06RKUf1TnAw7MKdVX9mjltLmy6JV6PJXEN9DKVEpJHlJ4WRpWlST54GSm7L5Ll4Uy4LgqVMek089bSaZTUwzdVjGXVEZmr7BG7tZE7e92O1pTlA233DbaVqOnVSOVVYbM8k27gt5juI+fIW23lSk7I7jUlRpUTKcGR4P40ivtanv1nbNclzvMOtwoLCaXDU4g07xRF+IpOepZ7Rtu0G3V3bZ1TobclMVUxBIJ5SNZIwoj6ZLPQWiJ2yiZiKon9Hy81T6NJosUrMt6/GrsUhs2JSlaWCc5ZVn5eo7lcN7XHQbltK149NhT6nVIBLdcfdUgkPFkjMzTktPLJ8jPuHRaLFXTqLBgKeN3hmEMmsuRK0ljOBrVbs5yp7R6BdKZqG26XHWwcY2zM3NRmeSVnl17hWKJpjsma4qnup6le1fZr1OtSn0ulyrteinKlmchaYcZPZzxrPJfbqMLN6TaizdtsXFT2afX4FNdeM4rpuMPNm2eFIM8KLs5GLi6rHeqF1Rbot6q+ya+wycc3HGCeZebP+laMkf6kfcI9H2fOR3q/U6xVjqNxViKuI5L3JNtMoNJpJKGyPoXLqeeQtaq6L02c52W3HdlB2MxapT6JAmUmCp1x85MpaZDyNXvG2kiwRF9T59w6RVL2myLWotZtqNS+GqTe8ORV5pRmY5dyi+JR5yXukNcpWym4adZBWoxeSCpDxqKSkoGXNKjIzS0s1ZSR/XIsrg2Vofetp+gVBiGuhMcMwzOilKYWnn7xoMy97J9RWIqiFpmmZuqKdtCevG0L8p8xiCiZSoriVSKc+pyO8RkZakGZZ7BT2Vdt1Wvsdo1aTRKfJt+Iz+ObktXFLSa8a0ljSRc+hmZjbKLsvl02TeDrlcak/4ijbpZnEJs2nD/qIknjT9CEJnZVXk2XFtF68EKoBESZLaYBE8otWTQheeSenUjMRaryXo8MdwVH2ptm2fzaar3JdIeeZS4Z6cnqNOoi+vUWVP2omVgXBWKzDYi1mjPrivwUKPCnc4bIs8/e/8hdSLEQd6WvWYctLMShwlQkRVINSnCPOD1Z5eQ5tJt9i+ttBTKQxUkW6jdyKsb8dTDT0hoz0ERKIjMzx1IT+KCNs/wAHarXlVCdb1Pl1mOzFqD7KXXWGTM0tmfMi58+mB867Viobm22rpuan1+oQ0wWVIbpB++hWkveV9MD6ePmY1Kn2k7D2mVS7CnJU3Nhoi8MTZkadOOZqzg+nTAvXTMxEKUVREzLlGwxkpV7qqNkNVuJZSY62paao+lZKf7NJEZ4MuXMWdR255l1F2lJoKKfAcU2bFQmLalytPU2kpSaS+moxulOsByh7QnrhtyoNwqdOT/8AiFLW0am3lfOjBkST/TvFdF2bVWiSag1aVxx6fS57xvrZk09Eh1hRn726WZ8v1IxSIqiLQvNVMzeUO69sCYFDtifSILO5rqDUmXUVLRGimR4NLhoIzznPTs5i9tK9KjV7erM+WxRXVQWVOsyKZOJ9h/CTP4TwtHT+oiFjXbarEqnQGaTcRsOxkaHUzITUhiWfzOIwWD/tMhrNG2clbMW66y/JjyKpUIDrJtU+GUWOktJn7rZZyoz7RP4rq/hsrqftJvKZYDd4Itqkey2km5Jb4twnltkeDU2nBkRf3Gf2F7VdpJyDtuHacBuoVavx+Jjoku7tplsuqnFERmeDIywXcNL2cWTcda2RQKSq4XKbSJhKTLhvQcvpTq5pbWZkaSPHQyMb5WtnDCzoEq26gukVWhs8PDfNsnUKb7UuIPGSPn0x1ERumEzsibP23r1qRXeu1btpsWFWFRjlRnoTqnI8hBFkyLURKIy+o1elbTLvrFo1mu0636NuKU+6h3fSnEm6hHXQkiP3sdpmRDbbeseQxdL1z3LViq1dUwcZlTTG4YjtnyMkIyfM+8zEa19njtDsOu26qpNvLqbj7hSCZNJN7zsNOeePuJtUi9KruXaydPsS3Lgg0xBHWj0pXMWomIp5wZuKSRnjJHjAu9nd31C5eNRPRQn2mkam5dHnb5tf/CbasOJP6mWB4gWPVaZYdFoNKuFMaTTk6VOKiJdjyS1GeHG1ZPHPsMjEeytmx0O7JlyVCbCdqT7Bxyap0IokdJH1UaCM8q+oRuvBO20uV3ZVGp+wt6TT6a1TSTcRt7iK6tRLUSiyrKzM8n98DpE+/a/a1Rt9N2UanR6LVVojMuxpSnHmF6SxvCMiSf6eYiStkL7+zl61yrbaHHKoqo8UTB+6RnnTp1dfrkWcvZ1VK1VqKu6rkTU6VR3CejRkQyaW44RERG6vJkrp2EQrEVQtM0yp6ZWGKDtZ2m1OorWUSDBYeWRHnkXYRd5ipi7eDJMOfNZoSqbKdS3wcWatU+OkzxqWk06Dx1MiMb8ez9mTc131CpSkyINwxURVxkoNKmyT1PVnn5CvoNgXBSGINMauxoqHDV+GlFMbKUtBHkkKdVksfUk5E2rjwi9E+XSEKStCVIPKVERkfeRj9D7ANmQAAAAAAA/S6j8AgHyvshkyKHtCmV2RIc9myq09SX8mZpSS9akqPu94k8x7gyJdV25Wvcb77ps1eov8O3q90mGlbtBljvwox0v/AKHDdsa4qA9VELcqlQOe1JSwoiYVqyRGWefoLFGy9LFUsOVFntNN2w0bamtwf+0GZ5MyPPu88nzz1HPsq8Oia6b3eb/vivW9Nm8KxbEaFEb3hHValpfk8s/htoyae73uoqrg2vyYmz217mptIacXV5nCrivLMzRjOdJljJ5LlnvEyRsrmJuOvz6fXo7MWtnmRv6eh+Q1yMsNOKPCS59wwObI5LljWxbx1pglUSoHNJ8o6sOpyZ6cauR8+uRad/dSNnZat3tXqdtFpdt3LSKcwzVULcivQ5K3FN6S5k5qIiM88uXL7iBf+0OvWy9UnkxLZZgwveSzNqf+1yk97baM6TPsJXMbNcVnOVjaHbtzJmoaRSUOJVHNszN3V3Kzyx9hqDmx6UlVxR4lfjt02trW48p6nIdlJNXVJPGfJPPuyJnd4hEbfusKztRU3blpyKNTEP1m5TSiHEfd0obMzwZrUXMyI+XIe498XJF2j0S1K/R6Ywc1hx5yVFfW4g9KTP3MkRl0wZGX6jXL3tE7csS0WnnalIqtAezGqVMgE8lrCtRG60as6enQ+pCJa7VUufbJRK7xE+pw4EN1Eqa9TlQWEKNJkSG0K59vM/8A7CL1X7+lttNr/qkVPbmfGVRymN0FEGnPLaNioTFty5enqbSUpNJduNRi/re1N1MOypdu01ma1cjhtJbfdNtTa86dOouRYVkjPB9BkjbNqrRJNSbtO449PptQkKkuNSaciQ6ypR+9ulmfL9SMWtyWI7WKnZ0v2pg6BJTIcN1kjVJMjIz+HBJM8d2BP40fgUkO+rweu6o2kug0U66wxxTbyZbhRSaPpqynWZ5PHIiCnbXGk7PKvcVbpu4lUuWqA7GYc1JdeIyItKj6EZn29Bs0Oz3I+1Gdd3GoU3JgphlFJs9STJRHq1Zx2dMCggbJ43+ErioNWnnIZq1QXPQ6y3oUwozynqZ5MjL7GJtV9kXo/spre2zb+4aTT6udAfZqjpNNKpEtx1cZSvhJ5K0l3kWU8uotIt93TV7tuqhUGi0lxVGUkkSJUhbaVEZZwoiIzMz7MYLlzFzbtqXJCnQVVe6I8mDDIkpYi01tlb5EWC3qzyZ9nw4Ge1LLcoN23VWVzkPpra0LSyTZpNnSRlzPPPr9BERV9yZp+znd0bRK7cexGo1ujMM0qZGlHDn/AIytTeDTk2TLvNRFz7MjrVkLqrlrU9VdRDTNNlP5Ra1INGktJmauerHX6jS6Xsp4bZzXbVlVYnPacxctMlpnTujM0mRGkzPODSN6tWDUqbQ40OtTo86UynQT7DG5SaCIiSWnJ88FzMTTE3vJVNNrQtgABozAAAAAAAAAAAAAAAAAAAAAAAAAAAF/S/yLX6/6mKAX9L/Itfr/AKmMdf6W/T/UlAADkdYAAAxS/wAq9/Yf+g1sbJL/ACr39h/6DWx1dP4ly9R5gAAG7nBxO+JzsjawxUW3V8Hbr0KKskmZJNySsyXnngzJKkfYdsIaGdhOOUK4Ismay5PqtSKob8kKJLZpWlTacZzyJBEK1xM+FqJiPKk203E47T6hQ6dvTaaaTxzzSsHrcMksxyMueVqMjVjmSS+omx5cKh1goLsNCmbUoKXzmKfWakKUR5Rpzg8k3nJ5PuFnKsU3otHj8Y2aGKkVUqKltmaprpZMu3kRKxgj6EkiGGrWJKqEG7WvaTKH7gktqW5uj/DjpJKd315maUqLPT3hWYm91omLWVLd/wB1tUCj16o2xT4tLmOMNOtqmKOT+KokpUhGnGOecGecdw2CrXRWJNwS6LZ1JiTpMFKDlypz5sx2lKLJNlpI1KVjmeOmSE+5LaVWJFupQ+21ApctMpxg0GZu6EGSCLsLBmR8+4Vcy1K/Dr9UqNqV+JBaqjiXZTEyHv8ASskknW2ZGWDwRcjyWQtMIvTKE/tFkRbOrtQm0pLFbpElMJ2Elw3W3HlGkkaFFzNJksj7xttvSa3L4h2twIcFlWk4zbTynHdOOe85YI/oWfuNaZ2eIYg0yN7RXJNFUKq1KRJRlyc6RHjOOScK0mRdCJJEN9PmYtTE/dFVvsAACyoAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA/UqUn4TMvsYGZmeTMzP6j8AB+mZmRZMzx0H4AAP0zM+pmY/AAAAAAAAAAAAAAAAB+qUpXxGZ47zH4AAAAAAAAAAAD9MzM8mZmf1H4AAAAAAAAAAAAAAAAAAAAAAAAAAKC/a6u2bQqdWZbS6+w3+EhXQ1qPCc/TJi/FdcdGiXBQ5tKqBKOLKbNtZoPCk9xkfYZHzET47Eee7T4mzGmT2GZd2SKhWK0oiW5JVMdaJtZ8zJpCFESUkfQsGJk6oybMgU2hwzmXDWZrq0wW5ThIUTZczN1z5EF/UfMxhaty9iY4B28o3s4k7spDdOIpmjp8Zq06sf1YGSqWM40dDk2rUiptRpDbjLLkps5KHm3Oa0u5MjMzPnkjzkUtiF75l6ol01hq5kUG76bAhzH4rkyO/T5CnWloRjWStREZGWfsNaRtHuh+z5F0RrbppUaMtxSnHpikrkMpWaSU0kiPmZF/UeDPoL5Nk1N9NVqFVrbUy45cFcFiQUfdx4iFdSQ2R559pmeRMq1mcXY1KtiLKQzEinGQ+akGe+abMjUksdNWPULVJvSoLsqdy1LaJatOoLMIoiWPajrb8lxs1JwSTJwkljkaiNJc8mXPAxTrzKm066blp9IbkTPaaKRESl1ZnNNJkkslnCTJSlF7pdnMbUq3am1fsmvxKjFKHJhpiriuxzNaNJK06FkeCLUZGZY54FVTNn7sSnWpDfnsutUiY5UJWGjLinlGoyMufukSlZ59wi1RelnhXVcMe8aTSa9RYMOPVUunGVGlqdeaNtOo96WCLGO1OcCZQbxXVLfr1alR0swKfIkNsK1GZvNtcjWeemVEov0EiRbjsm+Pbz8tG4apy4MZlKD1trWrK3NXToRERYGm/wDRtcS7MctZy6IiKSWEtkxBNDjiTXqVvVGo8meT6YyJ/FCPwyyVbaqmm0agFJZpsWu1aIUzdTZRsxo6D5ka1mRqPJGXIiyfMXGze/E3ZLqNPf8AZy50FKHFvUySb8ZxKs40qMiMjLHMjIZLjsyU9XWazbU2DCmpiphOtT4ZSWXGknlHLJGlSewyMXNp0F2iRnzmTjnzpK9469uktILuS2hPJKS7v1CN1+5O23ZQbaKjWIFmG1b25TNnyG4KXFuqbWg3D0kbZpL4s47sFkxjO5rgg1mlWvGpFPl1g6YciRokrJlhRKJCMrMs6TLPPGTMuQuL4t6o1xdGfpFRjQ5NNlcUlMlg3mnD0mnmkjI8lnJfUSqTQFQrrrlcffQ85UEstNoJJlum2yP3TPtyajMTMTciYs57P2vuJnyIERdrsyYJk1MXUakplDjxF76WSJJqNJHy1KxkbTDv1uo2DHuSnRWDU+s2SakzEMtIWSjSZm4rkaclnkRmZdgrS2fVeEubEoddgRaPLfcfMnqal6VHNZ5UTbhnjGTMy1EeMifdViOVFigKpE6O1Jo+om01KPxTLxKTg1OJ5ZX2krvFY3d0zsV1lbRpNbuk6FLTQZMhUdx9L9GnKfabNBkWlzUkjIzz1LI1+3rvuamW1dV2VeLAksyJe6gstyXVmp1KyaJpBGRYbySjIy5mZnyG3UCx6jCuWdWqpV4kiVJp3AoKLDKOmOZqyZoSR4MunXny6jBTbDqbdu29RqnVYUiLSZ6JRmzGU2b7aOaUq94/f1+8au3uC1Sb0vM69LqgXBTqdKtaItVUbcOIyzOy8g0ERmp7JaUp59mTL6j3TtoEmEi6yvGFDhroCWlurgPKebWTiTNKCNREevl6kNjOgOOX8m4n5CFMswDhsRySepClLJS1mfTngix9xSr2ftzaHckGqTCXIrM45pyGUY3Jp07oiI+unSXXkfMTapW9LVoW2UlT4S5f+HV0+W8hlLEKpG9Na1mREa0aSSeM8ySfIbPPu2vyL0q1v2xRYM3gGGluS5UlTTbbi8noXgjM+REZERZ7xlo1pVn2pFlXFWIEhmIrU3Hp1PTFJ1XQjdPmau/SWCyLG27ckUdu4HVS2nahVpbkrfJQZJbI0klCTLqekiIIir7pmafs0e570r1W2VOyqXEjQqvJnqpDmmQsiSvWbetlRFk/exjOMFnuHTbebnM0OEzVm4zc5tokOpjOKW2RlyLClERnyx1GmuWDUI9rWzT6TVojM6jSOLW7IjG41JdMlalKSRkfxKNRc+uB0Ms4LPMxNMTfuiqYtaAAAXUAAAAAAAAAAAAAAAAAF/S/yLX6/wCpigF/S/yLX6/6mMdf6W/T/UlAADkdYAAA8ukSmlkfQyMjFbwjHyepizX8CvsIYvRMx4Z1xE+WDhGPk9TDhGPk9TGcBfdOVdtOGDhGPk9TDhGPk9TGcA3Tk204YOEY+T1MOEY+T1MZwDdOTbThg4Rj5PUw4Rj5PUxnAN05NtOGDhGPk9TDhGPk9TGcA3Tk204YOEY+T1MOEY+T1MZwDdOTbThg4Rj5PUw4Rj5PUxnAN05NtOGDhGPk9TDhGPk9TGcA3Tk204YOEY+T1MOEY+T1MZwDdOTbThg4Rj5PUw4Rj5PUxnAN05NtOGDhGPk9TDhGPk9TGcA3Tk204YOEY+T1MOEY+T1MZwDdOTbThg4Rj5PUw4Rj5PUxnAN05NtOGDhGPk9TDhGPk9TGcA3Tk204YOEY+T1MOEY+T1MZwDdOTbThg4Rj5PUw4Rj5PUxnAN05NtOFM+kkvLSksER4IWRRWcF7nZ3mK6V+Yc/uMW6fhL7DXUmYiGWnETM3YeEY+T1MOEY+T1MZwGW6ctdtOGDhGPk9TDhGPk9TGcA3Tk204YOEY+T1MOEY+T1MZwDdOTbThg4Rj5PUw4Rj5PUxnAN05NtOGDhGPk9TDhGPk9TGcA3Tk204YOEY+T1MOEY+T1MZwDdOTbThg4Rj5PUw4Rj5PUxnAN05NtOGDhGPk9TDhGPk9TGcA3Tk204YOEY+T1MOEY+T1MZwDdOTbThg4Rj5PUw4Rj5PUxnAN05NtOGDhGPk9TDhGPk9TGcA3Tk204YOEY+T1MOEY+T1MZwDdOTbThg4Rj5PUw4Rj5PUxnAN05NtOGDhGPk9TDhGPk9TGcA3Tk204YOEY+T1MOEY+T1MZwDdOTbThg4Rj5PUw4Rj5PUxnAN05NtOGDhGPk9TDhGPk9TGcA3Tk204YOEY+T1MOEY+T1MZwDdOTbThEkRmksLUlGDIslzMRIaEuPklZZLBixlflnf7RAp/5ovsY1omdssa4jfEJvCMfJ6mHCMfJ6mM4DLdOW22nDBwjHyephwjHyepjOAbpybacMHCMfJ6mHCMfJ6mM4BunJtpwwcIx8nqYcIx8nqYzgG6cm2nDBwjHyephwjHyepjOAbpybacMHCMfJ6mHCMfJ6mM4BunJtpwwcIx8nqYcIx8nqYzgG6cm2nDBwjHyephwjHyepjOAbpybacMHCMfJ6mHCMfJ6mM4BunJtpwwcIx8nqYcIx8nqYzgG6cm2nDBwjHyephwjHyepjOAbpybacMHCMfJ6mHCMfJ6mM4BunJtpwwcIx8nqYcIx8nqYzgG6cm2nDBwjHyephwjHyepjOAbpybacMHCMfJ6mHCMfJ6mM4BunJtpwwcIx8nqYcIx8nqYzgG6cm2nDBwjHyephwjHyepjOAbpybacMHCMfJ6mHCMfJ6mM4BunJtpwwcIx8nqYcIx8nqYzgG6cm2nDBwjHyephwjHyepjOAbpybacMHCMfJ6mJ8VCUMJSgsJLP+ojiUz/KSK1zMx3WopiJ7PYAAzaAAAD8X8CvsIYmL+BX2EMXpUqAABZUGj1y+ahT5MvgrLr0+DEUonphbphGE/EaEuKJSyLnzIsHjkN4HC61s5uedUKu3MpVHri5j7q2KrUqm/hhtWdKOGTywksFgjwYiUw3ap7TqdFplrzodMqVRauHUUVuOhO9IyRqIjSZ9ezrguvQSrcv1mo1KpU2t0mdb9RgRimuszVIUk2Of4hLQZkZFg8jXLasauQIezJqYiLqt1b/ABul7JaVNKQg0cufUuXYLis2XIrN+1qbM0JotRoHspS0r/EJZrWZ+73YV1ECIe1ZCYSau7atfRa6sGmsGhGjQZ4Jw29WskdurHQWNc2g8Fc50CkUCoVuonDbnNlEcbShbalGWTUoyJOMF165LA1yRb+0KXaH+C32aAmmnHKEusk+s1qYIiSeGNPJZp+uMjZqJasql7Rnao2TZ0lNGYpzSjX+Ia0LUZ5Tjpgy5gliq20QmKpJg0WgVCtLhKJua5HeZaQwvBGaCNxRa1ER8ySMy9otLKlUmrpYknRZrxxn5h4LgXc6SS8jqXve6ZlyI+vIaLW9lT0W5qxPh2tblzxqpKVL1VN9TD8VaviTq0qJSM5MuhlkbE9ZVWctKBakaLRqVSZa1qq6qcSkJS0Z5NllKsmaldDWeO3Bcw7iVXL5iVCz7rqEJqqIpFNQptNThPIbXIWnkvcGZH8J8tRlg+eBb1q6JlOTDj0i2qzXZDkdDyjY0NoQky5anVmSTV9C5jWJdl19jZ7ctmQuGkUs45tUV5x7StCD/wDYu8v6exfaWM8xGvay7jqNwRpaIEKv0tMFuM3T5VTdhoiup+JzCCwvPLrzLADd7Hu2PdkWapuHKgTYD5xZkOTjWy4REeMpMyUWDLmQ2Ucl2d23XNnlDvKXKgUjePvcdEiw31JYPDZFoyZGouZYyecjqdPeckwIz7zW5ddbStbec6DMsmX6CYRLR6ltHWzdlZtykWxV6xUqYTS3OGU2lBpcQSiM1LMiLrjHU8GLCn33EqNonXYFKq8lSXzirp7MfXIQ8StKkGRciIj6qzjHMerZoE2nbQLwrMlLRRKqcXhzSvKjJtokq1F2c84GoOWNc7Vjz6dCfYalu1t6oLjplKaTLjKWpW6N1PvIyRlnHdgQNjol/uyrnh0CvW3U6DPmtrcicS406h0kfEWW1Hgy+osaLeMaq2zWK01DfbapjslpbSlJNSzYzkyMuXPTyyOcWzs6r0PaLb1xFQaJRoMM3W5EeLPckPqSpBkRqWssKLOMJLGMmYtotrXpSqfcdu01mjO0mpuy32qk7IUTrRPaj0G1pwaiM8ZyRAlbydqEUqXbb1Po86dUa9E42LAbdaQpLZERnqWtRJLGf1FoV9RYtrS6zXqXU6McVwmXIspn8RbhmRJS2Ze64RmZERkeBqE2xqwdgWpRpFvW3XypsFEeTEnuqbWl0iItTT5EeC65LHMQY2yisT7KrtKqUmPCRMksyqfSzkuTI8M28GaFLXhSkrPJGRciI+Qdzs3CkbREP1aHBrdCqFEOc5uob0l1l1Dq8GZJPdqM0KMiPkYy129qjAly0U+zK9UokRRpelp3bCPd6mgnFEayLnzIsHjkNUtPZ6/HuGFJl2JZtHaiOE4qVGdXIdcMum6ThOg84PKjPAg13Z5c0+r1gplKpFeKa+4uPUqlU30pjNK+Fs4yeRknpgj5gOt2vXIly2/BrNN3hRJjZONk6nSovoZd4tBza2Wq7s/2Z23THadGn1FqU3CeabkGRE2tZka0GSfeMiwenlyI+fIdKMsGZdRKH4AAJQAAAAAAAAAAp5X5hz+4xcILJJLvIhTyvzDn9xi4bPGk/sNdTxDHS8y5zb20Y7rpMyXBt6sR6U3HkG7Ud60km3GyVlCOeTVy5Kxgj+w026rqr06Js8pdAbuVMCssG65MYlsJmvkSM6N4rkSk/Eo8ERkeCG7bPbTqlB2UybfqCWCqLhTSSTbmpH4qlmj3sf8AEWRFpdmVeN/0Yb1Mf/8AZ5p1E/DucGpoklo5e9zL6Dn7uhLqd81GjsvlGs646lTqeg0v1B1TTRq0F7yiSsyUvkWdRFg+wZ5+0qmMt2y7Bgz6i3cLTjsIo6C1npSR6TSeMGeevQsHkaBV9m11VB2rx59LolZkSnXVNVqoVJ/3EKzpTwxe6WkjwRFyyWRs9o2RWqWjZuU1EbNvxJDEw0vaua0kSdHLmXL9BPc7JkTac7Ldn0+NaFdcuKCaTkUsja1NoUWUrN3VowZdCIzP6DPK2o0pm0KRcKINQejVCYUHh0oLfNO+8RpNPaZKTjBdciwtygT6ftJuutySaKBUm4qY5pXlRm2jCtSezmOb12gVi27ItSnLXEZqx3SbzKlK3jXvqcUnVjB8yPnjoHc7OjUG+Sm3EzRa1QanQZ8pKnIaZuhSJKU/FhSDMiURHnSfMU1Fv6m02yGak8danOyai/Cixn1JflSHicUWhJlgtPI8Z6F1EmDQ7nr96UetXdHplNi0XenGjQX1PqedWRJNalGRaU4LknGRQRtnFcZtSjGw7CauCi1iRU4zbqzUw6la1e4pRcyyk+uORh3OzYW78TNhV2DV6PWKBVYlPdmbhxSN4tkkn77TqTNGosdvQ8CMe0VmlxbUgR6RWqxLrFOOTGJK0LeVpIuThngsnnmrkQzqhX3X4VaTXCpdMiv056JHpcV3f7x5aTInFvGkjSXPGkv1GGg2fVYVyWNNkJj7ij0V2DK0u5MnVEki0ljmXI+YC9su8W7kl1OnyKXNpFXppo4mFL0qUklllKiUkzJRGXcNqGn0C358HaVddckE1wFSYitxzSvKzNtJkrJdg3ATCAAASgAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAGKV+Wd/tECn/mi+xifK/LO/wBogU/80X2Ma0fRLGv64QryuqNa7EMnIsufPnO7iHBiJJTr68ZPGTIiIi5mZnghT0W//aNyot6fQKpSaoqE5LcRJNBkhKTwWlSTMlZzkjLpjmIG19bdNm2zX2anToFSp8lwo6ampTcaQlaDJaFOERk2eOij5DWbMrFUu7a/7RkKozseLRXWSKkyjltMmtZYSt7BJUo8ZwXQiGF3RDa7MvWKqmWow43VXY9aOQ2xOnvIcWTqFqw24ZEWTMiPTguhEQsavtDpNJqlcjTW3ij0htk35KMKJTzp+4whPU1mXPyFDEsOqFseh0Fao7FxU9xUuG6S9SG5CXlONnqx0MjIj+5jA7syl1fZi/Sa3IincU6YVVmPGnWw5J1ZJCi6m3giT9g7nZeUfaIl+rRIFdoU+hKnObqG7JeZdQ8vqSDNtR6FH2Err0G2V+ZIp9EnzIURybJYZUtuO2pKVOGRdCNXLzHLbS2evsV+FKmWFZtHaiuE4qTHeXIdUZdDbLCSQecczzjuHXZTZvxX2iPBuNqQRn2ZIyEwiXN9nl8VedsxhVutUKqyp7h6G0RW0OLmGajwtJJPCEF0M1YxgWlAv5cy6I9vV63ajQKnLZW9ETJcadS+lBZXhTZngyLvGox7NvZOzGnW6pEBt6lSk5aZnrbRVIxGZmhS0kSmjPJd/QYLT2c12BtJoVxrolDo8CK0+09HiTXJD3voMiUpay97njBFjGTEd0s9j7R6nHtZ1+ZQ7grrMSXKTMqLRINLKEuqwREoyU5pTj4S5DY41zFO2lwHIlSWq3n7eXPJOrDR/iJw4ZdhkkzFJQaDtFoVsSaBCi2+4zLekqTLekrJURDrij5oJP4nJWSwZdxiyo+zp2mVanRkukujRrcXRlP68Om4pZGaiT3dTCB7RtYjKZ9o/wCHqsVt9faxqZ06c43m517zR25x054HmfedaTtepdFgUuTKoUin7/etONElZKWn/aMmerQkjxjqeeRGNLpuySfTozVKOybIqG6LQmsyXXCNaS6KcYIsmrHXCiIzHQKjblZgX9btYoEOnvU6NT/ZchlTxsGw3qSetssHkiJPJOf1DudmGLtPKfJecpFr1qpUdl9Udc+KbSz1JVpUZM6t4ZEfbj6joyMKNJ9h46kOGXTs4r1WqUxUa2rai1F5ajauGBOehuNkZ5JSmUllSi5Z97BmO1Uph2JT4ceTIXKeZaQ24+osKdURERqP6mZZCES59Y9zTWqHdc2oIqdYcjV+TFjx47ZvO6C0aUJLsSWT5nyIWFGv91+5YdDr9tVOgzJyVqhqkuNOoe0FlRZbUek8d41uXYlz/wCELggQZDLEmbX3aluUSlNFKiq0fhKdQWps1aT6dBW29s6r0a/rdr5UChUWJCcdJ9qLPckvmlSDLJrWWDLP9JY6gltUbafx8p9dItetVKkMPqjuT4ptLMlJVpUZM6t4ZEfbgeKxd9djbYqXQIlHlyKQ9CN1akLaSRma0kb3vHq0oIzI09Tz0MardWzmvVapTVR7atmNUXlqNq4IE56G42RnklKZSWVKLln3sGY3CdbtxQr3tms08otVbi072ZPckv7lwyNSDU8XIyUfumenkA2S/KrNolnVao0uG5MmR2FLbbbNJGR4+P3uWE9TLtwOYPXzXfYezKpz49UiuzpRNyo7RpWuoJOOZkoko5aVKPJEeMduB124oK6pQKlT2lpQ5KjOMpUroRqSZEZjnVJtS53YOz5qqQ4EZ23JWl82ZW8JxlLBoStPulzMz+Hs7wlENht2+Sq1anUSqUSp0KrMxTloYlGhW9Z6a0LQZpyR9nYKOm7RotKtC0X0wa9VlVpTrMclrQ9KNaTUZEsywR5MsZLBEWM9BsNQoE5/aSxW2ya4BFHehGZrwveKWky5d2CPmNbtqx6zT4OzlqUiNroLklc3S9nBLS4SdHL3viIBf23fzNRqdSpdbpM636pBjca5HmKQslR843iVoMyMiPkZCjm7XW4lCfrrlqV/2Bp1RqgaWyRIz8J6c6kErsNRY59gmXDaL9Qv+tViepDdBlW2uluOIWZupWbmoz0EWcae0ckuG7qpJ2XJtSnVW06gxuGoTD8SapcyU2RklCCi6dSFmRFk1ciBL6bjOk/HadSRpJxBLIj7MlkaRW79n092W5FsuvzKbENRPTfwmE4T8SkIcUSlp68yLn2DdYLamYUdtZYWhtKT+hkRDhtX2bXRPeqsebSqNWX5bzy2qzUao+e7QozNKeGLkWksEREeO0TKIbHem0OptJsaXatJmT6fW30rVoU2hbqTQaiZLWfuq5ZM+mEmWeY6klZmyS1INB6dRoM+Zcs4HKHLNueJY1gswGIEitW3IS69Gekmht5JIUjCXCI8clEfQdXTrXH/ABEkhxSPeSR5IjMume0IJctY2wpfoS641aFeXRI6nEy5qTa0s6FmkzIjVlZcsmZFyGyP1+Gd90hhMmoE3JpTs1OHUpim2RoPUtBlqNeD5HnBFkUdOsursbC6hajiYxVd+PLbSRO5b1OOLUnKsdyiEl20Jrlfosubuk06LbztNlqQ5lZLUSPhIi5lhJ8xCUWXtcaYosquptWvOW402pTNSJKCQ+ZHgsIzrJKj6LMsCPW7xqUPahTEQYtTqMWZQDktUqMaffdNxOFKMzJKcJyWozHOK1ddSa2VyrSptWtOoRkRThMPszFca+3nSlvhNOtLhlgsnyzzHYaTbVSZ2gUituIaTAYt8qe5lfvk9rQrGnuwR8wFXXNpUp3Z9dNRpFFnRa9RiNqRCk7vVFWadROGedK0kR55dRulk1KbV7Xp82qU+RT5bjSTW0+tC1Hy+PKTMsK6/qNRnWRVJiNpzWqM0VxkhMJZrzjDBIysiLl7xDbrKTVm7YgM3BDjQ6gw2TK247++QZJLBKJWC6kWcdgmELwAASgAAAAAAASmf5SRFEpn+UkVq8LU+XsAAUXAAAH4v4FfYQxMX8CvsIYvSpUAACyoNIrV+SYEmWmFZ9xVGHEUpL8xtpDTZafiNBOKJSyLnzIsHjkN3HCq5YF1VCfV2Z9Hp9eVMedVHqk+svIaYaVnQg4yexJYLBHgxEphsF135/tuzqr0ZyoOUmrOvKXEYby5JLcmaEGjv1Y7cF3jZbfvuJUJsuBV6dPoFTixzlrjVEkkamC6uJUkzSoi7cHyGmU+y7tptA2cohMU86jbxv8AEoef/DMjbUlJEZFnnyLJdM8xbt2nXLuqsyp3pHiUlK6Y/SmIMKRxCkpexrcW5giM+RYIi+4hKk2g7Un3NnVZqVGpVepkVbBHT62ptJNuGaiIjIsmpJH2GZYMbpXL6apdRj0an0mp12tnFRJdjQUJ/CQfIlLWsySWTzgs5PA0q4bb2iVTZtMsvgqITbUVEZqpJlnmUlBlgt0afwzMi5mZ47hsNRoNzUC8pdyWrCp9VTUobEabBlSTjrStojJK0OYMsYM8kZdgCRI2p0Zi0KvXXolQZVSHkR58B9sm5DC1LSkskZ4MveI8keDLoPLu0+NGq7MCoW9XoipqVKpqlsJVx5pIjNKCJWUngyP3schrtV2fXFVLZu+VPKnquO4ZURxUVhwyYZaYcRhGtXxHpSZmeOZjb7ut6oVO+LEqkRDZw6O/IclmpZEaSWzoTpLt5h3QwQb7YrFMuePKp1XolUpERT0mK8SCfQhSFGlxtRGaDM8HjuMuYiHtFjUqDasNqmVysTKxTuJikgkLec0knk4eSSSjzk1ck8hmqdrVSRc17zW22Tj1aitwYpm4RGp0kuEZKL+kveLmMNu2lVYNdsiVJbZJmk0RyDKMnSM0vHu8Eku0vdPmAt7ZvuJWUVluTTalTKnRyJcynyGtbyUqIzQpJIzr1ER4x2isc2mHDlQ/bdp3BSabLfRHanykN6NazwjUhKjUnJ95cu0R5tpXEq69oNSpUpqA5WafFj06WS8qQ62lRKMyLmnmfX9Rz+obMboqMem7u2KXClQpcd92W/XHZj8jQsjUpGotKTPmZ559gJdUtOpzpW0q+oEmU67DhKh8Myo/da1MkpWn7nzFjfF4Q7Pj016fFlyUzpRRG0xUa1ks0qMvd6nnTjBdpkI1s0KfT7+vGrSkNlCqhxTjGlZGo920SVZLs5kKPbTxu+sr2WqOU724g2eIzuzVunOSsc8H0yXTqJQurfvlqpV4qLVKNVaFU3W1PRmp6E4kNpxqNCkGZZLJZSfMVlW2mLprEie7Z9ynQ4+TdqCmUNpJJHg1k2pRLMv0H5Bot03BedOr1zxadR2qQy+3DjRZJyVuOukRG4pWEkSSJJYTjI5zWNmN31WiTqZPolNqFTcQvNdn1t5wnTzkjJjGEK7uwjIQl1qRX4y73ojDUmommXS35jbSFJKMtBGj3lpMtWvnyweOuRrcfbLEfoTddTa1xewC5SKhukG2x72kzxq1KIj6mksCxhWvVyuW1qg+00lqBQnoEn8YjNLytGCLvL3T5iLHs6rt7BXbUNpgqyqAuOSCdLRrMzP4un6gh0ph1D7DbzKiU04kloUXaRlkjHsRKQwuLSIMd4iJ1lhDayI8lkkkR8xLFkAAAAAAAAAAAAAAAAAp5X5hz+4xbp+EvsKiV+Yc/uMW6fhL7DXU8Qx0vMv0AAZNgAAAGJ+OxI3fEMtO7tRLRvEErSouiiz0P6jKAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAADFK/LO/2iBT/zRfYxPlflnf7RAp/5ovsY1o+iWNf1wny40eZHWxMYZkMLLCm3kEtKvuR8jHiDCiQGCYgRY8Vkue7YaS2nyIiISAGLcAAEoAAAAAAAAAAAAAAAAAAAAAAAAAAAAAABBYpFMYmqmMU2C1MV8T6I6EuH91EWROAQkAAEoAAAAAABBbpFMbnqnN02CiarmqQmOgnD+6sZ9ROABCQAASgAAAAAAAAAAEpn+UkRRKZ/lJFavC1Pl7AAFFwAAB+L+BX2FJKcfS+omzXp7MELtfwK+whjTTqsz1Kdyr3srvc8g3srvc8haANeSMMuOcqveyu9zyDeyu9zyFoAckYOOcqveyu9zyDeyu9zyFoAckYOOcqveyu9zyDeyu9zyFoAckYOOcqveyu9zyDeyu9zyFoAckYOOcqveyu9zyDeyu9zyFoAckYOOcqveyu9zyDeyu9zyFoAckYOOcqveyu9zyGGQ0qSppUhknlMr3jZuNEo0K6ak5LkfM+ZC6AOSMHHOVXvZXe55BvZXe55C0AOSMHHOVXvZXe55BvZXe55C0AOSMHHOVXvZXe55BvZXe55C0AOSMHHOVXvZXe55BvZXe55C0AOSMHHOVXvZXe55BvZXe55C0AOSMHHOVXvZXe55BvZXe55C0AOSMHHOVXvZXe55BvZXe55C0AOSMHHOVXvZXe55BvZXe55C0AOSMHHOVIs1GozXnV25GcnZOORueQxyvzDv9xi4T8JfYaV1WiOzOim8z3Ve9ld7nkG9ld7nkLQBnyRhpxzlV72V3ueQb2V3ueQtADkjBxzlV72V3ueQb2V3ueQtADkjBxzlV72V3ueQb2V3ueQtADkjBxzlV72V3ueQb2V3ueQtADkjBxzlV72V3ueQb2V3ueQtADkjBxzlV72V3ueQb2V3ueQtADkjBxzlV72V3ueQb2V3ueQtADkjBxzlV72V3ueQb2V3ueQtADkjBxzlV72V3ueQb2V3ueQtADkjBxzlV72V3ueQb2V3ueQtADkjBxzlV72V3ueQb2V3ueQtADkjBxzlV72V3ueQb2V3ueQtADkjBxzlV72V3ueQb2V3ueQtADkjBxzlV72V3ueQb2V3ueQtADkjBxzlV72V3ueQb2V3ueQtADkjBxzlV72V3ueQb2V3ueQtADkjBxzlV72V3ueQb2V3ueQtADkjBxzlVLckGgyWa9PbkhibNaV5bzq+gtZX5Z3+0QKf+aL7GNKar0zNmdVNqoi5vZXe55BvZXe55C0AZ8kYacc5Ve9ld7nkG9ld7nkLQA5Iwcc5Ve9ld7nkG9ld7nkLQA5Iwcc5Ve9ld7nkG9ld7nkLQA5Iwcc5Ve9ld7nkG9ld7nkLQA5Iwcc5Ve9ld7nkG9ld7nkLQA5Iwcc5Ve9ld7nkG9ld7nkLQA5Iwcc5Ve9ld7nkG9ld7nkLQA5Iwcc5Ve9ld7nkG9ld7nkLQA5Iwcc5Ve9ld7nkG9ld7nkLQA5Iwcc5Ve9ld7nkG9ld7nkLQA5Iwcc5Ve9ld7nkG9ld7nkLQA5Iwcc5Ve9ld7nkG9ld7nkLQA5Iwcc5Ve9ld7nkG9ld7nkLQA5Iwcc5Ve9ld7nkG9ld7nkLQA5Iwcc5Ve9ld7nkG9ld7nkLQA5Iwcc5Ve9ld7nkG9ld7nkLQA5Iwcc5Ve9ld7nkG9ld7nkLQA5Iwcc5Ve9ld7nkG9ld7nkLQA5Iwcc5Ve9ld7nkG9ld7nkLQA5Iwcc5Ve9ld7nkLmnmpURs3M6uec/cxiEpn+UQpqV3jwvp0bZ8vYAAxbAAAD8X8CvsIYmL+BX2EMXpUqAABZULqNQo92wGaLXKnWK5HchQKg/GW+cY45M6VYJrBmZrUXTUXxdhDcE/EX3HBKdQqhW7aq79IYRNk0q9ZFR4JaySmUlDh5Rk+WeeSzyyRCJS6dbW0O27iqaadT5chuetJrbYmRXI63Ul1UglkWovsIce+6VS6FNqderKHojdVcp5PohKaJlWs0k2ouedPQ19D6ikkvVq/Ltth87WqtChUaWqXIl1PQhaj0Gkm20pUZqI9XM+RchRSbXrL1qKirpMpTir0442jRkzjcRqNzHy6eee4RdLoVA2iW3Xak5T4EqSUxDanksyIjrKnW09VNkpJay+wg7L9oTF8nV0txpEdyHKcbQS4zjaTaJWlJmpRY1njJp6kPd00ydJ2s2VUY8R1yDEZmpfkJT7jWpKNJKPszg8CNsqbqdMm3RSarSJ8UvasiaxMWkjYfbdWak6FEfxY6lgENkum7qJaq4Ka9MOLxq1NsK3alEpSU6jLkXI8dO88EQw2ve1BuY5KKXLcS/GTrejymVx3W09ijQsiPT9eg1Pa4+9GvLZ49Gp/tJ5udIWmKRkSl4YUfumfLUWMlntIfsJqvXNeS7qZoMmiJhUp+FFaqpJS9KeWZGWtKTPS2RpLqfPIXFkra3ZyZKW1VCSmOpwmynKhOlEMzPBfjGnRjPLOcZFu/X2o13zYb9SRw8ellOXDTFM1JTqVl3e5wZGRY0Yzyz2jhF40y97msebTXqRfUmsqbTxDTzjDFPJRKIz3SEc3E8jwnl2GY6fMo9UevOrTEwJHDvWomIhzRglP5c/D/u5ly+oXTZYQ9r1mTHIZM1KQTMvQluSuG6lglK6IU4adJK7MGY34cfrFuVRf8ADlSaHHpkhVVbjwichpR+IlaXUGvJd5YMzHXmyw2gj6kki9BMIl6AAEoAAAAAAAAAAAAAAAAAAAAAAAAAABTyvzDn9xi4SWSSRdxCnlfmHP7jFy11R+g11PEMdLzLQUbXLMW0y6mpSDYcUaVOlDdNDBkePxVEnCOff2cxtFNuCm1KrzaZDkG5MhobdcRpMiNDhZQtJ9FJPvIcV2a1iqsbJ/YlOs2dUl1FUxpqSybfCqNa1p1PqNRGnHbyPOOQtbopdS2cWhalUpbrcuuQIiaG6g1aeL3pYRjtPQ57xF3ZGF3RZv8AO2g23Bhuy5U5aIjU86ap7cqNO/IjM0kZFzIsGWS5Z5CPI2l21GpcSa+/ObKWayjxjgPcS6STwpRM6deks9cYGt3DZcmn2jYtHgRHZyoFXjyJi0p1Hn3lOOq+mo+onbU5FzM16Cqnx667b5sKJ5dvttLm77VyIzc6N4+XtC6F9S9oFvVWj1KowJEp1unY4qPwjhSGs9MsmWvn9hVxdrlqSKtApuuqsTJzhNR0SaY+0Tiu4jUkhoNnIvK1qjfdcatiuTJUuPGXAaqL6X3pCiM0nrWjkWC56C6FyE2wJs1mvNVa6bOvSpXPLUTa6hJhNpjwkmfwsp3h6EF2njJhdNm9IvimUmm12o16sJdhQaqqCpbcJTfDHkiJtXXXgz5rLkJNA2iW1Xq0VKgTHynLSpTKJEVxgn0l1Ns1kRLL7DndctetSLWumKmlSnHJV2olttkjJux98gzcLvTgj5jd73pc2ZtGsGZDiOvQ4L8o5DyE5SylTREnV3EZ8iC5Z7rO1G1aTOkxZEuY8qMo0SHYkF19plRdSW4lJpIy7efIWVUvm3KY1S3pdSRuKo2p2G62hTiHkpIjPBpI+fMsF1McnriL3qB1un1Gm3i7OdW+iO3SnY8amKaPJIy58R8jLVnmfMha2XbVWYY2SJn0mQ2qkRpKZe8b/LL0kSdXcZ88GFyzbkbVrRcgOyUTpSltL3bkQoTxykn1ybOnWRY55xgSp93wJlMt2pUatMtwanOQwhzhVPb/ACR5a6kbasl8R9MdBFtalTI22C86rIhONw5ceEhiUpOEu6U+8ST+h9RpVItqts2ra0dylSkPRrqcmPNmjm2ybizJw/8AhwZc/qFyzoNa2jWxR6y7Spc9w5jJkT+5juOojGZct6tJGlH6mK6z78YVs0gXJdc1hpT61o1NNn+KZLUSUtoTk1KMi6FnIqaSqu2bUbjpZWpPrLVWqD0uLOiG2bSycL4XzUojQSemcHyGpLsOuv7OLIdcg1NqVRJEh2VT4MjhpelZnzZX8xcsF2kfYFyzsFrXnRLndeYpb76ZbKda40uOuO8Sfm0LIjNP1LkNiHINm9uk7d7NbdpN7R1RWFtNyblqROKLVyNCWsqMyPvyRDr4mESAACUAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAMUr8s7/AGiBT/zRfYxPlflnf7RAp/5ovsY1o+iWNf1wx3PctJtiG3IrMk2SdVoZbbbU468rGdKEJI1KPHcQr7Zvy3rkcmNU+W61Iht719iZHXGcQ38+lZEen6in2sO3Iz7HVQGKo5TScX7QVR22lziTj3Sb3nIiM+plzGl2TRK67tFqNSqVDuFymy6IuKlVdkoW48rUR7tRo5NZ7ufeMLt7OgUzafatSqkeDGmyErkr3cd96G62xIV2E26pJJUZ9mD5j1WtpVsUepzqbMlSlVCEpKXo8eG68stSdRKIkkeU46n0LkQ5fTaXdEGZCh2bSr0o7rT7ZORKs+1JpLTZH7xIWpRqwRZxpIjF/TK9LoG1LaFIi21Ua0lT8RClU1KFPIPdGZEaVKL3D7y6BdNm6Ve7YD9Co1Uo1bjtwp05mOh8oxyCe1KwbWCMjQo+mo/h7h7XtCt1NxuUJL8t6qNyiiOMMxHHN2syIyNRkWEp94vePl5DQV2jXGbXgqdpppmTbqbq7sKOZLKG0ayySjLlyIsmZcsmNu2c0qbTr52hTZkN2OzPqTLkZ5acE82TRFlJ9pEeQuPcO/KVTaBJqdfrbb0RNUdgFJTDUylpRKwTai5509DX0MTrZ2gW7clVcptNlSEz0t71LEqK5HU4jtUglkWovqQ521a9YXa8WK9SZJr/AMZKmraUj/8Ad99neGXy455G5XTS58rbJZFTYiPOQIkWciRJSn3GjWgiSSj+p9AuN9AAFlQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAASmf5SRFEpn+UkVq8LU+XsAAUXAAAH4v4FfYU8iWpp5SCQkyLtMxcL+BX2EBTTajypCTPvMhppzEeWepEz4QuPX4afMOPX4afMTNy14aPINy14aPIa7qMMdteVZUHG6hBkQ5bJLjyG1NOJJakmpJlgyyRkZcu4xDtyBTrbpTdNodPZhwmzM0toNR8z6mZmZmZn3mYv8ActeGjyDcteGjyDdRhO2vKHx6/DT5hx6/DT5iZuWvDR5BuWvDR5BuowjbXlD49fhp8w49fhp8xM3LXho8g3LXho8g3UYNteVJPjQqhUadOmQ23ZdOWp2K4alEbSlJNKjIiPB5IzLnkT+PX4afMTNy14aPINy14aPIN1GE7a8ofHr8NPmHHr8NPmJm5a8NHkG5a8NHkG6jCNteUPj1+GnzDj1+GnzEzcteGjyDcteGjyDdRg215Q+PX4afMOPX4afMTNy14aPINy14aPIN1GDbXlD49fhp8w49fhp8xM3LXho8g3LXho8g3UYNteUPj1+GnzDj1+GnzEzcteGjyDcteGjyDdRg215Q+PX4afMOPX4afMTNy14aPINy14aPIN1GDbXlD49fhp8w49fhp8xM3LXho8g3LXho8g3UYNteUPj1+GnzDj1+GnzEzcteGjyDcteGjyDdRg215Q+PX4afMOPX4afMTNy14aPINy14aPIN1GDbXlD49fhp8w49fhp8xM3LXho8g3LXho8g3UYNteUPj1+GnzDj1+GnzEzcteGjyDcteGjyDdRg215VLita1KMsZPIlFPWWMITy+ojyCIn3CIsERnyFoTLWkvw0dO4aVzTEReFKIqmZtKjoMWFQKY3TqPCbjQm1KUlpK1KIjUZmfMzM+ZmYiy6JRplyRq/LpbD1XjJ0MyFrUe7LvJOdJHzPnjI2bcteGjyDcteGjyGe6jDTbXlD49fhp8w49fhp8xM3LXho8g3LXho8g3UYRtryh8evw0+Ycevw0+Ymblrw0eQblrw0eQbqMG2vKHx6/DT5hx6/DT5iZuWvDR5BuWvDR5Buowba8ofHr8NPmHHr8NPmJm5a8NHkG5a8NHkG6jBtryh8evw0+Ycevw0+Ymblrw0eQblrw0eQbqMG2vKHx6/DT5hx6/DT5iZuWvDR5BuWvDR5Buowba8ofHr8NPmHHr8NPmJm5a8NHkG5a8NHkG6jBtryh8evw0+Ycevw0+Ymblrw0eQblrw0eQbqMG2vKHx6/DT5hx6/DT5iZuWvDR5BuWvDR5Buowba8ofHr8NPmHHr8NPmJm5a8NHkG5a8NHkG6jBtryh8evw0+Ycevw0+Ymblrw0eQblrw0eQbqMG2vKHx6/DT5hx6/DT5iZuWvDR5BuWvDR5Buowba8ofHr8NPmHHr8NPmJm5a8NHkG5a8NHkG6jBtryh8evw0+Ycevw0+Ymblrw0eQblrw0eQbqMG2vKHx6/DT5hx6/DT5iZuWvDR5BuWvDR5Buowba8ofHr8NPmHHr8NPmJm5a8NHkG5a8NHkG6jBtryh8evw0+Ycevw0+Ymblrw0eQblrw0eQbqMG2vKC5MU42pBoSRKLHUYWHDZcJZERmXLBiwktNlHcMm0kZF1IhChJJUgiURGWD5GNKZp2zaFKoq3ReWXj1+GnzDj1+GnzEzcteGjyDcteGjyGe6jC+2vKHx6/DT5iBBjQoFSqNQiQ22plRUhcp0lKM3TQWEmZGeCwR9mBd7lrw0eQblrw0eQbqMJ215Q+PX4afMOPX4afMTNy14aPINy14aPIN1GEba8ofHr8NPmHHr8NPmJm5a8NHkG5a8NHkG6jBtryh8evw0+Ycevw0+Ymblrw0eQblrw0eQbqMG2vKHx6/DT5hx6/DT5iZuWvDR5BuWvDR5Buowba8ofHr8NPmHHr8NPmJm5a8NHkG5a8NHkG6jBtryh8evw0+Ycevw0+Ymblrw0eQblrw0eQbqMG2vKHx6/DT5hx6/DT5iZuWvDR5BuWvDR5Buowba8ofHr8NPmHHr8NPmJm5a8NHkG5a8NHkG6jBtryh8evw0+Ycevw0+Ymblrw0eQblrw0eQbqMG2vKHx6/DT5hx6/DT5iZuWvDR5BuWvDR5Buowba8ofHr8NPmHHr8NPmJm5a8NHkG5a8NHkG6jBtryh8evw0+Ycevw0+Ymblrw0eQblrw0eQbqMG2vKHx6/DT5hx6/DT5iZuWvDR5BuWvDR5Buowba8ofHr8NPmHHr8NPmJm5a8NHkG5a8NHkG6jBtryh8evw0+Ycevw0+Ymblrw0eQblrw0eQbqMG2vKHx6/DT5hx6/DT5iZuWvDR5BuWvDR5Buowba8ofHr8NPmHHr8NPmJm5a8NHkG5a8NHkG6jBtryh8evw0+Ycevw0+Ymblrw0eQblrw0eQbqMG2vKHx6/DT5i2guG7FQsyIjPPIvuIu5a8NHkJsdJJZSSSIi7iFNSaZjtDTTiqJ7yyAADFsAAAPxfwK+whiYv4FfYQxelSoAAFlX6XMyHLqJtZpMcqui7ajHivx6vJhMoYjuLw02vSlTmklafqo8EOol1IcXtCp1Cz0XW1KsiuTF1KuTHGHIcUllJSpXum4ZmWlOOij93AiUuolcVJVUqZARNbck1JlUiITZGpLzaSIzUSi5Y94u0Y5l00eHKq0aTM0PUqKU2YndqPdMmRmSuRc+ST5Fk+Q5HTber1iNWFU5VHmVRqmszWpsalp3zsXfrJSEpRnK0p+Hl3CXOiVqs1LaXPVb9ShtVG3UsQm3m8uPKJDpacJyRLyZe7kz5kIuWb3H2lWnIhVSYxVDch0xtL0p8ozuhCVciMlacK59STnHaP2k7SrRq9bbpNPrLbk108NJU04hDx4zhC1JJKzx3GY1m5aNPX/DcVHiU6QdQKjsNFCbaPeEsiTlOnrnrkhYbRKRJfbsBunQHXEQaxHccSy1kmGybURmePhSR4Ei5XdkOmyrqfrFWi+z6OpreIajOEuKlSCPCz56zPOS0lyI8DxSdpVo1etN0mn1ltya6eGkm04hDx4zhC1JJKzx3GY0O9aFVpNO2vojUyY6qoHG4MkNGZyMNII9HzYMjLl3DZtolIkvs2A3ToDrqINYjOOJZayTDZNqIzPHwpI8ZEC9rl/wBsUKtN0mqVVtmevBm2ltbhN56bxSSMkZ/4jIW1v1unXDTuPo0lMqIbi2idSkyI1IUaVEWfqR8xzWkT5tj1u7Isq26tXU1WpOzGZlMYTIStKyIiafPP4enp73LHMT/4ckLTsrhmuKmJqmS1Ewg8pbI318kn2kXeJuWbLdV+21aspEat1E2pS0ksmGWHH3CSecKNLaTMi5HzMTDuygFbRXAdXiexTIsS9fuGecae/VnljrnkOebTYSo13qqkWnXtDlrjttlU7b0vpfIjMybdZ7k95lg8ilq9uXnXtnVJdqkabxlOrByyYhpaiTXovMicwnLaXuerH/mIuWdVtW+bdut5xmh1EnpDZalMOsrYc0/MSFkRmX1IU7212xmVpS5XUl+IptSuHdNLSkq0nrUScI5l1VjPUajYlEKo3vSqobO0hz2cTplIuR9DbTZqTjSSDTqWR57OWSITLYoM6NsJuenu0x9upSvaaijKZMnHTUtzd+71PJacfoF5TZvdzXvbtssxXazUkNFKTrYQ02t5bqeXvJSgjMy5lzxgZYV4W9Nt12ux6vEOksmZOyVK0k2ZdUqI+ZK+hlkcvuOjuMUa0Jj9Hu+PUIdKbY9pW8olSGTwWphxk+ZpzzyMkB2/kbO6483CflSFzG1wVTqcyicpgzTvHFsF7qnC56dXM8cwuizerd2k2ncNXTTKXVTVOXndtPxnWDdx10GtJEr9MjXaVtXgVtd5xoklqA7RiWqPJkRH1t7tKC1OOJwXRRmWgjyZFyGmIZuCsXzZk84d8TIUKoGp9+tRW2EM6kGWSaQWr/5j5ELyrRaq2W1mjnRaq45VkOS4MhuOa2Hi3KUaCWX9eS5J6hdNnQKxfFAtylU6RcFWZbcmMk40TLK1rf5FlSGkka8c+7kM0e+Lck2xLuGPVGnaTEIzkPJSo1NY6kpGNRHz6YyNFJqp2lddOuR+gVOrQXqGxBUUBknZEJxHMy3ZmR4Vq547uYpq9Qq3W6FtMr7NDmwE1uAzHh0xaP8AaXlNlzdW2nOFHnGOuC5hdFnRqVtLtCq1lqlQK025MePDJG04hDp4zhCzSSVH9CMxt6jwkz6YIc32h0eU/RrCYp1PdcKFVobjiGWs7htKFEpRkXwkR4yOkPcycxzyRiRpNPv6jQbWo9RuKvQllUVrbalsxnGmnVJyZkSVZNPIu3qfTqLS073t27XJDVBqJSH2CJTrK2lsuJI+itCyI8fXGBy+3LcqZUPZOxMpMouBqT7sttxg/wABOhelSyMvdLOMGf0G7HTpn/TqVS4R7gToO5OVoPdm5vjPRq6asdncIuLDaleLNjWbOrDiN5IQk0xmjQtSVu45Eo0kekuR8zwX1FHb20inwrPgVS8K9CdfnGpbJQqe+2o0lyMiZMjcPB8tWMC52wQ5VR2X3NDp8d6TLfhqQ2yyk1LWeS5ERdTHPL3tuqxbzi190ruOmvUliKpdtOEUlhxHVK0GRmpJ5zy6HnISmHWqXdFDqtDerEGpxnKYySjefUrQTOCyesjwacF2GKy3totqXDUyp9KqyXJajMm0OMuNE7jw1LSRL7/dMxzT/Ak2rbPLt9kR7nbn1Rxh5Pt+UjiZe6Mj6ERbszItJas9C7BHpNAVWqvSIz8baq6uHKafWVWlNtxY6kf1Es0++RdMJ6kYXks6FaO0in3HfVettpKkO09ZJYVuXS3pEkt4ajNJJThR4Is8y5lkb6Oe2sc2m7Vrwjy6ZUijVVbMmNOSzmMaUNEk0mvPJWehDoQmESp5X5hz+4xcI56S+wp5X5hz+4xct9UfoNtTxDHS8y0mn3zSoVpIrFwV2E6yuS6wh+NGcbJxSVGWhLR5WpREWDx1xkhbWzeNv3PFkyKLUmn0RuchK0qaWyWM5WhZEpJY7TIcmjW6+jZpSkVW37iVLiVSXIQ/SVk1Ng6nFaXEIVzWSiPoXYMtGpN3XNQbvpu9q5UydTjYiSq9DbizTf5+4Zp95SMctSu/kMLt7N/p+1Gy6hVW6fErrCpDqybaUptaGnVH/Shw0khR/QjGe4No1qW/U5dOq1V3M+KlCnI6WHHF4WWSMiSkzVy7s47Rz245NWuvZ+xZMOyKzTqkaWGVvyGEIiQ9CkmbqHc4V8J40lnmNutCjSYe1276jJivE05CgMMTFoMku6W8LJKu3n1C8llnVrwp79ntV2hVuA3DdkNMplvMLeRlThJNBoThRKPOOfQ+oyXTtBte15vB1mp7uWREpTDDDkhaCPoaktpUac/XA5rLt+rns+uOK3SpnEPXUUlplLJ6ltcQlW8Iu1OCM8ixvCoXQxfFVacj3RHpqzb4FVuU9lwpBafeN55WTSrPIiPkRBcs3qXf9sxbaj19VSN6kvr3bb8Zhx7Ku40oSaiMsc8lyFdStqVqV6VJp9Fqq/aSIrkkkSIL7ZJSlOTWZKSWSLrjt7BzW2KreNjbNnotPtatO1iZV5OTcjKkLitqMj3qyRgnDPPLGCMyMX9lOQkwqxFat+8nbgqEN85FYrVMU2byt2eEEozPQWeSUFyC5Zuyb4o9Ks2k1m4azFWiY0lSH48dxPEqPtbZwa8fTBmQh2nfKblv+qU2myI0misUxiW04hBpc3i1qJRKzzLBEXIyIyGl0alVi2mrBuWRQ6hUWKdRVU+VBjtapURxRke8S2ZkZn/SZFzIhf2K1UJm165a7IoM2kwZ1LjJZVJa0KdUlR5NeMkS8f05MyLGQuWdQAAFlQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAGKV+Wd/tECn/mi+xifK/LO/2iBT/wA0X2Ma0fRLGv64Y7iuWj24cP25ObhlMcU0ypwj0qUSTUZGZFguRdoiWze1v3TxaaFUkvvRkmbjTjS2lpL5tCyIzT9SLA1DbQs27g2duJp51I26wtZRSxlzDKj5Z5ZLqRH2kP2EVQu/aPAuNmh1OjU+lwJMVxypM7l+WtwuSCRkzNCeuT5Z6DC7ey6gX9R4Nr0qo3DXIjnHm8lqSxFdbbeNBqySUHlRGRFjB9TLl1Eym3VGq1wUlunVJngZ0B2U3FehutvuklZJ3hKVgkpLoaVFk85Ic5tq3aoinbKES6TLSdPqEt2Ulxk/9nIzcNCl/LnJYM+8huF0UefUdqUJ1hp5EVdAmRTmEk9Dbi1J0kauw+3H0ARL22t0CnUOvJoNWiyK3BjrWylbS1MqcT/RrwSVH/wkrI2SsXvRLdpFNlXHUG4z0xlDiGm21OOLM0kZmltBGoyLPcOVVU6w3sZmWGVkVhdWiQdwbjUdKoizSf8ANbcI/eUfUkkWrJjZH2Klad7RroeodSrFPk0WPANMBonZEJxHMyJvJHpVnmZdpBdNm5MX7bMi3nK5HqqHaW04TTzyG1mbCjxycTjUjqWdRFjtFi9cNLRWWKSmWldRkR1SW2mkm4RNEXxqNJYSnuMzLPYOawFVRuVed1KtKfu60hmHDozrRbySZEZG68ksk2k9XM1cyIjyMuzC2alYFUk0qoQjnoqscnU1WO2pSY60Jxwq85NLac+4fTqQXRZskG/6NAtilVG469CUU9x1tqUzHcaadUhSskSVZNJkScc+ply6iztO97du1yS1QaiUh+Ng3WXGlsuJI+itCyI9P1xgc0tm3Kj7M2WtTqTKLgKjMekodZP8AjN00KWR9MmZYM+8hs9doc6ftYmPx47jUeTbbsMpu7PQTpuFhJq78c8dwC1TtPs1VX9mprjJyNe73m7c3GvONO+06M55Y1dRuZD5lp1rTmLcatmrQtqTsxLXDuQ4cpr2a4RH/S6ZaUoPrg+ZfcfSFJilCpcKIRuGTDDbWXV61e6ki95XafLmfaESS0+e9tBmVCa9TU0Kj0yM4pLTdQbU+7KQks7wzQoibI+ZEXM+0xTVTaNOkbN6BWaZ7PptTq8tEUlTvejs4WonHOpZQRJNRHnoKq6bwqlYrs2l1K2rxj20w5uzTTaUtxyoER89TmS0Nn3JLJl2kNjq8piXQbeqMawn59LiuKJUGTESiZBSSTSlTbCuR9MYznBglL2cVasVp2TJmXRbFdp6EaCKjsqSpDmSwajNauWM8sdw2m4K1T7epD9TrMgo0FnG8dNJq05PBciIz6mNBtaI/Wdo0W5Kbb823qRHpzkV5EyMmK5LcUsjT+GR5wnBnk+/kLXbfT5dV2ZVaHToj0yS4pnSyyg1qUROJM8EX0yH2R90pnaZZz0ubGTXGEuxEmtzeIWhKiLqbZmWHP8A5cixte8aBdEKTKolRQ+1GPD5OIUytnln30rIjSWCzkyGv3pR3ZO0PZ+/Gp6nYUB2RvHENakRy3RknJ/088YFFdFs1Kr17aWyy2cRupUmMzHlvFoZcWRLynX07iPuyJGyN7WLJcN/RXWzJlSUmrcOElw1K0lu1acL5n/TnA3jHPA+etp9xyKjs7pdFXZdYp70eXBaU9IjpTGYUTiSLcuEf4mehaew+Y+g5SDdZebSs0KWhSSUX9JmWMhEkw0K6NqNuU5isxIFXjrrMOO6tCVNLUzvUpMyQbmNBqz/AE6siW3f1JpdnUCq3TPZiyqlCakbppta1rUpCVK0NpJStJGf6DnsZNYpOymo2A9ZtUl1RqG+0UltklQ5Oo1GT28z8R5zpxqyJVXduikUiymGYVdjUxqitNyn6NTm5M5EgkILdKJfNCepngupYMRdNnQ6ZetEuG3qnUbeqrKyhtqN1brKyOOoiMyNxoyJeOWcY59gp4V6yCuCjx5MmLJpT9vqqz8piMtJuKSaPeQkzNRJMlGenBn0GkWTSq6c7aO/PplfT7SprfCuVVKVPyDJCyx7haSPn8HUuQ2Gx6NUY9z2Y5Lp8lthi1CivqcaMktu5a/DV3K5Hy+hgh0CTclIjW2ivuzUeyHG0OokJI1EtK8acERZMzyXLGRbJPUkjLODLPMsDi1MpEte0FqxFJ127RJPtwlZyRNr5sx1F/wualF9EkO1CYAAASgAAAAAAAAAAAAAAAAAAAAEpn+UkRRKZ/lJFavC1Pl7AAFFwAAB+OfAr7Ch45zuR5C+X8CvsIOhPyp8hrpzEeYZakTPiVfx7ncjyDj3O5HkLDQn5U+QaE/KnyGm+nDPZVlX8e53I8g493uR5Cw0J+VPkGhPyp8g304NlWVfx7vcjyDj3e5HkLDQn5U+QaE/KnyDfTg2VZV/Hu9yPIOPd7keQsNCflT5BoT8qfIN9ODZVlX8e73I8g493uR5Cw0J+VPkGhPyp8g304NlWXPa3YVsVqqvVGbTVJlvq1PnHlOsJfPplxKFESuRY5kNqp5tU2CxCp8aPGiMIJDTLSNKUJLoRELjQn5U+QaE/KnyDdTg2V/7lfx7vcjyDj3O5HkLDQn5U+QaE/KnyDfTg2VZV/Hu9yPIOPd7keQsNCflT5BoT8qfIN9ODZVlX8e73I8g493uR5Cw0J+VPkGhPyp8g304NlWVfx7vcjyDj3e5HkLDQn5U+QaE/KnyDfTg2VZV/Hu9yPIOPd7keQsNCflT5BoT8qfIN9ODZVlX8e73I8g49zuR5Cw0J+VPkGhPyp8g304NlWVfx7vcjyDj3e5HkLDQn5U+QaE/KnyDfTg2VZV/Hu9yPIOPd7keQsNCflT5BoT8qfIN9ODZVlX8e73I8g493uR5Cw0J+VPkGhPyp8g304NlWVfx7vcjyDj3O5HkLDQn5U+QaE/KnyDfTg2VZU61GtalH1M88hIKc4RYwjyGGTyfcx8xi2JCdJe6np3DSuYiIvDOimZmbSr+Pd7keQce73I8hYaE/KnyDQn5U+Qz304abKsq/j3e5HkHHu9yPIWGhPyp8g0J+VPkG+nBsqyr+Pd7keQce73I8hYaE/KnyDQn5U+Qb6cGyrKv493uR5Bx7v8AweQsNCflT5BoT8qfIN9ODZVlX8e73I8g493uR5Cw0J+VPkGhPyp8g304NlWVfx7ncjyDj3O5HkLDQn5U+QaE/KnyDfTg2VZV/HudyPIOPc7keQsNCflT5BoT8qfIN9ODZVlX8e53I8g49zuR5Cw0J+VPkGhPyp8g304NlWVfx7ncjyDj3O5HkLDQn5U+QaE/KnyDfTg2VZV/HudyPIOPc7keQsNCflT5BoT8qfIN9ODZVlX8e53I8g49zuR5Cw0J+VPkGhPyp8g304NlWVfx7ncjyDj3O5HkLDQn5U+QaE/KnyDfTg2VZV/HudyPIOPc7keQsNCflT5BoT8qfIN9ODZVlX8e53I8g49zuR5Cw0J+VPkGhPyp8g304NlWVfx7ncjyDj3O5HkLDQn5U+QaE/KnyDfTg2VZV/HudyPIOPc7keQsNCflT5BoT8qfIN9ODZVlX8e53I8g49zuR5Cw0J+VPkGhPyp8g304NlWVfx7ncjyDj3O5HkLDQn5U+QaE/KnyDfTg2VZVrkxxaFIMkYMsciGJpw2lktOM9OYs5KUlHcMkpI9PcIMAiOSRGRGWD6jSmYmmZiGdVMxVETKvqkKJVZ1LmTmEuSKY8ciKolKTu1mk0meCPnyM+Riy493uR5Cw0J+VPkGhPyp8hnupw02V/wC5X8e73I8g493uR5Cw0J+VPkGhPyp8g304NlWVfx7vcjyDj3e5HkLDQn5U+QaE/KnyDfTg2VZV/Hu9yPIOPd7keQsNCflT5BoT8qfIN9ODZVlX8e73I8g493uR5Cw0J+VPkGhPyp8g304NlWVfx7vcjyDj3O5HkLDQn5U+QaE/KnyDfTg2VZV/Hu/8HkHHu9yPIWGhPyp8g0J+VPkG+nBsqyr+Pd7keQce73I8hYaE/KnyDQn5U+Qb6cGyrKv493uR5DDNcRPhvRJrDEiK+g23WnE6krSfUjLtIW2hPyp8g0J+VPkG+nBsqy55Rdn9rUapNToVLM3mVa2UvyXXm2T7DQhajSky7MFyG58e53I8hYaE/KnyDQn5U+QbqcGyv/cr+Pd7keQce73I8hYaE/KnyDQn5U+Qb6cGyrKv493uR5Dy5MW42tCyQaVEaTxkuR/qLLQn5U+QaE/KnyDfTg2VZanalDpdqRXmKHEJknl63XHHFuuOH2alrM1Hjs58hece53I8hYaE/KnyDQn5U+QbqcGyv/cr+Pc7keQce53I8hYaE/KnyDQn5U+Qb6cGyrKv49zuR5Bx7ncjyFhoT8qfINCflT5BvpwbKsq/j3O5HkHHudyPIWGhPyp8g0J+VPkG+nBsqyr+Pc7keQce53I8hYaE/KnyDQn5U+Qb6cGyrKv49zuR5Bx7ncjyFhoT8qfINCflT5BvpwbKsq/j3O5HkHHudyPIWGhPyp8g0J+VPkG+nBsqyr+Pc7keQce53I8hYaE/KnyDQn5U+Qb6cGyrKv49zuR5C4gOG7EbWrGTz0+4j6E/KnyExgiJpJEREX0FNSqJjtC+nTVE95ewABi2AAAH4v4FfYQxMX8CvsIYvSpUAACyoKuo3DRaZMah1KsU2JLd/lsPyUNrX9kmeTFoOBUWbZdCO4YG0imtruWTUJC1nKp633JralHu9yvSeS0GkiIjLAiUu5TqlAp5IOfNixSWSlJN51KCUSSyoyyfPBczEOVc1BiU1ioSq5S2IEjmzJcloS25/aozwf6DilOoszg9kNNuiK44ZzZZnGllrUhnQtTTbmeuE6SMj7hO2l1SlUm+UU+TT7bo0VqC2mPPqdLclk/lR/hMoSWhJJ7e08kIuWdlTWqWqlpqaanCOmqxiWT6TaPJ4L3845mZF+o8Qa9R6hPehQKtT5U1nm5HZkoW4j7pI8kPmiGgpWyLaVD9/cuVqMpBJhnDLQtxn3kM/wBBH1LzHUbzt2j0K5NnTlEpUOC6mpkybkZgm1Gg2V5JRkWTLkXULlnSJlbpMGoR4M2qQI06R/JjvSEIcc/tSZ5MZE1WnKpqqgmfEOnpyZySeTuiweD97OOR8hxSHMtOg1G6Yu0inku4pdQfdZW/CW+5LYP+UUdZJPBEnBERGWDGoxYdRkbHNncll1Uagx5cpye65B44mcrVuluMnyWkjzkz6GZGFyz6XpFYplajnIo9RhVBgj0m5FfS6kj7spMxWQrnjvVatR5O6iQac+1EKW86SEvPLSSjQWeXLUkuvM8kORbO3qZT7gnXLBulqrw4VNeVKKm28UCMpKeZEtaeSlkZHgsGfMxa3zSFx9i8Fqe0Spc+pxZcwiyeXHZCVKLvxzwFyzq7Veo71PkT2qtT1wY6jQ9JTJQbbai6kpWcEZdxjLSKtTqzF4mj1CJPjZ072K8l1Oe7KTMhyHbbQVQl2uunlHpFrxXXVzltUxMphlw0locdjlglFyUWo84yKuwKaqfUa5OtK7GqnJcpL0dBwKCVOiG6ZHu1KWR6VLSrOOWcZ5hcs6hel90u3qBXJcOVT6hUqUxvnKeiWknOpFhRFk09e4bXGc30dl3GN4hK8d2SzgfMVzybNVsRm0aLR1ovCJDRxbPBKTLZeJRbxx13TzSfM8mo9RGPpqn/AJCJ/wBij/lIIkl5iz4cspBxZcd8ozimnzbcJW6WnqlWOhl2kYjqrlJTFYlKqkEoz5KUy8chJIcJJZM0qzg8FzPA5HatyU60alf9FrnFM1adWJUyHFRGcWqU04ktKmzIsHn78u0U1GgszrX2KRZsYnY7kt0nWXEZSZbpR4UXdki5GFyztLNwNS6vT2qc/TJVMlRnJBSW5qTWrSZEWhBfGjmeVEfLl3jIm6reVIjR016km/KLLDZTG9Tpf8JZ5/oNOrUVmJtgt1mJHbYjt0GclDbTZIQgtSOREXIhoUK0qGj+GGVO9jxFVFUFyVxJsEbxOEvJKJeNRYwWMGFyzvdWqtOo8U5NXnxIEbON7KeS0nPdlRkQywpcafFblQZLMmM4WUOsrJaFF9DLkY+f9pEeSm6qBU65VmqXRPYrbbE6ZSCqTDb3I1pUlXJtSvd97HPGBuGwuC0y7XptPrq6tT5SmjSbVH9nRdZFzWynOFZLBGZERZILlnVwABZAAAAAAAAAAAAAAp5X5hz+4xcJ6F9iFPK/MOf3GLlrqj9BrqeIY6XmVIq5qO6S2oFWpUmabC32WCmII3CSR5PkZmSclg1Y5cxp917T0UGHbrCGaPIrtZTqTHVVUNxmixnUbxlzSfRJ494xrmxujwG9i1TqJQI5VJxNSSqSbJb0yI3CItRlnGCIsdBDpdLhSj2HnKgR3jXGeS4brCVZJLKTSR5LsPmWehjC7os67IuqiU5caNXKzSKfUnUJUcV2a2SiM+xOTIzLPQ8cxZSqjBiONIlzYzC3UqW2l11KTWlJZUZZPmRF1MfNNxVumzSuWK7CoFIqa3JKTpaqC7NqDp8yJes+WVcjIy5ER5GwWtAj1uJsWZqzHFNJgyjcbeI1EpSUJLCyPqX0PuC5Z2n/ABPQPZXtP25SvZurRxfFt7rV3a84z9BMdqcBqPHfdnRUMSTJLLinUkl0zLJEk84MzIj6Dlto2rQXdsN8xnqLAXDaahqajrjpNlClt++pKMaSM8czIsjR3WoiNkFrMT4rz9OaulaFRmkmpRtE477iU9TLHYXZyC5Z9D0qs0urqeKlVKFONlWh3hn0u7s+49JngxEoVZOZRHKhUlU6MhtxxK1x5iXmUpSoyIzc5ER95dh8hzOjv29XNqtty9nENtuPBbkJq0qJDVHZ3ZkRIaVlKSUvUWcYyQ1NqI65s5tuRMiPyrdiXLKeq0dtpS8s71eFKQXNSSVgzC5Z3puv0+fRZtQoVQptRbjtrUS25aDa1JIzwtwskku8+wuY8sXDAbpsJ+rT6ZCffjcSaOMQpGkiLUpCzxqQWfi6DlvHWdVTuqZYlLfU2qgyG5VQhtGxCySFaWzbMiJTn1JPIupiJSqPBrF17KY9VhNS4zdvPO7p5vUjUSUYyR8j69DC5Z2ql1On1eKUqkzos6MZ4J2M8lxGfukzITBzGwIEal7Xr+iU2K1DhbiE4TLKCQ2SjQeTJJcsn9B04SgAAEoAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAABilflnf7RAp/5ovsYnyvyzv8AaIFP/NF9jGtH0Sxr+uEqfUYNP3ftCZGi7zJI37qUasFk8ZPngiz9hFVcVERSEVVdZpqaWv4ZhyUEyr7Lzg/MaFtmgsVG5Nm8WYwmRFcrZk62tOUqTuj5KLtL6do1bbBSvZ98UiQ/KiUO12aetph9dGTPiMPasqJTXwtmZdF4+gwu3s7lBnRKhETLgSo8qKsspeZcJaDL+4jwIEG56BPqCoMCuUuTOT8UdmW2twv/AJSPI4zabLMC0L4q9LlKuyDIjII4jFHOnRHlFkjNskn73L4tJF07Rp1Uq1OmTbYepcm33lRapGU63RaE5HKMWoiw5IVzIuzHU+0Lps+mqncVEpUxmJVKxTYUt7m2zIkobWv7JM8mM1VrFMpENMurVGFBiKMiJ6S+ltBmfTClGRDgm0dFEpV711461Tos6a5qdp1x0JUluQegkkbDySNRIPphPaMlzcDItazqvXj/AMHzY8NxlhuVSlTqehGrBJUhZGaFGREac8yI8Bcs7uVYph0v2kmowjp2M8UT6Tax/fnAyyp8OIcYpUuOwclwmmCccJO9WfRKc/EZ9xD5/hqmVrZHfcWnUWnrjkpDzE2jRHWGagfI1KQ0vnqIklnSWD7BcXdd9Guyo7OE2+89NRFuCMch0o60IZVpMtCjURe9k+hdwXRZ15y4KM1MREdq9PRKce4dDKpKCWp3l7hJzk1cy5deYxO3Rb7NTKmvV2lN1EzxwqpbZO57tOcjn+zykwF3ZtGqr9Mal1BmrK3KltkpwsMpMibM/hMz7SHG7rq1NqNjVKNDj0CBUd2pa6NCoLrs6OrVkycfV8J96+zsC6bPqypVqlUtS01OpwYakN75RSH0t4RnGo8n0yZFkZqbUYVUhomUyZGmRF50vx3UuIPHXCiPA5PGpdOuLahartWhMTmm7XJ9CX0E4jWakFkyPkZ8z6iik0mYhvbXR7VirYInIqmIkRO7L3msuE2RYIjURH0C6LO206vUepy3otNq1PlymP5rLElDi0fdJHkh+TrhosCoNQJ9Yp0ac7/LjvSUIcX9kmeTHJqFUdnk+q2pHtShyF12E4kiTAiqiuQi0YUclRknKewyMzyOfFDbhSq1Cu65YNJrEibINcada6Zz0klKPSpp8+ayNOCLGMdAumz6tAa5s5iOwLFosaRMlzVtxyIn5bBsPKTkzTrbMzNJknBYM88hsYlAAAJQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAJTP8pIiiUz/ACkitXhany9gACi4AAA/F/Ar7CGJi/gV9hDF6VKgAAWVA7unLoAAHXqHXqRH9wAAPn1IvIAABpFSsBUqpSpEK7LnpsaUs3H4caWRtmZ/FpNaTUgj7kmRF2YG00KlQqFSItLpTJMQorZNtNkecF9TPqf1E4BCTsxgsd2AABKAOzBci7iAADvzjn15dQAAAMF3F5AAAHLuLAAAdmOzuD/QAAAAAAAAAAAAAAAAAABTyvzDn9xi3T8JfYVEr8w5/cYt0/CX2Gup4hjpeZfv6EHLuIAGTY7c8s94YLuLyAAAU1yW9Gr50s5LrzXs+aic3use8tBGREeS6c+wXICB+mfXszz5D8Ll05AAkOzGCx3B+hAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAxSvyzv8AaIFP/NF9jE+V+Wd/tECn/mi+xjWj6JY1/XC0Dsx2AAybH27A5YMsFg/oAAHXqRHjvID59ef3AADPoH6F5AAAHaZ4LJ9eQAAYLuIPsAAHf9eod2cHjoAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAJTP8pIiiUz/KSK1eFqfL2AAKLgAADHIUaY7ii6kkzFHxr3en9ou5f5V7+w/9BrY6dCImJu5teqYmLJPGvd6f2hxr3en9ojANtlOGG+rKTxr3en9oca93p/aIwBspwb6spPGvd6f2hxr3en9ojAGynBvqyk8a93p/aHGvd6f2iMAbKcG+rKTxr3en9oca93p/aIwBspwb6spPGvd6f2hxr3en9ojAGynBvqyk8a93p/aHGvd6f2iMAbKcG+rKTxr3en9oca93p/aIwBspwb6spPGvd6f2hxr3en9ojAGynBvqyk8a93p/aHGvd6f2iMAbKcG+rKTxr3en9oca93p/aIwBspwb6spPGvd6f2hxr3en9ojAGynBvqyk8a93p/aHGvd6f2iMAbKcG+rKTxr3en9oca93p/aIwBspwb6spPGvd6f2hxr3en9ojAGynBvqyk8a93p/aHGvd6f2iMAbKcG+rL9Wo1qNSup8zGcpjxF1T5COAmYifKIqmPCTxr3en9oca93p/aIwCNlOE76spPGvd6f2hxr3en9ojAGynBvqyk8a93p/aHGvd6f2iMAbKcG+rKTxr3en9oca93p/aIwBspwb6spPGvd6f2hxr3en9ojAGynBvqyk8a93p/aHGvd6f2iMAbKcG+rKTxr3en9oca93p/aIwBspwb6spPGvd6f2hxr3en9ojAGynBvqyk8a93p/aHGvd6f2iMAbKcG+rKTxr3en9oca93p/aIwBspwb6spPGvd6f2hxr3en9ojAGynBvqyk8a93p/aHGvd6f2iMAbKcG+rKTxr3en9oca93p/aIwBspwb6spPGvd6f2hxr3en9ojAGynBvqyk8a93p/aHGvd6f2iMAbKcG+rKTxr3en9oca93p/aIwBspwb6spPGvd6f2hxr3en9ojAGynBvqyk8a93p/aHGvd6f2iMAbKcG+rLOuW6tBpUacGWD5D9p/5ovsYjiRT/AM0X2MKoiKZsmmZmqLrQAAcrqAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAASmf5SRFEpn+UkVq8LU+XsAAUXAAAGKX+Ve/sP8A0GtjZJf5V7+w/wDQa2Orp/EuXqPMAAA3c4NZrV502kXZSbektyVzqiRqbU2kjbbLnjWZnksmRkWCMbMOGXElypV26LobLUmmVanwYxpLolpxO9PPbzcUR/YVqm3haiL+XXbqr8K2KK/U6lvDZbwSW2k6nHVH0Sgu0zEqiT01ekQqgyw+y3KZS8lp5OHEEoskSiLODHINorku5tMtLi24kuYijUhkj/mEtWJEnH9hLSk+wsn2j9vR6HcFcqdNTFhuRKIlEVSKrXVwY5LJJK1E0376uRl7xn2Cs12W2dnZ31m0y4vduOGhJq0ILKlYLoRd4xUyQudAjyVRZMVTqCWbEhJJcbz/AEqIjPB/qOG0CoTZOxZ1gnjV7Zq/s6Cht9bhNMqdJCktrV75pJKVmRnzwL+RGo1y3jcNPvGp7im0Ymo8WmLmnGQpG7JRvqwpJryfIufLAnejZZ1zB5xg8gZGXUhwZEuTJ2fVWlUabKdplVraKbRX31m4s2DNJuGk1czQWlzBn2EOwW9bkCgHJXDJ5cmUaVSZD7ynFuqIsEZ5PBfYsEJiq6JpsuAABZUAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAASKf+aL7GI4kU/wDNF9jFavplaj6oWgAA5XWAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAlM/ykiKJTP8pIrV4Wp8vYAAouAAAMUr8s7/Yf+g1vGOo2hfwK+wrlx2nFmpacqPtyN9Kvbe7DWomq1lQAteEY+T1MOEY+T1Ma8sMeGpVCAijUxEF+EinxUw31qcdZJsiQ4pR5NRl2mZ88jZOEY+T1MOEY+T1MOWk4qmvOUuA4cI1wo6uCPMXLZfgHjGUd3LlyESoWzQajUW59QotOlTkfC+9HStZfqZDbOEY+T1MOEY+T1MOSnBxVZc1TZj6rngyXJFPYoFNeXKg02HF3Zk8pJka3FZwfNSj5EXUbBWLcolafZerFHp855n+W5IYStSfsZkNq4Rj5PUw4Rj5PUxHJSnjqUDtPhOqiG7EjqOIrXHy2X4KsGWU9x4My5d4lC14Rj5PUw4Rj5PUxPLSjiqVQC14Rj5PUw4Rj5PUw5YOGpVALXhGPk9TDhGPk9TDlg4alUAteEY+T1MOEY+T1MOWDhqVQC14Rj5PUw4Rj5PUw5YOGpVALXhGPk9TDhGPk9TDlg4alUAteEY+T1MOEY+T1MOWDhqVQC14Rj5PUw4Rj5PUw5YOGpVALXhGPk9TDhGPk9TDlg4alUAteEY+T1MOEY+T1MOWDhqVQC14Rj5PUw4Rj5PUw5YOGpVALXhGPk9TDhGPk9TDlg4alUA9vpJLy0p5ER4IWRRWcF7nZ3mLVVxSrTRNXaFUAteEY+T1MOEY+T1MV5YW4alUAteEY+T1MOEY+T1MOWDhqVQC14Rj5PUw4Rj5PUw5YOGpVALXhGPk9TDhGPk9TDlg4alUAteEY+T1MOEY+T1MOWDhqVQC14Rj5PUw4Rj5PUw5YOGpVALXhGPk9TDhGPk9TDlg4alUAteEY+T1MOEY+T1MOWDhqVQC14Rj5PUw4Rj5PUw5YOGpVALXhGPk9TDhGPk9TDlg4alUAteEY+T1MOEY+T1MOWDhqVQC14Rj5PUw4Rj5PUw5YOGpVALXhGPk9TDhGPk9TDlg4alUAteEY+T1MOEY+T1MOWDhqVQC14Rj5PUw4Rj5PUw5YOGpVALXhGPk9TDhGPk9TDlg4alUAteEY+T1MOEY+T1MOWDhqVQC14Rj5PUw4Rj5PUw5YOGpVDLHdJl0lmRngjLAmSIzSGFqSjBkWS5mIkNCXHySsslgxbdFUTKu2aaohJ49Phq8w49Phq8xm4Rj5PUw4Rj5PUxlejDa2plh49Phq8w49Phq8xm4Rj5PUw4Rj5PUwvRgtqZYePT4avMOPT4avMZuEY+T1MOEY+T1ML0YLamWHj0+GrzDj0+GrzGbhGPk9TDhGPk9TC9GC2plh49Phq8w49Phq8xm4Rj5PUw4Rj5PUwvRgtqZYePT4avMOPT4avMZuEY+T1MOEY+T1ML0YLamWHj0+GrzDj0+GrzGbhGPk9TDhGPk9TC9GC2plh49Phq8w49Phq8xm4Rj5PUw4Rj5PUwvRgtqZYePT4avMOPT4avMZuEY+T1MOEY+T1ML0YLamWHj0+GrzDj0+GrzGbhGPk9TDhGPk9TC9GC2plh49Phq8w49Phq8xm4Rj5PUw4Rj5PUwvRgtqZYePT4avMOPT4avMZuEY+T1MOEY+T1ML0YLamWHj0+GrzDj0+GrzGbhGPk9TDhGPk9TC9GC2plh49Phq8w49Phq8xm4Rj5PUw4Rj5PUwvRgtqZYePT4avMOPT4avMZuEY+T1MOEY+T1ML0YLamWHj0+GrzDj0+GrzGbhGPk9TDhGPk9TC9GC2plh49Phq8w49Phq8xm4Rj5PUw4Rj5PUwvRgtqZYePT4avMOPT4avMZuEY+T1MOEY+T1ML0YLamWHj0+GrzDj0+GrzGbhGPk9TDhGPk9TC9GC2plh49Phq8w49Phq8xm4Rj5PUw4Rj5PUwvRgtqZYePT4avMWkJwnYyFkWM55fqIPCMfJ6mJ8VCUMJSgsJLP+opqTTbsvpxVf8TKAAMWwAAA/F/Ar7CGJi/gV9hDF6VKgAAWVB+6TxnB4+w/CHzlcEOfEnVqv1F5yuxo8h1xNVo9ycO/CbSrk3w6j3eUFkjLnkRMph3QrjgHeJ2z+N7TKEVQ+D8PdGs0fFnrkumBNq0/2aw06qJNk7x1DWiKybik6jxqMi6JLqZ9hDg91Vmvy9o7dVsWOciTJtBp/MjCH0sm8pRmhBlg3cdCPlk/0F/W3qajZdbMy2J0x2NLrMFxch2QtTzilPJ1k4ec5zkjT07MCLlnZtKuwjMfg49TrTj3dtCv1FbqNXVBjTGUMxI85xhtCjYQZqwky5/Tp9BsmxCbNmWE2VRmPzXY0uTFS++epxSG3VJTqPtPBFzE3G4rnkmsM0/hJilOtKe4hLJmwnSZFpUvoSjzyLtwY80SrQq5Tm59Le38RxS0IcJJkSjSo0njP1IxpFyMlUNr1Mpcl2QUGVQJiHWmnlN5ytsskaTLCsGeDLmQ5dbyk27sVo7lDnSYTdVraYdVmokqWqMxvlpM05Myb5ERGZY65EXLPpOU4UaO686SiQ2g1qwXPBFkxAtqsxbjoEKsU0neDltk63vUaVY+pdg57Eo1BtW4HYVCuiaop1OfUqjvSFzEPGlP8/WozNsyLl1wY0Jm3E07YBCvCHVau1X4EJEmK6mYsmmiJZfhk0R6DTjJHksn3hcs+hUzyVWFU7hJhGlknuJNk9weTMtBL6a+WdPcZCbpVjofkOVVaZIVtDrpb90kf4QJ4kEsySSzU57xF0I/r1GjvUFVJ2KUG849YrZ3EhmE6mQue4aNK3EJNs286TThRlzLP1C5Z9GkRn0IzH4ZYLKuRdcmOSz47F27UazSbpqUyHBpsWM9TojExUUntaTNb+pJkajJXu4zyx9RRWhWHm7f2hMwKxJqr0iuFS4EpS9asrQhBYzyPSWo8l10mYm5Z2e3qvGuCkM1Om7xUN41bta041kRmWovoeMl9BYklR9CPyHI7qoDD20Cy7Z4mbHpJUqS06zEkKZ3qUbvBGaTIy593MVV2MU2p3HUaTEg1uqNURpllxD1f9nxovuZLSeSWs8czUrP3EXLO44POMHnuGGc+iFDkSnyUTTDanV4LJ6Ulk8F+g+frZm1e4djJR27jYjyE1lyOniqkaUy2SUrEZMkvePJYwouZkQsLQloos6t2/Mp1WpcyVSH324yqwVShqJCT1LSozNaFe9jngj7guWdlturxrhoECsU4neDmtE81vE6VaT6ZLsMWI+cWrfTSdhFCvCFVKu3XIsaItlxM1ZNIQbqE7vdEejThR9mT7x9GNqNTTaj6qSRn5CYkl6AAEoAAAAAAAAAAAAAFPK/MOf3GLdPwl9hUSvzDn9xi2UeGTPUSMJzqPoXLqNdTxDHS8y96TxnB4EBNWhKrqqMl7NRTHKWpkknyaNRpJWenUjIfO6yl242dyV12TV2Wn945cNDuPUpadfQ4yz0aeiTSkjMbo3RKTJ2/v1FSpKX1UVqc0SpTiMuGpRfBnBlj+nGM88DC7ezsZpMiyZGX6AaTIsmR4Hz9akaXSdik294cipT7mahyEMKckuOIaRvMe62Z6T0pyeTIz5CupUO44rdLrtNepcOS+4ytdRfu1x9EolGWUqaWnQerONJYwfQLps+kiSZ9CPyFfXKvCoVPVNqj24jE4ho1aTV7y1ElJYLvMyHKCpdNuPaxetOuCtzWI7SIrjUBqoLjJM90WV5SZGeD7CPHafUalciEV/ZPUCqU+XUqfSbjTEps9UlRG9H3yE5UpJkS8EZkSjz0yFyz6U0nnGDyGDzjB57hxyp0+DUtpDNn1WqzYdtQqQ09T4zdQW0c5ZqMlGp3VrXpIi/q+o1ivVGXBtPalRKNWJc+iUtuLwMxySbq2HVrTrZJ3qZJPHUzMLln0VpPGcGGk84wefsOJXRQHKFc9jKp9brTcm4JBwqm6c1at8jc6j0pMzJB5LkaSLAzw7VJq8btsum1SqM0uTSGZkcnpjjqo0k1mRLStR6iLKSMyzz5hdFnZSIz6EP0kmZZIjMhyCk3BKvqsWvQVrdjyaWaplfQhZpUh1k9CG1Y7FqyrHdgVVMhwbwk3lUbtuaoU6p0ue+ywlqeqOmmtIL3Fk2RkSu/wB4jyFyzsxzyKspp3CzDNTBv8STJ7gueNBr6a+3T3CdpV8p+Q47TKmuZedOcYrL9UjOWi64mWaFMlIUThkTu7PoZ9405mgnD2Bwr1RWK4dxR4zb7D51Bw0tlvsaNGdJpwZ9SM/qF02fSQDFEWp2HHcWeVraQpR/U0kZjKJVAABIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAxSvyzv9ogU/wDNF9jE+V+Wd/tECn/mi+xjWj6JY1/XC0AAGTYAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAABKZ/lJEUSmf5SRWrwtT5ewABRcAAAfi/gV9hDExfwK+whi9KlQAALKg1qfYFp1Kre1J1tUyRPM9RvrjkZqPvPsM/uNlIfPl0yGq5/iCsQWrjmsw332k1CTcCKdHjrRywhtJl7iTLqpOT+uREph3ZFHgJrHtZEJkqkTBReJJPvk0R5JGflzzwIh2rQyadaOkxSbellOWjRhKpBGRk5j5skR5HG2ZdTuihbHm5NZqLDtSN5MuTGfNtx0ksKM8mXXOOv1z1Gw0FCLL2kV+kM1SpqoDVCTU1IlyFSVMrJayUpBryfQs4EDqMSlxIcqZLiRG2ZExZOSXUJwbqiIkkau/kREPyk0qFSYpxqXDaix1OKdNtpOCNajM1H9zMzMfMV71CVTrN/xdRiuGNJXu5ESr1G4kGp/Ki58KkzSeSP4CIsF1xgdHqsZm4dsLtLqlenwoLtDjvlDjTFR+IXrXk8kZGWOpkWM8s9Aumzf7wnUO2Irl11qMe8gtlH4htrW6hDi0p0kXcajTkSKfalAhMzyhUWCyzUz1y0JZLS+Z/MXQ+o4VeMt/wD6MtpVEj1V+qUilTobMGY+5vlJ1ONGto1/16FHjnzG6VuhrtO6bPn06sVh56qTyiT0SpinW5CFNKV8B+6nBpLGnGAG/UCzrdt1uS3Q6JBgJklpeJlrSbhdxn1x9BEQ3bbz0iwypzfDsQkPLhG1+BuVKMiIufek+Q5/VK5UrYptZsZmQ85W5MpEehvOLNbi48gz9/UfMzaInM8/6S7xYMcLbO0Wt7+U+3Ep1qsa5GTccJKFuZXzzqVyzzyCHSXKHTly3Za6eyqQ7G4Nbpp5qY5/hmfy8z5fUYnbdpMihNUR2mx3KQ0lCERDRltKUGRpIi+hkRl9h833dMl0W34Ny0wriiPOvsONVSo3ElbklBqLP+ypM0qMy/pIiwXPswOkVZv/ABdtYqVv3BVZ8KkwadHkw4sWYcXiVrzrcNSTJStPTGcEF02SNr1uSp8uHKfetaTT3HGoceHXact0m3lGZFu3GjJfvdx8uQsrCtCm29JepkuGcqpoke1lS0QdzEbdUk2ySzjkRpSWMdcHk+o57etMpVUtWgMu3TMrzVPuVqncWTy2DbQtXNtSiPDi04Iic693aNhuuqVG3rpvJVGfkLOnWu07FbccU6SVkpwteDM8qwWTPqeOYDrD9KhPVONU3oja58dCm2ZCk++2lWNREfceCFTXLJtiv1BudWqBTp0xGCS88ySlcuhGfb+o53SaXSqTTbWuNm/ai1OnOsk87Jlqlt1E1lza3JHhJmfQ0l7uOY6pcqlIt2rLQakKTEeNJkeDI9B9DEoRk2jb6KTLpiaHATTZazcfjbgt2tZ8jVp6Ef2Hih2ZbtvxpLFGoUGC1JSaHiZZJO8SZYMjPqZfQcfaXUKBsHau+n1CpP3BPgR0OyZEtakMIUoiNSUnlKNJH8WDx1PI80GHdlGrdEmQWY8JuXJbRIcl3bxqJraviJLa0kRrx7xaMdO4RdLti7cpLtvooaqZHXR0JShMM0ZbJKTI0lj6GRH+gsyTgiSRdOREOEXe5Hr9WuKZCbuGpM099yOuS5X00yLDcQWDShJGRmkj5mpRH+og066KtVtmuziPPrUuNFrM5yHUqkh0kO6EatKN52ajLGrqeAuiz6AnSWYEN+VMcJmOw2p11xXRCElkzP6ERCCdajm3SXGWZkhmpGRMusMKWhBGnUSnD/oSZdp9pkOS3ZQaPS6Nd9vxLqqEpldFcnFSHZLjzjCkEZk6T+cklRkRGgz5/YZaZGbo1J2Rx6TLmcNLmpce1Slua9UdRmkzM/hz0T0ILlnaSSZ9CMwIjPoRmOH2zAi3pT6/XLquiqU+qxJ0lk2o9SOOimIbUZI9wjIj90iVlRHkVkOfXLyibJk1KqT4bk9c5Mp+I6bK5LSEp0qPHaoiI8/U8Bcs+gzIy6kZD8HMbLhrtvapVbdgz6i/RzpbU1LE2SqQbbprUkzSpWTIjIi5ZHThIAACUAAACnlfmHP7jFun4S+wqJX5hz+4xbp+EvsNdTxDHS8y1r/AFo+2fa3+GqV7R17zf8OnOr5sdM/XAsajblGqVWh1SoUyLIqMP8vJWjLjX2MWoDGzdDpVMg0mnogUyIzFhIzpYbThBZPJ8vrkxTwLEtOn1c6pCtylMVA1at+iOklEfeXYR/YbIADRF7OqZUrouKo3JCp1Vh1Jxhxhl5rUpk229J5M+/6DapNCpMminR36bEXSjRu+ENot1p7tPQWIBYUE6zLan0aLSZ1Dp8imxE6I8dxolJaLuT2kM6LYoSKAuht0iEijuERLhoaJLauZHzIuvMi8hcAFhBmUinzX4D0uGy87AXvYi1lk2FYxlPceOQwzaWhL8yp0uPDbrzsbcIlPoMyMiPKUrweTSRn0IWgANTsK1pFBVVajWZUeZX6u+T8x+O2bbRYLCUISfPSRd/MxMrVl2zXag3PrNBps2a3jS8+wSlcumT7f1GwAFhAXRqaucmaqDH4tMc4hO6MGTJnk2y/4foMKrdoyreKgqpsY6KSCbKEafw9JHkix3Z5i1AB+ISlCEoQRElJEREXYRD9ABKAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAABilflnf7RAp/5ovsYnyvyzv8AaIFP/NF9jGtH0Sxr+uFoAAMmwAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACUz/ACkiKJTP8pIrV4Wp8vYAAouAAAPLyiS0tR9CIzMVfGs96v2izeTrZWk+hpMhVcA386/Qa6e234mWpuv+F741nvV+0ONZ71ftHjgG/nX6BwDfzr9Bp+WzvqPfGs96v2jVJ1j2RPrKqtNtynP1BR6lPLYzqPvMuhn9yG0cA386/QOAb+dfoFtMvqKiHQ7dhopaItNZaTSlLXBJKTxHNZGStPPlkjMSziUg6u5VTiNnUXGCirfNGVKaIzPQfZjJmJnAN/Ov0DgG/nX6BbTL6jTkbOdnyFyVJtWl5kZJzLGc564yfu/pgR6lY9IrF4TZ9biQp1GdpzENqI62alNqbWo9WewsKIuR5G88A386/QOAb+dfoFtMvqKddAtpVuHQDpMUqKeDOGlrS2ZkolEZkXbkiPP0E6fHpVQchOTYyX1wnSfjGpJ/hLIjSSi+uDMv1ErgG/nX6BwDfzr9Atpl9RplPoc+ZfZXHdEinOnAQ4xSmYTKy3aFnzW4pXVeCIsFyLn3jZzi0g6m/UVRG1TX2CjOvGjJraIzMkH2YyZ+YmcA386/QOAb+dfoFtMvqNOb2c7Pmzkmi1qYRyP5mWDPPPPLn7v6YFtcluWvc0dhmv0iLPbYLDW+bM1ILuJXXH6i74Bv51+gcA386/QLaZfUU8ugW1Mt5NBk0iIujJxph7nDacdDIi6H9eozwabQ4EriYcFpqRwyIeskmZ7lGdKOfYWTFjwDfzr9A4Bv51+gW0y+o1yl2fZtJrCqrTbfp8aomed+2xhST709iT+2BsUh+LIYdZfSbjTqTQtBp5KSZYMj/QfvAN/Ov0DgG/nX6BbTL6iJDjUmFR2qVGiNIprbW4TG3epsm8Y04POS+4paJZdl0KpnUaRb0CJOM8k8hn3kn/w5+Hr2YGy8A386/QOAb+dfoFtMvqNZqll2XVqz7WqdvU+VUTMjU+4zk1H3qLof6kJzVAtpqgLoaKTE9jrUpRwzay1lR5MyI+nM88hccA386/QOAb+dfoFtMvqKSgW5a9vQJMKi0eHDiySMn222eTpGWDJRnkzLHYY80y2bWpceCxTqRHjswX1SoyEJVhl1RGRrTz64MyF7wDfzr9A4Bv51+gW0y+o1ytWfZtcqiajV7fp8ucR53zrGVK/u+b9ci2eh0d6ZTpTsNo5FOJRQ1kjG4JRESiSRciyREX6CbwDfzr9A4Bv51+gW0y+oiJj0pFYcqyYyCqTjJR1SNJ6zbIzMk/bJmJ3Gs96v2jxwDfzr9A4Bv51+gW0y+o98az3q/aHGs96v2jxwDfzr9A4Bv51+gfll9R741nvV+0ONZ71ftHjgG/nX6BwDfzr9A/LL6iC+olvLUnoZ5IWBTGcFzV07hXvJJDq0lzIjwJpQWzIj1r9BpXttF2dG682ZONZ71ftDjWe9X7R44Bv51+gcA386/QZ/ltL6j3xrPer9ocaz3q/aPHAN/Ov0DgG/nX6B+WX1HvjWe9X7Q41nvV+0eOAb+dfoHAN/Ov0D8svqPfGs96v2hxrPer9o8cA386/QOAb+dfoH5ZfUe+NZ71ftDjWe9X7R44Bv51+gcA386/QPyy+o98az3q/aHGs96v2jxwDfzr9A4Bv51+gfll9R741nvV+0ONZ71ftHjgG/nX6BwDfzr9A/LL6j3xrPer9ocaz3q/aPHAN/Ov0DgG/nX6B+WX1HvjWe9X7Q41nvV+0eOAb+dfoHAN/Ov0D8svqPfGs96v2hxrPer9o8cA386/QOAb+dfoH5ZfUe+NZ71ftDjWe9X7R44Bv51+gcA386/QPyy+o98az3q/aHGs96v2jxwDfzr9A4Bv51+gfll9R741nvV+0ONZ71ftHjgG/nX6BwDfzr9A/LL6j3xrPer9ocaz3q/aPHAN/Ov0DgG/nX6B+WX1HvjWe9X7Q41nvV+0eOAb+dfoHAN/Ov0D8svqPfGs96v2hxrPer9o8cA386/QOAb+dfoH5ZfUe+NZ71ftDjWe9X7R44Bv51+gcA386/QPyy+o98az3q/aHGs96v2jxwDfzr9A4Bv51+gfll9R+PymlsrSk1ZMsFyEen/mi+xjM9DQhpayUozIsjDT/zRfYxeLbZ2s53b43LQAAYOgAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAABKZ/lJEUSmf5SRWrwtT5ewABRcAAAfi/gV9hDExfwK+whi9KlQAALKg8rWltClrMkoSRmZn2EQ9DklLduq8KdW6/Huc6ZGjSZUeNTURm1saGjNH46j94zVgz5GWMiEuo0qow6tTmJ9NkNyYb6dbTzZ5StPeQlD57hXbWaPs62dUKgMVBUiqwnHHXqcwh+ShDZFkmkOGScnq6nnBF0MbZs+uC6m6tNiV2HXyoaIi5CanX4jLC2HE9UqNpRkpBlz7DLBhcs6wKW4LpoVuuxGq5VYsF2WrQwh1XvOH05EXMcLuu9rjpFAfuWlXHctTUyaHi10RDFLdQaiSeDVhZIMj5HqMzPBja6hR5k3+IKjSvb01CHKMuWlkmmlIQgnGyUyWU50KPmZ/F3GQi5Z2MBw+mO3pWbPuG4f8aSofs2TOOJGaiNKStLK1GSXTMsqL3ccscu8ftxbQ7hqECyotJjVJuTWqUVTlro8Zt+QksJLS2lwySRZUeTPJ9OQm5Z28BySzq3fjsavw10usPKZhG7TJdditR3Fv8y3S92o0qLoZHy7ciqtO6a1TrkprN21u5IDsl4mHotapLZRXnFFySw81yR7x8tRnkuwLlncAHCrjr150uu1J+vTrkosdl9ZxHYNLam03cEfuG5p/FMzLmfTA7VSJrNSpUOdFkNSWJDSXUPNFhDhGWdRfQwuWSwABKAAAAAAAAAAAAAAAAAAAAAAAAAAAU8r8w5/cYt0/CX2FRK/MOf3GLbnu/dwatPLPTOBrqeIY6XmXoYuJY4vhd+1xOjebnWWvTnGrHXGe0cH/AMUXbRqhxd6VW4qG6h8jdJdJak0nd6vhJbfvkWn+pRlgxsDVNlv/AMQEudHr00o/sVuUTKENm2ts1qIms4zoz72euT6jG7ezroDiFuXJcsDZVMv+s16TUVx4zxNU3coSyoyc0JWsyLUauhnzIhCpdy7QG5MGcxBvSouPrbN+LNpkVuGbajLVoUhZrRgjyR8/qIuWd8GGXKYhsG9LfaYZIyI1uKJKcmeCLJ95mRDmaf8AE9y7Q7tpMK6ZFHplP4ZTSY7DbjyVLbIzIjUR4TnJn1Mz7hpl8z6zcezWoRqnV1omUS4W6c7IitISiaRPIJDiiMjwZZzy5ZILln0KA5hMduOqXwdlwLllU9ml01qVKqRR21Spi1qMixktCSLHPCe0a9cF33PQrf2hUd+qcZVaAzGfh1VDKW1qS6pOErT8OoiyRmRdoXLO4AOQV6VeNBuC00ldByf8SPcG6w9Db3URW7JetrGDMywfxGeRljf4vZr90Wkzc786W3TGqjTp77DaHm3TWZbtWktJpM046ciMLlnWgHM2LxmXS/ZkChvriSppql1Q0pLUw0z7rjZkZe6anOX2IQKXIu6+HbjqVMug6EzTZz0OFCbjNrbUbf8AVIUojMyM+uMYITcs6edUgprCaUcpsqkpk5KY+ffNsjxr+2eQmDmMe4aw5ecOJInxHEqtlyW6UFROMKkJWZbxC8ZMuXToNPYql7sbH4d+vXjIdktMoe4A4jW5dQbunCzxqNRkfUjLoXIRcs78AxxnDejMumREbjaVmRdmSIxkEoAABIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAxSvyzv8AaIFP/NF9jE+V+Wd/tECn/mi+xjWj6JY1/XDPVKrApLbC6lKajIfeTHaNw8a3FHhKS+piHV7poVHqsOmVSqxI1RmKJMeMtf4jhmeCwRfUaptq/wCrLZ/+Pw/+cUtEosv/ANIi5JC65MWhmBGeUyppo0uIUpeGjPTkkpPmRlg+8zGN29nXgFHe1UKj2vPmnUmKYpCSJMt5g30oUZ4LDZGRrM+hF2mOQR7suGjXjazZVa6J8Cq1BMGSmuUtuMzhRZy0ZESiV2kXPl1C5Z3sBX3E+5Ft+qSGFmh5mK64hZdUqJJmRjkCZ16wdlcO/HruOQ+zBbluU5UVvhnkcspNRFq1mXaRlz7AmSzt48POtsMrdfcQ00gtSlrUSUpLvMz6Dll7XFKlVhiHTrhrUJXCNSF0+hUopUhvWWdTriiNKS7k4I+RjUKhWa3c+w++2atUpzcmkyFsbx6O21IdaIkmSHklkiM888YMRcs7u5V6e3UYUBctopk1tTsZnPvOoSRGpSfoRGQnDl0adVLfuWyaW9V5VRiu0qXJkKebQS3jQglII9KSxpzgsfrkaLTr3vq4acmv02PeO8f1LixodLjOU80koyJJmpe8V05nyPPYF02fRY8uLQ02px1aUNoI1KUo8Eki6mZjlVVqV2Vu9LYpUSpPW2U6iuS6gyTKHVtOEpJYTqLBKIzMsnksdgrJb1wP0TaTa1UuKTKOkxUPMVEmW0vrbWhSlNrIi0mXu4yREeDE3RZ2Zh5qQw29HcQ6y4kloWg8pUk+hkfaQyDT9kUJ+Ds3t9EmoSJ6nITLqFvpSRtpU2nDZaSL3U9CzzGlbQbuuJ6/pdu0Ru4WoUCM2865QYbD761rzjUbqiJKSIuwjyfaQXLOygORUms3nMs2sSakudQ5dGdTIizKtHbYKeyRGZofSkzSXQyNSTLqR/QSrEuqq3jR67dSpaoENqOtiLSEYNcdaUajcdMyzqM8aS6aefPIXLOpgOHx517RtlEW/HrvN+QxATMXT1RG+GeQXVKlEWo1mXaRlz7B7vK9riqN3+x6IzcUeExAYluqoURl+Qa3SyRKN1RElJEWORHk+0hFyztoh1OqQaWmMqoym45SXkxmTWfxuKPCUF9THHZt43nC2XXLMqMSp06dTnmSgzp8Ztl2Q2tREetCTUnUXQzLqRl0GxXMqvW1TqAp24pc+RUK9EbdW6y0lKGlqIlNIIk8k/U+f1E3LOmAOD1e8rrrd011qltXYxT6ZMVEYKhU+O+hakkRmbqnVEZmZn8JERYxzE+r3NfMi3LHQve2/XajWjgSTfjp99nQsycU3kyLJESsEfUu4Rcs7SA5lSpletraGmh1Svya/AlUt6eRyWG0OtLbUksJNBERpMj6GQp7bk3pdFnRr3iXdGp63zU83TJDKCgNtJWadDi8a84LmrPUTcs7KA4fdd6XFVb1q1HoqLkag0pLJLct2GxIU444jXlS3lFhOD5YLng+Ys2a3tFm7OZi2KVUGK5HmpbS4/GabkvxMkanEtajRvCIzLGcGZZC5Z10BynZjckly410irV6uOyHmDdap9wUtMaUSkmWVIcR7i0kXUiyZd43S/6sVFtaVLKqtUleUNolORjkGlSlERElsualn0Iu8LjYgHDaLdFwU6/7ahOVW5p1NqshbD5VyltxkckGpO6NJErOezGMCfRiu+5nryfbvKXTYtKqkhiI0xFaWZkhCVaVmouaCz0LnzPmFyzsYDk9v3fWXqBYt1VKTmm1FsodUZQkkttuLPDb/TJe8RJPnjCvoNosiqza/W7hqZyVnRG5HAwGSxoUbWSddzjPNZmnrj3AuNwAaHtArFW/xNblrUKamlv1gn3HagbROKabaSRmltKuRrPJdehEYqmV3HSbw/whPueVUGKpTXpEaoKYaRKhrQZEZngtKiPVyyXYFyzd6NdVCrdTm06kVWLNmwvzDTKtRt88cz6deQuhyv8Ahxpr8LZ41IeqUiWiRIf0NOtoSTOl9wj0mkiM9R8zyZ8+g6oEEgAAlAAAACUz/KSIolM/ykitXhany9gACi4AAA/HPgV9hXcQz4qfMWLnwK+wp+AR4ivIa6cU/dlqTV9mfiGfFT5hxDPip8xg4BHiK8g4BHiK8hpajLO9eGfiGfFT5jSaps6teo1aTOW5PjlMUa5kWLOcajy1GWMutkeFf+fbkbfwCPEV5BwCPEV5CLUZL14ay/YttPWrTaAsnkxaakihPokKRIjnjGpDhYMjHu37LoFGTLM5E6pPS2TjvPVSauStTR9UZUfIvsQ2PgEeIryDgEeIryDbRlO7Uw53I2O2fLp66fNmVyVTiLDMR+quqZjEXTdo6FjsznoNyRQ6Ui4odbJ1w58WEqntmbnu7ozIzyWOZ5SXMWXAI8RXkHAI8RXkG2jJu1MKinW5RqfbtQokdx3gZyn1PEp3K8vGZrweOXxHjuFdPsO2ptBo1Kc4htNHaJqBLYkqaksESdPuuJwfMi59hjaOAR4ivIOAR4ivINtGTdqYa3RbKt6lwZ8Zbkyoqnt7mVIqMxch51vnhJrM+RFnljAg0zZxbkGoRZTs6sVBERwnosWoVJyQxHWWdJobUeCMs8s5wNy4BHiK8g4BHiK8g20ZN2phpdR2a23OmynuPrUaNLUpcmBFqjrUV41fFqbI8c888YG6QUQYEJiJCJpiKwgm2mkckoSRYIiDgEeIryDgEeIryDbRlG6vDPxDPip8w4hnxU+YwcAjxFeQcAjxFeQm1GS9eGfiGfFT5hxDPip8xg4BHiK8g4BHiK8gtRkvXhn4hnxU+YcQz4qfMYOAR4ivIOAR4ivILUZL14Z+IZ8VPmHEM+KnzGDgEeIryDgEeIryC1GS9eGfiGfFT5hxDPip8xg4BHiK8g4BHiK8gtRkvXhn4hnxU+YcQz4qfMYOAR4ivIOAR4ivILUZL14Z+IZ8VPmHEM+KnzGDgEeIryDgEeIryC1GS9eGfiGfFT5hxDPip8xg4BHiK8g4BHiK8gtRkvXhn4hnxU+YcQz4qfMYOAR4ivIOAR4ivILUZL14Q5Bkp9w0nkjPkYsjeYUjSpxBkZYMj7RVup0OLSR5IjwJpQEGRHvFeQvXFNouzomq82hpCtl1rLdWlcusKpilazpSqm6cIzznG6zjGeeOgvKjatFm3PBr+/lxqhEa4cuFkm2261zwhxBclJLPQXnAI8RXkHAI8RXkM9tGWu7Uwq6Hb9Fo1sJt+OknqWSVoNqQrea0rMzUSu8uZjX6fs0tiFKaWmXV34jKyWzT5FTdcitGR5LS2Z4wR9CPI3TgEeIryDgEeIryDbRk3amHOHbBZq993TVaq/NgtSzjlDl06eqO6tCWyJaT0HnTkuhl9hsr1lWw5ZqrXRH3FJMyXpadUlzeErVvNfXXnnkxsXAI8RXkHAI8RXkG2jJu1MNVq1hW/VI1OKTMqiJ8Bnh2amzPW3M0dynS5q/UfrdgWu1a1ToLaXii1NRLmPqkKXIfURkepTismZ5IhtPAI8RXkHAI8RXkG2jJu1MKyr0Kk1WbQpUtxw3aM9xETQ5giVp0+9y5lgeJVOiQ61ULlgNLl1p2EmKTByCQhxKDNSUlksJMzPqYtuAR4ivIOAR4ivINtGUbq8NI2ZW45S6ncFyVqLEgViuPk4qIw6TiYzRdEay5KUZ5Uoy5ZGet7ObYq1TlTlPVGEuaeqa1AnuR2pZ4we9Qk8KyXXvG4cAjxFeQcAjxFeQbaMp3amFHGtS34tQYlw2+GNinHS2mml6W0MGecEnvyfUY12fQV2Emz1Lf9jJZSwRE9+JpJWovex1yXcNg4BHiK8g4BHiK8g20ZN2phlacYaabbQ6nShJJLJ9hFgeuIZ8VPmMHAI8RXkHAI8RXkJtRlF68M/EM+KnzDiGfFT5jBwCPEV5BwCPEV5BajJevDPxDPip8w4hnxU+YwcAjxFeQcAjxFeQWoyXrwz8Qz4qfMOIZ8VPmMHAI8RXkHAI8RXkFqMl68M/EM+KnzDiGfFT5jBwCPEV5BwCPEV5BajJevDPxDPip8w4hnxU+YwcAjxFeQcAjxFeQWoyXrwz8Qz4qfMOIZ8VPmMHAI8RXkHAI8RXkFqMl68M/EM+KnzDiGfFT5jBwCPEV5BwCPEV5BajJevDPxDPip8w4hnxU+YwcAjxFeQcAjxFeQWoyXrwz8Qz4qfMOIZ8VPmMHAI8RXkHAI8RXkFqMl68M/EM+KnzDiGfFT5jBwCPEV5BwCPEV5BajJevDI+6hyO6SFkoyT2CHT/zRfYxIVGSww8ZKM8pxzEen/mi+xi1Nts2Uqvui7xclAgXAxDbqe93cOU3MbNtzRhxB5LJ93eQg7q3qddRV1c5CKlXUNwGtT2UP7vJpS2XfzPtEm+Y70qza21FmOQnjhumT7aUqUnCTM+R8uZcv1HDI0CqR7Q2MoZq6pEqRUULjuSWU6YyTYMtBEnGok8zLPM+0xzy6Yd8uWhU+5aLIpVYY38N/GpJKNKiMjySkmXMjI+ZGNRY2S28ioU+oSpdeqFQgPpfjSZ1TcfW2aTySS1ctP0wINOqlwWte0uj1utruCCqkO1Rtx+Ohl1tTaiI0EaCIjSf2yQ0Kn35ftWp7NfgRbucefTvmKexQ2XKctJ9E7zXvDLH9ffzx2BMwREu+3BHdmUGpxoySU+9GcbbLOMqNJkXP7jnlobJKQxb9DbrrU9T0ZhpT9MOetcLfpIjNW6I9Jnnny5CFf1cvVMykPsR69SKE/BQ6+5SILcySzJPGpt1K/hQku0iyZiPUdpM+Js1hyqTUCrlZkVJNM37NOU082ajzzjqMsuknsyRGYDeLk2fUivVddTVKrFNnOoS087S564u/Qn4UrJPxYyY80nZtbVKoFbokSNI9l1gzOUw5IUvJmWDNKj5kZ9ep8xpdj3Heabsp8ObBu2oUmUpSZT9ZpDMThfdylSFtKPJZLBkZdvUdIvudIplk16dCdNmVGhOutOERGaVEkzI8HyDsjuiUiyKZS5VFkofqMmRSGXY8ZyXJN1Whz4iUZl72CLBdwq5Gyu3XZrzzDtYhRX1mt6nw6i6zFcUfNRm2k8c888YGoy6re9Ko1nV1dysy3K2uLEcgPQ0Ew2byC/EI04UaiPmfPB5PkNgo8+v2/tBfoNbuIqxBfpblRQ/KjIZOMtCyIy9zBGjB558/qCW4NWzTGa7BqzDS2pMKGqAwhC8NpaMyPGnv90uYgIpFundNfjqfJyr1mIhc2Ip3JmwnKCUSewvexnvHHrjvm4oVHer1Juqt1PdYcJLVvk3TFJNWD/EWWrR/xajzy6jfKxeE2l3xVXFfjU+Jax1QoqEFlTpOF0VjV05YzgLlm6WjbkS1aKil06ROeiNqM2ymSDeU2nBESEmfRJY5F2CBddi0i5ZzU+SuoQam03ukzqbLXGe3ec6DUnqWe8aFNmXzTdnpX45djL60w0VFyknBQUU2lESt2lXx6tJ41Z69gmLq1yXRtKeo9Krz9DpfsWJUzJuO266lS1GRpLWRkWclkzz8PLqFxtCNm9vppbdPcTOfi8SmXIS/LW6c1xJERG+asmsuRHjkXITara0Rc6q1anpdaqcyCuI4htwktP8AumSDWnoaizgldhC+lcQ3BeOKlLspLR7olnglrIuWfuY4XRrxuWmViE5etcrVGfW8hEqLUqKg6crUfNLT7RmZdhEpR45ghdWLs1ttdMp9Lq7sl2p0uOwqo0VNRWuK28ZZJa2SPSZmZGfceBtt+WvbVSlQ6jWZkqkVA1JhMToMxcR5eo/da1J6kZ9CMazc17VO36htHkNG3ITS2YXBNOILShbpKIzUZERqLOD5n2Cuvyj3PS2LWcrV0lWmH65D3rTsRDO6XrIy3Ro6p6lhWeXPIJb2ezqgHa06gKTNXFnLS7KfclLckPLSZYUpxWTz7pC6r9Ag11qntzydNMGU1MZ3a9P4jZ5TnvL6DkNx3vc9UvGuwqQm6Y1OpUgorZ0Kksy94skkajdW4osdSwki6do6Ts0rFardsJfuamSadUWnlsmmQxuVPJLGl3Rk9OSPmWT5kYI7o9f2cUSsVeRU0SKvSp0nHEu0qeuLxGCwW8JPJR/XqJq7MoLEOitpacjxqHJObGw8eCc0qI1LUrJq+IzPJjSdqF51uPejVsUButtkiCU6Q/Rqe3Lk+8vSkiJxRJSnkeT5nzLoKz2jdtd2d3lArPt6mtxIhuxqnPpzUd+SjSetpaCNSez4ixyV2YDsnu3J24bCkVRN4quOAZwG1005BSi3KdZko0GXarkXTsEdnZjaFWNuoQ3J7lGmGUr2exPcKnyNXvazZzgyPOe4xzU7Uqa6XskaK6ZaUylIW0XAx8RzOMaiMi04UZF7uVZ5HnqJZ3zd1cnVB+lou2NDhSnYkZuj0ViTHc3StOXVrURmZmXMkknBHgguWdXuTZ/Ra7ObnGqoUyoIbJniqVLXEcW2XRCjTyMi7OXIHrCtxNtLpLzT6YZPcWqQuW4TxOl/7U3c6tRY65GnzLxuupQ7Jo/DqtuvV9T6ZTz8clLjJZIzM0IUeCUsiIyI84z2heFOumLZF40mrXWzNZRTlSY0om20TTSRHrbcbItOg+hLLnz7wQ261LGo1GnN1ePLqdWnG0aGZtSnrlqQ2rBmTZqPBEeC6C6uagU+5aS5Tas0pyMpSVkaFmhaFpPKVJUXMjI+ZGOUTV3nRNn9oN0qbWZtOXES5Nm06Ey9NZI0JNttDasJNBFkjVzPBENu2TXIdbiVGLJrzlWmQ3SJSZVPOFKZSZcidR0M8kfvJLHkEDHG2Y21TavTKvNqFZl1SHIJUWVUqot5eo+RNlq5GR9xFkXtu0+gwJtxUulyt5MkSDm1Bg3dS2lvJIs4x7pGSeRDT9udNnTptkHCrUmnEdaaaJLLSF4WZGaXfeI/eTg8F058xXwKRW6ltbviJSbicpBoYgb6W3GQ684okLxgle6kj5mfL7AlsF1WvNhbPWbKtGkNzKfIjrhqkTZZJKGg+i1FjU4fM8EnHMiG42vRY9u27TqRDM1Mw2UtEtXVZl1Uf1M8mf3HJH9pFwU7Zy046Rzq+5XXaEiRHiktS9C1FvEtZIjWZJ5FkiMxLsW4ryTdcCHNhXdUKTKNSZL9apDMThj05SpK2lGRlksaTLt6hcs6Tddr0u6YTUersuGbK96w+w6pp5heMakLTzSYp6PbFtWKp6qPy5KpcrRFXUarMW+8vUrCGyWroRmZERF9BaX9XXLZsysVlhpLz0OOp1CFHyNXZn6ZHLL/AKVdUS1KTOrV0pqrMqpQFPxVQ0NIaM3UmW5Unn17FZyQmUQ67a9AhWzRWaVSydKI0txad6vWrK1mtXP7qMWo5o3KuKu7U7ho0W4XqZSqWUR8kMx21rc1pVqbyouSTxzPr0xgT7CrlSqab4OfKU97Oqr8eMZpSW6bS2kyTyLngzPqA3wBxWhXfclctjZ/So9UKLWLhYfek1ZbKVKbQ1zMkIxpNZ5LHLkRGYuqVPuql7UmrbqFbRWInsR2Y0a2UNOOOk4lKTcJJcscyIywR5PlyC5Z1ABwKnXjdFKqsZ69a1WqI+bySkx51FQqmGRnzS2+2ZqLl0Uo8ZMd9IyMiMuZHzIwiblgSmf5SRFEpn+UkRV4TT5ewABRcAAAfi/gV9hDExfwK+whi9KlQAALKgGZEWTMiIu0wHLWrhvO5o1XqdAZojVBivSIrcWUSzkSybylStZHpbyZHjkf1EJdMTKjqJo0yGTJ7+WZOEe87fd58/0GYcUsecUS19j8fgoT3FKcRvHmtbjGGVnls/6T5YM+7I9XpdV/0e4G6JR6tblVrcpZqYpkemum421n43l7zShJF2n17CC5Z2keHXW2tO9cQ3qUSU61EWTPoRZ6n9Bze/Kzdtt0mLUX7gtuntbhtDrLsB19x6Tj3ktElZGojPoWM94pzrN2f4UtyZfVMoyp0y4IzbDCop5ZaVnCzSaj0u5yZHnlkLlnYwHL012/K9dF1U23XKBDiUiWlluRNYccW5lslaDSlRdp51fXGBVzdsTrGzigVpcOPHqlVlOwj1pcdYYU0pROOaUEa1J93kRFnmFyzsgDkGz3ahLrFzIokx6LWDeYcdalwKdJhkhaSzu1peLtLoZH2cxWUHapW5tbYaqVRtymOuPpbdolRjyIj7STVjBPrLQteOeCLB5xyC5Z3IByHaBtDrNDvF6llLpVv09pCFMS6pBffbnGacqw437rZJ6Hq+46PadTcrFuQJ77lPdeebJS109/fMGfboX2kFxbgACUAAAAAAAAAAAAAAAAAAAAAAAAAAAp5X5hz+4xbp+EvsKiV+Yc/uMW2TJvJEajJOSIu3l0Gup4hjpeZegHDKVtVrkmtoaqNQtykunIJtVEqkeRFeQg1Y5SVFoUrHMiIsc8C7zcR/xAS91UYHs5FIQ6bCmVmrca1e6R6sa9XPVjGOWBjdvZ1gByG3L+uU7Dk3xcXspFDjR3T4OOyon3nEr0JVrNWEpM8csGYoKdtoqCZsN6VLplRjyXUIcp0OkzWnmUqMiyl1adCzTnnnGewLlnfQHNnq9elXva5KJbZ0SLEpu4UiXOZWs/fbJWjSlRZP68sF3jUNoNzXDcOzaUlCoVMqdMrbVOqSEktxDi0uo0qbURkZJMzIzI88uQXLO8AOcT7hu2VcqLToa6KVYhwG5dTqMllw2UmszJKW2iPPPB9VchUVbaPX6Nbl6xqnFp5XPbjTDxOR0qVHktuqSSVEkzyR4M/dzyMLlnXgHKqpdd70at2+1Nj0J9i4V8PEjtk4hcR3QSyNxZmessZyREX0Hti5L4Zn3Lb8lFFl16BAbqUJ+MytLT6TVg2lINWSV7pkR57SC5Z1IBob17OVNNmtW3uFya8rfOb1OsmI6Cy8eCMveJXul9RVs3Pe1zya3Ls5iiM0ylynIjbE5K1vTlt/ERKIyJsjPkWchcs6bvW98TO8RvjTq3eotWO/HXH1Hsc3KuTDv+IU2jQ4VQO2nJbhuIJchlZOHlreEeDbyWcENYj33tATs4iXzKRbp0tLaXHoKWnCeeQbmg1pXqwk+ZHpwfTqFyzt4Dww4TzDTpEZE4hKyI+zJZHsSgAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAYpX5Z3+0QKf+aL7GJ8r8s7/AGiBT/zRfYxrR9Esa/rhYSWW5MZ5h9Opp1Cm1p70mWDLyMaZSdmlFpcaiR2ZVWeYosw5sFEiVvCZUadOgsl8BEfJPqPG025a1QZ1rQrebhOSaxPVCPi0maE/hmZK5HnBGWT7yLA1e99o9XtObTbenz6S3WXIypUqpHT5DrCU6sJShlvUvJl2mZFyGHZu6Y9b8J652a84Tpzmoi4RJ1fhm2pRKPKcczyQ1dWyqhFIXw86vxKctRqVS41ScbhmZnk/wy6EZ88EeBr9sbU6lVLduVxinJrFUpDCXmHIcV9hqaSuWCQ4klkaT6kWeXQZNm+0GoV6448GdXrZnIeJW8itMPwZbCiLolt3+YWeR4x07Q7Hdttw2HTKzLaltTaxSJjbSWCfpU5cdSm09EqxkjIvtkG9ntulbEihPxHZMSS7xD7r7ylvuvcvxTczq18i5kNSt25doVy0WdVKWi32GYU2UyluQ04apiGlmREkyVhvkWMnnJ88EQlM7Q6nc7NuQ7OiRI9SrEJye69UNSmobaFaFFpTg1q15IuZFyyHY7tht6wadRqo3UF1OvVWUyRkwdUqC5CWMlg9CTwRcu/I2Kt01is0ebTJmso0xlTDu7VpVpUWDwfYY0Jm77hpEys0O5m6a7VotLcqcObCQpLLyE8jSptR5SZHjtwYoH75vulWZSLzq7dvro8jh9/T2G3Cf0umSdaXDPGcmStOORcshcs6ROtCmTaTQqc8cnh6M6w9F0uYVqZIiRqPHMsFz6ZHupW9SZNxt1icozluRF00m1uETbjazIzTpPqrl2GNE2lX/WLfuw6W1Jp1Bp6WkLbqVTgPyWpK1ZyglN8kacczUfaJU+5XJ8LZ7MkMUCe9OrCGVPRlcSy2elX4jKzwaVYLt5lkyC5Z+ubHrYqEJynv1W4JdLb/AA24KqstbEUy6aEF0Muwjz9hlt6jVFzaXOqFXp7cGlppJUeK1JktuuzUpWSjc0p6J0l0PnzFDZyLwXVL1K1FUWPHbrry1rqCFuKkL0I9wiSZaCLBe8eevTkP2Hcf+KL42Z1iRGKK/uqm2+0R6ibcbbUlZJPtLKTx9AS2RvZFbSFIaU7WXKS2snEUhyoOKhJUR6iw13Z7M4G0xrbgR7slXE1vSqEiGiCtOot2TaFaiwnHI8n3jiz23CdKdkzYEykxIrTjiWqc/TJj7z6UmZEZvtp0JNWOWMkWeY7da1YTcFuU2roYdjJmMJe3LpYU2ZlzSf2PIRZE3WD7Lchhxl5JLacSaFpPtI+RkNBRsut5mRHZl1SuSoCXErYpMyqrcikpJ6iJLR81ERlnBmY169to9bpF4zaYqZR7eiRzSUZyrQn3UTywRmonke42Wfd58+0er3qFRqVZ2Xz6YmlP1R955SFNyDciko2TyolkWVJLmfLmfQB0Fy0KQ9Or8mUwqSVcabZmsuqy2pKCMiIixy5KPtGvsbJrfbcgrdmVyUUCQ3IholVBbqYxoMjJKCVyJPLB9uOWRDp1512hV6vUm+Cp0k6fSjrLUynNqaStolaVNmhRmZKz257RXv3Zf8OzyvWVGt5VF4dM5dLQTnEIjmRKzvs6TXpPONOA7Darg2eUqsVl6qsTq1R6hIJJSHqTOVGOQSeRayLJHjvxkXtEpVNtijJhwzNiG2o1muQ+azNSjyalLWeTMzPtMa7Qruk1baXIozSWvZHsSPU2TNBk7qcWZczz0xjlgaNtJuCZXdnW0SNOSxuqZU2ojGhGDNGW1e9zPJ5M+YDpd22XS7nfjSZTk6FUYyTQzPp8hUeQhJ9U6y6kfceRhpNmUaLR6tTWpU6aqe2cebKkzTfkKLTjBqPOkyI+mC6irqdwXPV70qVBs/2TFbpDbK5kqooW7vFuEZpbQlJljknmoz/QQ9ii5bi70XUmGo84645vm2lakErdNkZpPtI+pZ7xI2dVrUhv/C0dTzqVULHs9JvESl6Wt37xY973e7HeKyq7NaPOqr8+LOrlJXJXvJTNLqC47UlXapaC5ZPtMsZFNtPKpf8ASTYCqG1GcqJccTZyTMm0ZZMjUrHMyLrguvQZ2L1rFtT6rTr6RAkORKY5VmZlOSptDzSDwtCkKMzSojMu0yMQNhq1iUKp0GDSXmH2mYB64j7L60Px1/OlzOrUeTyZ5zkR6Ns7oVNi1Rtw51Sk1Ng40ubUZKn5DrRljRrPon6FgcqZ24VFKWqk5KpcmO5pUdHYpU0n0IPHJL5o0KURfQiPvH0HHcS8204jUSXCJRZLB4PmJGhtbNqI5RIUCLWa8ldOUpuPOj1RRSWE8sta08tJYItJlyF9alpU62eKchuTZc2Vp4ibPkKfkPaeSSUs+wsngiwOdpvGpUi1KpNolMpaJh3WunEy21u0PEpxKTUoyP8AmHnmr0Fm7cF/Q7uatmQVuSJ1QjLlxpbbbqGoiUKIlEtBnlzqWMGX1wIG53latPu2msQ6m5LZ4d9Mlh+I8bTrLqeikq7D5j3RbZhUet1GrR3JTs2e2w0+t9zXqJpJkk+nU8nk+0c8nbQLkpdkXo/Papjlet2UiOTrDatw+SyQoj0GeS5KxjIm1O5b6pFyUiBMYoEhNeNxuG2gnEcEtKNeXVGZ7wsZzgi5kA2ZNg0E7fn0Z9h2RBmzHJ6ydcPWh5atZqQosGnB9MdBjt2wadRai1OXUq7VJLOdwdUqC5BMZLB6EngunLmRiigXxWKEu7Yt6IgynqDCRUCkU1Cm0vNqJXu6FGeFEacde0aRH231Bo2ajJk02ZHcNJrpEWlTUPtpMyzpfUjQtRF9CI+8Ox3d9mxWJ0N+JMaQ9GfQbbjayyS0mWDIxzstllqJaaS9VKs9EhSGlRmJFVNxmG4hRGSUErJJM+RGR5PB4LGRJk3Hc1eu2p0mzfZUWNR9yUuTUm1uG844nWTaEpMtOEmWVH3jn9IqUiFZF5y59Lp7ktV4obdjSEb5olGthJqLpky6pPs5BI7TT7ehQLkq1cYN7jqmhpD+peUYbIyTpLHLqeRQz9mlDmVyZU+Iq0YpqjcmxI05bUaUrTjLjZdeRd5fUVO0K76tRq4cONX7UosdKEqRx6XJMh0zI85aQZaE9MHzyNLuK8q/eWxhqqwn4MGQ3WGoclSG3NLxE+lKVJIzJSSMzIzSrnjJANxu+x1QbLolFtujOVSPS1GbSiqPCzmOR4Wy9jTqyZkZHywKzZrY0yn3PNue5I0qAS6eqCaKpVSmyHSUsjUt1wsJSRERERF38+Y/b82mVC2arBtt2dTY1XKGiVNqTlPkPsZMzIktstZVzwfxHy+op6pfq7y2UX1CmIbekU+IX+2MRnmGJKVdDSh0iUkyMjyXPs5glvCNlFBNaUPVC4JVKStK0Up+puOQywZKIt2fUiMs4MzIdBLkREXIiGm06vyoN2RqNVSYRTZlORIpz6Umk9bafxW1H0MyLCi6cs9wl7Pq5NuWjv1eUhpEKTJc9npQnBnHSelK1HnmasGrs5GQlDZxKZ/lJEUSmf5SRFXhNPl7AAFFwAAB+L+BX2EFa0oxrUSc95icv4FfYVctg39GFEWnPUaURE+WepMxHZk3zXiI8w3zXiI8xD4BfiJ8g4BfiJ8hrtoyx3V4TN814iPMc/kbP1ImT00W7alSqNUHVvS6awlpSVKWXvbtZlqbIzyZ6e8+g3TgF+InyDgF+InyDbRlO6vDUoFhRIVNs+I3WHD/AMNms2nNCcvGptSOfPljVnl3DW7c2WVq21TFUXaPJYdmOG7IeXSozrrqj7VOLyo/tkdR4BfiJ8g4BfiJ8hGyjJvrw5vUtmdVm3UxcJbQJKamzHQw2tymsPJbMkkSloSr3UGoyNR4IuuBdqs6fPgQWLiu96rPQ6mzUWnlQ2mTLd5/DwjBYPPXqNt4BfiJ8g4BfiJ8g2UZN9eFfb1Ej0WrXBORN3yqvKKUpCiIiaMkJRpI+34cjWIWzSmxbOp1ERWZbcqmzHZ0OpMaW3mXFrUo8FzIywo0mR8jIbvwC/ET5BwC/ET5CdlGTfXhQW3QKpBluSa/elRrbhoU222bbcVpBH2mhsveV3KPoNfqmzaRWW1U+uXvUqjb5qIzgvx2DdMiUR6TkadeOzsPA3/gF+InyDgF+InyEbKMm+vDWLjtapT5y3qLek6kxnUJQ7DXHZmMmRFgtCXSPRy646i3su36baNAapVNeUtpK1urcdUWpxxZmpSjxgiyZ9CLBCw4BfiJ8g4BfiJ8hOyjJvrwmb5rxEeYb5rxEeYh8AvxE+QcAvxE+QbaMo3V4TN814iPMN814iPMQ+AX4ifIOAX4ifINtGTdXhM3zXiI8w3zXiI8xD4BfiJ8g4BfiJ8g20ZN1eEzfNeIjzDfNeIjzEPgF+InyDgF+InyDbRk3V4TN814iPMN814iPMQ+AX4ifIOAX4ifINtGTdXhM3zXiI8w3zXiI8xD4BfiJ8g4BfiJ8g20ZN1eEzfNeIjzDfNeIjzEPgF+InyDgF+InyDbRk3V4TN814iPMN814iPMQ+AX4ifIOAX4ifINtGTdXhM3zXiI8w3zXiI8xD4BfiJ8g4BfiJ8g20ZN1eEeQZG+4ZHkjM+Ys960pGk3UlksclYMVTidC1JM84PAlFAWZEe8T5DSuKZiLypRNUTNoaDV9nEqstO06r3xU5tvOKyqC/HYW6ac508QadeOzvxyF5MtJB3lBr9MrbsDcxCgyIiWkOIkMpMzSkzVzSZZ6lzGxcAvxE+QcAvxE+Qy2UZab68Nfodm0qn7PztGdIKo05bbjbqnCJBrStRq6EfIyzyP6CBS7Oq0R5hmRtBrUikRzTuoZIZbc0p6JU+ktai5YPpkbfwC/ET5BwC/ET5Bsoyb68OaItqsTtpF5VCm12oW8bpxUtSW2EOtSUE0WrCXCMjMj5ai5kLyTs6pTliybcZqcpDkiQU12orUlx9yQSiXvFZ5HzIuXQbfwC/ET5GHAL8RPkGyjJvrw1Gp2TIlSYVVh3ZLgXMzFKI/U2WGjTLQR5LeMnlHI84x0Ed3ZtAfti4KdLrkuVU67oOZVXySpxWhRGkkoLCUpLGCSXTI3bgF+InyDgF+InyDZRk314U9wW1FrNTteY5PNpVBk8ShKUkZPHu9GD58u/tH5Ipsal3VVLv38iS4unIinCYaJajJCjVlHPKlHnGBc8AvxE+QcAvxE+QnZRk314c92SUEma5X7okw5NMaqDpop0CYeHIzBnqUZo/o1rMz09gmztn60VCpO25d1RoUGqOqemw2G2nUrWosKU2pZZbM+8huvAL8RPkHAL8RPkI2UZN9eGswbHptPqsWXDqDyWo9IVSENOK3hmlSjUbilmeTVkxicsWGvZSix/aqyYTHTH4zQnXglkvOnOOzHUbXwC/ET5BwC/ET5CdlGTfXhJYU0zHaaJ1Jk2hKM564LA975rxEeYh8AvxE+QcAvxE+QbaMm6vCZvmvER5hvmvER5iHwC/ET5BwC/ET5BtoyjdXhM3zXiI8w3zXiI8xD4BfiJ8g4BfiJ8g20ZN1eEzfNeIjzDfNeIjzEPgF+InyDgF+InyDbRk3V4TN814iPMN814iPMQ+AX4ifIOAX4ifINtGTdXhM3zXiI8w3zXiI8xD4BfiJ8g4BfiJ8g20ZN1eEzfNeIjzDfNeIjzEPgF+InyDgF+InyDbRk3V4TN814iPMN814iPMQ+AX4ifIOAX4ifINtGTdXhM3zXiI8w3zXiI8xD4BfiJ8g4BfiJ8g20ZN1eEzfNeIjzDfNeIjzEPgF+InyDgF+InyDbRk3V4TN814iPMN814iPMQ+AX4ifIOAX4ifINtGTdXhIkutnHcInEmZl0IxDp/5ovsY9OQ1NtqWa0mSSz0Hmn/mi+xi8REUzZSZma4vCDdFrt1+rW3PclLYVRZpzUISglE6ek06TPPIufURbrs5VYq0as0isTKFXWGTjpmRkIcJxozzocbWWlREfMs9BA2s3fULRp0BynMMpTKeNt6oSWHXmIaSTnUtDZajz0Iaw5dlcuPZfdTsOsWvKmRoxqRMprjhkbZpM1kpkz1tLxyLJnz5jm7OlvFNtae1Rp8Wq3XWp86YREqalaY6mcdDaQgtKPr1yKiBs6lPXBTKndN0TK6dMfKRDbchsR9CyLBGtSC1Lx9T6ijolz3NTbVsegx00qdctZik5Hdc3iGGIyGkq1uFk1LWRHzwZZMW0G7ripNwu29d7FLcnPU56fBm04lpad3Ze8hbajM0mXLnnmHZPdr1g2LXpFuTmlXDWrfYlVOYqTCSwgzdbU6rCkKWWpvUntT16jcans6gHDoxW5NlUCfR2DjQpcUkuGls/iQtK+SyM+Z57eY1WnXrfz9gwr0ep9C9loicVJgFvCkuoL4loVnSnlzJJ55dvMW0677lqt4sUez2aVwkmjNVNEueleGdaiwZkk8qyR40ljmech2O6ypmz8mm6tJrNbm1euVKGqC5UH20I3TR591ttOEpLJ5PvMhlr1hM1jZxDtFdQdaZjIjIKUlojUrcmky93OOekUErabMt2gXMq64MX2zQnGWlFEWomJW+/lrTnKklkjyXMyx2igtzbHJduKnQ6hPolVjz5CY+7pkGYy7GNR4JRm6nStJHjPTvDsd3RLptesVSpLmUW76jRydSSHoxx2pbCiLtShwjJJ95l1FbSdmtMg0+hM0+oPKKm1VVXceMkqOU8ZGSiPGCSXP8ApLlgR2Llu+46nWXLUjURujUuU5BUmebhvS3EJI16TTybLngjMjGfYKZq2X01S290pT0k1IznSZvryX6AhjVs5nx51XkUW8qrS01WYuTKaZYaWk0qIi0o1EehXL4y5/TkLKnbPabTKhaz9PfebYoLchtDKyJZyDeSZKUtXXVkzP6mYibSLoqtClx2YFTtekx3G9Zyaw6ta1qzjShlGDMsf1ZGr0zatVZmzi7awhulyanQnyYQ/HS4UaVnGFElWFJLmfaHZPdsbezuo01bse2b0q1HojrqnVU9thp0m9Z5UTTiy1NkZmZ8uhmN9hR+EhsRydeeJpBI3j6zWteC6qUfU/qOau3VedCrltquePQl0qvTEQUMQd4T8RxacpNS1HhZFjB4IhIYuW77jqtZXakaiN0elSnISyqBuG9LcQkjXpNPJsuZERmRghYV+0atVpz8ij3tPgwJR/jQ1RmJrWehk2bhHoLryLPMftO2cU6mFaiadJkNMW+686hKyJRvqcSolGo+WOajPkQibBVKVsxp6lt7papEo1N5zpM315LP0FZW1XIe36ktQZ1PRTvZa3DZdbcM91vEbzorG8PsV0IgG3SLVhVC7pVeeklIakUtVJdikRGg0GslGeojznljA1k9lb7lOTQ5F41p61EkSCpSkNkZtkeSbN/Gs0Y5Y7hqVhT7zp1gVSdbcehlT4NRnvLbm7xTsoidUaiSacEjtIjPPMbBem1tFKo9sqhlFhTa7DKal+ch11mKjSRnlLRGpZ5URERYLtyHZLZK/Yipdwxq3b1cl2/UW4qYLqo7LbyHmEnlKDSsjIjLsPsFcrZZHO1rjoqq1NdKtS0zHJLyErcQotOe3Csmn6Yzy6CNsr2lLuqtSqJNdhTZTLHEon0+M+yw4nVg0Gh0iNKiyXaZGXcNh2m3HUrZosCTRYrEuZJqDEQmXjMiWTisGRGXQ/rzx3B2R3eK/ZL0y4112gXBPoFSkNIZlqjttutyUJP3dSFkZEosmRKLnzEqw7QatCPVGmqhKnnPmKmLck4NZKUlJHky6805zy6imh3DddGuukUu8WaM/ErC3G40imE4k2HUp1EhaVmeojIj94sfYaveW0uu0aXUXGq1ZMdMJSv/AMMWt6TJWSf6TWjklai7MHjIDfbzs07kq9FqbVXl0yVSt8bK4yEmZqcRpyerly64wZH0MRaDYsZt6pSbjqz1y1SZHODIkSUIbJDB8zaS2jkgj5GfafIaZcdYuWvXTswqVDk06FGqTK5CI8lDi9KzYNS9ekyJRaTwnuPmYnzr7jWo3tDqj1LiEcGpsxkcOg0KkuLbRpU6rnnBq6kXQuhgLmn2BV4BMwY9+V1FAZIkNQUttE4hBdEcRjXgiLHfgdBT7uOp47zHDbZ2ySHLip0KpT6NVo9QkJjkilwZbLsU1HglKN1OlacmRGfIy6i/ZuO/q7VrojW63bkaLR5qo6HpyHVqeIkErTpSZYMs/F9S5B2TN1x/0csHS3YXtJ7SuulXDXuiyStZL3fXpyxnqL2Xbbci+IFyHKWl2JDdiFHJBaVEtST1Z65LT0HKLnum4rttbZxW6E5ApnH1VDbrD5OLLfpUpJZNJlqayhRmXU+Q7kyThMoJ80G9pLWaCwk1duPpkTCGjVrZzHqlOu+IupvNlcUhuQtRNEZsGhKSwnn72dHb3i8rttN1e4Ldqq5S2l0Z1x1DaUEZO60GjBn2Yzkfm0KtSbcset1mChpcqFGW82l0jNJqIuhkRlyGlVy/q9adotVy6E0Yl1R1lqnRmEukUc1pNRm8rma8Fz9xPYYDbn7Mgy6/X6jPcOTHrMJuC/EWgiSSE6ueevPV6Clp1lVWFKZp5bQ6wqksadzTiSyl5KE4wk3iLeGnBY+w1qyNrEuqXPDosudRqqufrSy/TYMpgo6yTlJOJdLBpPB8yPPTkNQt+rzbMdvK8LiYodQqhVhdLakIZdS4l5RN594zUZMEk86SI1cjEdk93Yq5ZD0i4na3btwTqBOlpQ3O4dpt5EpKOSTNKyMkrIjxqLngVsbZZFj2zVKKiry1tzquirqfdQSnCWlSFGk+fPJo6/XoNcsva7In3XTaRUJtIqzdRdNpK6XClMKjKxkte+ThSTxjJGR8y5C4tG67vuORWpiUUWNRaRUJkJwlNOKfkboz0mnCsJx7uc5zz6cg7HdZVbZ9LcuaoVigXRNop1M0KnNNxGX94aUkkjQtwjNvkXZ28xDibJ40aw6rbCa5UHETJ/tFE5xKVPtu6kqI1H0X7ycnnGcispG0O442zlV93OzSG6QqGlbMKKlZPLeUskJNSzMyJJn2ERmRGXMU9E2zyjrcBmfPodTjTZCGDjU2DMaej6zwStTidKyIzLPw8smHY7t+qljTZTsKpwrnm0+52YxRHqqxGbPimyPOHGT9w+eTLHTI9O2Y/U7OrFHql01CqvVNG7cmukjDWOX4bacJTz6kICLku64K9WWrRj0Rql0eUcN1VRNw3JTpJJSiTo5IItRFk8j92CKWvZ6lbzO4dVUJiltZzoUb68lntwCFftbp0q4Y9LtKlU6q+0CWy6isttaI8Rrmh097n4zRqLR/xEOmU6GxToEaFDbJuNHbS02giwRJSWCISAEgJTP8pIiiUz/KSIq8Jp8vYAAouAAAPxfwK+whiYv4FfYQxelSoAAFlQfiVJVnSpKsHg8HnB9w9F1Icwtm4Ho9rXZOpdNosN6NXJTJ71/hWFYcwbzq1GfvH1PHU+mBCXTgHG7T2oVN+/aPb1Vn2vWG6qTiW3qGp0jjKQk1e+SzMjIyIyLB5G32ldc2s2vcFSksx0P06ZMjtJbIySpLJmSTVk+p45hcs3UByQ9odzSo2zxukU6lvT7mivPPE+a0NMqQhKskZGZ6SyfLmZ8i5Cypl81iky7kgXvGpypNGp5VPiKVr3bzR6vd0r5kr3cdQuWdIUpKE6lqSlPeo8EGpJqNJKTqIs6c88fYcJ2l1K9qjszkzq5T6IzRpy4jiGIzjhyYpG+2aTcM/dX2EZJxjPaNwqFyxKFfVzyZdPjEinUFmY5KaQfEOpI1/hmecY5cuXUzC5Z0cBzaiV/aFITSarNoNHfo1RU2aokF1Zy4bay5OKUsyQvHLJFg/uNVuTbWpu4qhCpNSt2mxqdJVGWVXakrdkqSeFGndJNKE5yRGeT7cBcs7mA1zZ7dTF6WpErUZlTBOmpC2zMz0rSZpPBmRZLJcjx0GxgAAAlAAAAAAAAAAAAAAAAAAAAAAAAAAAKeV+Yc/uMW6fhL7ColfmHP7jFwgs6S+w11PEMdLzIA4pH2kXm9s+VefsyhlSYTjvGMKU6Tz6EO6DNrmaU8vmznHYNjK7bqgXLbpVqn0cqFcDxMR0RnFnJiqNGtO8M/dVkiPOkiwMbt7OkAObMXNedzTqm7ZkOgtUiny1wyXU1um7LWjkvSSOSCzyIzyKqubWpabJpVYp1PYguyZT0ObInpcdjU51o8KJe6LUojPkRlgLlnXuoDj0u7a9X9lV2SItRtl+XGiKNE2lyVrQpBoM15b+NpZF0yfXmN52ZHVVWJRlV52G7MVHQpK4pLJJtmktOrWZmasdT6ZC5ZtADnW0O7qzRKpwsCo2jSWCQlSXq1JWpx4z6klpvBpIu8z5imj7VKlL2T1C5osKnu1KHOKESW1LOPI/ESnUnOFERkfLPT6hcs68PxRklJqUZJSRZMzPBEObIum76Ldtvwbth0NVOrzyo8f2cpzexXCRrInDXyWWOWSIhqNLn3IzTtrci4fY1TgxHXSXFUl00qWTZYQRGrk1p6l1zkRcs7wRkZEZGRkfaQxKkx0qNKpDCVF1I3EkZeo1yn3bb0Cm0mPUaxR6bLdiMLTDclIaUklILSSUqPOOwhoW3Gw7URaVRrLdBglVHpbClyiSetRreSSjzntIz8xNx2FEhhZKND7KiSWTNLhHj78x+NyGHFElt9laj6ElwjP/Uczv2zLbtfZfeL1u0eHTXX6YtLjjCTI1EXMiPn3jnE+iU5qyCkQNlFSpU1MNC01pp1sjjnpLL/ALizWZFzVgiyYi6bPpgBX268mRb9MebmpnpXGbMpaeRP+6Xv/r1Gn/4nuiu3RVYVnRKOmn0WSUWW9UlOapDuCUpDWj4cZItSs8+wTdFm/pUlZZQpKizjKTzzH6OBWndtStbZS9U4UBhc6Vdb0VcV9R4SbrxkadRdpHjn6DeptyXRQq1Z1LryaK7JrVQejvqhIcJDbSW9SdOo86s9TPl9BFyzoYDS6reDtLvuZS5TbXsqLRV1RxwiPe5SoyMi54xgu7qNUqt8X5CsaZeXsiheyFRSkx4W8cVKaQoy0rcPklXI8mksGWeom5Z18ByK+tpdWotYplPZOjUhmVCale0aw2+qO8tXVpvd9DLrlRjoNlVeRXbciz5hU7fuaiUdPlFJYVg8ZSsu/uPmQXLLwAASgAAAAAAAAAAAAAAAAAAABilflnf7RAp/5ovsYnyvyzv9ogU/80X2Ma0fRLGv64RrrotQrEdg6RX5tEmMKNSXWEJdbXksYcbVyWXkNbouzRmMdclVmrO1Oq1eHwL8pEVuKlLXP4W0FjOTzk8nyFftveuJp+z027KgMIdrDKFFJJz33c+4StBllvrkup8hLcua7a7XanSrQj0Ns6MpuPPmVLem25INJKUhpCOZEWepn2jBu9o2cSDoFFivXLL9sURRlTqqxGQ2tprSSd0pHNK04LB56jLDseRDeqVcrlbl3DXjp7sRh1bCGUNINJmaW2kciNR4yfPItdn9zyLkgT0VKEiDVqbLXCmMNubxsllgyNCu0jIyMRtotxVOgtRvZsi3oKXSUa5lalGhCTLolLafeWZ/Q+QdhpVi7PKvUdm9AplXuOrQ6K7DQU2irjIS4fabe9MtaEn2p7uQsKtbFVk7XHHKDMl0JiPb7bEeazGS6yRk6Rbo0qLSr3eeM5LGRY7KL8mXZUK3Tai5SZT9M3Z8bSlL3DxLzyIl8yMsd5kLTardk2z7dZnQIjbxuyUsOPvpWpiIg+rrpII1GkvoCUdnZtTXqBV4Fbly6pOq60Ozai5ht1TiP5akEnkgkf0kXQZqPatxx58dyr33U6jCjrJbcZERqOa8dCccT7yy7+mRUWRfVSrNGrUiVNtionDiHIZkUiQsyUZEZ6XGF++joXMz5irZvq+WrJiXpOpFC9hFFRJkw23XClbs8ZcSZ+4XeSTyeO0Ox3bHJsCWzWKjJt26KhRYNTdN6bCaYbdSpwywpTalFlsz5ZMs9BeWFbLdoWtEojMpyW3HU4ZOuJ0qVqWaufM+mcZ7Rz7aDtdKj3AmjUqZRqetMVuU5Lq6H3EK3nNKEIZIzM8czMzLH1GSmbZosiyKxVlRWZk+myWoZIhqWTEpx08NqQpaSUSTPOSMslgLwju2O6LEl1G6VXBQbhXRqg9HTFkGuC1LQttJmZaSc+A+fUuoqYWyhDdAuunruSZOO4XG3nZb7SFuIWjrzIyJRH0xgsYFvRp9+xqy1Guik0eVTZTazOVSlrLg1EkzJLqXD98j6ZT5CgoF0SoWyik1GkxLbpBPPvtqVMkKjxIxE64WSTk1LNRl8JH1Mw7J7tzu21UXC7bji5io3sWotVBOGyVvTQRlpPmWCPPXmKaTYshqszpdt3ZNo0Kqum9LhstNOpccMsKW0pXNtRkRZMs9Br9m7RJ9eq9at2qSKDUXG6Y5MROoqnCaIsaTQpK8nnnnJGINgzW41s7HI64ESQuS24lD7yTNyPhpR5bMjIiM+h5zyAdLsK2W7PteLRWZTktthTiidcThR6lmrnzPpnGe0Ra9aUifeVJuOnVh2nSYbSozzXDpdRJZUolGg8/CfL4i5jnadrVafuOTFJ216buZCmipNWcfjS3EkvSSieUW6LV1IuYuaw/c69vNHZgS6ammKpanTZd3pnut4jeH7p6Tc+VXTGQuiza7es1ujWfUaAmct5ExyS4b5tkk0b5RmZYzzxq7+YgSdnqfY9vN0ysSadW6HFKJFqjLSVGaNJEoltq91STwR4z17ReX9WZFu2RXKzCQ05JgRHJDaHSM0qUkskR4MjwNLm3neFEpUG5bgpdHRbbxMb+PHW4cyMThkW8UZ+4oiM+aS5l3mJ7Db7Vo1Vpr8h6uXTLrstaSQaVNNsNNlnOSaR0M+8zFJtmpcqsUCjxYSJalnWIilriEZuNIJZZcIyLljrnsGswzuY9re0Bq0WqSUhXAqcfqZrNtJE2rCSSjmZn35wWBa0baLU5FHo1WqMCLHhKqbtJqxoUpW4dSo0IcQr5DWREeS7evIQLmkWRMTcEar3PckyvyIJLTBbcjtx22NRYNRpR8S8ZLUff0FA3slmx4E6kQLynQ6DKU6o4rMBgni3hmaiN/Goy5n9ccsi5rV61CLVLpKlU0qhCt+ElbqGyM3XpSveJpOOwk8z5GfvEKHZvtGqlx15iLKqdozWXjUS2ILr0eXGMizg23ubnMyI9OMcw7HdcPbPXTo9pR6XcK4dRtot2zMTGQ6ThGjQolNmeCyk+/kJknZ5T5rd0tVKS68zXJbc33C3aoriEpJJoVk+ZGklZGtM3qVAo11S4VEhnOO4jp0dhgzaKS8smyJx1RmfPnzMuwi5C/g1G94sx6JddIpEqA9FedTNpalk2wpKck06lZ5PJZ95PkQCTQrYuJioR5FXvyoVWEwvW3HbiMxycLsJxaMmsundkWdt22iiP19xMpT3taYuYojQSd0akJTpLnz+HOfqNIp10z4Gym1p9HYtmjtyoxGtc+QpmLFLBmSUN5Na8n2EY8WNtMqFYl3LTprlDnyqTB41ubSjc4dzJH7hpXzyXLoeA7HdZI2X7iwqFb0KvSI8ujTOOi1BMdKj3mtai1NmeDL3zLGewdEjpcRHaQ+7vXUpIluadOtWOZ47M9w40raFfUGyqbetUplvFQHUMrkQ2Vu8VpcUSdaVH7hczI9J55do7Qeo0nu8ajL3dXTPZkTBKlvKjtXLbVToLksoqp8dTOsiJSkEf9RJyWRFuG0IddtyDS5Uh9l2App2JNYMkusPNlhLiepZ+ncZkOK27Kq9v3Hdd0V2n0Kq1xFTKlxVME8h3iXEtpShC1mZIZwo8ljOcjpH+J7uturUhF7xKG7TKrLRCbfpSnSXFdX8BLJfxEZ8tRY+wi5ZdW7blwQ6k1Kr96T6whnO7jpitRWzyWPxCRzXj6mXMQHNm0GRR67AlT5RnUqqdXakMETbsN73dJoPnk0mjOT656DDaly3PcdyVVlhmjsUalVN2FIW4ThvvJSkjToIj0kZZ5mfXPIhuNxzZVOocyXAZjPSWkGpCJL5MNZ71rP4SLqJ7ChoFtXFEqrMqu3tPq0dgzNqKiI1FQfLH4ho5uenMZrTtBFu0muQUTVyCqk6TNNZtkndm8fNJFk847+0c/pO1Oqt3lRKTUajaNXYqsk4xJorjxuRuRmSlGrKVF0LljPYLdFzX7W63c8K2oluMx6PMNhL9QN0zeLdkrSSUHyPn8RnjmXIR2O7ZINiU9Gzdizak65NgtxyYU9jdrPB5JZYzpUR4MvsI9JtK448yP7Tv2qT6dHWlTcZMVphayLolx1Jall39Miy2c3N/jGzKbXDjcKuSlZOMkrUSFoWaFYPtLKTx9Bsgmw0WbYcxuvVCoW3dE+hs1NZOzorTDbyHF6dJrbNZfhqMiLJlnoLewLWbs6226OzLdmNoeddJ10sKPWs1YPmecZxntGxgFgAAEoBKZ/lJEUSmf5SRWrwtT5ewABRcAAAfi/gV9hDExfwK+w197fb5eN5jUeMZGunTuZalW1aAKj8f/ADfUPx/831GvF7ZcvpYT5aIEGRMeQ6tthtTqkstm4syIs4SkuZn3EQ5DbFmSLtsSrImcbRXJVwP1iAqRHI1pLeGps3GVcjI+1Jjp345dN76gZvmfPe+oji9nN6aTB2Z1Q7roFfrV2LnyaQ64tuO1Tm4zCiWg0nhCD5K6e8Zn0GZOzeoRpNZj0u7ZsK36q66+/T0xkKWlxz49Dx80pPuIs/Ubh+P/AJvqH4/+b6hw+zm9Ndouz9NMespZVJTn+Goj0UiNnHEbxKU6j5+7jT9eonSrLizborVVnu7+LVKaimvQzRgtBGrJ6s9uru5C0/H/AM31D8f/ADfUOL2c3podS2XVipUI6FMveY9RWTaOIwuE3rQTa0qInHCMjcLBYLp2HzwNnl2VFn3FWajPeN+LVKYimPRNGMISasq1Z6nq7uWBa/j/AOb6h+P/AJvqHD7Ob00+m7O6ywmBT5171KVb0BSDYhIjoZeUSPhQ4+k9Sk/TBZEiTYlWg1SbIs26nKHEnvnJlQ1wW5SDdV8SmzUZGgz6n1LI2j8f/N9Q/H/zfUOH2c3pKosJ6nUxiLJnSag82XvypONbh9pngiIvsXQTRUfj/wCb6h+P/m+oni9nL6W4Co/H/wA31D8f/N9Q4vZy+luAqPx/831D8f8AzfUOL2cvpbgKj8f/ADfUPx/831Di9nL6W4Co/H/zfUPx/wDN9Q4vZy+luAqPx/8AN9Q/H/zfUOL2cvpbgKj8f/N9Q/H/AM31Di9nL6W4Co/H/wA31D8f/N9Q4vZy+luAqPx/831D8f8AzfUOL2cvpbgKj8f/ADfUPx/831Di9nL6fkr8w7/cYuEHjSfdgUis5PVnPbkZPx/831F66N0RF2dFe2Z7NXb2cpRsmm2R7TUaZKHUcZuOadbmv4NXPHTqLms2qVSctVfGG17CkokEW7zv9LZox193rntE/wDH/wA31D8f/N9Rnw+2nN6arIsKrwqlUHrRu6RRINRfVJkwzhNyEpcV8SmlKwaDPr28xKTYb1LtiDSrSr82juxVLWb620SUyVLPK1PIVyWZmZnyMsDYPx/831D8f/N9Q4fZzemoUbZe3Har71YqvHVStQzgvyI0NuI2lvnzJtHI1ZPmZmZmNqsqjz6DbsWmVSqFVXYxbtuQUYmPwyLCUmkjMjMi7e0Zfx/831D8f/N9Q4vZzemp17Z7UJF1zq7b9xIpT1QJtMpD1NalmegsFu1LPKOXZzLPYI0LZWcazqtQF16RJKfUUVA5b7BG4SiWlZkrBkSjM09Sx16Ddfx/831D8f8AzfUOH2c3pCum1yr1btionLNg6JMOWTe71b7KDTpzktPXOeYoZmzuS7JvJDNeU3TLlbWbsRUVKjYeUkk7xK8kZlgvh9Rtf4/+b6h+P/m+ocPs5vTGxa1H4WCidS6dNkxWG2CkvxEKWehJER5MjMunfyGO+bcK6rbdpJyTiE4605vSRrxoWSsYyXXGBI/H/wA31D8f/N9Q4vZzen5eFEK5LVqlFU+cdM6OqObpJ1aM9uMlnzGmNWLejlNKlztoeulmzwy241GaZdNvTpwTmo8HjlnA3T8f/N9Q/H/zfUOH2c3pKolLi0SjwqXT2zbhw2kstJM8mSSLBZPvGqTrHns3HNqtr3G/RE1JxLtRjFFQ+h5ZFjWjV/LWZdT5/YbD+P8A5vqH4/8Am+ocXs5vTSmtlKGrLj28msOqQzWyrBSHGdSlYc17s/e5n/xeg2S/bSO6SpkiJUXaVVqXIOVCmNtpdJtZlpMlIVyUky7BY/j/AOb6h+P/AJvqHD7Ob01en2FKYr02uVysv1+VJpa6e9HWwhlLhGecIIjwgj6Y7zyZjkVYp9w1i2H7MpMm8URlJSwxSptGQhLKSUXuuzc4U2ks9OZ4LqPoX8f/ADfUfuZGMZex+ocPtPN6a/XrRrstMf2LdblOSmM3HdiyILcyOrSnGpKFY0mfbz5ixsG0Y1nUZ6FHfVIdkPqlSHjbS2lbiuulCfdQnuIhO/H/AM31D8f/ADfUOL2jm9LcBUfj/wCb6h+P/m+oni9nL6W4Co/H/wA31D8f/N9Q4vZy+luAqPx/831D8f8AzfUOL2cvpbgKj8f/ADfUPx/831Di9nL6W4Co/H/zfUPx/wDN9Q4vZy+luAqPx/8AN9Q/H/zfUOL2cvpbgKj8f/N9Q/H/AM31Di9nL6WUr8s7/aIFP/NF9jGVnXwkjeaunLUMVP8AzRfYxMRamYVqm9VMqy/7XdummwmolSVTJ0GW3NjSSZJ4kOI6ZQZkSi+mRUTbFqzNWk1W2LpXRqhPS37RzBQ+zJcSnG9JtR+4o/oZ9gybVr+ZsaDTs8IUuoPGy05NcUiOyRFlS3DSRqwXcRZMa1Y21Z+46u5b6Zluza0/Gcfhyaab6o2tJZ0OpWRKTy55IzyOfs6O7f7Ktdi1aY9HblSJ0qS+qVLmSMbx91XVR45FyIiIi7hUXvY8ivV6DW6RWEUuqxWFRkrfhImNG2oyM/cWZYVy6kYrrev+qXFW4tDgUluNVYSj9v8AEZNuERciJvBlrNfVPcXMxGvm+a7RqtLYiS7KpjEfmlusT1qkPpxnUSG/gI+hErmHYXNjWLJtm4qtWJteeq0mpMttvb2OhrSpB/0EnkSefJOOXeYv7ppM6rQW0UqtSqNLaXvEPMoS4lXLGlxCiwpP05DQi2oVGbbljVOk0iO49cUxcNcdx08IMiV7yVl2ZTnJkfLsyMsS7b5dueoWk5TLdO4GoyZ7UtD7xQyYUrThaTLWa88uWCDsMkTZ+/Sirleq9VRV647TXojao8BuGjQZZwaEZ1qMyIsmZ9xCotLZ5WapYFCpdYuiotW+5DZOTSFxEIe6EZtG8fvEjPLSZZxyyMlZvORVdmE6XXaJT3J8CstU6TFUta46nEuoLeIMjJWPeIyIz6lzF1UrnvGdfddt21qfQzTTm2HeMqLjpJ98jyk0o5mZ45GWCLtDsnun1+x5bldVWrSrzlv1J2OiK/8A7KiSw82j4NTajL3iLkRkfQZJNjHV7SnUW6a3Oq7kxxLxyjShk2FpwaTZSksIIjLJFzFdQb8qVWsKdVip1PYq0Ca5T5SJEwmYrbjaiJTm8Vz0c8469gprU2m1SXe9Pt6pSbUqaqi26pl6hyHVkwpCTPDpL6keOwOyO7Y6TZtbRVo066Lxl1duESjisNxkxEEZljU7oP8AFMi78FnngVT2ypRW7b0ODXdxUqI8+9GluQkPtKN1SjPUyo8GZauR5yWMjTabVbiasPaRLudmjVWFHqLqOHUp9RKdI2yNPMyw0RYwRGR5yN/qN0XFOuJ237JgUk34EVl+ZKqbjhMtm4WUtpSj3jPBHzzggSx0LZxOhXO5XapcztTlu05ynrQcNDLaEq5kbaUHhJEeeXPPeJVH2epp0OyI/tNTn+GSWRK3OOJ1INPf7vXPaKSrbTarTbPud6TSYrVzW+8yzIjbxS47pOmWhaFcjwZZ68yMhPK67upF0UGHdNMoqKdXJBxo/AvuKejL0Goic1FpV06pwHY7sdx7N6zXkyYE68nX6FINWqPJpjD0hCVHk0ofPmWOw9OS7xbzbHdRcdvVahVddO9lRCgLYcYJ8pEfKfcyZkaVe6XvcxuoCbIu1Pa3Hel7L7qjxGXX5DtPdQ200k1LWZl0Ii5mY16Bs/qVVptIi3Fc0ybbzLTD3slcVDa1LQSTSl10veWkjL4TIj5czHTS5dACxdr1DtoqVeFxV7izdOr7jLG7xut0ky+LPPOe4hqVXo8Oztn9Wo82LUq8iszJTiGoUM1qJbxmtKVYM9JEeC1nyHTh+kZl0PAWGi2DaE2k7OUUuoVCUxXZqVPzp7Cy3xSF9TJRkZGaSwnu90V8bZtUJdxUyqXXcqav7MkFJjIapjUVw1pzp3jqcqUXQ8ciMyHSQCxdoMnZrEmUavQJdQkZqVUOrMyGEk25EdwnTp5nnBozz65Hum2VWV1Ip1zXdMq62WXWYzLcdMVlGssGtxCD/EURdp8voN7ALF3MpGy15FGtdml17hapQIyorMp6CiQ04lWNRmyo8ErlyMjyQyUHZpKp9dq9WqFyPVKXU6YdOd1xENJb55I20pMiSkufu8+vUdJALF2jVqwE1PZVHss6kbSWmGGeM3OTPdGk86M9unv7RvKeWPoAANFk7OYkyn3FElz3/wD8WqJVJp5lJIciOpJBJNJ5PJkaCPJ9+Bjg2JVJVYp028bperzNMfKTDiphtxkJdIsJW5pMzWos8uhZ54G/AFi7XLPtkrberqylnJ9qVFyoGRt6d1qSktHU8409eXUZb5tpi7rZk0eTIdjIdNC0utkRmlSVEpOUnyUWSLJHyMXwAOV/9F9YmVSiT63eHFuUmaiWzHj0tqMwrT2KSg8mrGSJWeWeg3S2rcKiTLhkFKN/2vMVLNOjTusoSjT15/DnPLqNgALF2ubPLYKzbRhUNMs5hRlOq3xt6NWtxS+mTxjVjr2DYwAAAAEoAAAASmf5SRFEpn+UkVq8LU+XsAAUXAAAH4v4FfYQxMX8CvsIYvSpUAACyoADTYd+RFWvcFWqEVcN6hvPMTIpr1KJSOacHgs6yNJly/qIQluQDnr1/wBUkSW6bQLUeqlbbjNSZ8fjUMNQt4WUtqdUXNeOeCIY521ONDsitV2RSJbE2jSW4s6mPLInGlKWlOSUWSMsLJRGXULlnRgHOJO0epQK9EptTs6fHVU0r9kqRKacVKWkiM0rSX8o8HnmZ8iMY3b7en2/eUOv0GdR6rRoByJEVmaRmtpSFGlTT6C5Gek+eORhcs6WP3mQ5FJuq5G9oFk06kUtx+jzKaby0Oz0Epwj3epxZqTkzbI+n9WTEtd9x7doV01VqnVGYUSvnBWwuYbqlqUpKctZL3E8+TfT68wuWdRAaDS78qRXXTaJc9rSKJ7VJz2c+cxuQTqkJ1GlZJL3FaeeOYwHtGnSlz5lDtOdU7fguONPVFEhtClKbPCzbaP3lpIyPmXdyIwuWdFAUlk15N0WnTK2iOcVM5kniZNeo0Z7M4LPkKm6bprtNnuRqJabtSbaJJrlSZ7UJlRmWcIUvJqMu3kA3EBzde1SN/0dKutmkSXN3NKC7CS6k1kvebs9KiylXPmWOv0EqmX5Uiuqm0W5rWkUQqtrKnSDmNyCdUhOo0rSn+WrTzxzC5ZvwHkuo5tL2hVCe1VXqBa0+fQoZvMO1NuS2hWtGSUbTR+8sknnmRkfLkQutkEp+dsxtuVLfdkSHYaFrddUalrM+0zPmZhcs28Botbvqci5JtDtS236/Np6ELnLKUiM0xrLKUkpWdS8c8F39Rje2kNLo1Idp9Dqcit1VbjUekOpJh1K2/j3ilckoTy97mR5LGQuWb8A0ih3xJeqrtHuWgvUOtFFXMYYOSiQ1IbT10Op5ZLlkjLlka2ztdqarZj3Q9ZE1q2DIjkzTnNmtotWk1JaxqWkjxz5Z7guWdcIjPpkx+Di98zbgre1+3qExEqCKEqKcxJwqsUU306kZeVgs4TqMt2Z+91G+UC8EVa2a3V0wlNJpb0pndG7qN3cZ55xy1afrgLlm2AWT6DmE/awhmh2tJiUdL1Rr8Q5jMZ+e3GabSREZkp5eCzz5ERcxIuS6n3dm9RqNcoVUpbrDzDa2GJxINzU6giU1IRnUjnzPBZ5l2hcs6OA0et3tObrb9FtO3Xq/UYbTbkzMtEZmOSyylJuKI8rMueCIQp21KNEtCp1ddHmJqFLltwptLWoidacWoiLCiySiMlZIy6/QLlnRQGgU+/aki6KZSLltWTRW6sa0U+Sctt/eKSnVpcSn+Wenn1Mb+AAACUKeV+Yd/uMXCfhL7CnlfmHP7jFwgs6S78DXU8Qx0vMgDkzG16W9ayblRaMtVAYcW3PlFMbzHJK9BqQgyI3CLqeMfqLuPf8xNx0iFVLYmQKVWV7qnVBUhCzcXp1ETjRc28l0yZjG7ezfgHP5F+1WZU6gxaVoyq5Cpz6o0mZxjcdJuJ+JLRK5uGXTs5iNVtrNNZtyjVKlQnJkirOuR2I8l9ERLTjf8xDzi/dQZdO3J9AuWdJAc1rd5XC5s4uKos24/TapDjGtpXGNOsqI0mZutOpylenrjBcywNm2c1GqVWy6VMrsPhJzjKTUnfpeNwsFhw1JIiI1dcdgXGyANRuu5q5TJyo1EtR6qEhKVLkyJzUNgzP+lCl5NRl24IUv/SpHPZ3OulFIkGuDL4N+ETyVK3mskHoWnKVFz5GXX6Bcs6QHMc/g3/Um7mpVMuS1JNGj1dam6fKVLbf1rJOrS4hPNszL6mNVpl4XDKg7TV3JSpDdOpq3SQcepJS4xpQWGUKSnJGZe9r7DMLlnah+6VdxiDQXSkUOmvtk4SHIzSyJxetREaCP3lf1H3n2jlO2W0Wqdb1Rr0Gu3OxNclM+43VnUtJ1upSokoI8EWDPBdgDsmFdxhpUXYY5ddlsN2bs6u2dSKxX3ZaqcvQubU3H90ZcyUjUfun9SHNX6tQoNsIm0avbQ2q+UdCmnZS5RxieMi5rNxOjd5PmZ8sCLps+mgESkrfcpMJcxbLklTCFOrZPKFLNJZNJ92eg1ObfE125JlLti25FcRTXEt1GQmU2wllZlnQglfzFEXUix9xN0N4PJdR+Diln7QXaHszfr09idUzkXG/CQ046e+QlbpklPvZ+HGNP+g3Jd61KDULYg123Dp8uuTXYiWympe3KUI1EszSnBmfTT2d4XLN5AazMu5iFeb9ClMbtlimKqbkw18koSoyNOnHcWc5Goz9q1Rh21LuZdmT/wDDaWd7GmKlNkt0jPCVKawakIP5ufZyC5Z1QBzi4tpi4Fch0WkUZE+pvQ25q0Sag1DQlC+iUrc+NX0IhutuVJ+r0hmZKpsulvryS4soi1oMjx1IzIyPsMuoXLLIAASgAAAAAAAAAAAAAAAAAAABilflnf7RAp/5ovsYnyvyzv8AaIFP/NF9jGtH0Sxr+uFbe1qJuVNPkRp7tMq9NeN+HNbQTm7UZYNKkK5KSZdSECl25dkdEt6oXi3KnKZU1HJqmoZjtKP/ANopBHqWouePeIvoN1AY2btBpezdihSKTOoFQcj1eMs+OmPpNw6khZ5cJ4slk880n/TyIuQrXdmVTj1urSaJczMGHU5CpL5OUtp+ShSiwZIeUeSIuzJHjmOoAFi7m9B2ZKpNMs+GdX35W9Pdmk4bGDkEslFpP3uRlq69uOg2ONa5s7SZd2cWSifpqKdwu7+HS5r16s/pjA2UAsXc8l7N1SLarVJ9qEk6jWCq293Gd376FbvGrn8HX69BslHt46deNervEk4VUSwncaMbrdEovizzznuIX4BYu5g/soJ61Z9JOsYeerblbZeOKS20LUojJtxtRmTiSxzzjI90zZxV0XXQ69WLnZmPUtbhpix6aiMyaVpMjwSTySunMzPp0HTACxdzWZs1mvQLupjVfQmk151UlLK4ZGuM8o0mpWslFqThOMYL7ixrVk1I64qtWpcJ0Wpvx240onYiZLEhKPhUaDMjJRZPmRjeQCxdzeZsvTKtKuU5+suv1itPtSZtTeZIzWpsyNKSbIyJKSIsEWeWRst12yderNtTylkx7GnHM0bvVvsoNOnOSx1znmNjALAAAJQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACUz/KSIolM/ykitXhany9gACi4AAA/F/Ar7CGJjnwK+wpcTe/1IaURdnqVW+ycAg4m9/qQYm9/qQ02e2e/wBSnDml07O5lWv5ipxZrLNvy1MvVeErOqQ6wZm0pOCxz90lZPokuo33E3v9SDE3v9SEbPZyepadV7auWlXXVK/ZD9IcVVktFNhVTeJRrbLSlxC0ZMj04IyMuwVM/ZxV5tm3FHl1CE/cVcnMTJDqUqbjoJtxsyQkuZ4JKMZPqY6Pib3+pBib3+pBx+zk9Neum2ZlWvSyqxGdYTGojr7khK1GS1k41oLRgsHz65wKy4LKqNRqt8SWHoqW65SG6fGJalZQ4lLhGa+XJPvl0z2jdMTe/wBSDE3v9SDj9nJ6lpU61K/HrVmVSjOUtx2kRDgzGpalpSptWjUps0lzUWk8EeCEKZs+qj9HrkRMiFvJ1xorDZmpWCZS4hRpPl8WEny6fUdCxN7/AFIMTe/1IOP2cnpr92W1MrF62ZWIzjCY1FfkOyEuGZLUTjWgtBEWD59+ByB253LQhVy27cuagM08n5JtsVGLIRUI6lqUakNNEnDvvGelWSz9R3/E3v8AUh4UzIU6Tim21OF0WaUmov16hOn7TyepUeyWnyqVs0tuFUGlNS2oaN42ssKSZlnBl2GNPu7Z5XKheNQqsWNbVZjTTb0FXDeNUEkpIjS2hOUqLqrHLJ9o6fib3+pBib3+pBx+0cnpy6j7MazA2dO267Kpi5HtluoIcZJTbO6J1LhkSMe4fIyJJZLpzG43bbUysXlZlXjOMIjUWS+9IS4ZkpRLaNBaMFgzz34GwYm9/qQYm9/qQcfs5PUufQ7QvGgx6lRLbqVF/wAPzHn3mnpbbhyYm9M1KSki91fNR4M8Y7jG3bPaJJtuyKLRpzjTkqFHSy4tozNKjLtLJF/oLPE3v9SDE3v9SDj9nJ6aTUrYumj3dV65ZMijPIrBNnLh1XeJJtxBad4haMnzLGUmX6jxMsy5lNUWsIr8aZd1MW8reSmNMV5DuNTGE+8lJYLCuZ9+RvOJvf6kGJvf6kHH7OT00yl2tcVSuD/EF4yaWidHhOw4cOm6zZb3nxLUtZalGeC5YLH1EeZYdTf2FKspD8MqocJMbempW51EsjznGccu4b3ib3+pBib3+pBx+zk9Ne/wzM/6QqFXt7H4SBSHYDiNR6zcUpBkZFjGn3T7RrcezLwprFwUSkz6IVAqrsl8pLyHOLZN7OUEkvcPr8R+Q6Lib3+pBib3+pBx+zknDnMixa+1YNtUNlm16qVNhJjyYVWjqWy44WMLQ6Rak45/08/oK2Bsqq7FmXFTikU2LIqz8d5qnxVunCibtxClaDXlWVaT7CLpyIdYxN7/AFIMTe/1IOOMp5Jw0ypW3c9HuWo1uyX6O8dUQ0UyFVd4hBONp0k4haCM+ZEWUmQrZezmqyrbq6ZVQiSLgq9SjT5bhJU2wgmloMm0FzPBJTgjPqfcOi4m9/qQYm9/qQcftHJOFBeFtTK1dVmVOK4whiizHZEhLhmSlJU0aCJOC5nnvwNtEHE3v9SDE3v9SDZ7OT1KcAg4m9/qQYm9/qQnZ7N/qUWV+Yc/uMXCDxpP7Cld1bxW8+LPMTCKZgsHy+5DSum8R3Z0VWmeznrWz6qI2HVCzDkQvacht5KXSUrdEa3dZZPTnp9BsFwWxNqL1lLYdjpKiTG5EjWo/fSlo0GSOXM8n24GxYm9/qQYm9/qQy44y05JxLQ49tXpbE6ptWbKoD1IqEtcxKKml1LsRa+a9Ojkss8yI8DwvZ9UqXY0ai0lyiVh3fOyZzNbimpiY44epSiNOTbwZnjBGN/xN7/UgxN7/Ug4/aeScOX2rstnwabdKJK6XSlVqEqImnUo3VxGVGR/i/iHnUeSLBERERDfrDh1inWtBg3EmnlNioJgjgrWptSEkRJP3iI9RkXMugssTe/1IMTe/wBSDj9o5PTml67P63U7ymVeJGtytRZSG0IZrinv9i0lg92lGUmR9Tzg89ojUrZfWoWzqsW45KpSpEqqInNLYSppkkE4lZp0Y9z4TIiLJfUdUxN7/UgxN7/Ug44ynknDX70tqZXLis2fEcYQzRp6pUhLhmSlJNs04TgjyeT7cDXZtkXCpe0CFHfpS6VciXHmFrUtLzLykEkkqLBlo5dS5/QdCxN7/UgxN7/Ug44yck4as9sztmp+zJVepTcuqxIzLBvk+6kstpIiwSVEWMl3CftIt6Vc1ov0qnuMtvreYWlTxmSSJDiVH0Iz6ELrE3v9SDE3v9SDj9o5PUq6/qM/cVk1qjQ1ttyJ0VTDa3TMkkZl1PBHyGnFTdqEqgewpaLNjQlxeDXJbdkPOJRo0GokKSSTPHYZ4HQsTe/1IMTe/wBSDj9nJOGK2aQ3b9u02kMOuPNQY6GEuOfEokljJjUTtm56Dc9Wm2dKpC6dWZJSpbFSJzVGdwRKW0aPizgj0njmXUbnib3+pBib3+pBx+zknEuWt7Mq2mwI9DdnQnpzdxlWFvmpRJW3vdZ/08ln3dPqNu2kWxUq9IoVUt+REZq9ElqlR0TCUbLupOlSVmnmXLtIbJib3+pBib3+pBxxlPJOGgs2hXZtzVKuXhIpzkaVRXKc7GpqXDNojMzMkaiyvlk89c8iIcouC5arUNnr9mUa4qDUWzZRDjstx5CKo8klERNrZNOlsyLqrPZ0H0rib3+pDwlmQl03Uttk6fVZJSSj/XqI4/ZyemiXtZ1dq7MBtin2lWYjMVtootajrSuOskkSlIdQRnz7sEL3ZdacizraVT5UpDy3H1vk0yazZjEr/wBk3rM1aS7zGw4m9/qQYm9/qQnj9o5JwnAIOJvf6kGJvf6kJ2ezf6lOAQcTe/1IMTe/1INns3+pTgEHE3v9SDE3v9SDZ7N/qU4BBxN7/UgxN7/Ug2ezf6lOAQcTe/1IMTe/1INns3+pTgEHE3v9SDE3v9SDZ7N/qU4BBxN7/UgxN7/Ug2ezf6lJlflnf7RAp/5ovsYzmT5MPb8+Wjl0GCn/AJovsYvTFqZZ1TeqJWgAAxbgAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAJTP8AKSIolM/ykitXhany9gACi4AAA/F/Ar7CGJi/gV9hDF6VKgAAWVAAajCvqC7bFdrExh2GdFdeZmxlqJS0Kb6EWOuotJl/cQhLbgGgMXU1/ixl2osVOEv/AA8dTejnIJbDSCXkyNsi5ul83dyGK1NpMm4n4LzFpVRFGnKSTFQafZkEkjLJKdbQo1tl9VdO0LlnRAFBQLkbrFwXDSm4zjS6O82ytxSyMnTWgl5IuzGcCrpl9HU7WVWIFBqct3jXYSIcYkuLUpCzRqNXJKU+7nJ9AuNzAaLbd+yJ90NW/XrbmUKpPsLkRyclMyUOITgj95sz0nz6GGxaoTKnYTUmpSnpck5sxBuvLNStKX1kksn2ERERfYLjegGnz6y1F2jnCV7QU6iiuTNBSCKMaUuY/l4/mf8AFnpyGuMbX0qolOr0q1axHt2VpSuoam1E24o8EkmyPWss8tRFjuC5Z1MBpVFvl+XdkehVe26lRnJrS34L0hxtaZCUY1ZJBmaFcy5GKSDtWlVCmvVKnWXWpVLivPNTJLTrX4W7UZGaEmZG7yLJ6S5dOoXLOoANTqt4OFSabNtmhVC4iqDRPsHGUhpokYI8rdWZJSfPkXU8CrpV/N1umXVDn0ufR6xRoinZcQpCFrShSFGlTbyMpyZEf2MLlnQAHNmr/On061IVOolVrE2r0w5UZCpKDdPSSeTjisFkyVk18i5fUTqjf0qJcCaDHtioTK0qnInlGZfbwRqUaTQpZmSSwZfFnB55Bcs3sBzBrau9LosqoUyzq1L9nOON1RreNIOEpvOssmf4hkRZwns7hcVzaLAhQ6SqlQ3qrOqsbi4sRLrbGWuXvrW4ZJSXPH3C5Zu4DQoG0mK/Rq7Il0x+HVKPFOXIpypDTpqRgzI0OIM0qI8GWewxXs7VXSapVQqNoVmBb1RW001UnXGlElbnJOpoj1kkz/qMLlnTQHNaVdVxSNtVXoD1If8AYrERo0ucQ1paIzXh8y+IyXgi09SxzHSgAAASgAAAAAAAAABTyvzDn9xi3T8JfYVEr8w5/cYt8kSCMzIiIsmZ9g11PEMtLzL9AcxXtaacU9Lp9vzJlAZUsnKimZHQZkgzJSkMKWTi08uRkXMYrivmsf4+s2PbdOdqVDqkdx81tPtIKQkyT73vcy3ZHky7c4IY3bWdTAcati9K/FrN+Mx6LVrl4OuuoSlEhCERWCSWEpNw+fb7iRuyb3RNtKmVygUWq1f2jyZisIJKkHzzvVKPSgiMsZM8Bcs28Bo1sX85U69KodaoEuiVhmIc1LDkhqQlxojxkltmZEf0MUrG19K6FDr79q1dm3XFaJFQ1tqJhWrSRE3nWss8tRFj7hcs6mA0mk346/dkGjVa26lSUVFK10+TIcbWmQSCI1EaUmZoPBkeD5jTLFv2ux6DUnF2/W7iZiVSYUmah5H4DSXD0pQSz1OYT/Snp0C5Z2kBqMK+6dUa9blPpra5MeuQXZzEslaUpSjGUmk+eef6YFfc98yYxXrAo9LdeqVBgokJXvUElZuINRKIj+TGTI+uOQXLN+AcwoO0SbHse3H6vQp8m4aqgkRYLDra3JeEko3jUR6UI5559Mi1pl8LqD0+jVijzrer6YTkpqNIcQ4TrZEZa23EGZHg8ZLqQXLN6AafsemyqlsvtqZUJLsqW9EJbrzyjUtZ6j5mZ9TG4AAAAlAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAxSvyzv8AaIFP/NF9jE+V+Wd/tECn/mi+xjWj6JY1/XC0AAGTYAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAABKZ/lJEUSmf5SRWrwtT5ewABRcAAAfi/gV9hDExfwK+wp5DklLyiaJWjswnI006bs9SramAK7ey+5X7A3svuV+wacc5ZckYWI5hdWz2pVS/m5kKVHbtmoLYfrMVRmS3XWDy2aS/4vdJX0SQ37ey+5X7A3svuV+wOOcp5YwoKhbtSe2iuV2I5FajHRV09tThGs0vG5qIzRyynH1HPkbMK7KrsOR7Htq35DElEh2r0aS8hx0kqI1ETGCT73MveM8ZMdg3svuV+wN7L7lfsDi9nL6aUq37uol8VypW17GlU6tracd45xaHIq0IJGSJJHrI8ZxyFEnZzcrWzuJRylw35jFVenSI5vuMsz2lLWom1rR7yc6iPHMsljmOpb2X3K/YG9l9yv2BxezljDldmbOa3StodLuF2lW7SYTLD0d6LTnnHHPeIsKUtZe/zLpywN52XW/Nti0G6ZUzZOSmVJePcr1J0uPKWnngueDLIu97L7lfsDey+5X7A4vZyxhr1VtufK2guVpo2OCVQ3KcRGvC96pzUXLHw47RSSrHq7ux+h2wg4ntOEqIp0zdPd/huJUrCsc+RHjkN83svuV+wN7L7lfsDi9nLGFNW6BNnbQLXrLBs8HTWZTb5KXheXCQSdJY5/CeRzbZmm9pdhuQ6B7DOmypk5ripS1k7Ey+slGSCLDnaZcy+o7FvZncr9g8ME8w3oYZJpGTPS20SSyfMzwRBxTk5Yw5rc2zeqtxLah0VEKtUilQjiLptSlORkOL7H9TfVXZpMsDBZOzWuUOXezshihxWq5TUxo8enKWTbThJWnCtRZP4iM19p55Dqm9l9yv2BvZfcr9gji9nL6aXQbNqkGtWLKfONuqLSHIMrS4ZmbiiQRaeXMvdPnyF5GoMxvafMuBRs8A7S2oaSJXv7xLilHyx0woueRcb2X3K/YG9l9yv2CeL2csYajblpVOnW1e0CQcff1ibNfi6XDNJJdSZI1HjkfPn1Gs1nZVLkQLUmlColVqtJpaabIp9UI1Rnklz1IWRZSojzg8cyMdU3svuV+wN7L7lfsDi9nL6c6pmz+c3atzR00K1aJOqcFcRhilNqLBmRllx4yLJZMuRJ5fUXV3WnUats9o9EhnHKZEehLc1uGSMNLSa8HjnyI8chte9l9yv2BvZfcr9gcXs5fTWvYdbh7Vnq9Cbgv0eoQmokreOqQ8xuzUZKQnBkrJqLtIbsK7ey+5X7A3svuV+wOOco5YwsQFdvZfcr9gb2X3K/YHHOTkjCxAV29l9yv2BvZfcr9gcc5OSMLEBXb2X3K/YG9l9yv2Bxzk5IwsQFdvZfcr9gb2X3K/YHHOTkjDBK/MOf3GLVaEuMqbXnStOk8dxlgVDhqNajX8RnzEknZeORKx/aNK6bxDOiq0y4zE2SVCkIXTotr2PWI+tZs1SpNqJ9KVGZlvUEk94ac9SUWfoNzrNp1mHVrMqFtx6Qv2K05GfiqNUZrQ4SSNTRESsYweEn5jc97L7lfsDey+5X7Blxe2vL6a7YNtT6DOvN6cbBoq9XdnRt2vUZNqSRFq5cj5dOY1B/Z7ciNn9s0llcGS7TXXVzKa5KcajzEqM9JG4gtXu5zjGDHUd7L7lfsDey+5X7BPF7OX05XY+ziuUW/VV16BQKZBeprsRUOmuuKNCzMtJrUssuH158sFywLV6xawvYnCtRKontVk2jUe9Pde68SzwrHd9Bv8AvZfcr9gb2X3K/YHF7OX0pbhoE2oXnZ9VjmzwtJOQcnUvCj1tpSnSWOfMj7hqVv29tCt6kTqXTSt5xibNlPJffec1xEOrMyMkknDnI845YPlzHR97L7lfsDey+5X7A4vZy+nPX7ArFvLtCZZ7sKdKoMR6GtmorU0mQl0yNSiUkj0nnJ9BnpFm3C7Vb4m156nJduCntxmjimo0sqJpSDIyMsmRGfXt7iG972X3K/YG9l9yv2Bxezl9ObwbOu9ijWrNR7GYuW3ELittKdWuNMjmgkmSlYI0KPBH0PAs4Fr3FWLlVcV2nTYsuNT34MGDAcU4hG9L3lrcURGZnyLBFyG672X3K/YG9l9yv2COL2cvpV7NKJLtuwaHRqkbRzIUcmnTaVqRqyZ8jwWeo2UV29l9yv2BvZfcr9gnjnKOWMLEBXb2X3K/YG9l9yv2Bxzk5IwsQFdvZfcr9gb2X3K/YHHOTkjCxAV29l9yv2BvZfcr9gcc5OSMLEBXb2X3K/YG9l9yv2Bxzk5IwsQFdvZfcr9gb2X3K/YHHOTkjCxAV29l9yv2BvZfcr9gcc5OSMLEBXb2X3K/YG9l9yv2Bxzk5IwsQFdvZfcr9gb2X3K/YHHOTkjCxAV29l9yv2BvZfcr9gcc5OSMLEBXb2X3K/YG9l9yv2Bxzk5IwsQFdvZfcr9gb2X3K/YHHOTkjCZK/LO/2iBT/wA0X2MZSW+pl/fEZFo5ZLAxU/8ANF9jF6YtTMKVTeqJWgAAxbgAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAJTP8pIiiUz/KSK1eFqfL2AAKLgAAD8X8CvsIYmL+BX2EMXpUqAABZUABpVR2m25Aq8mAtc9/hFm3LlxoTjsaKoizh10i0p/wDLtEJbqA1M9oFBK1qdXydlLi1Ev9jYbjqXIkHz91DScmZ8hmt+9aTW25e5RPhy4jZvPQp8VceQlvn72hXMyPHUguNmAc4i7ZbTktRJCDqyadJNKfaC6e4mK0tR4JK3cYI88j7jGxXPetKt6U1EfRPnVBxG9TDpsRcp7RnGs0oLkn6n3GFyzZQGpu7QbeatWXcLkl5NPhuoZlJWypD0dalJSSVtqwaT94j59nMYE7SKH7JcqLjFYaZ3/Dx0OU50nZasai3KMZWRl29AuWbmA0+39oFJuCRNgRG6jAq0eOcgodShrjOqb8RKVdU55ZFLal2zJ9u7P5VUqimp1YcUl1DcNKkyjJCj0mfLdEWM5Lux2hcs6UA0SVtUtyPNeaNFWdiMOqYeqLNOdXDaWk8GSnSLHI+Ri3ua86TbzkZiQU2bNkoN1mHToq5Ly2yxlehBck8+p4C5ZsgDXadelCnUObVuLVFiwSPjEzGlMOxjxnDiFFlJ8yx355DSa7tTZlyLdYt72hDdmVdiOsp9PUyUmMol6lNGssGWSTzLmX6hcs6wA/HlE2la1Z0oIzP7ENLt7aXb1fbW/A9oJgNx1SXZ78RTcZsk/ElTh8tZfKWQG6gNLpm0mhT6izFNmrw0SFk3GlTac6xHkKPoSHFFg89mcZGa49oFIodSdgHFrFSmMkRvt0ynuSdzkslrNJYLJdmQuWbcA1f/AB7bf+EU3KqokmkKXuiWbate8zp3ejGrXnlpxkV9P2mUOoMVFLDFVZqMKMcs6dKgONSXGy/qQ2fNZZ7guN4AcptbaO5cNo21U5bsykS5lSbiOl7NM25KlJUehs1HyQZF/MLODLA2OvbSKDR6s/TjbqlQkxjxK9mwXJKYvb+IpJYTy546hcs3MBqVV2iW1TKJSqw9PU7TKm7uYz8dpThKXgzwZFzI+WMYznkPVqX7R7lqb9Nit1GFUmW98cSoxFxnVt9NaUq6pz2hcbWAAJQAAAAAACnlfmHP7jFun4S+wqJX5hz+4xcJLJJIu4hrqeIY6XmQBolK2l0S4Y8oqL7V0ojPOqm+z1GywpBHklKP3dZYzpzzGnXdtGqjMOyabQplRN+ts752roou+UpOnJGhnOnUZ/EnPulzGN29nbAGgTdp1FpJrjvtVypnDLRMnQqU44w2tJe/qUktJY6mRZwLSqbQLdpzdGdemOOs1htbsJyO0p0niSRHgiLnk8lgsZMLlm1gNBa2r229FkLaarK50del2mpprpzG+3UprGSTj+o+QnytottRrZptwOTVnSZ7xR2nktKM0rPPJSeqcaTI/ryC5Zt4DVbav2iXBV1UuOU+JUNJuNx6hEXGU+guq2yWXvJECj3zS4dlqrdZrTkqPxjsZDy4e5ccWSzSTSGk5NRljBGXXGQuWbyA0mFtBo9aplaTDen0yowIa5LjE6CpqQ0gkmZOk0vGsuX64wMLu0eiUan2+3VJU+ZLqkLiY62YKjXJwRZw2jOlR55JILlm+ANdtC8aTdaZaaYcpqVDUSZMSZHUw+yZ8y1IVz5jYgAAASgAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAGKV+Wd/tECn/mi+xifK/LO/2iBT/zRfYxrR9Esa/rhaAADJsAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAlM/ykiKJTP8pIrV4Wp8vYAAouAAAPxfwK+whiYv4FfYQxelSoAAFlQcUo9VrFoUS46RBojFdh8XLdaqTFQYSwW8M1GmRqVlCkmZkZYPoO1l1HHJ8XZ2hVcue7IUCcqJV1QnJSqabe5VkiJCiI8OERq5uGXPP0ESmGtU6y59a2cbOazHhy5xUyG6T0CJMVEfcQ7gyU04RlzLBcjMskY2qybR0T6jVStet0x8oDsVh2rVhUp5evqgm9SiIskXM1foNttvaFbtarDdGgnMiy1NmuM1LhORkvoT1NrUREoiLny7Bgq+1K1aXUpMORLlOlEXu5cmNEceYiq7nHEkaUn/oIS1is2tWXv4aU23Hpzp1r2ey0cMjTq1ktJqLrjPIz6iJfVkzzvddweyKvWYEqAzHWzSamcSRHcb5cy1JJaTI+/keRuaLpfVtMfpqZDTlCTQUVNJtoJRqUbii1ErqZaSLkLKRe1Fj2KV3uOvlRDZS/vCZPXpUZEXudepkA5fVrEmu7KLoj0m2p8SpVV+MtMSXUjmSHkocQepw1HpSZER8iUfIhvO1Bu5jgUcrcbqDsJDmKkzTHkNS1N6cJJtS+RFq69Dx0Fpct90K3ZUaLNdlPzZDZPIiwoq5DxN/OpCCMyT9TGowdoK6jQr4qaKyiPTqbNaahzG4W+NptSWzMlNng1HqUZc8GWfoAobLti429qR1yZRa1GpjlGfhpdqlRTLf1mpJkSsHhGehEXdz6i1t6163Go2ypl+nPIdpMhxc5Jmn/AGcjaWRGrn3mRcs9Rt1f2jUCg1dVImrnvVRLDcgo0SG48txCs80kkjzjHPu5CXT77tydaz9xN1FDVLjmaH1vpNtbKyPBoWg+ZKzgsdeYDlVctqvxqhUVWva9yUSsvuuLZk0qstnTlrNRmTjiHD5EfVRaciwvayay5c0C4J9PqNe10xqHNbo1QOE828k8mtJEpJLQeo+RnywNzpu1G2Z9QgQULqLE2c8TMdiVBcZU5kjMlESiLKcEfvF9BucySzCivSZbqGY7CDcdcWeEoSRZMzPuIgsXcZibOpFQtC5Ew6LLotQnqjrZTVaoqY5I3KyWknSMzJsjMjTyM+QnXM5dl2yrVQ7ZsqmtUysMSJTj0hpfJKVEamySfNBZ5meD5lyG0UfabblVqcWEyqpMHLXu4j8qA6yzJPmZbtxRYVkiyXeNfp21Bmn1y7YdxLlyCp9TNiM1AgLeW0wTaT1L0EfLJn7xgOozEmuO+lBZNSFERd/IcrpVkVSofw9laUhJ0yquxlJ0uGXurJzWRKMs8jxgzLvG6Tb4t2HbMSvu1FCqZMxwy20KWt9R9EoQRajV9MDHat9UO5pj0KA7Kj1FlG9XDnRlxniRnGvSsiyn6kJQ5ZSrJemyoMOdZNzIcZdbU89OuRaoaTQoj1pIlqNfTJFpL9Bc3XFvJ27qomRBuefS1qQVMTRak1EYQ3p5k8ZmS9Wc5Pny6DZz2r2jx/D8dIOPvuH9oFEcOHvc40b7GnOeXXAx0q9eGrF7quKay1S6RLaZjGTeFYU0lWksc1qMz5F1EJaFQLEuhjZxTGlUskVmjXAupop8iQSikN61cidyeTwrJKPtIdBpU+47jrpyJlpNUSC1FcaN+oqQuYtauiWzQZklHfnqNypstM+AxLQzIYS8klk3IbNtxJH8yT6H9BJE2RdxKiUK412ZZNIl2/MiyaFWmVPqWttSXGkpcy6kyV8PvEXPn9BeUn/Eth1GuxIlrSq/DqNRdnxpcKQ2gy3h5NDxLMjLB8tRZ5DqIBYu45TbGrVPp9ntyYrbshFwu1Wc3HURtxUuE4eCM8ZIjMiyXaNqqFHqD222jVpEZaqWzRX4zknJaUuKdIyT1znBdw3kAsXU9r11NwQZElER+IbEp2Kpt5STPU2o0mZGkzLB4FwPDTTbLZIZbQ2guiUJIi8iHsAAAEoAAAFPK/MOf3GLls8aTP6CmlfmHP7jFun4S+w11PEMdLzLmezG36rSNjcykVCC5HqThT8R1GnUo3FLNHQ8c8l2iJR7brLH/RHvae6j2Oy8moZNP+zmplKSJXPtMjLlkdYAYWb3cErlKvuplWoVVpdzT57y3kR3IlWbi03dHnRySZL5FjJGWTMsZwLqzLWrMRGyop9MdbOjQ5LU3Xp/2dZpIk5wfbzwZZHYQCxdpFrUifE2r3lVpMVbcGazDRHkHjDuhGFEXPPI+8c3qVKq9D2f2rGkU1JVNN1qfbiyFkROEpbik5MskWS6H9h38QqlS4NT4X2hFbkcK8mQxr/9m4nOFF9SyYmxdojEev3df9v1epUB+36dQt+rMp9tb0lxxJJ0pJBmWgsZyZ8+4avDsq42LRt6WxTtdUoddk1L2c86lByGlrVjCuZErBkZZHcAEWLuaS3bnuhmuuvWk1SIyqS/Fa4w0LnvvKSeEoUhRklvmXU+Z9wjW7bdWj3Vs8lSae4himUJ6NKWZpww8ZIIknz68j6DqgCbF2j23SKhF2rXlVJMVbdPmx4aI75mWHTQgyURc88j7xvAAAAACUAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAxSvyzv9ogU/8ANF9jE+V+Wd/tECn/AJovsY1o+iWNf1wtAABk2AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAASmf5SRFEpn+UkVq8LU+XsAAUXAAAH4v4FfYQxMX8CvsIYvSpUAACyr9LqQ4rULVrT9uV+L7KfWuTd6JyG8F+JH3rZm51+HBH5DtI0qsbTrYpU+REekTZC4yzbkOQ4Lr7bCi6ktaUmkjLt58hEphhvek1CdtI2ez4kR16FT35apTycaWSUzpTn7nyGsURu57Mplbt1FmPV4pcyS/ElNutHFfS6o1EUjUZGnGcGWDyRDeKvtBtmkwKROmVH/YqsRnDeaaU4l3CdXYWSMy6F2nyGS1b4oVzuy2aZJeRKiJJb8eXHXHdQg+ijSsiPTy6iBrNNt2r/4+VIlQI0WOu10QFORE6Yrb+8WZtoLOSIiMv0Gl1Wn3hJ2JyrFZs6cmoRYqGFSlPNmw8SVkf4WFalGZF0Mix2mNpvna9R4tp1x+2p6lVGK0ZxpD0NfDPLJREZIcMiQs+vIjHU46jcjsrV8SkJUf3MgS5tMj121b/l3DBoEquwKnT40VxENxBPxXGs8tKzIjQrVzMj5GQ1qTblyzrL2lJk0ByLUKvUWpMaI0tK9afws4UXIzLB5PvIxvMvaracV2U0uXLcciSXIshLEJ102VIPCjXpI9Kc/1H1F67dVGQ9Qm0zCeKtqNMBbKTWh0yRrP3i5EWC7QQpKLSZrO1mr1V6I4iG5SYsdqQZFhS0qWa0l25LlkaDU7UqpUO9HZDbMNxV2oq0NE15LLU1CN2ZI1HyIlGRkWe3A689cdNZr79FW64VQYh8etBNmZEzkyzq6ZyR8uo1d2+LLuu36jxDb1RorMPjZJvwHDZNtPPGTLBrL5S5kZfQBqFz3HVbh2gbPo8y1plHS1UVuaprrRuqMmlZJtKFGZoLtVyLoOxVtjiqROjlEZm71laOGeXoQ9kjLQpWDwR9M4HL7Jqmyih1phFsRGIEmZ+GzNVFeJpxSsfhofXlOT5ciPqOkRa7AlXFPobLizqUFpt59BoMkpS5nSZK6H0MIJcZotFumHV6exaVLu+gpakI4liqT2pNNSyRlrSjJmo+RHp04/QdB2dUidTa9fj8+GthqfVjejrWRfjNbpJZL6ZIxYP39b0ekT6m/McbgwZx06Q4plXuPEokmWO7J/F0GBzaPbbVKRPefmttOvKYYaXBdJ6QpJZPdt6dSiwZcyLADn1v2ncVJtCwao3SFyajbz0pUikuLShxaHTMtSDM9OsiwZZPoZjYY8Kt3pfMKtzqFLt6nU+BIjIOa4g5D7jpEXwoM8JTjPM+Y2y1L1ol0vyY9KfkFLjJJT0aVGXHdQk+ijSsiPB46jZAsXcYt9N2UOyI1kqsRuoyo/4KZclxtdMdRryTi8nqzjnp05yIsrZzWJt13PcMYnYlbhzWJdINav9kkGllJLLd5MsK5o1HzLkO4gFi6BQZ0ipUeJMmwH6dKdQSnYr+NbSu0jxyPn0MTwASgAAEgAAAAAAAAAAAAAp5X5hz+4xbp+EvsKiV+Yc/uMW6fhL7DXU8Qx0vMv0AAZNgAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAYpX5Z3+0QKf+aL7GJ8r8s7/aIFP/NF9jGtH0Sxr+uFoAAMmwAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACUz/KSIolM/ykitXhany9gACi4AAA/F/Ar7CGJi/gV9hDF6VKgAAWVCHB681e0yVWoNRgXlIkvvPJiIpD7EWnGyedGpz4yPHUz55HeAETCYcVta2qy3T9kTc6kyW1UlyRxyVoL/AGf8JSUmr7njBi+r9s1Gr7SrhWht6PBn2ydPRPIvdS6pa+We8iMjHTACxdwa6W7pqOx2VZDVizU1CHDajm9ltURzQafeZMj1KUeMkWCx2mO6xEmmOwlRGSiQkjI+w8EMgBYcRsCv1GhKvNEG0Z9YKVcU0kvQDbwpevGHtRkaS/4uZYHpNn1+1rbsGS3Tl1aTQp0iXMhQVJNSUvJX7jWoyJRINRERduB12kUeBR0y00yMmOUuQuW+STM9bqzypXM+0+7kJ4ixdyims1ys7SKpXZVuz6ZBkW9wrBSTSazXvFHpWSTMkr5/Dk+WB5RT5dJ/hnkwKjGciS2KK8l1hwsKQrSrJGXeOsiLVIEWq02TAqDJPw5LZtPNGZkS0mWDLlzE2LuPTjuC7bFo9ox7Rl0/KYinak443wjLbakr1tKI9SlGScEnBHz5i8nlWbX2pVWtR7cqVbp9VgxYza4Btmppxs1EeslKLCTyR6h0uMw1FjNR46CQy0gkISX9KSLBEMgWLuEf4ZuJ/Z7X40qiSG6hKukppRk4XlrfpUayPtTgj5jddqrlzNyaOuitVdykEThTvYqGlTc4LQSN5yJPXOOY6EAWLuM7KqRXo+02q1aqUu4I9PmU1tDUisyEPvKUlXRWnk2fP4P1HZgAIAAASgAAAAAAAAAAAAAAAAAAABTyvzDn9xi3T8JfYVEr8w5/cYt0/CX2Gup4hjpeZfoAAybAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAxSvyzv8AaIFP/NF9jE+V+Wd/tECn/mi+xjWj6JY1/XC0AAGTYAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAABKZ/lJEUSmf5SRWrwtT5ewABRcAAAfi/gV9hDExZZSZF3CPul93qLUq1MYDJul93qG6X3eoteFbMYDJul93qG6X3eoXgsxgMm6X3eobpfd6heCzGAybpfd6hul93qF4LMYDJul93qG6X3eoXgsxgMm6X3eobpfd6heCzGAybpfd6hul93qF4LMYDJul93qG6X3eoXgsxgMm6X3eobpfd6heCzGAybpfd6hul93qF4LMYDJul93qG6X3eoXgsxgMm6X3eobpfd6heCzGAybpfd6hul93qF4LMYDJul93qG6X3eoXgsxgMm6X3eobpfd6heCzGAybpfd6hul93qF4LKOV+Yc/uMW6fhL7CO7TXVuKUSklqPOBMJlZERY9RpXVExFpZadMxM3h4AZN0vu9Q3S+71Gd4a2YwGTdL7vUN0vu9QvBZjAZN0vu9Q3S+71C8FmMBk3S+71DdL7vULwWYwGTdL7vUN0vu9QvBZjAZN0vu9Q3S+71C8FmMBk3S+71DdL7vULwWYwGTdL7vUN0vu9QvBZjAZN0vu9Q3S+71C8FmMBk3S+71DdL7vULwWYwGTdL7vUN0vu9QvBZjAZN0vu9Q3S+71C8FmMBk3S+71DdL7vULwWYwGTdL7vUN0vu9QvBZjAZN0vu9Q3S+71C8FmMBk3S+71DdL7vULwWYwGTdL7vUN0vu9QvBZjAZN0vu9Q3S+71C8FkaV+Wd/tECn/mi+xi1cjrcbUgywSixkYWKebLhLIzM8YweBpTXEUzDOqiZqiYZQGTdL7vUN0vu9RneGlmMBk3S+71DdL7vULwWYwGTdL7vUN0vu9QvBZjAZN0vu9Q3S+71C8FmMBk3S+71DdL7vULwWYwGTdL7vUN0vu9QvBZjAZN0vu9Q3S+71C8FmMBk3S+71DdL7vULwWYwGTdL7vUN0vu9QvBZjAZN0vu9Q3S+71C8FmMBk3S+71DdL7vULwWYwGTdL7vUN0vu9QvBZjAZN0vu9Q3S+71C8FmMBk3S+71DdL7vULwWYwGTdL7vUN0vu9QvBZjAZN0vu9Q3S+71C8FmMBk3S+71DdL7vULwWYwGTdL7vUN0vu9QvBZjAZN0vu9Q3S+71C8FmMBk3S+71DdL7vULwWYxKZ/lJGHdL7vUZ2iNKCI+oipNL0AAKLgAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAP/2Q==" style=undefined width=542></div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>115. </span> What is the causative organisms of sporotrichosis which is most commonly affects gardeners? </p><ol class=mt-3 type=A><li>Haemophilus ducreyi</li><li>Neisseria meningitidis</li><li>Sporothrix schenckii</li><li>Salmonella</li></ol><button aria-controls=explanation-O5M aria-expanded=false class="btn btn-secondary" data-target=#explanation-O5M data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-O5M><p class=correct-answer><strong>Answer:</strong> C</p><strong>Sporotrichosis</strong> is a fungal infection caused by the dimorphic fungus, <span style="text-decoration: underline;">Sporothrix schenckii.<br></span>It is characterized by a papule at the site of inoculation, followed by ulceration and lymphadenopathy.<br> It is classically seen in <span style="text-decoration: underline;">gardeners</span>. Lymphocutaneous disease is the usual manifestation with localization to skin and soft tissues.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>116. </span> Which of the following is associated with neurofibromatosis? </p><ol class=mt-3 type=A><li>BCR-ABL</li><li>NF1</li><li>CFTR</li><li>APC</li></ol><button aria-controls=explanation-MVH aria-expanded=false class="btn btn-secondary" data-target=#explanation-MVH data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-MVH><p class=correct-answer><strong>Answer:</strong> B</p>Neurofibromatosis<br><br>1. It is the the most common neurocutaneous disorder. <br>2. There are two types: Neurofibromatosis 1 (NF1, or von Recklinghausen’s syndrome) and neurofibromatosis 2 (NF2). <br>3. Both are Autosomal dominant disease (Caused by NF1 gene on chromosome 17).<br>4. Neurocutaneous disorder characterized by café-au-lait spots, cutaneous neurofibromas, optic gliomas, pheochromocytomas, Lisch nodules.<br>5. Optic glioma occurs in 15% of patients with neurofibromatosis type 1.<br>6. Initial signs are freckling, café-au-lait spots, Lisch nodules, neurofibromas, axillary or inguinal freckling and bone abnormalities.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>117. </span> Which of the following is characterize by polydipsia, hypernatremia, serum osmolarity &gt; 300 mOSm/kg and urine osmo­larity &lt; 300 mOSm/kg? </p><ol class=mt-3 type=A><li>Diabetes Mellitus type 2</li><li>Diabetic Ketoacidosis</li><li>Diabetes insipidus</li><li>Diabetes Mellitus type 1</li></ol><button aria-controls=explanation-41V aria-expanded=false class="btn btn-secondary" data-target=#explanation-41V data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-41V><p class=correct-answer><strong>Answer:</strong> C</p><span style="text-decoration: underline;"><strong>Diabetes insipidus</strong></span> (DI) is defined as the passage of large volumes (&gt;3 L/24 hr) of dilute urine (&lt; 300 mOsm/kg).<br><br><strong>It has the following 2 major forms:</strong><br>1. <span style="text-decoration: underline;">Central</span> (neurogenic, pituitary, or neurohypophyseal) DI, characterized by decreased secretion of antidiuretic hormone (ADH).<br>2. <span style="text-decoration: underline;">Nephrogenic DI</span>, characterized by decreased ability to concentrate urine because of resistance to ADH action in the kidney.<br><br><span style="text-decoration: underline;">The predominant manifestations of DI are as follows:</span><br>1. Polyuria<br>2. Polydipsia <br>3. Nocturia<br><br>1.Labs: Hypernatremia and Low urine osmolality with large urine volume  <br><strong>2.Water deprivation test</strong> is used to differentiate between psychogenic polydipsia and DI.<br>3. Administration of DDAVP after water deprivation can distinguish between central and nephrogenic diabetic insipidus.<br>4. Patients with central DI will have an increase of urine osmolality by at least 50% following the administration of AVP or DDAVP, whereas patients with nephrogenic DI will not have such an increase.<br>5. The treatment of choice for central DI is <strong>desmopressin</strong> ( administered intranasally)</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>118. </span> Which of the following antidiabetics is associated with lactic acidosis? </p><ol class=mt-3 type=A><li>Sulfonylurea</li><li>Insulin</li><li>Metformin</li><li>Glimepiride</li></ol><button aria-controls=explanation-F3F aria-expanded=false class="btn btn-secondary" data-target=#explanation-F3F data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-F3F><p class=correct-answer><strong>Answer:</strong> C</p>Metformin<br><br>1. The best initial medical therapy for type 2 Diabetes is metformin. <br>2. Metformin works by blocking gluconeogenesis.<br>3. Metformin is particularly beneficial in obese patients, because it does not lead to added weight gain and there is no risk of hypoglycemia  <br>4. If a patient with type 2 diabetes cannot be controlled with metformin, then add a second medication. <br>5. Metformin (biguanide) is the only antidiabetic drug that causes some weight loss. <br>6. It is very important to assess the patient's renal status before starting metformin, since this drug can produce lactic acidosis in patients with compromised renal status.<br>7. Thiazolidinedione drug (pioglitazone or rosiglitazone), Sulfonylurea, and insulin lead to weight gain with long-term use.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>119. </span> A 66-year-old man presents to the doctor with difficulty swallowing solid food and recently fluid for the last 4 months. He also complained of weight loss. His medical history is significant for GERD. He is a heavy smoker for 20 years but he quit recently.<br><br>Which of the following is the most likely diagnosis? </p><ol class=mt-3 type=A><li>Esophageal cancer</li><li>Achalasia</li><li>Diffuse esophageal spasm</li><li>Zenker diverticulum</li></ol><button aria-controls=explanation-PIO aria-expanded=false class="btn btn-secondary" data-target=#explanation-PIO data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-PIO><p class=correct-answer><strong>Answer:</strong> A</p><span style="text-decoration: underline;"><strong>Esophageal cancer </strong></span><br>1. The two major histological types are squamous cell carcinoma (SCC) and adenocarcinoma. <br>2. The risk factors for adenocarcinoma include Barrett's esophagus, chronic GERD, smoking, obesity, high dietary calorie and fat intake. <br>3. The major risk factors for squamous cell cancer of the esophagus are smoking, alcohol.<br>4. <span style="text-decoration: underline;"><strong>Presents</strong></span> with progressive dysphagia (initially solids, later solids and liquids), weight loss, odynophagia, reflux, GI bleeding, vomiting, weakness, cough, hoarseness.<br>5. Weight loss is very common with cancer.<br>6. Barrett esophagus (intestinal metaplasia of distal esophagus secondary to chronic GERD) commonly precedes adenocarcinoma.<br>7. <span style="text-decoration: underline;"><strong>Complications</strong></span>: poor prognosis; local extension and metastases are frequently present by time of diagnosis  <br><br><span style="text-decoration: underline;"><strong>Diagnosis:</strong></span><br>1. Endoscopy is the best initial test.<br>2. Barium swallow shows narrowing of esophagus and abnormal mass <br><br><span style="text-decoration: underline;"><strong>Treatment</strong></span> <br> 1. Surgical resection (best initial therapy)<br> 2. Radiation and chemotherapy <br> 3. With severe, unresectable cases, a “stent” is placed to push the esophagus open</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>120. </span> What is the best initial therapy for a patient with pheochromocytoma? </p><ol class=mt-3 type=A><li>β-antagonists</li><li>α-antagonists</li><li>Surgical resection</li><li>Pegvisomant</li></ol><button aria-controls=explanation-4PO aria-expanded=false class="btn btn-secondary" data-target=#explanation-4PO data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-4PO><p class=correct-answer><strong>Answer:</strong> B</p>Pheochromocytoma<br><br>1. Pheochromocytoma is a rare neuroendocrine tumor ( 90% found in adrenal medulla ) <br>2. Paroxysms of very high blood pressure, headache, palpitations, abdominal pain, tremor, <br>and excessive sweating is classic, and suggests sympathetic hyperactivity induced by catecholamine release. <br>3. Pheochromocytoma is due to catecholamine-secreting tumors of the adrenals.<br>4. Presents with headache, palpitations, tremors, anxiety, and flushing. <br>5. Pheochromocytoma is part of MEN II. <br>6. Most accurate test:  CT or MRI of the adrenal glands  <br>7. Elevated urinary catecholamines (vanillylmandelic acid) are diagnostic.<br>8. Always give an alpha-blocker first, followed by a beta-blocker; doing this in the wrong order can precipitate a very dangerous increase in blood pressure.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>121. </span> Which of the following is associated with burkitt’s lymphoma ? </p><ol class=mt-3 type=A><li>HPV</li><li>EBV</li><li>H pylori</li><li>HBV</li></ol><button aria-controls=explanation-TZL aria-expanded=false class="btn btn-secondary" data-target=#explanation-TZL data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-TZL><p class=correct-answer><strong>Answer:</strong> B</p><table class="table table-responsive table-sm table-striped"> <tbody> <tr> <td><span style="text-decoration: underline;"><strong>Oncogenic microbes</strong></span></td> <td><span style="text-decoration: underline;"><strong>Associated cancer</strong></span></td> </tr> <tr> <td>EBV</td> <td><strong>Burkitt lymphoma,</strong> Hodgkin lymphoma, nasopharyngeal carcinoma, 1° CNS lymphoma</td> </tr> <tr> <td>HBV, HCV</td> <td>Hepatocellular carcinoma, lymphoma</td> </tr> <tr> <td>HHV-8</td> <td>Kaposi sarcoma</td> </tr> <tr> <td>H pylori</td> <td>Gastric adenocarcinoma</td> </tr> <tr> <td>HPV</td> <td>Cervical and penile/anal carcinoma (types 16, 18), head and neck cancer</td> </tr> </tbody> </table></div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>122. </span> A 22-year old girl presents to the physician with right side pulsating headache with photophobia and nausea. She reports that during the headache, she prefers to be in a dark quiet room. Which of the following is the most likely diagnosis? </p><ol class=mt-3 type=A><li>Cluster Headaches</li><li>Migraine headache</li><li>Tension headache</li><li>Subdural hemorrhage</li></ol><button aria-controls=explanation-7P4 aria-expanded=false class="btn btn-secondary" data-target=#explanation-7P4 data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-7P4><p class=correct-answer><strong>Answer:</strong> B</p>Migraine headache <br><br>Unilateral ( 60 % are unilateral, and 40% are bilateral ) pulsating pain with photophobia, or phonophobia and may have aura.<br>Other symptoms include nausea and vomiting and fatigue may be manifested  <br>Precipitating factors :<br>1. Stress<br>2. Oral contraceptives<br>3. Menstruation<br>4. Exertion<br>5. Foods containing tyramine or nitrates (chocolate, cheese, processed meats) <br><br>Drugs used for acute attacks of migraine ( Simple analgesics are always given first) : <br>1. Simple analgesics (e.g., acetaminophen) and NSAIDs.<br>2. Best initial therapy: Sumatriptan or ergotamine. (triptans for acute attacks of migraine when simple analgesics or NSAIDs fail.) <br>Pophylactic treatment include:<br>1. Beta blockers<br>2. Calcium channel blockers<br>3. Valporic acid</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>123. </span> Which of the following is true regarding sickle cell anemia? </p><ol class=mt-3 type=A><li>It is a sex-linked, recessive, inherited disorder</li><li>Patients with sickle cell should receive pneumococcal vaccination</li><li>Hydroxyurea may increase the frequency</li><li>Diagnosis made by history and physical examination</li></ol><button aria-controls=explanation-SBF aria-expanded=false class="btn btn-secondary" data-target=#explanation-SBF data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-SBF><p class=correct-answer><strong>Answer:</strong> B</p>1. <strong>Sickle cell disease</strong> causes a chronic hemolytic anemia occurring almost exclusively in blacks.<br>2. It is caused by homozygous inheritance of Hb S.<br>3. Patients homozygous for Hb S have an abnormal beta chain, resulting in fragile, relatively inflexible RBCs that can plug capillaries, causing tissue infarction and that are prone to hemolysis, causing anemia<br>4. Sickle cell anemia is an Autosomal recessive inherited hemolytic anemia<br>5. Sickle-shaped RBCs cause vaso-occlusion and are prone to hemolysis, leading to severe pain crises, organ ischemia, and other systemic complications.<br>6. Acute exacerbations (crises) may develop frequently.<br>7. Infection, bone marrow aplasia, or lung involvement (acute chest syndrome) can develop acutely and be fatal. <br>8. Anemia is present, and sickle cells are usually evident on the peripheral smear.<br>9. <span style="text-decoration: underline;"><strong>Diagnosis</strong></span> requires Hb electrophoresis.<br>10. Painful crises are treated with analgesics and other supportive measures.<br>11. Transfusions are occasionally required.<br>12. <strong>Vaccines</strong> against bacterial infections, prophylactic antibiotics, and aggressive treatment of infections prolong survival.<br>13. <strong>Hydroxyurea</strong> may <span style="text-decoration: underline;">decrease</span> the frequency of crises and the acute chest syndrome.<br>14. Key: Prevent infection by using vaccinations and prophylactic antibiotics; limit painful crises and risk of acute chest syndrome by giving hydroxyurea.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>124. </span> A 23 year-old man who is known to be HIV positive presents with a history of mild fever, cough and difficulty breathing. A diagnosis of pneumonia is made. A transbronchial biopsy was ordered as the patient did not respond to antibiotic treatment (see report).<br><br><strong>Alveolar biopsy</strong><br>Soap bubble like intra-alveolar exudates and small cyst like structures identified by silver stains<br> <br>What was the most likely cause? </p><ol class=mt-3 type=A><li>Aspergillus fumigates</li><li>Cryptococus neoformans</li><li>Pneumocytosis carini</li><li>Chlamydia trachomatis</li></ol><button aria-controls=explanation-9D1 aria-expanded=false class="btn btn-secondary" data-target=#explanation-9D1 data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-9D1><p class=correct-answer><strong>Answer:</strong> C</p>1. <strong>Pneumocystis </strong>jirovecii is a common cause of pneumonia in immunosuppressed patients, especially in those infected with HIV and in those receiving systemic corticosteroids. <br>2. Symptoms include fever, dyspnea, and dry cough. <br>3. Diagnosis requires demonstration of the organism in an induced sputum specimen or bronchoscopic sample.<br>4. Diagnosis is made histologically by finding the organisms in cytologic (broncho alveolar lavage) or biopsy (transbronchialor open lung biopsy) material from lung. (shows <span style="text-decoration: underline;">soap bubble pattern</span>" cotton candy exudate", and silver staining shows the organism which is comma shaped) <br>5. Treatment is with antibiotics, usually trimethoprim/sulfamethoxazole or dapsone/trimethoprim, clindamycin/primaquine, atovaquone, or pentamidine. <br>6. Patients with Pao2&lt; 70 mm Hg receive systemic corticosteroids. <br>7.Prognosis is generally good with timely treatment.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>125. </span> Which of the following conditions is associated with chronic epigastric abdominal pain, malabsorption and weight loss? </p><ol class=mt-3 type=A><li>Gastroesophageal Reflux Disease</li><li>Cholangitis</li><li>Irritable bowel syndrome</li><li>Chronic pancreatitis</li></ol><button aria-controls=explanation-909 aria-expanded=false class="btn btn-secondary" data-target=#explanation-909 data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-909><p class=correct-answer><strong>Answer:</strong> D</p>1. Chronic pancreatitis is persistent inflammation of the pancreas that results in permanent structural damage with fibrosis and ductal strictures, followed by a decline in exocrine and endocrine function.<br>2. It can occur as the result of chronic alcohol abuse but may be idiopathic.<br>3. Initial symptoms are recurrent attacks of pain.<br>4. Later in the disease, some patients develop malabsorption and glucose intolerance.<br>5. Diagnosis is usually made by imaging studies such as ERCP, endoscopic ultrasonography, or secretin pancreatic function testing.<br>6. Treatment is the same as for acute pancreatitis, with IV fluid resuscitation, fasting, parenteral analgesics, and acid-blockers, but with the addition of oral pancreatic enzyme supplements and/or insulin as needed<br>7. Recurrent attacks of acute pancreatitis may cause ductal damage, chronic persistent inflammation, and ultimately fibrosis, leading to pancreatic insufficiency.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>126. </span> A 39-year-old man presents to the physician with fever, dyspnea and a nonproductive cough. He tested positive for HIV 2 years ago. His temperature is 39 C, blood pressure is 133/80 mmHg, pulse is 100/min and respirations are 20/min. Chest x-ray shows interstitial infiltrates. <br> <br>Which of the following is the most likely diagnosis? </p><ol class=mt-3 type=A><li>Pneumocystis jiroveci</li><li>Sarcoidosis</li><li>Tuberculosis</li><li>Wegener's granulomatosis</li></ol><button aria-controls=explanation-FOC aria-expanded=false class="btn btn-secondary" data-target=#explanation-FOC data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-FOC><p class=correct-answer><strong>Answer:</strong> A</p><span style="text-decoration: underline;"><strong>Pneumocystis jiroveci</strong></span><br><br>1. Causes <strong>Pneumocystis pneumonia (PCP),</strong> a diffuse interstitial pneumonia.<br>2. Most common opportunistic infection in persons with HIV infection.<br>3. Suspect P jiroveci pneumonia in <strong>any HIV patient</strong> who presents with a<strong> nonproductive cough</strong> and <strong>dyspnea</strong>.<br>4. Presents with dyspnea on exertion, fever, a nonproductive cough, tachypnea, weight loss, fatigue, and impaired oxygenation.<br>5. When a person with AIDS, <strong>CD4 &lt;200</strong>, and hypoxia has bilateral interstitial infiltrates, you still need to confirm that PCP is present. <br>6. CXR may show diffuse, <strong>bilateral interstitial infiltrates</strong> with a ground-glass appearance <br>7. Treatment: TMP-SMX</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>127. </span> A 25-year-old male comes to the doctor with diarrhea. He just returned from a trip to South Africa, where he developed foul-smelling stools, abdominal cramps and bloating. His temperature is 37 C , blood pressure is 102/68 mm Hg, and pulse is 90/min. Physical examination is unremarkable. Which of the following tests is confirmatory for this patient's condition? </p><ol class=mt-3 type=A><li>Colonoscopy</li><li>Stool ELISA antigen</li><li>Microscopic examination of stool</li><li>CT scan</li></ol><button aria-controls=explanation-VOM aria-expanded=false class="btn btn-secondary" data-target=#explanation-VOM data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-VOM><p class=correct-answer><strong>Answer:</strong> B</p>1. <strong>Giardiasis</strong> is infection with the flagellated protozoan Giardia duodenalis (G. lamblia, G. intestinalis).<br>2. Infection can be asymptomatic or cause symptoms ranging from intermittent flatulence to chronic malabsorption.<br>3. <span style="text-decoration: underline;">The most common symptoms</span> are foul-smelling stools, fatty stools, bloating, flatulence, nausea, malaise, and abdominal cramps.<br>4. Places where giardiasis is widespread include: sub-Saharan Africa – all the countries south of the Sahara desert, such as South Africa, Gambia and Kenya <br>5. <strong>Transmission</strong> can also occur by ingestion of contaminated food and by direct person-to-person contact, especially in mental institutions and day care centers or between sex partners.<br>6. <span style="text-decoration: underline;">The major source of giardiasis is waterborne transmission</span>, including via fresh-appearing mountain streams and poorly filtered municipal water supplies.<br><br><strong>Diagnosis:</strong><br>1. Stool ELISA antigen is &gt; 90 percent sensitive and specific and is more accurate than 3-stool ova and parasite exams. <br>2. CT scan of the abdomen is not useful.<br>3. Colonoscopy is helpful in patients with unexplained diarrhea.<br><br><strong>Treatment</strong> is with metronidazole, tinidazole, or nitazoxanide or, during pregnancy, paromomycin.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>128. </span> What is the strongest reversible risk factor for stroke? </p><ol class=mt-3 type=A><li>Hypertension</li><li>Obesity</li><li>Hyperlipidemia</li><li>Smoking</li></ol><button aria-controls=explanation-GQ9 aria-expanded=false class="btn btn-secondary" data-target=#explanation-GQ9 data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-GQ9><p class=correct-answer><strong>Answer:</strong> A</p>Hypertension is the most powerful risk factor for stroke, including both hemorrhagic and thrombotic types. Hypertension is a major risk factor for stroke, myocardial infarction, vascular disease, and chronic kidney disease.<br><br>Hypertension is the most important potentially reversible risk factor for stroke in all age groups; high blood pressure (BP) is also associated with increased risk of recurrent stroke in patients who have already had an ischemic or hemorrhagic event.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>129. </span> A 25-year-old man presents to his primary care physician complaining of wheezing and breathlessness during exercise. <br><br>Which of the following is the most appropriate next step in management? </p><ol class=mt-3 type=A><li>Beta-adrenergic agonists before exercise</li><li>Montelukast</li><li>Oxygen</li><li>Theophylline</li></ol><button aria-controls=explanation-ENE aria-expanded=false class="btn btn-secondary" data-target=#explanation-ENE data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-ENE><p class=correct-answer><strong>Answer:</strong> A</p><span style="text-decoration: underline;"><strong>Exercise-induced asthma<br></strong></span> <br>1. <strong>Asthma</strong>: Reversible airway obstruction secondary to bronchial hyperactivity, acute airway inflammation, mucus plugging, and smooth muscle hypertrophy. <br>2.<strong> Exercise-induced asthma</strong> is a condition of respiratory difficulty (bronchoconstriction) that is related to histamine release, is triggered by aerobic exercise, and lasts several minutes.<br>3. Exacerbations (i.e., sudden bronchoconstriction and airway inflammation) are triggered by allergens (e.g., dust, smoke, pollen, fumes, pet dander), URI, exercise, stress, 􏱯-blockers, aspirin (rare), and sulfites (rare). <br>4. <strong>Risk factors</strong>: 􏱧family history of asthma, allergies, atopic dermatitis, low socioeconomic status <br>5. <strong>Clinical features</strong>: cough, dyspnea, wheezing, chest tightness; tachypnea, tachycardia, prolonged expiratory duration, decreased breath sounds, wheezing, accessory muscle use, possible pulsus paradoxus; cyanosis, decreased arterial O2 saturation (Sao2) on pulse oximetry, or difficulty talking in severe attacks.<br><strong>6. Short-acting beta-adrenergic agonists administered 20 minutes before exercise are the first-line treatment for isolated exercise-induced asthma</strong></div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>130. </span> What is the drug of choice for a patient with hiccups? </p><ol class=mt-3 type=A><li>Chlorpromazine</li><li>Sertraline</li><li>Propanol</li><li>Oxygen</li></ol><button aria-controls=explanation-OLU aria-expanded=false class="btn btn-secondary" data-target=#explanation-OLU data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-OLU><p class=correct-answer><strong>Answer:</strong> A</p>Various agents have been reported to cure hiccups. <strong>Chlorpromazine appears to be the drug of choice.</strong> Haloperidol and metoclopramide have been used successfully. Several anticonvulsant agents (eg, phenytoin, valproic acid, and carbamazepine) have effectively treated intractable hiccups in typical anticonvulsant doses. Gabapentin has been effective in patients with central nervous system (CNS) lesions and in some other groups.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>131. </span> A 30-year-old man presents to the physician with shortness of breath for the last 4 months. He is a nonsmoker. He has a family history of cirrhosis. Chest x-ray reveals panlobular emphysema.<br><br>Which of the following is the most likely diagnosis? </p><ol class=mt-3 type=A><li>Acute liver failure</li><li>Asthma</li><li>Alpha 1-antitrypsin deficiency</li><li>Chronic obstructive pulmonary disease</li></ol><button aria-controls=explanation-KE2 aria-expanded=false class="btn btn-secondary" data-target=#explanation-KE2 data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-KE2><p class=correct-answer><strong>Answer:</strong> C</p><span style="text-decoration: underline;"><strong>Alpha1-Antitrypsin Deficiency (AATD)<br></strong></span><br>1. It is an <strong>autosomal recessive</strong> disorder leading to deficient levels of alpha-1 antitrypsin (A1AT) leading to cirrhosis and panlobular emphysema <br>2. The initial symptoms of alpha1-antitrypsin deficiency include cough, sputum production, and wheezing. <br>3. Dyspnea is the symptom that eventually dominates AATD (84%).<br>4. Patients with AATD frequently develop dyspnea 20-30 years earlier (at age 30-45 y) than do smokers with emphysema and normal alpha1-antitrypsin levels.<br>5. Cigarette smoking accelerates the progression of emphysema in patients with AATD. <br>6. The <span style="text-decoration: underline;"><strong>diagnosis</strong></span> of AATD is established by measurement of the serum A1AT level, followed by confirmatory genetic testing. <br>7.<span style="text-decoration: underline;"><strong>Treatment</strong></span>: 􏶑Alpha-1 antitrypsin infusion and liver transplant or lung transplant may be needed in severe cases;</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>132. </span> Which of the following is the most commonly feared sequela of giant cell arteritis? </p><ol class=mt-3 type=A><li>Retinal detachment</li><li>Permanent visual loss</li><li>Arm claudication</li><li>Acute renal failure</li></ol><button aria-controls=explanation-UDC aria-expanded=false class="btn btn-secondary" data-target=#explanation-UDC data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-UDC><p class=correct-answer><strong>Answer:</strong> B</p>1. <span style="text-decoration: underline;"><strong>Temporal Arteritis</strong></span> (Giant cell arteritis) is due to subacute granulomatous inflammation of the large vessels, including the aorta, external carotid (especially the temporal branch), and vertebral arteries.<br><strong>2. The most feared manifestation is blindness </strong><br>3. <strong>Risk factors</strong>: include polymyalgia rheumatica (affects almost half of patients), age &gt; 50, and female gender. <br>4. Presents with headache and pain in one or both temples, visual problems (decreased vision or blurry vision) and polymyalgia rheumatica (proximal stiffness in neck, arms, hips). <br>5. <strong>Temporal artery biopsy</strong> can be done within several days after treatment, for confirmation of the disease. <br>6. Any delay in the treatment may result in visual loss.<br>7. Giant cell arteritis must be treated immediately with <strong>high dose glucocorticoids</strong> once the clinical diagnosis is made.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>133. </span> Which of the following is the most common causes of intraparenchymal hemorrhage? </p><ol class=mt-3 type=A><li>Hypertriglyceridemia</li><li>Uncontrolled diabetes mellitus</li><li>Uncontrolled hypertension</li><li>Hyperlipidemia</li></ol><button aria-controls=explanation-88T aria-expanded=false class="btn btn-secondary" data-target=#explanation-88T data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-88T><p class=correct-answer><strong>Answer:</strong> C</p>1. Hemorrhagic stroke occurs in about 20% of all cases. <br>2. <strong>The major risk factors for stroke include</strong>: increased age, family history, obesity, DM, HTN, tobacco use, atrial fibrillation (Afib)<br><strong>3. The most common causes of intraparenchymal hemorrhage are uncontrolled hypertension.</strong><br>4. Intraparenchymal hemorrhage typically occurs in basal ganglia and internal capsule <br>5. Pontine hemorrhage accounts for 5-12% of cases of hypertensive intraparenchymal hemorrhages.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>134. </span> A 22-year old woman presents to the physician with chronic anterior knee pain that is worse with climbing stairs. Her past medical history is unremarkable. Her vital signs are within normal limits.<br><br>Which of the following is the most likely diagnosis? </p><ol class=mt-3 type=A><li>Patellofemoral pain syndrome</li><li>Patellar tendinitis</li><li>Juvenile rheumatoid arthritis</li><li>Osgood–Schlatter disease</li></ol><button aria-controls=explanation-LET aria-expanded=false class="btn btn-secondary" data-target=#explanation-LET data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-LET><p class=correct-answer><strong>Answer:</strong> A</p><span style="text-decoration: underline;"><strong>Patellofemoral Pain Syndrome (PFPS)<br></strong></span><br>1. <strong>PFPS is the most common cause of knee pain seen by primary care physicians, orthopedic surgeons, and sports medicine specialists</strong><br>2.The common presentation is knee pain in association with positions of the knee that result in increased or misdirected mechanical forces between the kneecap and femur.<br><strong>3. Knee pain is the most common presentation of patellofemoral syndrome.</strong><br>4. The pain characteristically is located behind the kneecap (retropatellar) and most often manifests during activities that require knee flexion and forceful contraction of the quadriceps (eg, during squats, ascending/descending stairs).<br>5. Pain may worsen in intensity, duration, and rapidity of onset if the aggravating activity is performed repeatedly.<br>6. It is a common condition among adolescent females. <br>7. <strong>Diagnosis</strong>: Anterior knee pain that increases with activity.  <br><span style="text-decoration: underline;"><strong><br>Treatment</strong></span> <br>1. Ice, rest, NSAID, knee brace<br>2. Physical therapy: for quadriceps strengthening and ham­string stretching</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>135. </span> Which of the following is associated with unilateral, severe periorbital headache and conjunctival erythema? </p><ol class=mt-3 type=A><li>Migraine headache</li><li>Cluster headache</li><li>Giant cell arteritis</li><li>Tension headache</li></ol><button aria-controls=explanation-8DC aria-expanded=false class="btn btn-secondary" data-target=#explanation-8DC data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-8DC><p class=correct-answer><strong>Answer:</strong> B</p>Cluster headache<br><br>1.Usually occurs in middle-aged men ( Males are affected more often than females).<br>2.Presents as excruciating, unilateral periorbital headache that lasts 30 minutes to 3 hours.<br>3.Almost always unilateral<br>4.Accompanied by ipsilateral lacrimation, facial flushing, nasal stuffiness and discharge, conjunctival injection and May present with Horner syndrome.<br>5.100% oxygen (treatment of choice) is an effective and rapid method to abort an acute attack of cluster headache.<br>6.Prophylactic therapy: prednisone and ergotamine</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>136. </span> Which of the following is characterize by elevated free T4 and T3, low TSH ? </p><ol class=mt-3 type=A><li>Euthyroid sick syndrome</li><li>Hashimoto thyroiditis</li><li>Hypothyroidism</li><li>Hyperthyroidism</li></ol><button aria-controls=explanation-G06 aria-expanded=false class="btn btn-secondary" data-target=#explanation-G06 data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-G06><p class=correct-answer><strong>Answer:</strong> D</p>1. <span style="text-decoration: underline;"><strong>Hyperthyroidism</strong></span> (Thyrotoxicosis) = ↑↑ T3, T4 level and ↓↓ TSH levels. <br>2. Excess production of thyroid hormones<br>3. Multiple causes, but<span style="text-decoration: underline;"> Graves disease is most common.</span><br>4. <strong>Clinical features</strong>: weight loss, increased appetite, heat intolerance, anxiety, diaphoresis, palpitations, increased bowel frequency; staring or lid lag, tremor, tachycardia, increased pulse pressure, warm skin, hyperreflexia, possible atrial fibrillation<br>5. <strong>Complications:</strong> thyroid storm</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>137. </span> Which of the following is true regarding hereditary angioedema? </p><ol class=mt-3 type=A><li>Mild trauma, pregnancy, and ingestion of certain foods may trigger attacks.</li><li>Clinical presentation is usually at an older age</li><li>Treatment involves dehydroepiandrosterone (DHEA) administration</li><li>It is related to excessive amyloid deposition.</li></ol><button aria-controls=explanation-8Y2 aria-expanded=false class="btn btn-secondary" data-target=#explanation-8Y2 data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-8Y2><p class=correct-answer><strong>Answer:</strong> A</p>1. <strong>Hereditary angioedema</strong> and <strong>acquired angioedema</strong> (acquired C1 inhibitor deficiency) are caused by deficiency or dysfunction of C1 inhibitor, a protein that regulates the classical complement activation pathway.<br><br>2. C1 inhibitor deficiency or dysfunction results in increased levels of bradykinin because C1 inhibitor inhibits activated kallikrein (required for the generation of bradykinin) in the kinin system pathway.<br><br>3. <strong>Onset is usually during childhood or adolescence (hereditary)</strong> or <span style="text-decoration: underline;">during later adulthood (acquired),</span> often in patients with a neoplastic or an autoimmune disorder.<br><br>4. <span style="text-decoration: underline;"><strong>Triggers</strong></span>: In all forms of hereditary and acquired angioedema, attacks can be precipitated by mild trauma (eg, dental work, tongue piercing), viral illness, cold exposure, pregnancy, or ingestion of certain foods; angioedema may be aggravated by emotional stress.<br><br>5. <span style="text-decoration: underline;">Symptoms and signs</span> are similar to those of other forms of bradykinin-mediated angioedema, with asymmetric and mildly painful swelling that often involves the face, lips, and/or tongue. Swelling may also occur on the back of hands or feet or on the genitals.<br><br>6. Pruritus, urticaria, and bronchospasm do not occur, but laryngeal edema may be present, causing stridor (and sometimes death).<br>7. <span style="text-decoration: underline;"><strong>Diagnosis</strong></span> is by measurement of complement levels.<br>8. C1 inhibitor is used to treat acute attacks.<br>9. <span style="text-decoration: underline;"><strong>Prophylaxis</strong></span> is with attenuated androgens, which increase C1 inhibitor levels.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>138. </span> Which of the following findings supports this diagnosis of Parkinson's disease? </p><ol class=mt-3 type=A><li>Memory loss</li><li>Action tremor</li><li>Bradykinesia</li><li>Hemiplegia</li></ol><button aria-controls=explanation-EVM aria-expanded=false class="btn btn-secondary" data-target=#explanation-EVM data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-EVM><p class=correct-answer><strong>Answer:</strong> C</p>1. <span style="text-decoration: underline;"><strong>Parkinson disease</strong></span> is a slowly progressive, degenerative disorder characterized by resting tremor, stiffness (rigidity), slow and decreased movement (bradykinesia), and gait and/or postural instability. <br>2. In most patients, symptoms of Parkinson disease (PD) begin insidiously.<br>3. A <span style="text-decoration: underline;">resting tremor</span> of one hand is often the first symptom.<br>4. Rigidity develops independently of tremor in many patients. When a clinician moves a rigid joint, semirhythmic jerks due to variations in the intensity of the rigidity occur, producing a ratchet-like effect (cogwheel rigidity).<br>5. Slow movements (<strong>bradykinesia</strong>) are typical. Movement also becomes decreased in amplitude (hypokinesia) and difficult to initiate (akinesia).<br>6. Rigidity and hypokinesia may contribute to muscle aches and sensations of fatigue.<br>7. <span style="text-decoration: underline;">Diagnosis is clinical</span>. <br>8. <strong>Treatment</strong> aims to restore dopaminergic function in the brain with levodopa plus carbidopa and/or other drugs (eg, dopamine agonists, MAO type B [MAO-B] inhibitors, amantadine). <br>9. For refractory, disabling symptoms in patients without dementia, stereotactic deep brain stimulation or lesional surgery and levodopa and an apomorphine pump may help.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>139. </span> A 59-year old man presents to the doctor complaining of malaise and stiffness of his neck and shoulders for the last 5 months. Symptoms are worse in the morning. Examinations reveals decreased active range of motion in neck and shoulders.<br><br> <table class="table table-responsive table-sm table-striped"> <tbody> <tr> <td>White blood cells</td> <td>6000/uL</td> </tr> <tr> <td>Erythrocyte sedimentation rate </td> <td>104 mm/h</td> </tr> </tbody> </table> <br>Which of the following is the most likely diagnosis? </p><ol class=mt-3 type=A><li>Dermatomyositis</li><li>Polymyalgia rheumatica</li><li>Polyarteritis nodosa</li><li>Giant cell arteritis</li></ol><button aria-controls=explanation-VQD aria-expanded=false class="btn btn-secondary" data-target=#explanation-VQD data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-VQD><p class=correct-answer><strong>Answer:</strong> B</p><span style="text-decoration: underline;"><strong>Polymyalgia rheumatica </strong></span><br>1. Usually occurs in elderly patients (rare before the age of 50). The mean age of onset is 70, and it is more common in women. <br>2. Risk factors include female gender and age &gt; 50 <br>3. Presents with pain and stiffness of the shoulder and pelvic girdle musculature with difficulty getting out of a chair or lifting the arms above the head. <br>4. Hip and shoulder muscle pain (bilateral)<br><strong>5. Stiffness in shoulder and hip regions after a period of inactivity is the most prominent symptom </strong><br>6. Other symptoms include fever, malaise, and weight loss. Weakness is generally not appreciated on exam. <br>7. It is a diagnosis of exclusion<br>8. <strong>ESR is greater than 40 mm/hour</strong>.<br>9. The <strong>treatment of choice</strong> for polymyalgia rheumatica arteritis is low-dose prednisolone.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>140. </span> Which of the following is the most significant risk factor for a patient with Abdominal aortic aneurysms (AAAs)? </p><ol class=mt-3 type=A><li>Smoking</li><li>Uncontrolled hypertension</li><li>LDL &gt;120 mg/dL</li><li>Uncontrolled diabetes mellitus</li></ol><button aria-controls=explanation-V7I aria-expanded=false class="btn btn-secondary" data-target=#explanation-V7I data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-V7I><p class=correct-answer><strong>Answer:</strong> A</p>1. Abdominal aortic aneurysms (AAAs) are relatively common and are potentially life-threatening.<br>2. Abdominal aortic diameter ≥ 3 cm constitutes an abdominal aortic aneurysm.<br>3. Patients at greatest risk for AAA are men who are older than 65 years and have peripheral atherosclerotic vascular disease.<br>4. The<span style="text-decoration: underline;"> most common cause is atherosclerosis</span>.<br>5. AAAs are usually asymptomatic until they expand or rupture. An expanding AAA causes sudden, severe, and constant low back, flank, abdominal, or groin pain. Syncope may be the chief complaint, however, with pain less prominent.<br>6. Most clinically significant AAAs are palpable upon routine physical examination. The presence of a <span style="text-decoration: underline;">pulsatile abdominal mass is virtually diagnostic</span> but is found in fewer than half of all cases.<br>7. <span style="text-decoration: underline;">Risk of rupture is proportional to the size of the aneurysm.</span> <br>8. Patients with a ruptured AAA may present in frank shock, as evidenced by cyanosis, mottling, altered mental status, tachycardia, and hypotension. Whereas abrupt onset of pain due to rupture of an AAA may be quite dramatic, associated physical findings may be very subtle. <br>9. AAAs generally affect elderly white men. <strong>Smoking appears to be the risk factor most strongly associated with AAA. </strong><br>10. <strong>Diagnosis</strong> is made by ultrasonography or CT, Ultrasonography is the standard imaging tool for AAA.<br>11. <strong>Treatment</strong> of abdominal aortic aneurysms (AAAs) is with surgical repair</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>141. </span> Which of the following is the mode of inheritance in wilson's disease? </p><ol class=mt-3 type=A><li>Multifactorial</li><li>Autosomal recessive</li><li>Autosomal dominant</li><li>X-linked recessive</li></ol><button aria-controls=explanation-U3A aria-expanded=false class="btn btn-secondary" data-target=#explanation-U3A data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-U3A><p class=correct-answer><strong>Answer:</strong> B</p>1. <span style="text-decoration: underline;"><strong>Wilson disease</strong> </span>is a rare <strong>autosomal recessive</strong> inherited disorder of copper metabolism that is characterized by excessive deposition of copper in the liver, brain, and other tissues.<br>2. Patients present with hepatitis/cirrhosis, neurologic dysfunction (ataxia, tremor), and psychiatric abnormalities (psychosis, anxiety, mania, depression)<br>3. <span style="text-decoration: underline;"><strong>Examination</strong></span> may reveal <strong>Kayser-Fleischer rings</strong> (green-to-brown deposits of copper in Descemet’s membrane) as well as jaundice, hepatomegaly, asterixis, choreiform movements, and rigidity. <br>4. <span style="text-decoration: underline;"><strong>Lab</strong></span>: low serum ceruloplasmin<br>5. <strong>Liver biopsy is the most accurate test.</strong><br><br> <span style="text-decoration: underline;"><strong>Treatment</strong></span>:<br>1. Dietary copper restriction <br>2. Penicillamine or trientine</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>142. </span> A 31-year-old man comes to the doctor complaining of food sticking in the throat and halitosis. His medical history is unremarkable. Which of the following is the most likely diagnosis? </p><ol class=mt-3 type=A><li>Zenker's diverticulum</li><li>Esophageal stricture</li><li>Achalasia</li><li>Esophageal cancer</li></ol><button aria-controls=explanation-N8S aria-expanded=false class="btn btn-secondary" data-target=#explanation-N8S data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-N8S><p class=correct-answer><strong>Answer:</strong> A</p>1. <span style="text-decoration: underline;"><strong>Zenker's diverticulum</strong></span> is an outpouching of the mucosa through Killian's triangle, an area of muscular weakness between the transverse fibers of the cricopharyngeus and the oblique fibers of the lower inferior constrictor. <br>2. The pathophysiology involves retention of food material, regurgitation, subsequent aspiration and resulting  pneumonia.<br>3. Presents with bad breath, difficulty initiating swallowing, regurgitation of food several days after eating and dysphagia.<br>4. Barium study is the best initial test.<br>5. The treatment is surgery</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>143. </span> Which of the following is the most common cause of dementia? </p><ol class=mt-3 type=A><li>Alzheimer's disease</li><li>Dementia with Lewy bodies</li><li>Frontotemporal dementia</li><li>Normal pressure hydrocephalus</li></ol><button aria-controls=explanation-JXG aria-expanded=false class="btn btn-secondary" data-target=#explanation-JXG data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-JXG><p class=correct-answer><strong>Answer:</strong> A</p><strong>1. <span style="text-decoration: underline;">Alzheimer’s disease</span> is the most common cause of dementia.</strong><br><strong>2. A positive family history is the most important risk factor.</strong><br>3. Alzheimer's dementia causes a gradually irreversible and progressive cognitive decline (memory <br>4. loss) that presents with memory impairment and one or more of the following: apraxia (difficulty in carrying out activities), aphasia (language dysfunction), agnosia (difficulty in recognizing objects), or disturbed executive functioning (organizing, planning, abstraction). <br><strong>5. There is no impairment of consciousness.</strong><br>6.  CT findings of diffuse generalized atrophy (cortical &amp; subcortical), flattened sulci, enlarged ventricles  are characteristic.<br>7. Cholinesterase inhibitors (e.g donepezil) are first-line therapy</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>144. </span> Which of the following is the most appropriate treatment for herpes simplex virus (HSV)? </p><ol class=mt-3 type=A><li>Lamivudine</li><li>Acyclovir</li><li>Fluconazole</li><li>Ribavirin</li></ol><button aria-controls=explanation-7U0 aria-expanded=false class="btn btn-secondary" data-target=#explanation-7U0 data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-7U0><p class=correct-answer><strong>Answer:</strong> B</p>1. Herpes simplex viruses (human herpesviruses types 1 and 2) commonly cause recurrent infection affecting the skin, mouth, lips, eyes, and genitals.<br>2. Transmission of HSV results from close contact with a person who is actively shedding virus. Viral shedding occurs from lesions but can occur even when lesions are not apparent.<br>3. Both types of herpes simplex virus (HSV), HSV-1 and HSV-2, can cause oral or genital infection. Most often, HSV-1 causes gingivostomatitis, herpes labialis, and herpes keratitis. HSV-2 usually causes genital lesions.<br>4. Common severe infections include encephalitis, meningitis, neonatal herpes, and, in immunocompromised patients, disseminated infection. Mucocutaneous infections cause clusters of small painful vesicles on an erythematous base.<br>5. Diagnosis is clinical; laboratory confirmation by culture, PCR, direct immunofluorescence, or serologic testing can be done.<br>6. Treatment is symptomatic; antiviral therapy with acyclovir, valacyclovir, or famciclovir is helpful for severe infections and, if begun early, for recurrent or primary infections.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>145. </span> Which of the following is associated with acromegaly? </p><ol class=mt-3 type=A><li>Lack of adequate parathyroid hormone</li><li>Thyroid dysfunction</li><li>Excessive cortisol secretion</li><li>Excessive growth hormone</li></ol><button aria-controls=explanation-PE7 aria-expanded=false class="btn btn-secondary" data-target=#explanation-PE7 data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-PE7><p class=correct-answer><strong>Answer:</strong> D</p>Acromegaly is a clinical syndrome that is characterized by growth hormone (GH) excess from somatotroph (pituitary) adenomas. Its clinical features result from the high GH concentration, which also causes excessive production of insulin-like growth factor I (IGF-1). IGF-1 excess leads to the excessive growth of bone and soft tissues. Direct and indirect effects (via IGF-1 ) of GH excess also contribute to cardiovascular manifestations. Patients have an increased incidence of coronary heart disease, cardiomyopathy, arrhythmias, left ventricular hypertrophy, and diastolic dysfunction. The overall leading cause of death in patients with acromegaly is cardiovascular, accounting for 38-62% of deaths.<br><br>Gigantism and acromegaly are syndromes of excessive secretion of growth hormone (hypersomatotropism) that are nearly always due to a pituitary adenoma. Before closure of the epiphyses, the result is gigantism. Later, the result is acromegaly, which causes distinctive facial and other features. Diagnosis is clinical and by skull and hand x-rays and measurement of growth hormone levels. Treatment involves removal or destruction of the responsible adenoma.<br><br></div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>146. </span> Which of the following is the gold standard test for obstructive sleep apnea ? </p><ol class=mt-3 type=A><li>Nocturnal polysomnography</li><li>Pulmonary function test</li><li>MRI</li><li>Head CT</li></ol><button aria-controls=explanation-GCU aria-expanded=false class="btn btn-secondary" data-target=#explanation-GCU data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-GCU><p class=correct-answer><strong>Answer:</strong> A</p>1. <span style="text-decoration: underline;"><strong>Obstructive sleep apnea</strong> </span>(OSA) is a disorder that is characterized by obstructive apneas and hypopneas due to repetitive collapse of the upper airway during sleep. <br>2. Episodic cessation of airflow during sleep leading to desaturations and frequent arousals <br>3. <strong>Risk factors</strong>:obesity, sedative use; males more than females <br>4. Patient presents with fatigue,excessive day time sleepiness, snoring, gasping or choking during sleep, morning headaches or confusion, impaired daytime function because of sleepiness; obesity common, anatomic abnormalities of palate or pharynx may be visible.<br>5. <strong>Polysomnography</strong> (overnight sleep study in a sleep laboratory) is the <strong>gold standard test.</strong> <br><span style="text-decoration: underline;"><strong><br>Types</strong></span> <br> 1. <strong>Obstructive</strong>: obstruction of upper airway during sleep with continued respiratory effort; most often associated with obesity or abnormal pharyngeal anatomy <br> 2. <strong>Central</strong>: loss of central respiratory drive leads to cessation of airflow and respiratory effort <br> 3. <strong>Mixed</strong>: combines both obstructive and central characteristics<br><br>1. The treatment of a mild to moderate disorder usually starts with weight reduction, avoidance of sedatives and alcohol.<br>2. If this is not effective, surgical resection of the uvula, palate, and pharynx can be performed.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>147. </span> Which of the following conditions is associated with recurrent aphthous ulcers, abdominal pain, weight loss and perianal lesions? </p><ol class=mt-3 type=A><li>Behcet Disease</li><li>Irritable Bowel Syndrome</li><li>Diverticulitis</li><li>Crohn’s disease</li></ol><button aria-controls=explanation-WVW aria-expanded=false class="btn btn-secondary" data-target=#explanation-WVW data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-WVW><p class=correct-answer><strong>Answer:</strong> D</p><span style="text-decoration: underline;"><strong>Crohn’s Disease</strong></span><br>1. <strong>Site of involvement</strong>: entire GI tract may be involved with multiple “skipped” areas; distal ileum most commonly involved; entire bowel wall affected <br>2. <strong>Symptoms</strong>: abdominal pain, weight loss, watery diarrhea <br>3. <strong>Physical examination</strong>: fever, right lower quadrant abdominal mass, abdominal tenderness, perianal fissures and fistulas, oral ulcers <br>4. <strong>Extra-intestinal manifestations</strong>: arthritis, ankylosing spondylitis, uveitis, nephrolithiasis <br>5. <strong>Labs</strong>: ASCA frequently positive, pANCA rarely positive; hemoccult positive stool; biopsy diagnostic <br>6. <strong>Radiology</strong>: colonoscopy shows colonic ulcers, strictures, “cobblestoning,” fissures, and “skipped” areas of bowel; barium enema shows fissures, ulcers, and bowel edema <br>7. <strong>Treatment</strong>: mesalamine, broad-spectrum antibiotics, corticosteroids, immunosuppressives; surgical resections of severely affected areas, fistulas, or strictures <br>8. <strong>Complications</strong>: abscess formation, fistulas, fissures, malabsorption <br><br></div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>148. </span> A 36-year-old woman is diagnosed with tuberculosis three months ago, now she complains of numbness, tingling of extremities and ataxia. Her symptoms started after the anti-tubercular therapy.<br>What is the most appropriate next step in management? </p><ol class=mt-3 type=A><li>Niacin supplement</li><li>Pyridoxine supplement</li><li>Iron supplement</li><li>Folic acid supplement</li></ol><button aria-controls=explanation-WEQ aria-expanded=false class="btn btn-secondary" data-target=#explanation-WEQ data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-WEQ><p class=correct-answer><strong>Answer:</strong> B</p><br>All patients who are started on anti-tubercular therapy should also be started on vitamin supplements, especially pyridoxine , to avoid peripheral neuropathy and other neurological complications. <br><br><br><img alt class=img-fluid height=404 src="data:image/jpeg;base64,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" width=539></div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>149. </span> What is the treatment of choice for a patient with cluster headache? </p><ol class=mt-3 type=A><li>Acetaminophen</li><li>100% oxygen</li><li>NSAIDs</li><li>Metoclopramide</li></ol><button aria-controls=explanation-LKM aria-expanded=false class="btn btn-secondary" data-target=#explanation-LKM data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-LKM><p class=correct-answer><strong>Answer:</strong> B</p>Cluster headache<br><br>1.Usually occurs in middle-aged men ( Males are affected more often than females).<br>2.Presents as excruciating, unilateral periorbital headache that lasts 30 minutes to 3 hours.<br>3.Almost always unilateral<br>4.Accompanied by ipsilateral lacrimation, facial flushing, nasal stuffiness and discharge and may present with Horner syndrome.<br>5.100% oxygen (treatment of choice) is an effective and rapid method to abort an acute attack of cluster headache.<br>6.Prophylactic therapy: prednisone and ergotamine</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>150. </span> A 50-year old man presents to the clinic with fever, cough, sputum, weight loss, and night sweats. Which of the following is the best initial test to evaluate this patient for tuberculosis? </p><ol class=mt-3 type=A><li>CT</li><li>Sputum acid-fast testing</li><li>Pleural biopsy</li><li>Chest X-ray</li></ol><button aria-controls=explanation-GPK aria-expanded=false class="btn btn-secondary" data-target=#explanation-GPK data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-GPK><p class=correct-answer><strong>Answer:</strong> D</p><strong>Tuberculosis</strong> (TB):<br>1. Caused by Mycobacterium tuberculosis, an acid-fast bacillus.<br>2. TB is acquired by inhalation of respiratory droplets spread by coughing.<br>3. Previous BCG vaccine has no impact or effect on recommendations for treatment.<br>4. Primary TB is seen with the initial exposure.<br>5. Secondary TB is the reactivation of a latent infection.<br><br>Epidemiology:<br>1. TB affects approximately 1/3 of the world’s population.<br>2. TB is the world’s 2nd most common cause of death from infectious disease after HIV/AIDS.<br>3. Saudi Arabia is considered as a moderate burden country. <br><br>Risk Factors:<br>Approximately all patients with TB have one or more of the following risk factors:<br>1. Recent immigrants (in the past 5 years from endemic area).<br>2. Prisoners<br>3. HIV positive<br>4. Healthcare workers<br>5. Close contact with TB patient<br>6. Steroids use<br>7. Alcoholics<br>8. Hematological malignancies<br>9. Diabetes mellitus<br><br><br>Diagnosis:<br>Chest X-ray: <br>1. Best initial test.<br>2. Cavitary lesion in the upper lobes.<br><br>Sputum acid-fast testing:<br>1. Definitive diagnosis.<br>2. Obtain morning sputum. <br><br>Pleural biopsy:<br>1. Most accurate diagnostic test.<br>2. Invasive, not used routinely.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>151. </span> A 55-year-old man presents to the physician with persistent cough for the last two years. He is a chronic smoker with a 35-year history. He also complains of shortness of breath.<br><br>Which of the following is the most likely diagnosis? </p><ol class=mt-3 type=A><li>Chronic obstructive pulmonary disease</li><li>Lung cancer</li><li>Asthma</li><li>Interstitial lung disease</li></ol><button aria-controls=explanation-9NB aria-expanded=false class="btn btn-secondary" data-target=#explanation-9NB data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-9NB><p class=correct-answer><strong>Answer:</strong> A</p>1. <span style="text-decoration: underline;"><strong>Chronic Obstructive Pulmonary Disease</strong></span> (COPD): Combination of chronic bronchitis and emphysema, leading to expiratory airway obstruction.<br>2. <strong>Emphysema</strong> (“<span style="text-decoration: underline;"><strong>pink puffer</strong></span>”): Dyspnea, pursed lips, minimal cough, <br>3. decrease breath sounds, late hypercarbia/hypoxia. Patients often have a thin, wasted appearance. Pure emphysematous patients tend to have few re-active episodes between exacerbations. <br>4. <strong>Chronic bronchitis</strong> (“<span style="text-decoration: underline;"><strong>blue bloater</strong></span>”): Cyanosis with mild dyspnea; productive cough. Patients are often overweight with peripheral edema, rhonchi, and early signs of hypercarbia/hypoxia. Look for the classic barrel chest, use of accessory chest muscles, JVD, end-expiratory wheezing, and muffled breath sounds. <br>5. <strong>CXR</strong>: Hyperinflated lungs<br>6. <strong>PFTs</strong>: ↓ FEV1/FVC; normal or ↓ FVC; normal or ↑ TLC<br>7. <strong>ABGs</strong>: Hypoxemia  <br><br><span style="text-decoration: underline;"><strong>Risk factors and causes</strong></span><br>1. Tobacco smoke (indicated in almost 90% of COPD cases)<br>2. α1-Antitrypsin deficiency—risk is even worse in combination with smoking<br>3. Environmental factors (e.g., second-hand smoke)<br>4. Chronic asthma—speculated by some to be an independent risk factor <br><br><span style="text-decoration: underline;"><strong>Treatment</strong></span>: <br>1. <strong>Smoking cessation</strong>—the most important intervention <br>2. <strong>Oxygen therapy</strong>: Shown to improve survival and quality of life in patients with COPD and chronic hypoxemia <br>3. <strong>Acute exacerbations</strong>: O2, inhaled β-agonists (albuterol) and anticholinergics (ipratropium, tiotropium), IV +/− inhaled corticosteroids, antibiotics.<br>4. Severe cases may benefit from noninvasive ventilation. Consider intubation in the setting of severe hypoxemia or hypercapnia, impending respiratory fatigue, or changes in mental status.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>152. </span> Chlamydia is usually treated with which of the following? </p><ol class=mt-3 type=A><li>Doxycycline or Azithromycin</li><li>Penicillin</li><li>Amoxicillin/clavulanic acid.</li><li>Metronidazole</li></ol><button aria-controls=explanation-MNR aria-expanded=false class="btn btn-secondary" data-target=#explanation-MNR data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-MNR><p class=correct-answer><strong>Answer:</strong> A</p>1. Chlamydial infection can cause disease in many organ systems, including the genitourinary tract. <br>2. Chlamydia is usually treated with either doxycycline or azithromycin.<br>3. Metronidazole is a treatment for bacterial vaginosis and trichomonis. <br>4. Uncomplicated lower genital tract infection is typically treated with a single dose of azithromycin (1 g po) or with a 7-day regimen of doxycycline (100 mg po bid) or some fluoroquinolones (eg, levofloxacin 500 mg po once/day).</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>153. </span> Which of the following is false regarding systolic hypertension? </p><ol class=mt-3 type=A><li>It is often caused by mitral regurgitation</li><li>It is more dangerous to elderly patients than an elevated diastolic pressure.</li><li>Systolic hypertension is a condition that usually affects the elderly.</li><li>Untreated systolic hypertension can lead to an increased risk for stroke and cardiovascular disease.</li></ol><button aria-controls=explanation-A50 aria-expanded=false class="btn btn-secondary" data-target=#explanation-A50 data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-A50><p class=correct-answer><strong>Answer:</strong> A</p>1. Isolated systolic hypertension is common in the elderly and is closely linked to cerebrovascular events and acute coronary events.<br>2. Untreated systolic hypertension can lead to an increased risk for stroke and cardiovascular disease.<br>3. Isolated systolic hypertension (ISH) is defined as a systolic blood pressure (SBP) &gt;140 mm Hg and a diastolic blood pressure (DBP) &lt;90 mm Hg.<br><!--90-->4. The cause is the loss of elasticity of the arteries that occurs with aging.<br>5. Other causes include thyrotoxicosis, arteriovenous fistulas, or aortic regurgitation. <br>6. Treatment involves lifestyle changes (e.g., exercise, sodium restriction, weight loss) and the use of hypertensive medications.<br>7. In most instances, low-dose diuretic therapy should be used as initial antihypertensive therapy in the elderly.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>154. </span> Which of the following T lymphocytes would have an very low count in a patient with advanced AIDS? </p><ol class=mt-3 type=A><li>Helper</li><li>Natural killer</li><li>Memory</li><li>Cytotoxic</li></ol><button aria-controls=explanation-BG5 aria-expanded=false class="btn btn-secondary" data-target=#explanation-BG5 data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-BG5><p class=correct-answer><strong>Answer:</strong> A</p>1. <strong>Human immunodeficiency virus</strong> (HIV) infection results from 1 of 2 similar retroviruses (HIV-1 and HIV-2) that destroy CD4+ lymphocytes and impair cell-mediated immunity, increasing risk of certain infections and cancers.<br>2. HIV produces cellular immune deficiency characterized by the <strong>depletion of</strong> <strong>helper T lymphocytes</strong> (CD4+ cells). The loss of CD4+ cells results in the development of opportunistic infections and neoplastic processes.<br>3. Initial infection may cause nonspecific febrile illness. <br>4. Risk of subsequent manifestations—related to immunodeficiency—is proportional to the level of CD4+ lymphocytes. HIV can directly damage the brain, gonads, kidneys, and heart, causing cognitive impairment, hypogonadism, renal insufficiency, and cardiomyopathy. Manifestations range from asymptomatic carriage to AIDS, which is defined by serious opportunistic infections or cancers or a CD4 count of &lt; 200/μL. <br>5. HIV infection can be diagnosed by antibody, nucleic acid (HIV RNA), or antigen (p24) testing. <br>6. Screening should be routinely offered to all adults and adolescents. <br>7. Treatment aims to suppress HIV replication by using combinations of ≥ 3 drugs that inhibit HIV enzymes; treatment can restore immune function in most patients if suppression of replication is sustained.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>155. </span> A 50-year-old man presents to the emergency room with persistent cough. He was diagnosed with lung cancer two months ago. He is a chronic smoker with a 40-year history. The patient denies fever, chills, weakness or chest pain. Laboratory tests showed:<br><br> <table class="table table-responsive table-sm table-striped"> <tbody> <tr> <td>Sodium </td> <td>126 mEq/L</td> </tr> <tr> <td>Potassium</td> <td>4 mEq/L</td> </tr> <tr> <td>Creatinine</td> <td>1.2 mg/dL</td> </tr> </tbody> </table> <br>Which of the following is the most appropriate next step in management? </p><ol class=mt-3 type=A><li>Give IV steroids</li><li>Normal saline</li><li>Prepare for surgery</li><li>Fluid restriction</li></ol><button aria-controls=explanation-LYP aria-expanded=false class="btn btn-secondary" data-target=#explanation-LYP data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-LYP><p class=correct-answer><strong>Answer:</strong> D</p><span style="text-decoration: underline;"><strong>Syndrome of inappropriate ADH secretion (SIADH) </strong></span><br>1. Nonphysiologic release of ADH, resulting in hyponatremia.<br>2. Hyponatremia results from an excess of water rather than a deficiency of sodium.<br>3. Caused by CNS pathology, sarcoidosis, paraneoplastic syndromes, psychiatric drugs, major surgery, pneumonia, or human immunodeficiency virus (HIV)<br>4. SIADH is commonly seen in patients with intracranial hemorrhage &amp; lung carcinoma. <br>5. ADH is characterized by hypotonic hyponatremia with euvolemia (without hypertension or edema). Low plasma osmolality (&lt;280 mOsm/Kg) with high urine osmolality (&gt;100-150 mOsm/Kg) in suspected patients is diagnostic.<br><strong>6. Water restriction is the initial treatment of choice. </strong><br>7. Rapid correction of serum sodium levels can lead to central pontine myelinosis.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>156. </span> A 26-year-old male comes to the office and complains of a chronic cough, fever and night sweats. <br>His chest x-ray reveals right upper lobe fibrosis and his sputum is positive for acid-fast bacilli. Which of the following is the most likely diagnosis? </p><ol class=mt-3 type=A><li>Lung Abscess</li><li>Tuberculosis</li><li>Histoplasmosis</li><li>Fungal Pneumonia</li></ol><button aria-controls=explanation-AJX aria-expanded=false class="btn btn-secondary" data-target=#explanation-AJX data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-AJX><p class=correct-answer><strong>Answer:</strong> B</p>1. Tuberculosis properly refers only to disease caused by Mycobacterium tuberculosis (for which humans are the main reservoir). <br>2. Most (about 95%) primary infections are asymptomatic and followed by a latent (dormant) phase.<br>3. TB results almost exclusively from inhalation of airborne particles (droplet nuclei) containing M. tuberculosis. <br>4. They disperse primarily through coughing, singing, and other forced respiratory maneuvers by people who have active pulmonary TB and whose sputum contains a significant number of organisms (typically enough to render the smear positive). <br><br><br>Classic clinical features associated with active pulmonary TB are as follows (elderly individuals with TB may not display typical signs and symptoms):<br>1. Cough <br>2. Weight loss/anorexia <br>3. Fever <br>4. Night sweats <br>5. Hemoptysis <br>6. Chest pain <br>7. Fatigue<br><br><strong>Diagnosis</strong><br>Screening methods for TB include the following:<br>1. Mantoux tuberculin skin test with purified protein derivative (PPD) for active or latent infection (primary method) <br>2. Acid-fast bacilli (AFB) smear and culture using sputum obtained from the patient: Absence of a positive smear result does not exclude active TB infection; AFB culture is the most specific test for TB <br>3. HIV serology in all patients with TB and unknown HIV status: Individuals infected with HIV are at increased risk for TB<br><br><strong>Management</strong><br>Physical measures (if possible or practical) include the following:<br>1. Isolate patients with possible TB in a private room with negative pressure <br>2. Have medical staff wear high-efficiency disposable masks sufficient to filter the bacillus <br>3. Continue isolation until sputum smears are negative for 3 consecutive determinations (usually after approximately 2-4 weeks of treatment) <br><br>Initial empiric pharmacologic therapy consists of the following 4-drug regimens:<br>1. Isoniazid <br>2. Rifampin <br>3. Pyrazinamide <br>4. Either ethambutol or streptomycin</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>157. </span> A 41-year-old man returns from a week-long trip to Egypt. For the past two days he has been passing frequent bloody diarrhea associated with crampy abdominal pain. Abdominal examination shows diffuse lower abdominal tenderness but there is no guarding or rigidity. His temperature is 37 C , blood pressure is 134/86 mm Hg, pulse is 86/min, and respirations are 16/min. Which of the following is the most likely diagnosis? </p><ol class=mt-3 type=A><li>Giardiasis</li><li>Salmonella</li><li>Shigella</li><li>Staphylococcus aureus</li></ol><button aria-controls=explanation-QX8 aria-expanded=false class="btn btn-secondary" data-target=#explanation-QX8 data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-QX8><p class=correct-answer><strong>Answer:</strong> C</p>1. <span style="text-decoration: underline;"><strong>Shigellosis</strong></span> is a type of food poisoning caused by infection with the Shigella species.<br>2. it is a major public health problem in developing countries where sanitation is poor.<br>3. Shigellosis is spread by means of <span style="text-decoration: underline;">fecal-oral transmission</span>.<br>4. <strong>Symptoms</strong> include fever, nausea, vomiting, tenesmus, and diarrhea that is usually bloody.<br>5. <strong>Diagnosis</strong> is clinical and confirmed by stool culture.<br>6. <strong>Treatment</strong> of mild infection is supportive, mostly with rehydration; <strong>antibiotics</strong> (eg, ciprofloxacin, azithromycin, ceftriaxone) are given to moderate to severely ill and high-risk patients with bloody diarrhea or immunocompromise and may shorten the duration of illness and decrease contagiousness.<br>7. Ampicillin was widely used in the past but is no longer an effective empiric treatment in the United States because of antibiotic resistance. <br>8. <span style="text-decoration: underline;">Avoid antimotility</span> agents because they have the potential to worsen symptoms and may predispose to toxic dilation of the colon.<br>9. Clear liquids followed by a low residue, lactose-free diet are recommended until symptoms of shigellosis resolve.<br><br> <table class="table table-responsive table-sm table-striped"> <tbody> <tr> <td>1-6 hours</td> <td>Staphylococcus aureus</td> </tr> <tr> <td>12-48 hours</td> <td>Salmonella, Escherichia coli</td> </tr> <tr> <td>48-72 hours</td> <td>Shigella,Campylobacter</td> </tr> <tr> <td>&gt;7 days</td> <td>Giardiasis ,Amoebiasis</td> </tr> </tbody> </table></div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>158. </span> A 21-year-old man presents to the physician with shortness of breath and hemoptysis. His vital signs are within normal limits. Chest x-ray shows bilateral pulmonary infiltrates. Laboratory tests showed:<br><br> <table class="table table-responsive table-sm table-striped"> <tbody> <tr> <td>Serum creatinine</td> <td> 2.0 mg/dL</td> </tr> <tr> <td>Urinalysis</td> <td>Dysmorphic red cells</td> </tr> </tbody> </table> <br>Which of the following is the most likely diagnosis? </p><ol class=mt-3 type=A><li>Endocarditis</li><li>Acute renal failure</li><li>Pneumocystis pneumonia</li><li>Goodpasture's disease</li></ol><button aria-controls=explanation-J52 aria-expanded=false class="btn btn-secondary" data-target=#explanation-J52 data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-J52><p class=correct-answer><strong>Answer:</strong> D</p><span style="text-decoration: underline;"><strong>Goodpasture's syndrome</strong></span><br>1. Deposition of antiglomerular and antialveolar basement membrane antibodies.<br>2. Goodpasture's syndrome involves the lungs and kidneys (Pulmonary-renal syndrome). <br>3<span style="text-decoration: underline;"><strong>. Clinical features</strong></span>: rapidly progressive renal failure, dyspnea, hemoptysis, myalgias and hematuria <br>4. Lung disease precedes kidney disease by days to weeks.<br>5. Anti-basement membrane antibodies is the best initial test.<br>6. <span style="text-decoration: underline;"><strong>Treatment</strong></span>: Plasmapheresis, corticosteroids, immunosuppressive agents.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>159. </span> A 19-year ­old female presents to the physician with malar rash, arthritis, proteinuria, thrombocytopenia, positive ANA, and anti ­dsDNA. Which of the follwing is the most likely diagnosis? </p><ol class=mt-3 type=A><li>Reactive arthritis</li><li>Systemic lupus erythematosus</li><li>Sjogren syndrome</li><li>Behcet’s disease</li></ol><button aria-controls=explanation-D03 aria-expanded=false class="btn btn-secondary" data-target=#explanation-D03 data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-D03><p class=correct-answer><strong>Answer:</strong> B</p>Systemic lupus erythematosus<br><br>1. Systemic lupus erythematosus (SLE) is a chronic inflammatory disease of unknown cause that can affect virtually any organ of the body.<br>2. Presents with Fevers, malaise, weight loss, abdominal pain, vomiting, conjunctivitis and blindness. <br>3. Common findings include malar rashes, oral ulcers, arthritis, photosensitivity, CNS symptoms, cardiac symptoms, and renal symptoms.<br>4. More than 90% of patients have arthritis most commonly affecting MCP and PIP joints. <br>5. Decreased complement (C3 and C4) <br>6. Positive ANA in 95% of patients<br>7. Anti-DsDNA antibodies are highly specific for and confirms the diagnosis of SLE. <br>8. Hydroxychloroquine (DMRAD) is the safest drug for systemic lupus erythematosus (SLE). <br>9. Prognosis of SLE depends on renal involvement .<br>10. Chronic renal failure is the <span style="text-decoration: underline;">most common cause of death in patients with SLE.</span></div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>160. </span> Which of the following is characterize by low free T4, elevated TSH ? </p><ol class=mt-3 type=A><li>Euthyroid sick syndrome</li><li>Hyperthyroidism</li><li>Primary hypothyroidism</li><li>Central hypothyroidism</li></ol><button aria-controls=explanation-VFR aria-expanded=false class="btn btn-secondary" data-target=#explanation-VFR data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-VFR><p class=correct-answer><strong>Answer:</strong> C</p>1. <strong>Hypothyroidism</strong> is a common endocrine disorder resulting from deficiency of thyroid hormone. <br>2. <strong>Iodine deficiency</strong> is the most common cause of primary hypothyroidism and endemic goiter worldwide.<br>3. In areas of the world with sufficient dietary iodine, hypothyroidism is most commonly caused by the autoimmune disease <strong>Hashimoto's thyroiditis</strong>.<br>4. Presents with weakness, fatigue, cold intolerance, constipation, weight gain, depression, hair loss, menstrual irregularities, and hoarseness. <br>5. Examination reveals dry, cold, puffy skin accompanied by edema, bradycardia, and delayed relaxation of DTRs. <br>6. The initial test of choice is <strong>serum TSH level</strong>, followed by free T4 levels. <br>7. <strong>TSH</strong> is the most sensitive test for detecting primary hypothyroidism in ambulatory patients (TSH alone may not be a useful tool for the diagnosis of hypothyroidism if pituitary or hypothalamic disease is known or suspected)<br>8. <strong>Levothyroxine</strong> is the treatment of choice.<br><br><img alt class=img-fluid height=180 src=data:image/gif;base64,R0lGODlhWAIQAdUAAPj4+BwYG26TFrCsk1JaN83MzZq0Webp0+jkwZaThFJPSmNvPnVxZrCur+HcvNrWtI2Jdt7myt3ZuK7CfOTk5JStVMTBr3ODRuTgvpCsTr66nvb17n+TTMDHj/Du4NbSsqOfiYyiUtvXtdra2oF9b7THh8fVpYmnQc3Jq15aVIGhNS8sKaO6a6C8XO7t7uzoxNbhvtPeuMzZrjs5MvHtyNLOr524Wurv3EZEO4WDg6CenmllXXmbKJavV9zYt////yH/C1hNUCBEYXRhWE1QPD94cGFja2V0IGJlZ2luPSLvu78iIGlkPSJXNU0wTXBDZWhpSHpyZVN6TlRjemtjOWQiPz4gPHg6eG1wbWV0YSB4bWxuczp4PSJhZG9iZTpuczptZXRhLyIgeDp4bXB0az0iQWRvYmUgWE1QIENvcmUgNS4wLWMwNjEgNjQuMTQwOTQ5LCAyMDEwLzEyLzA3LTEwOjU3OjAxICAgICAgICAiPiA8cmRmOlJERiB4bWxuczpyZGY9Imh0dHA6Ly93d3cudzMub3JnLzE5OTkvMDIvMjItcmRmLXN5bnRheC1ucyMiPiA8cmRmOkRlc2NyaXB0aW9uIHJkZjphYm91dD0iIiB4bWxuczp4bXBNTT0iaHR0cDovL25zLmFkb2JlLmNvbS94YXAvMS4wL21tLyIgeG1sbnM6c3RSZWY9Imh0dHA6Ly9ucy5hZG9iZS5jb20veGFwLzEuMC9zVHlwZS9SZXNvdXJjZVJlZiMiIHhtbG5zOnhtcD0iaHR0cDovL25zLmFkb2JlLmNvbS94YXAvMS4wLyIgeG1wTU06T3JpZ2luYWxEb2N1bWVudElEPSJ4bXAuZGlkOjc0MTE3RkUzMjAwNzExNjg5QTgyREEyMkJENEQzNDExIiB4bXBNTTpEb2N1bWVudElEPSJ4bXAuZGlkOjZBQUEwN0QyRTA5RjExRTI5QjNCRjNCNDM3ODRGQUNDIiB4bXBNTTpJbnN0YW5jZUlEPSJ4bXAuaWlkOjZBQUEwN0QxRTA5RjExRTI5QjNCRjNCNDM3ODRGQUNDIiB4bXA6Q3JlYXRvclRvb2w9IkFkb2JlIEluRGVzaWduIENTNS41ICg3LjUpIj4gPHhtcE1NOkRlcml2ZWRGcm9tIHN0UmVmOmluc3RhbmNlSUQ9InV1aWQ6MWFjYTQ0YmUtYzAzNy03MjRhLTliOTAtYzMyYjM3ZmYxM2QyIiBzdFJlZjpkb2N1bWVudElEPSJ4bXAuZGlkOjg5OTVFMDAwOUQyMDY4MTE4MDgzRUZFQTRBNTJFN0EzIi8+IDwvcmRmOkRlc2NyaXB0aW9uPiA8L3JkZjpSREY+IDwveDp4bXBtZXRhPiA8P3hwYWNrZXQgZW5kPSJyIj8+Af/+/fz7+vn49/b19PPy8fDv7u3s6+rp6Ofm5eTj4uHg397d3Nva2djX1tXU09LR0M/OzczLysnIx8bFxMPCwcC/vr28u7q5uLe2tbSzsrGwr66trKuqqainpqWko6KhoJ+enZybmpmYl5aVlJOSkZCPjo2Mi4qJiIeGhYSDgoGAf359fHt6eXh3dnV0c3JxcG9ubWxramloZ2ZlZGNiYWBfXl1cW1pZWFdWVVRTUlFQT05NTEtKSUhHRkVEQ0JBQD8+PTw7Ojk4NzY1NDMyMTAvLi0sKyopKCcmJSQjIiEgHx4dHBsaGRgXFhUUExIREA8ODQwLCgkIBwYFBAMCAQAAIfkEAAAAAAAsAAAAAFgCEAEABv/An3BILBqPyKRyyWw6n9CodEqtWq/YrHbL7Xq/4LB4TC6bz+i0es1uu9/wuHxOr9vv+Lx+z+/7/4CBgoOEhYaHiImKi4yNjo+QkZKTlJWWl5iZmpucnZ6foKGio6SlpqeoqaqrrK2ur7CxsrO0tba3uLm6u7x2ETHAwcLDxMXGx8jJysvMzc0wEdHS09TV1tfY2drb3N3e3+Dh4uPk5ebn6Onq6+zgG0onAvLz9PX29/j5+vv8/f7//05kGEiwoMGDCBMqXMiwocOHECNKnEixosWLGDNq3Mixo0eJEZRU4EGypMmTKFOqXMmypcuXMGPGzNCjps2bOHPq3Mmzp8//n0CDCh1KtKjRo0iTKl3KtKnTp1CHVgiZZKTMq1izat3KlQfNqGDDih1LtqzZs2jTql06VWTXt3DjymX5da3du3jz6t3Lty/ZtlXnCh5M+Gpdv4gTK17MuLHjn4CRWC1MuXLlw48za97MubNnoJGPTLZMuvRbzJ9Tq17NuvVfqpJNy56NFbXr27hz684d2sho2sCDn7S9u7jx48j59i7yW7hz2sRzGpievLr169iDLifS/Ll30tFrGrBRIQSHEBVsGFg8vgf17PDjy5cKW/T3+6bD2+BAYMaKACvMQEAI67nHwQwz4FCBWQZcgOACBTbYHw4cFLiTDQs8aINYBmQ4/8MFFuY1XYE2ODgDhGqViCABIeLU34c2hIBDggSeZcCLF2w4H2LbDdEdfkDKFV2HARRpZJEr5GggkiGYZQMBReKwHpFGKslTC1AGQEALHOJQ5AI64tXgiuthGGWYZ5kZwAxo3mSAlwEs0EIIRlaYJpxg7shjfb4F6edgxKlZZIL/IVmhARwwyaCJEBoQQqE4EGAnTxhq2OWXba6lppQ9qElApmSNKWCLNr2JqYw0khqWDXiCquddPQrx45+01qYTokYmuWAFCxg5Q6eJAtikeDYUWyyp4xmLrLHquXlsDy0Eu0IFLaj3XqnUJRthtsxK1+10zUrXarLhjtjiiO5xa//shcyG2EKvAeCg3rtFfkquhei6mS26yZbaLk7aOqtsq+4VK7Cy+k6JcMHPXohnC/die26+rz4V6w+z1qrxS7bdaCiX7tFbJAfRKupeCAsQEOkCF7gnXgUXECAzAS1HCPPMNLvcAwcXXMABzPAm2XPPHNwUwtAV8OyzATD33APKMl9QAb5QE7DAzkQj22rMVteo9KSOIq10eSnTPPVNMXJt9pRHZ/khiPBuyfUChx7d84I1NX2BeT0TGDOKac8sdYR2F11TjGWD2KrewyKa8so1Pp01f1ZzoB7ldKvaKZwtz12j3VLfNPSkFTd1ccYbp66SbY/Wi6ajM1subZMNFnr/JA4EOjrDkVHmHsLuvOM+Xtx08h4vk2VegKTHWs753woL2B5vjYhKHymm4tYL58du463mr8ATIP0Mk5YoPYA5CnokyvVmWWXJI08ZbAAhZJnyoONdcD75G266Ye23e1jrAmAn9+UKRLiKF7yQdIEFfklVrKoX8D42PyU5qlCkKx1b+MQc1XkQJqhJYACshLZjJXAFIdiPkXCQskKByVRrWkCGojQdOJ1ohloaXr1QhaQE6a9IFnxYlrbUuuf5x0gvHOAKZnSkPAFse2uaoLzmNynggWmC8dreDBZUIl/hwHYkc1ChAqSgoAFogig0gBX7By8cYGlQvmqB8gb1RUPp/zBe05nfErEopwGGEUlWgxMKVQigM+bqjGAkVQRXqMX0wOlTnYLXrzTolNN98JJ0yUkX49eTE6YwS/Kygcik5McWOG8FK8hAKU85yLjlUVFPct0FAUSyITpvUE36XZQiacceLNCJbhJky3qQpUGOiwPPIxDwkjSdH8aJPOGbWgXcJp42Hu6XNZnjCEU2yR4A7wJvRBLLpFYoArgnA3CSkv9gOIMaua+PGAznlkxpP/jFKwNUWhOBkIk9nCxyhM10oRyRNDUYApOSSrEkJhc6HE3OcQUZlM7sENW3Y4FylvHaG9NCkEtIabQ86PHUeKSFz02mcpPqtOUAwQmtOW5Rjf9f4tJ61pi95k2nlC7lpZY2FD6QhdONEz0ZBu8opTv+ijpWvCUB95PMWI6sWgMF0NmYSstRxgiD/6uAQEtZzAUMi6P7ZJJ6tApELjmVRZp8pI5+yrRC5aiIkUNoQjnIHYbalSSo2SQBSVUBVU5tdp0KXH9WOB0DLlFS/zNspCynUxZ5cj0V+GY4wXRWpdqpQYMqz1APZ79MGVRHZF2qHxeppG+S6KFU4pRNOFesNpYpbjr6rEFFZi9Q6mhTIZJsG+GXRvHUc7TzO2POXinVvJnWPUNUJMHc49L02HKOqpXrXN1yV4aGkJ/PdNPvUCmnicroSAGiYU1w2MQCkReJd3T/bFA9RdY0VraIl82pH0nU2Zo6MbQVcqpXn3c24IGNn9NqY5g+i9vGxrZVm5wBDA81xNgmt1S6jVJUt1iq3w4VUXU8UjsJOS3jAnFKD/Yna8UjrfRIi5hAdJV06UPdk/TDJPNQiT5cLA+W8KMl9HAOcYB3VJvoFZyzc+qJfubaTkGMAy2sU7GOnOSnuvKxS1rTHNH63ufFN7PeTPHhlhvMfuK3mYOCbU2+eduH+lK8q01xgT11YOy194eTZB5adRrdLG9zt0F1jwCHKso5NXCCWyqxhwGK3Hopt58J7i8Qk7niDba4JCowgaQnTWkTyKADkJ60ClBiABlUWtIlMMBJ/ybg6ROspASe/rSlS8ASFUxA0hOIR3BsIyhzqidGyzQxQUtpAKuijGXG0mWcfp0+XMf0yXmGoVvLpFIrT6m5QjayNg8qnuV+uQeRBdBm7bylmlh1vfNdJ23bnF2nujCxhhbPQ6c6O1+7VaahhWf8ZLiA9KjHbSfEW7YJLedDx2utF9VpOVXcaO3Q1UcoOQEAlnADkgigBEOYgABgDPEkRMDUPBCADITQg5XAQAkHkLEBPEAEALAaONHRIsuih8TL7Tqexv53kKEJxOINkuZ3NjSUdYrlTjWbls/OrF5PZEBq69nLm1VfN+08Quae2864i1E6r2moCon56NkVIdALnf9Dm+ybAFP7Lh7XWcwKTROJlrXBGkUpYEFj+7j9TisSnY49jHKy4EhRqElUEIEb+P0GQgDA328Ag5LAJgIurvgBZBAMGLzjBzFw+MZ/0HGVfPwHgx985FNygndsQNKPlzh0dqI74xkJrSfEpyBlZruirn6wa5ra63mcHmQjTzwD3Cln62XZoMd+Og4EEJdLZe3NVq/lNsEigny1oOMjspeYzRX7dI91YEoxQiFmbq6OCHTcYjRA0pM3AaMaL5W9z+2hBRHXISliDU+QwtX2Fd6nGxiUqOD+PDgByW+w6ftvmgc9IARUkQEUJwQsUA8Z4HmmpnEc53FCQID+538yZgL/PwAAPSAPnfcDiDd6pDdN5wM9ERJk2AVI/AU7xkM+N2VAg5JfticsFuJUe7V7zTNf2hd7BXMBMyIg9dNPXZZd2LZtyhZXVqR8kYMoWLQmpHN2SJIBV/dZVKdl6xciY8I7KEhnzyY9MhNT89UhH9go6Ad32edjj0SELzhtBDd/PqF3KqECJBdyLkaBHpCAP2ACE+dwFSd6JSEAMfCAGTd5lZcSlydrL6EC7yADdciAG/B/shEe43E0KcMyGYAmhdN8VbM3WPMz6YJkMsMyOpNHZcOJBVI4NTGJxMJWpaI0BJI0PlMXovg0HLUrvVZfOYGKN6E0NDEepph8QNQDf1Mz/24CNFbji26iNFLTijVBi7j4UHFFiwADjHSjM5LjM6XSNpxoN6nIM5h4Mg0UjJGTAURTi31jE8w4i3cDjIPjY1HVW2hoFGqYEmz4A264dyRHh3voAYr4cEKAhw4XEvbYhw1oeUIgiC5xAjEQASyQhx/XcBzYScwSLgnjLwhDMQzTMAfjkOlyLfnSIA30dBKzLRPzWrtkStgVUeIhkfnSMyw3QmhCZt2iEw1Jes9iLgnjiQ7iOjPJLhQpMRV5kR5ZkRZpktfCk6T3Hi15MiwDPHW2jixWfyvxjvHocCxggAIwAVJph/lYhyRBlT9QAhPHgJTngD+QAREogTBRcR2Alf/5YRww6IJJ4XwCIj7pZhQw1HO6SGgpEnwkWTp6BYVKSRTtaH9tiBIJuWkZuHkZV3EbMHgk9wNnKXn/CIhCsAGSOZmSSYAscQKOJwQmMGtq6T5VqBQABF5ghxTMMz0tQmaaok3M1Gh6BYJ9yY4HJyst4ZTDsXB06I8AgHH4mAQ3cJD++JUAmQSWuRIKNwQRMJyLeBx8UzSaUxRMozZe1ZxBIYqkMo5qsZxnU3AZgI1x9ZpLGRutFph5WHEHuWlayZWHKQQdkAEV0J4VMAEkBwAj4ZV/KJj5aAMskJ/6qYgrgU8l8A79OBvhwRoy+RTakpNHUaDSIZFqoaAF56DeKRT/f3kStGkSByAEHpChHvB4bribBwhjNqCZ8uCHYKkC9wAT8hCiW4mW4BGhLvqiSjmh8giPeWgAS2AA8nCHLEqIGvib9XkSgRgTLBABMIBxJKECgCcDC+lPBhMU5AKj4mFK0gmlVKoYMgpp4vmbLFAXGVBxdLib+phxJyCAv1kBLFoSgXimKSEAUfkDNoCVPKqkAroT9NadpIdkMoQ3dhEwnyEhLDOlVRqoe3GlR5qlGYh4WDlxgJeIYIqWmKmeI2qAKnAClFqpm3Z5PTCplVqpnLdwhTcPHXCVc6oTbnWGnbJud+E4nPgZ8mSqgvqqdkGoPFChUykE6AljFPgDEldx/zcwDQfweB6wgJMHAJQpmQBwgJdHrMUKAAfAnw6XqxEwAROwh/DorC1KqnfXE4l2FwXmGWflqrAarmchqzyqkDwQErmZEgGogbuJBDBgmV6JBBJ3eUiQiCpBrURwAEaanNgagyVpQj7WXODSnHwKMBHykwDrY651LghaksQCoelyK0F5kfqSsD5nkxH7kADTsOliseL6sTxBrhPQARNwpCVQAiWrEhNwsl5xsi7rsiywrzxgAx3wsjZLgCxgszabsirBAiYQDTLgmyi3E9tmA9s5NLlzqvijij/TIuTxNelhNByljTVitMSYtO3ZRn1VKljjM1FrE6oUUkdzHlN7E/8gpad5A1Y4AVbNFzZEEznf2gNhi7Zq62OqqFFSyDerCK4gK6iymnE15nCBu6aBmw+Eiw+CO2MrUbhqWhrEsW0piSTCE30f8n7qp27Kd7m6BFEsJye+JD1LlEL6YzuolDsHAl5Xk2ac+x/+gUqTElmodLlCFbv/8yilGyNwmSujWVk94CVJUruo1FtTCEiR44Go27fIixN/W11/8rgjc2++wn04oLSFVL1bl0+ohF6ztERo55nSu5dGEgLkl71xiZSnRzAm1Z0wBEm4VQGCtHwPxLuo6SjhC3yHhDzMEyAThCLJi7zLy7xB4rzjV0H58zGquTfOVFTz41XTJ1qkGyn/e1MlBVwk6DF95FM0AzQgKFOqvXs7NCNJMsh+AUtQ1ZeOlkMlvyJPXDK/NpdC0rI3HKBWK1Utygio/Quj/wvA+CHAsrOJuIhT79Nrytiq4NJgSmQ5xYI5SzZfVmVU49FrC7s9xTZa+xZRGPVWTcU14CRKzaXCdmZBLexU4GRK7cVRLjQ1ctQzA3rDUJrDOvwdPLweZMwz5PVHNpg3y4aa1PsrGSBQNzHHf1YnRAVi/fRYalVhMRUsS4c2zyVevdYCR5uSW+TFLMwkoWU1VpOSObI9S5Q5IMPGH+vGb/wccYxh5/NU0BUinNMDQFhi6TdgMXzKe9WtIyZUFOyEh+NS//oFKgnGPBYkRidILbb0xbXLJLlnen0ERYMiu6AMq6I8ysLBw9FSKALSM/EEXTjxTax8dwm0RddmINRMMyM5yDWxXNtLILWMxyOzO+oIMPCVTBOsQA2UWZSsZfQrLBlMb/oMIkm8ABnGls3szLGJMdCsOtIMSkYGxGyJUZbzMN7mWjR4sfESWF/mfby7x7LHgxJdR0nJyFESlwg2YcLMe8QMLMjjX9UiSq74NBxwHsUCMxwZ0H470KhT0HBMtE9lS0JcJ+T3KdVSTOIrSeKrVOJXPvW00/HzPc33UCTTAu5rk8OndSpJKdqkZfsGTrFIzw0GQ9MLMUD9UwnNzuYxKP9G1gJ6LNOB+sw2Pao5EU9Bs3JjZMdR4s/It28rwHqZxdAk8tZIlkit2U7KZjXLVCPDN2bSJ519fNhY9zaeOdI7JSgCgkYEMkBEN3D7hgM9A9Q2jNbrqNZrnZb9isW8Q77g5FJHqCC4d4T6tB4rRTgfuGylF75SZzwQVSA0hTYLJMIX4j5zJtVrwiREfMxaUiime8rmBM6mx8yc3cY0/dm1Qhxl4zsvwkJtg1iUszf+nCBXgy+8koMslJ28IjNxBTsIQt1cc1lQEym0w4vTHZ02UTYZNFKC7BOIEjv4wh/lLTXRXSJRwzbTrd/ijXvZXc2diDLeLSmbvdxo6NnObRn/gdKkBYNt7REw2vLEU8PLTHPhTOpZG3Lh4OKQ5IImL+3hAhMiqpQB1AQUEeMs7dke68Iw+NLh1PHiPsY0ncKwGf7ECj7Tj9bgO/ygo4t8Oz7ke9LjPn7TjRZ9UYK2RN7kecHgR04Ya7wjjvKIwujkWA4rzR3lP453C5PlYL4WUM7lczHlYX7mMj3mZB4XZo7mbn7DF5MBjbvm/Prmdr7ccT7ndF4aJ4Bt7vnngB7ogj7ohF7ohn7oiJ7oir7ojN7ojv7okB7pkj7plF7pln7pmM7oGTDQRAoDnv7poB7qoj7qpF7qpn7qqJ7qqr7qqt4Orv7qsB7rsj7rtF7rtn7r/7iuDo/XC7ze677+68Ae7MI+7MRe7MZ+7Mie7Mq+7Mze7M7+7NAe7dI+7dRe7dZ+7die7dq+7dze7d7+7eAe7uI+7uRe7uZ+7uie7uq+7uze7uMOAA2gAw0w7/Qe7w2wcO7uCPZe7/XuAkJAATrAADtAAg3g70LgAjqgAxZQcvaO70QwAvJu8F5QAPK+654A8Pze8GGw7xnfABZvBACvAxQABiE/8m3gArKMJBKf74ug2kcyAj+gA/uz8D9QAEWSAiXnuysvBAlQJAUABiRQJDAPCg1gegDy8VsAAMrMO0OPBEUfAA0ABk8f9SfPzqTLujvP8ojgu6ALIBRg82tCAv85kAJIMvJgvwM5DyBZrwM+DwY5ACBN7wlPr23ZiwNIrwUAoADalivPE/dGMPVSXyRU3wYUUPgjsDszMAKFn/VI4PBGAACOr/Vv4AKL77sFQPkjzwAA8vNCEPQBkAA1XyRoPwRKr/ZGwPYBwPmkH/lNAPlF8PYr4Pec8PQksAGFf/uP7/iu3/hKgPkUoPcrcPmFz/pEAPglR/xMEPnGDwcugPjv0AA7sANNrwM7wAAukAApkAAFkAIzoAAJYPEWsAM4gAM7oPqSHwfAH/dkH/xDMAI5kAMLf/ZpvwJr3/ZCAP3jzwBDnwADDwSu34/CSDWGI5Jidhz+coHV6Fm1XrH/We2W2/VqG4FADqtL5QC5WeIHMM9wJErVlWAqEhuuQjr3hgOQhix2cHB2CoYadnao2nJS2H7q7vIUxQS/NDefXGYCZvQsxMjaPlN+cKRWxMRSAIYSWlszOW1vcXN1d3l7fb34pqqipEgs/J4KxBQKmps/V4SsdMQSf0hmpRKJLS4Dui1YZ0ujhH/P0bsAS61SQHfESH7gZ2ccKVRnU/S0gpG5AAmSlQ3JqDFJSBHJ1yqFkIDpcHkCpQeAKgWDMP3gEyDFiBH0dPxQNobCCHcr/kFUuZJlS5e9gjka4mKhFAU6pI3M1iraFWoBEgFKQKEAHxw/RiScF+CoxI4UuEGR/yLzZdVbgJoo0NpxqStj1FboIHpqCLwZxxqwYofF35eHI3OUPDnH4pCfVMyiVfvjodUtEkPFqiZ1hpC2kz5dhIcDFlJWIf1GljyZ8q2YVlyoyYZjjs6dUqRV+ZmIDyqM3zQyRXwQrKOKAXZINVeZdhVAOxPRK7XhE4Mnd5MGesIAVOgrh9VlXNx4xGPZeANcDA75B/EZfDPWnvkpsOMAbFTJS33xiVmaUnDMgCMmtnb37+FDvHwFQAEd9AL4Ds7MmQVoxu2qxgVWVkgvvYTuGikR4gpUDwdWriuHqvgiAyQFHTDEUAh4zAmuwQMDwcpAcSasAjmAMlKlwfVgE0kMHf82YIWNn+CAg0SDaqENMH5+cIeZwVIzbQgGR1DREEO0WovCJZlsMov5JsHQmkEIBCC49oZ4radpqqGAwCNxUACHkJoLQIcoGFuqwCO1ik1CJ/1aBwvzhhhpBjHD1MoCQMDUSoESnzhxi4eg6VMBMgDgYwdAqPjJUAUowPG9HZ8IYwV30kytsEBV85EOCgCEU9RRtYNyPyuCsZK9KrQMdbQfPsFyEgr4wVSVUmRB6YkNQH2OVJfkvILOSfZ6goI5JM3y2C0EBSMjTzvplbDSTssEgGX70o7SmcT5jtODfvhJnp8E8Q+1X9FN1y8oUwtADgBc0IGV2K5kVUVXByunm3D/VzDnJyBHIgGWEfgg4011IQrWimHVtCaBFQoDIDEhNiBOSLb6wOymKx4id5BP9vUMMt6io9hi7IRzb8CJqiBuKk4hzEeYDdxhKh9ZEc5ZZ19UpKoAcSAGOpGRLm71ioESwUcMQ5QiQpxMpQJFAQjnwCYAQHfOReEqTgqtTKY+8RblFaYWY98nxUiJOCVRRoLmpW82UYzZACFbnG6yrc2FqRXg8QeDLubjJmiY6UQzKXLwO+vFGf9ihwJT+qjbFRpJYoYVfHsCgBQKdBVia4oQZw0rGLhckt9krvyHhzlrnJcGTMeCAbKNk3xp6v4uO7qzs3i89d92OPQK/2YQJLOw/1dIXDSIcbZAdwX2DWcF3mvbwAUeYfkJd8F/2KCAERqjo5lQXS/f/CGsV9zYAiwoICXrw0f/eizgVdyFZtSH14X4sxzBfVbndz5cAAB+9AugFYgCPiwk0Avpq0IBOHMG+rhgf+IrQKj0x78kfA+AFWzSDi5XHLlBTYAlNOEJUVg+NPUrRyn8gsxyZBQNupCGNbThDSVDlALMYAfqwyEWCtCAY1whiNT74RGRmEQlciIBLVziE6EYRSlOkYpVtOIVsZhFLW6Ri1304hfBGEYxjpGMZTTjGdGYRjWukY1tdOMb4RhHOUaxAxOw4x3xmEc97pGPffTjHwEZSEEOkpCFNP/kIRGZSEUukpGNdOQjIRlJSU6SkpV85A22cAIBbJKTnfTkJ0EZSlGOkpSlNOUpUZlKVa6Sla105SthGUtZzpKWtbTlLXGZS13SMgZbMEEHgBlMYQ6TmMU05jGRmUxlLpOZzXTmM6EZTWlOk5rVtOY1sZlNbW6Tm9305jeziUktIMAB5TTnOdGZTnWuk53tdOc74RlPec6TnvW05z3xmU997pOf/fTnPwEaUIEOlKD+9OETMCACHyyUoQ116EMhGlGJTpSiFbXoRTGaUY1ulKMd9ehHQRpSkY6UpCU16UlRmlKVilQEBx1CQlcaU5nOlKY1telNcZpTne6Upz3laEv/twBTnw6VqEU16lGRmlSlLpWpCwWqFoTaVKlOlapVtepVsZpVjT41C1HV6lfBGlaxjpWsZaUoV7HgVbOula1tdetb4WpStF5BrXG1613xmle9anWuVqirDzCAAMEOFgMSkGhgDdtTDGDAphJIrAgcgIDEolQCCGBsRC2r0MXuNaKBHexnExpZB6R0shqt7GU5q9HI/jW1KO1rFerqABBAgLa1HYAPRvtQBwwgAQ8o7U0NmwAQOJamDrisAzQAARTk1qQS+EACBsBchkrgAcJ1gARAkAAR/Havu63tdyEwAAxYAAIWkO5IjcvdilLXuq3FqAPIG133yvS1CFWoQzFQ/5NWQO+8gHVHDfpbUwmIAA7XlalhSUCC0WIAAgHQAGpL6gAUcKSwDnXABwpEzgf51r0SwEDNdsIAGoAgACCAsEh3mwINBHiiziVbhedLUQyQeAcIiPFK6/vS+zY0vw5GgQUsoAF4KIC4C3WsbEnA4elOVgIGfmiT1euDIlN0wHe6rpMxCuWIatnIPlAPYxns4MJi+aJT5rKUP0ACEDAXyhe+k2QTAIHtGpnMDT1znbPqYXiA4MdABnINEEBiE08Xzy0u52QxIItBEzrAbcZwCmB8484OID8ntnM5Jd3RHP+grj2uAQbKuVg+rPjKGPjAAzDwAsOa09QfAHU5a4Bq5v8u9gM1AGxuD42BBzwA0ww9tJ0JrIDF1sDVDlBorxd66CanN9ag5rGpAVxYyOYXB+QMswZe8IBoJ1u6Hh4tq3eNW2h728iZXSioiY2AYDNWsD6YtgiajetQa5vVHyg2WPXsYHKe08OCZqy3483thv4a4NE27AtIPADJnrvVzjYyuj+AgAdcKtKZxi+lGWBpKUM8vQJPtsNxy+LUbrrTqlguQxFAnAE8IAV8ZgIKIJACV0NgBxbgHOU+MIAHYQ7AgB3A1CDGgA+UkwQMEEHpgrdo5Cpg0VIOtgaAvgNA61zpUAdBDVqegMvNgAE99/AAbo6DBBg3ATuPAwIaPIDZFUj/4ShIgYIN69y3O4ABSX7cAF4g5H7NIMnXxToErouBn/dLxW92AAl2wOsalK5fNS8nCFJggbVH3u2EN+9X8y1ex24esP5uctn71XUMQB0Cx7V6QiFg9gRgAOufCNOKBQ/0yP97xrLXQBMqbnGGCr7ST5Yt0JkOatIvGAR4ALMdLn9jku9496r4dKgRwAcL1IByiakBPCL+ODgsITpN4H7GZwwKBjBAFeAXE6YepoDcptzBbBbBzhVAAndAehTqNyz7NTAKwnMfB9EmMebIDzYQAPQKhATQDhS4bu0ejA9OjvcgAAHuxCg0QAPmhQEEh9cmbAcWK1fGD/40bAYga/4Q/w8UAK3B0sMIwEYBUND+tCrfNGDfzKnfSgzUiCP+MOUBvGwFhs4H8A8Bhmz8WGHlUsD1FOAFZQEHGIBDzCvRpKADCS/3dM/neg+/sCEBWeEBMWwGHOvDKKzJpmYHlc+lOI35zk0VNAAF0FDyokPCWCEFou1xIo44NPAFHEAVIOAFsk09eO1BagAP63AGUM0dZmDFfLD93EzYmOz9AuABXwAB3AEFCtG8DhEBKLDE8DDMGAABUKBfLAAPfcAdQEDDcKCwwkwBHuAFaIDSSGDEvsPGMOBxlksCjU0V8O4FMIA4HpD6aoz6pscP54+cmAC5YIMG8LDBQOAFZMEU8RAeav+sEd0h+bAq3/LETyIv0CxRFREAD0lsFY1R2t5MAwQQFcExE61R4eDrUhwAD8ExBTQRYlAADyVg/qBQ93gv4ywMHPsPD2vADF+AOB7sA9RjBj5tEzMx05bvoTAgGPrlaR5sE1fg0/RMB9kPBcDscXou+mbgA3wABLBtsVBAD7nwGL9uES2L0prO6dIDt3zgBRoM2yjtAXnvGNdx4cpJPRxAFu7w3EaBHSXAEEjRGG2MDTMRw9TPAXRRssywJPND1XALw3DAKCkH4RbxBXQyOoBRCzdxBlZusc5wAANA4XiwJdkNG1asBV8RFMDEELBN0GgAFkXg1HzAJ0dBA0evFVH/4OpssR4tK+EWK+0uzNXgkMQe8NzWcR4trh5P7Ba/0sZ4UBVfgNISIO9WAAJWAO/40iDFsOTc5bsGYOjYkB3PDQ5T7iEDj3N6LiEzMh3JKwUehCkCkTSlzMtwoLLgsNuCzcAO8MFkM7LgsC5JALXOEgXI8rKoSz0cyxAWTCxxiyADyx+lUvNSsrIUjTgdwDR18QWwQbyM7AEMjwlQbSAuBQI+jQl189pGCwHIUuSaygXzcrFIUdAQQEUWkkAg8QtHc7kiawDkrzUzMfzE6yzns18cLDuJEyAhLcoyDTHxa2pObjkvBQEejQYo8yNXcXbAMAyDigwBSxUizj0rTCgv/+sVJXJ2AMzDTHPBmGDm3oEEfg4QPyw1Fyo3fQBzTqzKWDA3I6slJQBzyAkcS2/34AEF/DG3Biw6kROwlBNEfbMtAfG6kLOyuvHhOAcFrpNAt7M7m1QTYw4a8E4WyrMlzzM9zRIetBO/4PNBdmD81JQEIFEWxAv3LgxTGAACQIBH/XOx5FBN05QBhFPMrvRAo/DipnD3pqbnHFTYRFQEUkABXmBRHYCHNK61DhK/TK6/2FADQ3NESdNEYRM1RWDCFEAEBOsFvPNFwVDC3IXSdBPYrOz+wBRVWVTMhLHG6OxBJEDRGJMNhS0uRxFJ/RREvbD/VsAAj3M2R9IAk83LZv8AKncAGVsx2TZRAa4S3jTgtDbSKr0UzMCUB8U0z86yTHmMLTknHUcVBaoVKhlgFEzsAEsvG2sgP/byK/vyG2hgVD/gwWQhAXJ1EwE1UHcP4xLTH0N0HBcr4WYAAiS0MlfgJGNsUnmsUnVrEzEVsESTREuzU5lAAlSxXimxQIxrCC/0RVmzzmwUN8HURJvgKZuMAlegIx+TIxBgFHDgAQYLG/SVV+nw2hgLRAFLFmZnxYr1yHgRErPRZxHgKDcRByJOsLCBHR0gGEksMrPxUUcxW321LNGz/cbUwdpzsYxL0KTyDgWL+hDxFbkuNRVTA+rVWUnAFt3UFsGxxgQrIVf/QARkVlQFy2IMM0ExjgY8NLAoDdLm1h3EyyjvpDI7dggNVdIctvkCoEEHLgNDFPsKsUQ/DDYxUtv6hU5JABpM7AtnjdJI8skITGW5VWt5b3SRayE5t18eDAOwQexAYMh47WlhQ1+TdMLs0XC7MGgNiwnXAASsgyIldl5llx6k9Wm1ECDdBQQgbxElVF4BS0zxTz2ZKt9SQE3VVF/h0wf4gAGyixbBTHQLMvxwwHkfJzpekMTizwLYr+Wed/VglymEix761V+lEAm1F3zPEn4VxcDOMjW5EzYiVVIzU0OrUyAtFQXi4LjIz9U613LJrwZ+N3hcDQSQBwJkYQZeUQE+/4DJenIFIHe6REABUgA3ta4sj1OEvw0cE6wVcEA7mwwCkKfriA9NB7Blv41CLytrB82xUiAFiKvfFmL2JGAfM26GgcYONNABggfVoI4nIMDDHqYsE20Qz5OGofGqPGztApRyEGAAKhPd0hcUFo26pkY3HWt2lgbslvIDtO/BJIAEgAbwjowyxWANFGAHCu0wB0A9vjjjHoCO56bvzq1OGeDKZodhG/aAIarWNNSpiK2hag3NbI2h7G26Mhmw7lUDXE0CztC5NHLguPN+HWqTpUzb7ssBStn03OUFzLVaUcvDOpkimYuViY26amDH4A0HY9QimQuVN04EJhA/JXmUaf95Al3N3gxrk8splj/ZB7TNl6V5l7fTmsGq1mpgm7k5l6f542JZBCCMuj54ujAgliurBjSAgptsm3HQw9TZk2EsmeVZmPG3mruZmzXSuOL5+Rwq1uJO2wK1cQltosisyejs0hSa2zBt2aSMuSDLWcFVt0oLyiLaTV35N2NQtzZ64AzszHAr7tqxIJfM937N10rrnEI6oenMnAiNybAMpPNsneIupjt6oRnNwIyLSE962ZDN11y6j6PQp9EpsYj6t85MpjEUqiLZqGbYR6bsvWIuOopMGH9TpQRvCHX4nrm6q73aowg6qRisCUZYqsn6llFgB9YMq/84hgv4q+E6rr//OqyTipV/WrVq16Eqy9hWipU9TK4BO7Dhmq6RivM8yrBzKqoFe7EZGzMztLEhO7Il26sJe7It+7Ix264qO7M5u7M9O6s2+7NFe7RJm6hCu7RRO7VVW6VI7gFE4LVhO7Zle7Zpu7Zt+7ZxO7d1e7d5u7d9+7eBO7iFe7iJu7iN+7iRO7mVe7mZu7md27gfQAwJaAOou7qt+7qxO7u1e7u5u7u9+7vBO7zFe7zJu7zN+7zRO73Ve73Zu73d+73hO77le77Zmwvo+77xO7/1e7/5u7/9+78BPMAFfMDPe4Zgy7WfO8EVfMEZvMEd/MEhPMIlfMIpvMJ9+wHEialXe8M5/7zDSeoBPIALWMvDSbzETZyhQFzEm/rEWbzFUzvFH9vFZXzGSxvGNZzGcTzHMdvGu2rFdfzHgdyreTytfDzIjfzIM23I6WrFm8xrswxBW2yIFRuipjyjqhyxcarKSQrL9dqooVyqNi/MOY/Lh0rLh3rKyVzAvpyqlNyvItnDQHkAzhDkJuoBRnmrPkCh3pKaJcrOP8rONfQti7ykHHqhwk2l7JzPG2rP3Q0uv8rO7S3S7c23BJ2yhJqiDr2r31IlF93Rc8rTwarNYUtDiZgnpM56Ybf/rPfitJIS16CAm4z8lEyjrniLBW8GGJmyHiCUBywF+HjNOerWJzrZbi8Ub/9v9by1cwMyIIf1MbXyrTnqiD0Z2O3sA1Tw0m/s1j04dF8dp4yygcVK1O0LITc4vJ7XFKH8LBfXosJPJt2FMam8Oldg1jNqfsvyX78D2tFrFEqvOE33pNrd0hww7xZR35MKexkh4XcgMv3NpO7UtB5tbyUtdUm68wre24s33EM8xn0NIEXYFgULHpD9p9PrFh/SQ3/LuJzc4k2M0b3Nw1Zemu9c3GL+od0zt+xdumLSslbeuCxsZ8fMPVP+5lFuwtqWla2M6MWt20ANzmH+4YQexT1d5QE33xl945Q+5Jrc2WCezhvrLNX2s3i+4bHe4cjNnHEN5aXsOZmy7A/aQyP/ntpbK3Wl1+J/tOwjLb1evumjnupTWu0v1eCbStx17B5hNrFGj0eJuVqNzFxRbXZ2nbYGAKHP7S412ALecwbvdbnudZdnKwFOTgKC7OEsIM747LiQK84S4PJynsdMUgRMf+gWf7Lga+XMFZTjbAAga/c+4PMfbLQsgMQYIJTvRPBoC2hRYAAo2MhyDgVybugGAAQgS2MlH6GlfflN7fPvtRU3f9mSi053EJQfLLlWn7EGQIPLmqYyT+AbnpXPv/yPeAAalLoGwAJoebbCi9d2HRsgAAg0H4nDMYBANBiJz+eQHJO+WWrZvGKz2i236/2Cw+ImZhDYrXAPhw8DCkAw/06HBjl4yCWoge8Bug/U+EGA4KEkQPCxtaGA2BE5oKzsyI1ZXmJmPXj8dHp+/mCIZEWurGggIGCwWaA4fKwoIJCRBFggMKwwBPAGKLi2gawEDMNhuAWAvGgEkCw3KxAHzGgUpaysOUDwDq+ALD3scBMnHNdWY5U1z/Qq1GCkBKBLSODMYOzu9uJYsJWxF2PgBEevAOVmKBBXTNkbBrN8IEgQYIAZEOJmOLAQrV0/ZN/+9ZpRK8EzCAjCjaPmAIMCHLW4DYjXDV2mmk0kYBCn4cWxnjjffNRAsFsCBBZ8PQmW7MUAgLzc1Sg4EUGNeL1IPIm0kRcDKlZsgg0rdoy6BP8SScxCFsdB1YI4lEScGC0FCmi9dgjrlUIEzgTdeO0QUYrS2MI2N4FKLEoLhpcpEgjBgKDIB4QPG9vCRQwCCgu1FOA0M2MACqFLgT5zpsHUDg2Hzqy69gDBGwWum8p7UYtEqwErZsw+t4iMmQAMWu2m8QZtG2YkaOjj7NmXCAzMvJWOx8C6xB2k6wXAQdo3cAkzyhNRMANKmhUk7hCEYGG6GtrJEEjCbkEfSWYQaGxDAgqvKeAAAvGM9loAKbi2DWGGiYGTOJBRVOEH9oFA1QwrkGbaAC/EUw1O13wAC4ed7QKBEbu8V4MD8SRQ2oSxNdOKXwt+BaGOO16ijknRKKH/1mTa2TgNCi9IZE8SFgyzQysySRfPAAgw81Z2U0nyII9bboFYYp8slgURCRDETWurVCYLLZml+EIRL+zyYYhuUqnLC6g59wwOK62k3ogr8IXDCjVMxhQcCOyggGQI0IAGCggIl44ZO/AkygpVPDADDvRAmhuLbjqg21LifMgnQRa8UBcEbj4g6C2hniPqAKsc5YwZp7yAZDOgwpmMcr6O5KZkE5YE3UQ0IPACBAxcCORkGAhK6BKaVsLlFhJK1ctOqG2jAQ0v0PDApXceWgoDy8yQALI0ROUQuR+W9W2u6hlxxmShSlQFE9by26+Peopg36qTqoJvMzRINAOhRvly/wyVZ7hpqLogUPMCo2YUlWW1/XLp5ZedhIkFEbSCwECZRaV5WS237AJMc804kEa1EpToUWqpzULENX9mZO8VNH9AhggWDECCKY9GekVZOWdaYKezioCQZLsoQQYzDDigKT1NxKWMc+AglBQC3TJMydjyIGCGQxCJ04/VEKOmwKCLlFWSobqAcEta6q2R3p70iIADDhtz7AO2JICQuOKExr0CBIg8LugDTRsoEdQr1aABCNqp8sasmJEAeQLxWLDNN02wdWmOhbNemI+SBfjrf7XMinoNsehqkhO1puVfWhiftEppZBqE3ySEt26Yxx+HfNMHNRi+0mQSrfBB0ypnhv/GB4v0vMMDsKWzEp67OpezA37Cs0K9zN20yiskbJjGhkjLM1wbFeVBec/n4o/LCi6XIgW30xdx4JAasBWICWcL0jXegYMCLS09c0MdLBRArgyd5wH7so5BSrIKEGxFAQPo0wy2RwTBGU4CrRpc8gyXk9z05Bg/SQa0svUbVFHtQDNw4QDk9ptoOAQZn1NIQUyhgaSp0Cv7aiETM/E6ekSDaHBoVP1u4gN7xKV2PSOBHDiou6W5QVA/LJ7Gmgih5X2peW0wGk0M9wJSTUFNa2RTAAB4NXFV4QqRQIHN8lS+6KHvGnQwzkMMhwIXxYMErvEf/dp4PxoajnIjuofRXKT/Gbc5gRnei0VSlNKfZiBQbN0SXzLqUpQIpg+AdUnBBV8gqO0V8JNxwICbiLYLXKnHhA5AIT1WiLx+Yat2WbCZejRgTGPOBw/+ERdaODgDEAhBEkH0nDkmYoFjzscBtKvEK1S3RDOCEwyve5kC3vAfqlVChWnQlRZr1UXfPVJdEhGhBSTAjIwdL5xjQaNiRpGOs7gJdSCSR9RkQYQD0VEZ9FCWQaA1qCVgQJqt9GMzzBfIFUjgdnt6wsM4cwYaHANEg+qUI9VxuiQWSCkUW5tmSLJQiawqigg4qE4e5gwHSBIio0ziDiAwt6XptIMvnSJq4vQCIohKlhiAABePgbAp/+YyK7xUoeB+yS9soaIIWiWlMnaBKoeRAGsnLGf9SEqDUF1NFZbrnK9CmoDAmMEZnDIDAfVpVy6MEyKfMeBy3CSBtBnnqe0E5cu+iLEXyG02oXoDPrV010zwExRqZAs7EvCBY4hgnjiRW9W2sQKWTaMaRjAFoRy0hg+QaqLkqygg15O+2bCICCg4VV3c4QAReLaR9jNp/sIWyfNwSA6a4VARVvM/+/yCDdtIQXGNU4MPFFSUVYQUa7oIPCfkZ4SjPe74VOKAN3TQP1QEQREksAtlRPWEOEihL1uILRDUYEDyfcf4kusAiWxHp2lIYKcSUAQUAJGtCaiBCCpziiKYIf+lBAEBESxAkLo+NsKPjAPqrsgLk1QmGcVlx04sJ4ctvvNQ8RyodjVQWeM5VsJjiCyY/JkOExNDAeoJT0fAa48Z1FQc8RAcMWZFD4UICmZ9XO3aJPin00ZDU8MohwOAfJ5oFChpZGBs/jjJtc+ILRfR4DEkMSO/8LiCsrw4yN/0WsWMDKN2QA3GMHgcXI8cQyLhYUc0VuWfF1iAHZpixw7+Kjdd2oO91HLvC01h6CZdMM7EsIcvYFmK4mWyzYKSmwGZQQxU+CY8BJlBR1YzDYIICsIqtisyuKg0S88Sxpoas2Q8vDvCcpA58bJxqHsMizyO2hIs9oQayVCD0QkOL2v/QN0AEnWcI7roCA8YnQJ4w00JWCQhI2ywIiP6HgzU4D2LgDYEiOCIUeCU2QzQ4rJT0OwBpaDPyLZfRhTJBhUmgLwF1B1EcmGBzSmAAVXjIQMU8JhhZ5Kp1TDL1owgoHfvcodMaHcbMeAZGQvow0cUkXX6nQIQoKDaGRdtDSBgbrxoFQQJ0KDhzJLCzPqXid8lActbzvJvTPwJFff3yIdzXxLUYF90sLh/QfgNgx/c4STwNwRcRIaME/3X8s71XRnObhC4uw0dN7e+l0AH3rw72yPEbtSdboREeUebtvEBIezH9C/sGmQuJoVkiqCKby7qXksQDERTsQqRxf0rBrot/074fnelcXNmizrGzwbv9g+v7iaTSUceQpULl10yFQVju93ZfQx/VIvuC2cYvQ23eCxIb/Ko+7sTJL+KVfDl76F/Oxk2RnjAm9FAMezJbfeux8F/sw2rM5DdcTKZUfhk9JUHveFJf3Z9/tXsbfi8Ewyvx5kWfjh9/9nvl9/7trdB+cfnQtpDsfZr5X77XKKZFLV0Se0XRgLzuYbLxO/+98M//vLvV/d7Pf/CodlIw/EfJneELWPcXwAK4AASoADW3/cV4Pj5QYywW2mQ3JbQQSJ0UgJSYAVa4AUWzgFi4PhdnhasRPjpyEpY1QaSYAma4AligQai4AqyYAu64Asen/8KwuAM0mAN2uANgoUM4uAO8mAP+iAL6uAPCuEQEmERil8QGmESKuESMiG/IGETQmEUSuEUdsETUuEVYmEWDmH9TU4XeuEXgmEYiuEYkmEZmuEZomEaquEasmEbuuEbwmEcyuEc0mEd2uEd4mEe6uEe0uEH3MDHeIIHCOIgEmIhGuIhImIiKuIiMmIjOuIjQmIkSuIkUmIlWuIlYmImauImcmIneuIngmIobuIGAGIpmuIpomIqquIqsmIruuIrwmIsyuIs0mIt2uIt4mIu6uIu8mIv+iIr5gE9COMwEmMxGuMxImMyKuMyMmMzOuMzQmM0SuM0UmM1WuM1YmM2auP/NnJjN3rjN4LjNYoAJ5Si/WnhOaJjOragFapjO7rjOw4gO8LjPNJjPaqYPNpjPurjPnIMPvLjPwJkQNaEPAqjQBrkQSJkE1ih7JXeCLZQdSRe+mEWEwkG9G1J8iGg5y3G6wUg9g2TRSZPRaKfTXDkCu5dRmrhE74CsOWbj9nVfUHAAxoGzZQd67yewRmd/2md8tEkeaHcSG7fd1Ud6EFdzrXQ1fVfWEgAbqWcSXrG1rkjEmaEnpnbhTkk6yDAnwFlJqROChSStTABA2BNvVXRjgzSuXjgKp3Eb1wl02FLCW0bPNjCVvJIFrWlGODUoK0gMqxNVJIjIKpRehiECMIY/1RGzwT+THlpASTkns4VwWKWV1bC5U1o1RJtDREUpMh8U1fOlGKm0DcVZME9JmROYBHYwxKcn2emkJgwwWV2EmP+TMcZJiQMBgL8JGWq5tbMwb7AZhP9X1/+Sf/15k205hO45muqJm52Ega42rUkp24iJkrNzHOCZnW6nzrkFxcM52oSp2Xqpg0GYc/IwiKQS1+uQg3knOuxBfTkCJoIAunRAwY8wHO153pKAA1EVfah52Vt2xw8FxFo5gOA3gDRgA+gJ+ppUHXyxcg8D38WXkaxZ2vWw+D8VctQBXv6gAgIhmXeluH4p4Ce53tuW/XhhIG+w+0Qxk1iQIP+HT2sxP/z0CZ6jiahoQFB1E5wssFKzKeLzMyHuii2uQifyGiH6id9+kNz4h2E4gRvxmeJWGbTVEKI4gEbaOhrfifgXKfa/NKSoueSZqgT/Mx3UikOhmeV2F5GIY4/9FCbCVMZUBoOqAgTWMc1TAMDBKkGiJBPTUOc3s+bxgRcfleQ6UKQ7gAJoJYulBM3CcXp2M4k4MYkMI54RCkIiAeeQl032CnCUaop4IB/MacY4cC55EKxsSl+5FtS0EwKYE0KcMY1oIIG0KlIbI9WlMOYDEUK+MYOnMQOYE1GoAEx7IAruIFt5IIvaIBGxJgjsY6EcEga9E369MP7AIQIfZhYHuoAbI7/BqBBLJRGNFyK27hpNwTrSiApZRJPGvhXX6TABxhNdv6WojRHrNrpiqYbX9BBqMrcAOAAox4fdiKPrS6af9GBAlBYGJVDGySAAiTlDAYhFC0IafSEKlSHaLAcO3zEG7gHCRDEdqiDcXhcoz2MoDAABBBEOaiDLnicKZSQfYjE0MEGBiAElAlDApFlG1EWa3ysrjKDvoxIAHzAraBsPCjA9mBGy7KDQ4CQKTSbqGhKWB0NS8zlhGHApUzaHnDFxw4tBwVRLbRskOlqpuAAAnzAxkKAONTHNjTtLjxZ2YbHdy7rC70GWgSnfArtsgzDRwjOlh3Rp7GtPbBqPDCXOojE/8cyl10OE9dWLCjhwyRMw8HeBJR27Mju2IWQzkp4liVJ2dn5K2MgLvyAEiwonFzqyy5VD12eoFQia4xp2xNUhhrkSmWsB+g+ymRE0S5NRSrsxjPMwOzeToHYLiqkwjbgwPa8kuTZAx6AGh8hSv10E4SJmTLQbvWwxP/81yTczU7gbqWFx8KIQDRMCbSErYHUgtmQy8SIWE5QLzsIkBwQBPCCzs1UyYUMib2skKE8R7LEimYlSz5IXuXSqC1ALQN9FkNtRyqsxspumQXQUi0ULkI5gyrIDaHIzZEkSwMZ7qn5wmycBJCISnDZD0rNgo1KXu4ylipcgwcLDmIy3ea+WP8Gp8LYeoo8rOh5KExE6cJX0qBKGhylLcijMNYrbE+3mAG9RWANqM1D5CVG5En0VJUmIXHUlJAPDMBOLEGeAUcNocIjNRNQbEzqKIqcepV9FEUWGUpfdtPg1EKGvI1DTCgbkJTE7UrrFgGK2ub8HMMRo464KPHBmM5lOPEKPcxoXFZEXchatUG3CFfmFg5WhWwbXIMCR/AidAp6TYWZVc35tcEuJBsVR4KgPEq5asaUcI3a0EAtrEpjNk0ZI/EUrAcdVwb8OENdsM/2sbDSxMlDAJatdJBv+MWHUBOZ/iXzfJ9Itp0RC+3ZHJopGERz0l3XFJJcfoB/BKPgCEwh6dD/9lAJCaRAkKkBtJRHCqEQopTugF7KZbTMisbCMbREaEAaGciNBLQN9/TuEqQwWbrNIKEFSb2LpfCXRDDqn9RArVARTaTO11aVNnQDwb4Dc8rwIU+XInMMVhnINvwH+4kAJ21QXOHnZJKUG3uVP6CBJXnGNg/D7l5w9LAf90gCK53DvzbNUzmuI9fRgWAUM2grDujKvtGylg7TBKt0Od8agCjMDDBAo4zzDYZnyRjdQdmuBXSHy7FcHUxEJTSzP1eLXGYOANIDNZfwFVxz0Y5sD10xL3FNt/jADZPCAJlzHRlIy6iKKlwXGVyDD8QDAMEChdYzJuPzZDgHDaTADAjG/0Uz11+ZTjqlT0AfTDw3qkEPTqgcwg4ARIdNtUOjQ0f/r4icjzw4irikVAE9h+CQnGVjMvq+Q8L0FKl+8mRTZkqjzkp3Svv9zEtbtdK0TU4nAEb4FGqtBwiOWi278wRhVzqL8wOkACuZm3no6g4GIWaocROIQK9oQEWAlGT8rAh09f2kgBSxzxOcxyBR2FYPTlotXD0Ax1EEbrLwDfh6aHC/R0OTs1eSQcs0l1nMpTpsd9SgcSW/jK5OKGp+dCZV1GYpjHvMlGDnK2uBaXcLdB+/DWPjRzUUTL6wUxeNkiWbro5INDk9MunCUlApA2grUKSMtvZolAYbdWoLE9fESf+UkvLK8GQq47ETmAdwlELZshIzNMUs7zQhESM+uLe/CtEM/EcvqzZSB3Mafd8g4YC00BIKbMhzOavFLO+ARPlkEAQKZMoAJ8s2nIs0g/PftK/F6Mp6aXSyrMaeqPcS5QRClNl7r7Ur+A0O6MvJokqy4NczgIbdxcPpUPPURO1eKwUaiIiBE4GB1TkB2xQNMIMCPHcqiANjPxX0vkDvTjhluzFEA9ML0USnmAKqBEgqpMr8IACIW7g9g3T1aBKypIopPEClKw1d8d6LTISoLOy7nsSGYK+ubMeIKMmty02K73hRzx5gNbCszwplcVadqEdOGrkp9pqXIQ7UVZaiwen/6Ciu8D5OnR0DxobORTyKl4M3O7tHAhQrcNxOMySA0ZgCma33I7Wzm8d31CJDl92KSJC7/vl4tUfDDmTFXKwK1eToH+UljgAORivFuF/EO6QVZug7YNx62EoCukNANICAYFH4dAH8ZW+bBHirAsPwDiDCtHtzaIv4f78Q9GxsusePipQrTuyCApgFEB3Df4sJ2G47MXS7/kGEnMGF2crkjuPYDgi90JfDy8e8cSTFC8Fl1ICPch95P0EmpfZCLLikG7ADzgujNly94yS9vppJmJnYwdJDccen15NDolwWbjRukrxICrT7CVGvB9ZAvkWpxgLDK2SQmsJBsX5rMELA/9aTwLCVgaDo6t/fc9jjchrnQfeKFXGUySSEWZ6ZBBHoaXiA0HYQdxVYBw8/k/ioBMJ+/thw2oVDiMuP/qlpSpihQLFavswVd2j/PTos1e76g8a+g9k7jjAAB8UAu4z/PS8I+cj8PWw/bkJY1+MHKzc5+dD+hHvc5WP9Q/wcWn79/p6C6f3oQlaM6vOj4BP2HdGQxkoUng8Y02XxpnwaEx6oeUa4BnxaJxmoX2Topiik/xK4RmZSJiykmGbyPxD4JA7UioHw+TCDQIKG0qAwjqQQ89BoPtOqwyGRCMNVcVKC2K0+VPO4OrVoaty2GfPJSjDgupKosdAL4yNzKyNDTP9UXGRMJCT7cnPAqAEU7MM87NvL2nKwQAEzLLzKetjLdHSDi6JrIwRja5ylrbVFFM3l08PSODWMrBK9JS42Pr598Phhbnb+wRBhHMKYGhXyuh76cvSSzXzE5n7cHvPSFHpJCBjAmDYkdEAgCdBgW2pC8NbOVh0cJYTAQoAjhfj1EwavHyw327ilgncNGbJwCRHtM5jR4kZx5thIFIYwFS6FIjmim5iSoq5hZkyeBKlS5syJyp7djEZT585CDkgoCKDg4a0hDIDucJcEHwQkPN8MULBihYVvTq1exZpV61auXb1+tWrzprOcYM0qhTBjB4qqtnzOYLCmiwUGA9rqdKD/AYeCdmf9/gUcWPBgwoPFjmVWtnDWL66MNa6qx4E0rA4XX8acWfNmzlwPI1bceWbLiTG5VhSdWvVq1q3Pfh4b2vVs2rVt38adeyZsnJR1/wYeXPhw4n55P5NdXPly5s2dDz9O1vdz6tWtX8f+N3qz5Nm9fwcfXnyi7Ymnj0efXv164OWhnWcfX/58+oTdd6+fX/9+/irvPwAwQAEHJLBAAw9EMEEFF2SwQQcfhDBCCSeksEILL8QwQw035LBDDz+88IMbEGvmhgNORDFFFVdksUUXX4QxRhlnpLFGG2/EMUcdd+SxRx9/BDJIIYckskgjf9yARCWXZLJJJ5+EMkop/6ekskorr8QySy235LJLL78EM0wxxySzTDPPRDNNNddks00334QzTjnnpLNOO+/EM0899+SzTz//BDRQQQcltFBDD0U0UUUXZbRRRx+FNFJJJ6W0UksvxTRTTTfltFNPPwU1VFFHJbVUU09FNVVVV2W1VT43gBUAAGDdAABmABhhBBeckfWZXp38NctgebVVymGnLLbJZKtc1s9Za322VmTHPNZVaxEtYAYctuV2hQZ+0GEGcVfIgZkNFNCB1xTKJRGABnb9gYEEttyB3WcYSNdJC0ZgJocdrKQABwpIpMACZiiYgd8qLVCg2T1dUEBbbnGYYd4mCyiAGYYd5jIHBv+uBTlRFyzAOCqMLdhAhwB0cMGFBpr4YQNyeYVLSRcCMPgHBezFMoFvb9r5yYqZacBiKkcIQOGxGljBVhcYGLhKpjnOE4ACSGYggAauVnrJHf79YWoxdTA6ZLMNZQAHZ3AAu98ZYp65GQBmIEHJEby1dd0fMLYVAHhvdcHvH1xQ2AWMk7w12YL51Xusggso1gUccui7710LjnqEAuDd4G/B71bYaguiBiBcCvpmJvAN+HYG88Fvmtp1ua+OOuYkRzj99gKSXB3y1vctVnDZm9H8786p1mGF2pvc4OtdG5gBVwvgdQHx1GeVVdcfpK+dAuMH7lX40Xkt/mzz7dxB7Wb/Upjhb8Ph5nnuuhGzYIUAVvg3hRQiXiEFACiYSjP8NQIFME1tTBPXDHJWL2YkT1zp41kzHLgCHOBuBvdrWAL+VYCdUcxbDJjBCmaQMQ1KMAU/AN3eKBbCcuVAKivQwQYS9oN6KQAH+CuWCylGggo+g2kkGNfPRnBDFvYrBznQWgNSkDYKNsCGK1DArgDAAAr2b2AEzMG48uWCNIQwX0jsmjOSt7wlbSAFUkkY9EAYQoN9rRnZGgG+doAziFWRXVkcmORa+DEOZtGLqWNfCH92PkK+KX3OKIBU8KU0me3AAg2A5A9JtDoYDiwFWkMhDHUGNpk14G44YFkBVjYrEijv/wcpqJsodeA3epQtdd4anAJOOIIZ5GBgJDihKFMQuKwlwG9s+0EOFNCMBAwzhQrYga3GuIEEjHADAMxYVAwmym8lL2O0TNozBrIDXr4NADjYpbswWcoUZExllAsYJpGWLhdeE5woDMrAErCCXe1gl2FbQcaUSEYJmvJJFNAfv17GgMAd8mVR+8kpjbA7BShgYANJlwvUEq8ZJIkBuQxACgbmwrxxE1wrCGMhRXqmQ7aumPbDQcZkCMWJBSCCz3BBPpmxxPXVjWkDY9oG1smMi8ptBunSW0/NNTNa7SqmOUjS+36AA4vlIJcgJVrT+nVCpxLTmFB9l8awGr0fQHOp9v9SwLwmJ8FsOuOmWgVA/WonzB+UEl7hKpZQdTavn75ReXfLGegAqDQGfGxJY4xSX6MKr6nNLV2G1Zn6Eqm0BCgWfzOM11Mztre7+vOULx1pZsVU0pusDigjAEDcbkU3m8n0sjXdXl13wEeoLrVsDMhfuca6vnKdMYTzSh4FcwAvpk6VslGDXg6pekJmFDOT/HKBBvknUK56FZTNCOvcckbZMIrtBxaIng7UR7ToyVW7zRAsM9C112bIbHStBZ0oJwZFJgEWSrDlbrHExtZE7ipo4MJBsuoHr3UYraeJjFp9X7betmnWwGHiLAV2sLybpUu0qZ0fYmI62cadcn7ClGH/xhYrXp6t9rT35TAKMVaAqI1snvl1rW8BHF/fVrW4VwUtOD254eB2VabPFe+8YKnV6kr1utndbtjeBt8GbpfIOmOZaQeXzxQeN5ENsMAj99VeyzqJyDXGp61ARwK/3hfL16VnzKKCA3j9158Arh+Uo1yAkB7YzVri7M3KRgFMPlh+5nLYhGdqL1Qyg5ZspW6/ULzkb+ktB9ul80sLkEw/ByBjOK7qioUs3GAOkxk7uGrBwgxm5trKufma6ybBW9ZmWBe7q3N0M+wZr7Z9l6dtC+tXS03PJoNOzw08rPVu4t7UMSBJsxpLeLFs3SWmNMTwnK5ReErmd0b2t8wAMHmL//stYL/Z2ljawdvISgKMNWBbtXIpr4wwOBz41RmNNBiIFWDuOeZrwzYupwW2ZSsF1A2A8QbKSwG4A4yB0L4FbOswRRm15BUroRAtgAuNGQAKIC0BIwgXJgfy8JtlbGjMGOtASGABILZ21sXaLw29VQB6ZOzIzVR123r7sgQU4JyBzmTGXLg1lRlsnm3+wTqW19hd4fEmpVyldYUeFOjai4pbQ6LBXqZhmJk5wFA9egHWkbFsU+3aV2dSAiJMtEBOToo7GOT28LU9/S2t3sEcZA5AfVA/Q+2NgVxwv9wdMabmIOxvjNgMyqmxFCSzAeUagUevy4Bi6YBdzaTb37sad//Ep8ACZQfAoRsAgB3wiwRp/1kBUlBu7IaxAISHtq8HB8QZKCBnZCt1hFHfr595W1y+7KrbY88vADRWW61Xsg8Ff92/7yp5IQ28Qz9frOEPFdR2l5sfAT5FUOsgmYZHIUHbDj7l58xfVsd69qFUbScpnkpHRky1iMUk8SPL6r8qP4kwJkGuPin9UJKWsnTtAo02iQJQYwBydx8lSYdf11biPu0TQDXZAFuakoTLvU95GR0YAaZxpT6BJCdZNCDCrbtzEgoIF3MbwA2EFOxTEu2yQAVsKHQZFA8cCxKQIiqhgHr7Gw50wRf8ExNklBaEwRq0wRvEwRzUwR3kwR70wR/BBMIgFMIhJMIiNMIjRMIkVMIlZMImdMInhMIolMIpzD4TOZIrxMIs1MIt5MIu9MIvBMMwFMMxzBHsywAB4IE0VMM1ZMM2dMM3hMM4lMM5pMM6tMM7xMM81MM95MM+9MM/BMRAFMRBJMRCNMRDRERAFAAYUBIWyIBHhMRIlMRJpMRKtMRLxMRM1MRN5MRO9MRPBMVQFMVRJMVSNMVTRMVUVMVVZMVWdEVUjAAqlMVZpMVatMVbxMVc1MVd5MVefJQgAAA7 width=396></div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>161. </span> A 61-year old man presents to his primary care physician for a routine check-up. He has no symptoms. His past medical history is significant for hypertension and hyperlipidemia. Laboratory tests showed:<br><br> <table class="table table-responsive table-sm table-striped"> <tbody> <tr> <td>Alkaline phosphatase</td> <td>500 U/L</td> </tr> <tr> <td>Alanine aminotransferase</td> <td>30 U/L</td> </tr> <tr> <td>Aspartate aminotransferase</td> <td>20 U/L</td> </tr> </tbody> </table> <br>Which of the following is the most likely diagnosis? </p><ol class=mt-3 type=A><li>Rheumatoid arthritis</li><li>Paget's disease of bone</li><li>Buerger's Disease</li><li>Acute viral hepatitis</li></ol><button aria-controls=explanation-18R aria-expanded=false class="btn btn-secondary" data-target=#explanation-18R data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-18R><p class=correct-answer><strong>Answer:</strong> B</p><span style="text-decoration: underline;"><strong>Paget disease of bone</strong></span><br>1. Pathophysiologic mechanism is impaired bone remodeling in focal areas of the bone.<br><strong>2. The single most common cause of asymptomatic isolated elevation of alkaline phosphatase in an elderly patient is Paget's disease.</strong><br>3. Paget's disease of the bone is characterized by excessive bone destruction and repair. <br>4. <span style="text-decoration: underline;"><strong>Labs</strong></span>: increased alkaline phosphatase; increased urine hydroxyproline; normal calcium and phosphorus<br>5. Alkaline phosphatase level is the best initial test.<br>6. X-ray is the most accurate test.<br>7. X-rays may demonstrate osteolytic lesions and expanded hyperdense bone; bone scan will detect diffuse “hot spots” in areas of active disease<br>8. <span style="text-decoration: underline;"><strong>Treatment</strong></span>: bisphosphonates and calcitonin</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>162. </span> Which of the following is the most common cause of community-acquired pneumonia? </p><ol class=mt-3 type=A><li>Pneumocystis pneumonia</li><li>Streptococcus pneumoniae</li><li>Streptococcus pyogenes</li><li>Haemophilus inffuenzae</li></ol><button aria-controls=explanation-3O3 aria-expanded=false class="btn btn-secondary" data-target=#explanation-3O3 data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-3O3><p class=correct-answer><strong>Answer:</strong> B</p>1. <span style="text-decoration: underline;"><strong>Community-acquired pneumonia</strong> </span>(CAP) is one of the most common infectious diseases and is an important cause of mortality and morbidity worldwide.<br>2. Patients with bacterial CAP typically present with fever, usually with a productive cough and often with pleuritic chest pain.<br>3. The clinical presentation of atypical CAP is often subacute. In addition, patients with CAP due to atypical CAP pathogens present with a variety of pulmonary and extrapulmonary findings (eg, CAP plus diarrhea). <br><strong>4. Streptococcus pneumoniae (pneumococcus) is the most common cause of community-acquired pneumonia. </strong><br>5. PA and lateral CXR required to confirm the diagnosis</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>163. </span> A 41-year old woman presents to the clinic complaining of palpitations, heat intolerance, sleeplessness, frequent sweating episodes, nervousness and weight loss despite an excellent appetite. Which of the following changes would you expect most in this patient? </p><ol class=mt-3 type=A><li>Increased TSH, decreased free T4</li><li>Decreased TSH, increased free T4</li><li>Increased TSH, decreased free T4</li><li>Decreased TSH, decreased free T4</li></ol><button aria-controls=explanation-YSN aria-expanded=false class="btn btn-secondary" data-target=#explanation-YSN data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-YSN><p class=correct-answer><strong>Answer:</strong> B</p>1. <strong>Hyperthyroidism</strong> “Thyrotoxicosis” is characterized by hypermetabolism and elevated serum levels of free thyroid hormones.<br>2. <span style="text-decoration: underline;">Clinical features</span>: weight loss, increased appetite, heat intolerance, anxiety, diaphoresis, palpitations, increased bowel frequency; staring or lid lag, tremor, tachycardia, increased pulse pressure, warm skin, hyperreflexia, possible atrial fibrillation.<br>3. <strong>Graves disease</strong> and toxic multinodular goiter probably account for more than 90% of all hyperthyroidism cases <br>4. Graves disease (toxic diffuse goiter) is characterized by hyperthyroidism and one or more of the following (Goiter, Exophthalmos and Infiltrative dermopathy)<br>5. <span style="text-decoration: underline;">Graves' ophthalmopathy is the most common cause of exophthalmous.</span> <br>6. Thyroid-stimulating immunoglobulins (TSI) are present in patients with Graves' disease. <br>7. <span style="text-decoration: underline;">Radioactive iodine therapy</span> is the preferred treatment for most patients with Graves' disease. The contraindications of radioactive iodine treatment are pregnancy and very severe ophthalmopathy. <br>8. Radioactive iodine uptake (RAIU) used to differentiae between primary and secondary hyperthyroidism.<br>(↑ RAIU → primary ,↓ RAIU → secondary hyperthyroidism)<br>9. <span style="text-decoration: underline;">Diagnosis</span>: <strong>Thyrotoxicosis</strong>: <strong>↑↑ T3, T4 level</strong> and <strong>↓↓ TSH levels</strong>.<br>10. <span style="text-decoration: underline;">Complications</span>: thyroid storm.<br>11. Untreated hyperthyroid patients are also at risk for cardiac tachyarrhythmias, including <span style="text-decoration: underline;">atrial fibrillation</span>.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>164. </span> Patients with infectious mononucleosis are at risk of which of the following? </p><ol class=mt-3 type=A><li>Splenic rupture</li><li>Parotitis</li><li>Malignancy</li><li>Burkitt lymphoma</li></ol><button aria-controls=explanation-8VH aria-expanded=false class="btn btn-secondary" data-target=#explanation-8VH data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-8VH><p class=correct-answer><strong>Answer:</strong> A</p>Infectious mononucleosis is caused by Epstein-Barr virus (EBV, human herpesvirus type 4) and is characterized by fatigue, fever, pharyngitis, and lymphadenopathy. Fatigue may persist weeks or months. Severe complications, including airway obstruction, splenic rupture, and neurologic syndromes, occasionally occur. Diagnosis is clinical or with EBV serologic testing. Treatment is supportive</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>165. </span> A 51-year-old female presents with marked hyperventilation. Laboratory evaluation reveals a blood pH of 7.22, a<br>serum bicarbonate level of 14 mEq/L, a serum lactate level of 7 mmol/L and an anion gap of 19 mEq/L. Her past<br>medical history is significant for non-insulin dependent diabetes, hypertension, and renal insufficiency. Which of<br>the following medications most likely caused this patient's signs and symptoms? </p><ol class=mt-3 type=A><li>Metformin</li><li>Glyburide</li><li>Clonidine</li><li>Enalapril</li></ol><button aria-controls=explanation-8CW aria-expanded=false class="btn btn-secondary" data-target=#explanation-8CW data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-8CW><p class=correct-answer><strong>Answer:</strong> A</p><strong>Lactic acidosis</strong> is a condition characterized by the accumulation of excess lactic acid in<br>the blood. Normally, the principle sources of lactic acid are erythrocytes, skeletal muscle, and the integument.<br>Lactic acidosis is not uncommon in any severely ill patient suffering from respiratory or hepatic failure, cardiac<br>decompensation, septicemia, or bowel infarction. Cases of lactic acidosis have also occurred in patients taking<br>metformin. Metformin is a biguanide oral hypoglycemic agent used as an adjunct to diet in the treatment of<br>non-insulin dependent diabetes. The risk for developing this disorder is increased in renally impaired patients,<br>such as the patient in this question. Furthermore, lactic acidosis occurs more frequently in those taking<br>nephrotoxic medications such as aminoglycosides and radiological contrast dyes. The other medications are not<br>associated with the development of lactic acidosis.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>166. </span> A 83-year old man brought to the emergency room with sudden visual loss in his right eye. The patient also complained of fever and right sided headache. Erythrocyte sedimentation rate is 91 mm/h.<br><br>Which of the following is the most appropriate next step in management? </p><ol class=mt-3 type=A><li>Refer to ophthalmologist</li><li>Antibiotics</li><li>High-dose IV glucocorticoids</li><li>Check intraocular pressure</li></ol><button aria-controls=explanation-CWH aria-expanded=false class="btn btn-secondary" data-target=#explanation-CWH data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-CWH><p class=correct-answer><strong>Answer:</strong> C</p><span style="text-decoration: underline;"><strong>Giant Cell Arteritis (Temporal Arteritis)</strong></span><br>2. Giant Cell Arteritis “GCA” is the most common form of systemic vasculitis in adults. <br>3. GCA may begin with constitutional manifestations such as anorexia, fever, malaise, myalgia, night sweat, and weight loss. <br>4. GCA should always be suspected in a patient older than 50 years who presents with headache and pain in one or both temples, visual problems (decreased vision or blurry vision) and polymyalgia rheumatica (proximal stiffness in neck, arms, hips). <br>5. <strong>Temporal artery biopsy</strong> can be done within several days after treatment, for confirmation of the disease. <br><strong>6. Visual loss is one of the most significant causes of morbidity in GCA.</strong><br>7. Prompt initiation of treatment may prevent blindness and other potentially irreversible ischemic sequelae of GCA.<br>8. Giant cell arteritis must be treated immediately with <strong>high dose glucocorticoids</strong> once the clinical diagnosis is made.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>167. </span> A 35-year-old woman comes to the doctor with dry eyes. She also complained of difficulty in swallowing solid food. Examinations shows bilateral parotid enlargement. <br><br>Which of the following is the appropriate management for this patient? </p><ol class=mt-3 type=A><li>Colchicine</li><li>Calcium-channel blocker</li><li>Cyclophosphamide</li><li>Artificial tears for dry eyes</li></ol><button aria-controls=explanation-IYV aria-expanded=false class="btn btn-secondary" data-target=#explanation-IYV data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-IYV><p class=correct-answer><strong>Answer:</strong> D</p><span style="text-decoration: underline;"><strong>Sjögren syndrome </strong></span><br>1. Autoimmune disorder with lymphocytic infiltration of exocrine glands <br>2. Can be seen in association with RA, SLE, or primary biliary cirrhosis <br>3. It is characterized by dry mouth (Xerostomia), dry eyes (keratoconjunctivitis, with burning, itching, and foreign body sensation), nasal dryness, vaginal dryness, chronic bronchitis and reflux esophagitis. <br>4. Positive anti-Ro (anti-SSA) and anti-La (anti-SSB) antibodies. <br><br><span style="text-decoration: underline;"><strong>Treatment </strong></span><br>1. Artificial tears for dry eyes<br>2. NSAIDs, steroids for arthralgias, arthritis <br><br></div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>168. </span> A 26-year old lady comes to the doctor with a history of amenorrhea and galactorrhea of 6 months duration. Pregnancy testing in the office is negative. Which of the following is the most likely diagnosis? </p><ol class=mt-3 type=A><li>Pituitary apoplexy</li><li>Prolactinoma</li><li>Craniopharyngioma</li><li>Tic douloureux</li></ol><button aria-controls=explanation-JKN aria-expanded=false class="btn btn-secondary" data-target=#explanation-JKN data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-JKN><p class=correct-answer><strong>Answer:</strong> B</p>1. <strong>Prolactinomas</strong> produce amenorrhea and galactorrhea in young women.<br>2. Prolactinoma is the most common pituitary tumor. It presents differently in men and women. <br>3. Men: presents with impotence, decreased libido, and occasionally gynecomastia.<br>4. Men are more likely to have the signs of mass effect of a tumor, such as headache and visual disturbance. <br>5. Women: amenorrhea and galactorrhea in the absence of pregnancy has women presenting early. <br>6. The most accurate diagnostic test is an MRI of the brain.<br>7. Diagnostic workup includes ruling out pregnancy (pregnancy test), ruling out hypothyroidism, <br>8. Best initial therapy: Dopamine agonist agents, such as bromocriptine or cabergoline.<br>9. Most prolactinomas respond to dopamine agonists.</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>169. </span> Which of the following is associated with Guillain-Barre syndrome ? </p><ol class=mt-3 type=A><li>Drooping of one or both eyelids</li><li>Memory loss</li><li>Cranial nerve involvement</li><li>Bradykinesia</li></ol><button aria-controls=explanation-2D4 aria-expanded=false class="btn btn-secondary" data-target=#explanation-2D4 data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-2D4><p class=correct-answer><strong>Answer:</strong> C</p>1. <strong>Guillain-Barré syndrome</strong> is an acute, usually rapidly progressive but self-limited inflammatory polyneuropathy characterized by muscular weakness and mild distal sensory loss. <br>2. Cause is thought to be autoimmune. <br>3. Diagnosis is clinical. <br>4. Treatment includes IV immune globulin, plasma exchange, and, for severe cases, mechanical ventilation.<br><br>Cranial nerve involvement is observed in 45-75% of patients with GBS. Cranial nerves III-VII and IX-XII may be affected. Common complaints include the following:<br>1. Facial droop (may mimic Bell palsy)<br>2. Diplopias<br>3. Dysarthria<br>4. Dysphagia<br>5. Ophthalmoplegia<br>6. Pupillary disturbances</div></div><div class="question-container mb-4 pt-4"><p class=question-text><span class=question-number>170. </span> A 65-year-old male presents with complaints of difficulty with urination. He reports that he has difficulty initiating urination and that his urinary stream has less force than it used to have. He has some dribbling and awakens three times each night to urinate. His exam reveals an enlarged prostate with no masses. Urinalysis is normal. Which of the following is treatment of choice? </p><ol class=mt-3 type=A><li>Ciprofloxacin</li><li>Amitriptyline</li><li>Tamulosin</li><li>Oxybutynin</li></ol><button aria-controls=explanation-FY3 aria-expanded=false class="btn btn-secondary" data-target=#explanation-FY3 data-toggle=collapse type=button><i class="fa fa-heart"></i> Explain</button><div class="collapse explanation-text rounded p-4 mt-3" id=explanation-FY3><p class=correct-answer><strong>Answer:</strong> C</p><strong>1. Benign prostatic hyperplasia</strong> (BPH) is nonmalignant adenomatous overgrowth of the periurethral prostate gland. <br>2. Symptoms are those of bladder outlet obstruction—weak stream, hesitancy, urinary frequency, urgency, nocturia, incomplete emptying, terminal dribbling, overflow or urge incontinence, and complete urinary retention.<br>3. Diagnosis is based primarily on digital rectal examination and symptoms; cystoscopy, transrectal ultrasonography, urodynamics, or other imaging studies may also be needed.<br>4. Treatment options include 5 alpha-reductase inhibitors, alpha-blockers, tadalafil, and surgery.<br>5. Use of alpha-adrenergic blockers (eg, terazosin, doxazosin, tamsulosin, alfuzosin), 5 alpha-reductase inhibitors (finasteride, dutasteride), or, if there is concomitant erectile dysfunction, the phosphodiesterase type 5 inhibitor tadalafil<br>6. Avoidance of anticholinergics, sympathomimetics, and opioids</div></div></div> </div> </div> </div> <script crossorigin=anonymous integrity=sha384-KJ3o2DKtIkvYIK3UENzmM7KCkRr/rE9/Qpg6aAZGJwFDMVNA/GpGFF93hXpG5KkN src=https://code.jquery.com/jquery-3.2.1.slim.min.js></script> <script crossorigin=anonymous integrity=sha384-vFJXuSJphROIrBnz7yo7oB41mKfc8JzQZiCq4NCceLEaO4IHwicKwpJf9c9IpFgh src=https://cdnjs.cloudflare.com/ajax/libs/popper.js/1.12.3/umd/popper.min.js></script> <script crossorigin=anonymous integrity=sha384-alpBpkh1PFOepccYVYDB4do5UnbKysX5WZXm3XxPqe5iKTfUKjNkCk9SaVuEZflJ src=https://maxcdn.bootstrapcdn.com/bootstrap/4.0.0-beta.2/js/bootstrap.min.js></script> <script crossorigin=anonymous integrity=sha384-pEQEqworOLIVB/Sf2Wwa1hyQ6OJEOnY0/IIIJDVJeAeURcs135rPsK+WdkVFJ0SF src=https://cdnjs.cloudflare.com/ajax/libs/anchor-js/4.1.0/anchor.min.js></script> <script id=inline>anchors.add('.question-text');</script> </body></html>